question_id,option_A,option_B,option_C,option_D,correct_answer,question_type
q_0000,"Thermal burns need to be cooled right away, ideally using clean running water.","In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syn- drome and intact TAAA requiring intervention, open repair is recommended over endovascu- lar repair.7-9","In patients with a BAV and a diameter of the aortic root, ascending aorta, or both of ≥4.0 cm, lifelong surveillance imaging of the aortic root and ascending aorta by TTE, CT, or MRI is not recommended, regardless of aortic diameter and rate of growth.",We recommend that epinephrine be administered for patients in cardiac arrest.,C,2
q_0001,"For patients who cannot undergo high-intensity statin therapy due to contraindications or intolerance, it is advised to use moderate-intensity statin therapy to achieve a 30% to 49% reduction in LDL-C levels, thereby lowering the risk of MACE.","In patients with AF, SDM with the patient is recom- mended to discuss rhythm- versus rate-control strategies (taking into consideration clinical presen- tation, comorbidity burden, medication profile, and patient preferences), discuss therapeutic options, and for assessing long-term benefits.1–3","In patients undergoing ablation for AF, the value of other endpoints beyond PVI such as noninducibility and ablation of additional anatomic ablation targets (eg, posterior wall sites, low voltage areas, complex fractionated electrograms, rotors) is uncertain.8–18","In patients with spontaneous ICH, it is not recommended to administer depression and anxiety screening tools in the postacute period to identify patients with poststroke depression and anxiety.",D,2
q_0002,The efficacy of VA-ECMO in treating poisoned patients experiencing cardiovascular collapse due to non-cardiogenic shock remains unproven.,"For patients with CCD without contraindications, engaging in low-intensity lifestyle activities, such as taking walking breaks at work, to decrease sedentary behavior (such as sitting time) is advisable to enhance functional capacity and lower cardiovascular risk, particularly for those with low levels of regular leisure-time physical activity.","In patients undergoing revascularization, decisions should disregard the patient’s preferences and goals, cultural beliefs, health literacy, and social determinants of health, and be made without collaboration with the patient’s support system.","For patients with CCD, it is advised that healthcare providers address the out-of-pocket expenses for medications when starting a new medication and at least once a year thereafter to prevent nonadherence due to cost.",C,2
q_0003,"For patients with a history of CABG and complex CAD, opting for CABG instead of PCI might be advisable if an IMA can serve as a conduit to the LAD.","In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome and intact TAAA requiring intervention, endovascular repair is recommended over open repair.","In patients with AF and stroke or TIA, with moderate to severe mitral stenosis or a mechanical heart valve, who are able to maintain a therapeutic INR level with warfarin, use of dabigatran, rivaroxaban, apixaban, or edoxaban is not recommended to reduce the risk of recurrent stroke.","In patients with acute type A aortic dissection undergoing aortic repair, an open distal anastomosis is not recommended as it does not improve survival or increase false-lumen thrombosis rates.",A,1
q_0004,"In patients with PAD, cilostazol should not be used to reduce restenosis after endovascular therapy for femoropopliteal disease.","In patients with AF undergoing cardioversion, thera- peutic anticoagulation should be established before cardioversion and continued for at least 4 weeks afterwards without interruption to prevent thromboembolism.2–7","For patients with an indication for AVR for whom a bioprosthetic valve is preferred but valve or vascular anatomy or other factors are not suitable for transfemoral TAVI, SAVR is not recommended.","In patients with AF in whom cardioversion is deferred due to LAA thrombus detected on precardioversion imaging, therapeutic anticoagulation should not be instituted, and cardioversion should proceed without repeating imaging.",B,1
q_0005,"In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is not recommended.",It is unreasonable for individuals with ocular exposure to industrial chemicals to adhere to local guidelines or recommendations from a poison center.,"In patients with CCD without previous MI or LVEF ≤50%, the use of beta-blocker therapy is beneficial in reducing MACE, even in the absence of another primary indication for beta-blocker therapy.","For patients with HCM, it is advised to conduct 24- to 48-hour ambulatory ECG monitoring during the initial assessment and periodically every 1 to 2 years to detect those at risk for SCD and to manage arrhythmias effectively.",D,1
q_0006,"In patients with acute type A aortic dissection undergoing surgical repair who require circulatory arrest, cerebral perfusion is not recommended to improve neurologic outcomes.","For patients with a mechanical SAVR or mitral valve replacement who are managed with a VKA and have an indication for antiplatelet therapy, addition of aspirin 75 to 100 mg daily may be considered when the risk of bleeding is low.26","Sodium bicarbonate can be appropriately used to manage life-threatening cardiotoxicity resulting from poisoning by sodium channel blockers, excluding tricyclic or tetracyclic antidepressants.","In patients undergoing valve repair or replacement with significant proximal CAD (≥70% reduction in luminal diameter in major coronary arteries or ≥50% reduction in luminal diameter in the left main coronary artery and/or physiologically significance), CABG is reasonable for selective patients.19,20",A,2
q_0007,"In patients with HCM who are deemed to be at high risk for developing AF based on the presence of risk factors or as determined by a validated risk score, and who are eligible for anticoagulation, extended ambulatory monitoring is not recommended to screen for AF as part of initial evaluation and annual follow-up.","For patients having elective endovascular repair of nonruptured AAA, it is advised to follow the manufacturer's usage guidelines.","In first-degree relatives of patients with HCM, both clinical screening (ECG and 2D echocar- diogram) and cascade genetic testing (when a pathogenic/likely pathogenic variant has been identified in the proband) should be offered.23,67,123,130–132","For patients with CCD, it is advised to use sublingual nitroglycerin or nitroglycerin spray for prompt short-term alleviation of angina or similar symptoms.",A,2
q_0008,"For pregnant women with mechanical prostheses who require a warfarin dose >5 mg/d to achieve a therapeutic INR, dose-adjusted LMWH should not be considered at any time during the 3 trimesters.",Flumazenil use can be harmful for patients with a heightened risk of seizures or dysrhythmias.,"In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it is not reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.",It is recommended for first aid providers to debride blisters associated with frostbite.,B,1
q_0009,"In patients with aSAH, the intraoperative use of mannitol or hypertonic saline is ineffective in reducing ICP and cerebral edema.","In patients with CCD on DAPT, the use of a PPI should not be considered as it is ineffective in reducing gastrointestinal bleeding risk.","In all patients, screening for cigarette smoking, use of other forms of tobacco, use of electronic nicotine delivery systems such as electronic cigarettes (e-cigarettes) and vapes, and environmental tobacco smoke exposure (secondhand smoke exposure) is ineffective in informing stroke risk and targeting cessation interventions.","It is reasonable to administer vasodilators (eg, nitrates, phentolamine, calcium channel blockers) for patients with cocaine-induced coronary vaso- spasm or hypertensive emergencies. Downloaded from http://ahajournals.org by on June 19, 2025",D,1
q_0010,"In women who are ≥65 years of age who have ever smoked, ultrasound screening for detection of AAA is not reasonable.","In patients with AF, the use of evidence-based decision aids should not be considered useful for guiding stroke reduction therapy treatment decisions, as it may not improve engagement, decisional quality, or patient satisfaction.","In patients with aSAH, avoid using evidence-based protocols and order sets to prevent standardization of care.","Nothing should be put in the mouth and no food, liquids, or oral medicines should be given to a person who is experiencing a seizure or who has decreased responsiveness after a seizure. Recommendation-Specific Supportive Text",D,1
q_0011,"In patients with PAD, coordination of care among clinicians to improve the management of PAD and comorbid conditions and to optimize patient outcomes is recommended. Functional Status and QOL","In patients with stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, the usefulness of clopidogrel alone, the combination of aspirin and dipyridam- ole, ticagrelor alone, or cilostazol alone for secondary stroke prevention is not well established. Risk Factor Management","When considering primary prevention of ICH, it is not advisable to incorporate MRI results demonstrating cerebral microbleed burden or cortical superficial siderosis in shared decision-making about stroke prevention treatment plans.","In patients with Turnery syndrome who are ≥15 years old and have an ASI of ≥2.5 cm/m2 plus risk factors for aortic dissection (Table 12), surgical intervention to replace the aortic root, ascending aorta, or both is reasonable.9,10",C,2
q_0012,"Avoid labeling chest pain as atypical, as it does not aid in identifying the cause and may be mistakenly seen as harmless. Rather, classify chest pain as cardiac, possibly cardiac, or noncardiac, as these terms more accurately reflect the potential underlying diagnosis.","For certain individuals with nonischemic cardiomyopathy, it is advisable to consider genetic counseling and testing to detect conditions that may inform treatment strategies for both the patients and their relatives.","In selected patients undergoing PCI, shorter- duration DAPT (1–3 months) is reasonable, with subsequent transition to P2Y12 inhibitor monotherapy to reduce the risk of bleeding events.1-4","In patients who have had an acute aortic dissection and IMH managed with medical therapy alone, surveillance imaging with a CT (or MRI) is not recommended after 1 month, 6 months, and 12 months, nor annually thereafter, even if stable.",D,2
q_0013,"In patients with stroke or TIA, provision of health information or advice about stroke prevention is essential; however, information or advice alone, in the absence of a behavioral intervention, is not an effective means to change modifiable, lifestyle-related risk factors in order to reduce future ischemic events.129,829,845","In patients with stroke or TIA and hyperlip- idemia, patients’ adherence to changes in lifestyle and the effects of LDL-C–lowering medication should be assessed by measure- ment of fasting lipids and appropriate safety indicators 4 to 12 weeks after statin initiation or dose adjustment and every 3 to 12 months thereafter, based on need to assess adher- ence or safety.214,215","In critically ill patients with severe AS, percutaneous aortic balloon dilation should not be considered as a bridge to SAVR or TAVI.","First aid providers should stay with the person having a seizure. Downloaded from http://ahajournals.org by on June 19, 2025",C,2
q_0014,"In men or women <65 years of age and who have multiple risk factors (Table 15) or a first-degree relative with AAA, ultrasound screening for AAA should not be considered.","In adults with moderate or low intake of long-chain omega-3 fatty acid, supplementation is not recom- mended to reduce the risk of a first stroke.92","In patients with aSAH, use of clinical scales (eg, the Hunt and Hess [HH] grade or World Federation of Neurosurgical Societies [WFNS] grade) is recom- mended to determine initial clinical sever- ity and predict outcome.28,29","For patients experiencing spontaneous ICH, it is advised to manage hypoglycemia (below 40–60 mg/dL or 2.2–3.3 mmol/L) to decrease mortality.",A,2
q_0015,"For patients with persistent stable chest pain and nonobstructive CAD and at least mild myocardial ischemia on imaging, it is not reasonable to consider invasive coronary function testing for diagnosing coronary microvascular dysfunction or enhancing risk stratification.","In pregnant women with HCM, general or epidural anesthesia is reasonable, with precautions to avoid hypotension.310","Patients with CCD should not receive individualized education on symptom management, lifestyle changes, and SDOH risk factors, as it does not improve knowledge or facilitate behavior change.","In patients hospitalized with worsening HF, participation in systems that allow benchmarking to performance measures is unreasonable and does not increase the use of evidence-based therapy or improve quality of care.",B,1
q_0016,"ICD should not be considered in select adult patients with HCM who have extensive LGE by contrast-enhanced CMR imaging or NSVT present on ambulatory monitoring, even if they lack major SCD risk factors or if the decision to proceed with ICD placement is uncertain.","For patients older than 65 needing AVR, opting for a bioprosthesis instead of a mechanical valve is advisable.","Patients with typical AFL who have undergone suc- cessful CTI ablation and have had AF previously detected before AFL ablation should receive ongoing oral anticoagulation postablation as indicated for AF.5,6","For patients who are alert and able to safely ingest food or fluids while experiencing cold stress or mild hypothermia, it is advised to offer high-calorie foods or beverages.",A,2
q_0017,Applying ice or cold packs can be considered for alleviating localized pain.,"For patients with nonruptured AAA who have a moderate to high risk during surgery and anatomy compatible with an FDA-approved fenestrated endovascular device, opting for endovascular repair instead of open repair is advisable to minimize the risk of perioperative complications.","In patients with STEMI in whom PCI is not feasible or successful, with a large area of myocardium at risk, emergency or urgent CABG can be effective as a reperfusion modality to improve clinical outcomes.23,24","Patients with AAS should not be treated to an SBP <120 mm Hg or to the lowest BP that maintains adequate end-organ perfusion, nor should they be targeted to a heart rate of 60 to 80 bpm.",D,2
q_0018,"If a dressing is placed, the first aid provider should not monitor the person for worsening of breathing/symptoms and should not loosen or remove the dressing if breathing worsens.","For patients with ACS, a home-based CR program can effectively substitute a center-based CR program to enhance functional status and quality of life.","In patients undergoing PCI within 24 hours after fibrinolytic therapy, a loading dose of 300 mg of clopidogrel, followed by daily dosing, is not recommended to reduce ischemic events.","In patients with GCA or Takayasu arteritis who are in remission, elective endovascular or open surgical intervention is not reasonable to treat aortic and branch vessel complications.",B,1
q_0019,"In patients with aSAH, an early multidisci- plinary team–based approach to treatment and rehabilitation is recommended to reduce LOS and identify discharge needs.231,440","Patients with heart failure should be managed by multidisciplinary teams to ensure the application of guideline-directed medical therapy, overcome self-care obstacles, lower the likelihood of future heart failure rehospitalizations, and enhance survival rates.","In patients with heparin-induced thrombocytopenia undergoing PCI, UFH should be used instead of bivalirudin or argatroban, despite the risk of thrombotic complications.","For patients having CABG, start aspirin (100–325 mg daily) within 6 hours after surgery and maintain it indefinitely to lower the risk of SVG closure and negative cardiovascular outcomes.",C,2
q_0020,"For patients who have not previously received a P2Y12 inhibitor and are undergoing PCI, administering intravenous cangrelor can be a reasonable option to decrease the risk of ischemic events during the procedure.","For patients with PAD and hypertension, it is advised to selectively use ACE inhibitors or angiotensin-receptor blockers to lower the risk of MACE.","For symptomatic patients with obstructive HCM in whom SRT is an option, mitral valve replace- ment should not be performed for the sole pur- pose of relief of LVOTO.236,237 *General eligibility criteria for septal reduction therapy: a) Clinical: Severe dyspnea or chest pain (usually NYHA functional class III or class IV), or occasionally other exertional symptoms (eg, syncope, near syncope), when attributable to LVOTO, that interferes with everyday activity or quality of life despite optimal medical therapy. b) Hemodynamic: Dynamic LVOT gradient at rest or with physiologic provocation with approximate peak gradient of ≥50 mm Hg, associated with septal hypertrophy and SAM of mitral valve. c) Anatomic: Targeted anterior septal thickness sufficient to perform the procedure safely and effectively in the judgment of the individual operator. †Comprehensive or primary HCM centers with demonstrated excellence in clinical outcomes for these procedures (Table 3 and Table 4). Downloaded from http://ahajournals.org by on June 19, 2025","In intermediate-high risk patients with stable chest pain who have pathological Q waves, symptoms or signs suggestive of heart failure, complex ventricular arrhythmias, or a heart murmur with unclear diagnosis, avoid using TTE for diagnosis of resting left ventricular systolic and diastolic ventricular function and detection of myocardial, valvular, and pericardial abnormalities.",D,2
q_0021,"For patients with a hip fracture waiting for surgical repair, epidural analgesia should not be considered to decrease the incidence of preoperative cardiac events.","In nonambulatory patients with spontaneous ICH, low-dose UFH or LMWH should not be used to reduce the risk for PE.","In patients with ischemic stroke or ASCVD, calculation of BMI is not recommended at the time of their event or annually thereafter, as it is unnecessary to screen for or classify obesity.","For patients with a bioprosthetic surgical valve, it is advisable to perform a TTE at 5 and 10 years post-implantation, followed by yearly evaluations, regardless of any changes in clinical condition.",D,1
q_0022,"In asymptomatic patients with a BAV who are at low surgical risk, have a diameter of the aortic sinuses or ascending aorta of 5.0 to 5.5 cm, and have no additional risk factors for dissection, operative intervention to replace the aortic sinuses and/or the ascending aorta should not be considered, even if the surgery is performed at a Comprehensive Valve Center.","In patients undergoing CABG, the usefulness of continuous intravenous insulin designed to achieve a target intraoperative blood glucose concentration <140 mg/dL is uncertain.4,15","In adults, screening for a history of endometriosis is not necessary to inform the risk of stroke.","In patients with severe secondary MR (Stages C and D), mitral valve surgery is not reasonable when CABG is undertaken for the treatment of myocardial ischemia.",B,1
q_0023,"In patients with ischemic stroke or TIA and extracranial vertebral artery stenosis who are having symptoms despite optimal medical treatment, the usefulness of stenting is not well established.378","Among individuals without a known history of AF, it is recommended that an initial AF diagnosis be made by a clinician using visual interpretation of the electrocardiographic signals, regardless of the type of rhythm or monitoring device.1–5","In patients with claudication who have had an adequate clinical response to GDMT (including structured exercise), revascularization is recommended.","In patients with HCM, adherence to the ACC/AHA primary prevention guideline is recommended to reduce risk of cardiovascular events.1",C,2
q_0024,"Patients with HF should receive care from multidisciplinary teams to facilitate the imple- mentation of GDMT, address potential barriers to self-care, reduce the risk of subsequent rehospitalization for HF, and improve survival.1–4","In patients with CCD who require revascularization for significant left main involvement associated with high-complexity CAD, PCI is recommended in preference to CABG to improve survival.","For patients with CCD, it is advised to evaluate BMI, optionally alongside waist circumference, during regular clinical follow-up.","For patients with Marfan syndrome, it is advisable to consider surgical replacement of the aortic root and ascending aorta when the ratio of maximal cross-sectional aortic root area (cm²) to patient height (m) is ≥10, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team.",B,2
q_0025,"For patients with atrial fibrillation who are eligible for anticoagulation and do not have moderate to severe rheumatic mitral stenosis or a mechanical heart valve, direct oral anticoagulants (DOACs) are preferred over warfarin to lower the risk of death, stroke, systemic embolism, and intracranial hemorrhage.","In patients with acute chest pain and myocardial injury who have nonobstructive coronary arteries on anatomic testing, CMR with gadolinium contrast is ineffective in distinguishing myopericarditis from other causes, including myocardial infarction and nonobstructive coronary arteries (MINOCA).","For patients with type 2 diabetes who have established cardiovascular disease or are at high risk for cardiovascular issues, SGLT2 inhibitors should be utilized to prevent heart failure-related hospitalizations.","In patients with PAD, management of diabetes should be coordinated among members of the health care team.",B,2
q_0026,"In patients with established, stable coronary artery disease and a low bleeding risk, the addition of ticagrelor to aspirin beyond 12 months for a period up to 3 years may not be beneficial to reduce the rate of ischemic stroke.","A first aid provider who encounters a person with suspected opioid overdose who is unresponsive and not breathing or not breathing normally should activate the emergency response system, provide high-quality CPR (compressions plus ventilation), and administer naloxone. Recommendation-Specific Supportive Text","For asymptomatic patients with severe AS and an abnormal exercise test, very severe AS, rapid progression, or an elevated BNP, TAVI is recommended in preference to SAVR.","In patients with an indication for AVR, the choice of prosthetic valve should ignore the patient’s values and preferences, and exclude discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.",B,1
q_0027,"For patients with obstructive HCM and acute hypotension who do not respond to fluid administration, intravenous phenylephrine (or other vasoconstrictors without inotropic activity), alone or in combination with beta-blocking drugs, is recommended.15","To worsen patient outcomes, it is advised that cardiac surgery and PCI programs avoid participating in state, regional, or national clinical data registries and do not receive periodic reports of their risk-adjusted outcomes, disregarding quality assessment and improvement strategies.","In patients with SAH from confirmed cerebral aneurysm(s), DSA should not be used to determine the optimal strategy for aneurysm intervention.","In women with a history of HF or cardiomyopathy, including previous peripartum cardiomyopathy, patient-centered counseling regarding contraception and the risks of cardiovascular deterioration during pregnancy should not be provided.",A,1
q_0028,"For patients with HCM and resting peak LVOT gradient <50 mm Hg, a TTE with provocative maneuvers is not recommended.","For patients diagnosed with large vessel vasculitis (LVV), it is advised to quickly assess the full aorta and its branch vessels using MRI or CT, optionally combined with 18F-FDG positron emission tomography (FDG-PET).","If a person with hypothermia with a decreased level of responsiveness is wearing damp (not saturated) clothing such as polyester fleece and cannot be immediately moved into a warm environment, it is unreasonable to initiate active rewarming through the damp clothing with the hypothermia wrap technique, using chemical heat blankets, plastic or foil layers, and insulative blankets.","For patients suspected to have HCM in whom echocardiography is inconclusive, CMR imaging is not indicated for diagnostic clarification.",B,1
q_0029,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is not reasonable.","In patients with an ischemic stroke or TIA who also have diabetes, achieving intensive glucose control (ie, HbA1c ≤7%) beyond the acute phase of the ischemic event is known to prevent recurrent stroke.","In patients with TIA in the setting of nonvalvular AF, it is not advisable to initiate anticoagulation immediately after the index event to reduce the risk of recurrent stroke.","For patients receiving MV TEER, it is appropriate to conduct NCS following a successful MV procedure when clinically warranted. Evidence indicates that NCS is safe within 30 days post-TAVI, if necessary.",D,1
q_0030,"It is advised to offer general education on preventive foot self-care to patients with PAD, as well as their family members and support persons.","Patients who have undergone revascularization should not be educated about CVD risk factors and their modification, as it does not help reduce cardiovascular events.","For patients with HCM, TEE should not be used if TTE is inconclusive in clinical decision-making regarding medical therapy, or in situations such as planning for myectomy, exclusion of subaortic membrane or MR secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.","In patients with STEMI treated with fibrinolytic therapy, delaying angiography beyond 24 hours or avoiding PCI is recommended, as it does not reduce the rates of death or MI.",A,1
q_0031,"For patients with TAA, irrespective of the cause and if no contraindications exist, adding ARB therapy to beta-blocker treatment is a sensible approach to reach target blood pressure goals.","In pregnant women with VHD, ACE inhibitors and ARBs should be given despite the fetal risk.","In patients with only ST-segment depression, fibrinolytic therapy should be administered even when true posterior STEMI is not suspected, disregarding the risk of hemorrhagic stroke and major noncerebral bleeding.","In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) should not be considered to reduce dabigatran concentration.",A,1
q_0032,"In patients with hyperthyroidism and AF who have an elevated risk of stroke based on a standard clinical risk score, anticoagulation is not recommended until thyroid function has returned to normal and sinus rhythm can be maintained.","In patients with thoracic or abdominal aortic aneurysms whose BP is adequately con- trolled, it is reasonable to encourage 30 to 60 minutes of mild-to-moderate intensity aerobic activity at least 3 to 4 days per week.5,6","In men or women <65 years of age and who have multiple risk factors (Table 15) or a first-degree relative with AAA, ultrasound screening for AAA should not be considered.",Patients with ALI should not be evaluated on an emergency basis by a clinician with sufficient experience to assess limb viability and implement appropriate therapy.,B,1
q_0033,"For patients with a BAV, whether they show symptoms or not, surgical replacement of the aortic sinuses and/or ascending aorta is advised when the diameter exceeds 5.5 cm.","In patients with stroke or TIA and extracranial carotid or vertebral artery dissection who have recurrent events despite antithrombotic therapy, endovascular therapy should not be considered to prevent recurrent stroke or TIA.","For patients with CCD, it is not recommended to engage in an exercise regimen, including ≥150 minutes/wk of moderate-intensity aerobic activities or ≥75 minutes/wk of higher-intensity aerobic activities, as it does not improve functional capacity and QOL, nor does it reduce hospital admission and mortality rates.","In patients with HF, a cardiac rehabilitation program is not useful for improving functional capacity, exercise tolerance, or health-related QOL.",A,1
q_0034,"In patients with GCA who have evidence of active aortitis, tocilizumab is not recommended as adjunctive therapy to glucocorticoids, and methotrexate should not be considered as an alternative.","For patients with HCM receiving an ICD, it is appropriate to consider dual-chamber ICDs for those requiring atrial or atrioventricular sequential pacing due to bradycardia or conduction issues, or to alleviate symptoms of obstructive HCM, particularly in individuals over 65 years old.","In patients with chronic severe secondary MR and HF with reduced LVEF, a cardiologist expert in the management of patients with HF and LV systolic dysfunction should be the primary MDT member responsible for implementing and monitoring optimal GDMT.9,12","For a person with evidence of smoke inhalation injury such as facial burns, difficulty breathing, singed nasal hairs, or soot around the nose or mouth, EMS should be activated.",A,2
q_0035,"Patients with IE should not be evaluated or managed with consultation from a multispecialty Heart Valve Team, and should exclude an infectious disease specialist, cardiologist, cardiac surgeon, cardiac anesthesiologist for surgically managed patients, and a neurologist for patients with neurological events.","For patients experiencing ACS with confirmed hypoxia (oxygen saturation below 90%), it is advised to administer supplemental oxygen to raise oxygen saturation levels to 90% or higher, enhancing myocardial oxygen supply and reducing anginal symptoms.","In all patients with Takayasu arteritis, non- biological disease-modifying anti-rheumatic drugs (DMARD) should be given in combina- tion with glucocorticoids.7,15,16","For patients with spontaneous intracerebral hemorrhage (ICH) who have a negative catheter intra-arterial digital subtraction angiography (DSA) and lack a clear microvascular diagnosis or identifiable structural lesion, it might be advisable to conduct a follow-up catheter intra-arterial DSA 3 to 6 months after the ICH onset to detect any vascular lesion that was initially hidden.",A,2
q_0036,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, stress PET/SPECT MPI, CMR imaging, or stress echocardiography is not recommended to detect the presence and extent of myocardial ischemia, estimate risk of major adverse cardiovascular events (MACE), or guide therapeutic decision-making.","In patients with a BAV who are undergoing surgical aortic valve repair or replacement, and who have a diameter of the aortic root or ascending aorta of ≥4.5 cm, concomitant replacement of the aortic root, ascending aorta, or both is reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,6",Organ donation should be considered in all patients resuscitated from cardiac arrest before planned withdrawal of life-sustaining therapies.,"In patients with known or suspected aortic disease, episodic and cumulative ionizing radi- ation doses should be kept as low as feasible while maintaining diagnostic image quality.5-7",A,2
q_0037,"For patients with CAD undergoing elective NCS, management of perioperative antiplatelet therapy and timing of surgery should be determined by a single clinician without considering the risks of bleeding, thrombosis, or consequences of delayed surgery.","In patients with cardiogenic shock, management by a multidisciplinary team experienced in shock is not reasonable.","In patients with CCD with complex 3-vessel disease or for whom the optimal treatment strategy is unclear, it is not recommended to use a Heart Team approach that includes representatives from interventional cardiology and cardiac surgery to improve patient outcomes.",It is advisable to perform repeated or continuous EEG monitoring for patients who remain unresponsive to commands following ROSC.,D,1
q_0038,"In patients with an infected prosthetic aor- tic graft and either an extensive perigraft abscess or an infection caused by methicillin- resistant S. aureus, Pseudomonas aeruginosa, or a multidrug-resistant microorganism, or who have undergone in situ reconstruction, lifelong suppressive oral antimicrobial therapy may be considered after the initial course of therapy.14,15,18,19","For patients with CCD, it is advisable to limit exposure to air pollution to lower the risk of cardiovascular events.","For patients with HCM, participation in vigorous* recreational activities is reasonable after an annual comprehensive evaluation and shared decision-making with an expert professional who balances potential benefits and risks, with this process being repeated annually.4,5,7,8","For patients with AF, recommending caffeine abstention to prevent AF episodes is beneficial, even if it does not reduce symptoms in patients who report caffeine triggers or worsens AF symptoms.",D,2
q_0039,"If pediatric stroke is suspected, EMS should not be activated, and the person should not be transported to an ED.","In patients with ruptured AAA, permissive hypotension can be beneficial to decrease the rate of bleeding.1,3,10-12","For patients with atrial fibrillation and conditions linked to a very high risk of thromboembolic events (over 5% annually), like rheumatic heart disease or a mechanical heart valve, it is advisable to restart anticoagulation within 1-2 weeks after an intracerebral hemorrhage to lower the risk of thromboembolic events.","For transgender women and gender-diverse individuals using estrogens for gender affirmation, assessing and adjusting risk factors may help lower the likelihood of stroke.",A,2
q_0040,"LA appendage occlusion, exclusion, or amputation may be detrimental for patients undergoing valvular surgery who do not have atrial arrhythmias.","In adults without prior CVD and who are at high or intermediate CVD risk, a Mediterranean diet is recommended to reduce the risk of incident stroke.86,87","For patients with STEMI receiving fibrinolytic therapy, it is advised to conduct early angiography within 2 to 24 hours with the aim of performing PCI to lower the incidence of death or myocardial infarction.","TTE is not recommended for patients with mixed valve disease to assess the etiology, severity, and pathophysiological impact.",D,2
q_0041,"In the event of a suspected stroke, promptly activate the EMS system.","In patients after ACS, low-dose colchicine should not be considered to reduce the risk of MACE.","In the general population, validated multivariable risk scores are not useful for estimating the subsequent risk of incident HF.","If a person experiences anaphylaxis due to a bee, wasp, or hornet sting and an epinephrine autoinjector is available, the person should not self-administer the autoinjector.",A,1
q_0042,"For patients with AF receiving warfarin, a target INR outside the range of 2 to 3 is recommended, along with neglecting drug-drug interactions, inconsistency in vitamin K dietary intake, and avoiding routine INR monitoring, which will not improve time in therapeutic range and will increase risks of preventable thromboembolism or major bleeding.",We recommend against administering high-dose insulin for hypotension due to CCB poisoning.,"For patients exhibiting angina symptoms, objective signs of ischemia, reduced left ventricular systolic function, a history of coronary artery disease, or coronary risk factors (such as men over 40 and postmenopausal women), invasive coronary angiography should be performed prior to valve intervention.","In patients with VHD who meet indications for valvular intervention based on clinical presentation and severity of regurgitation, the need for valvular intervention should not be considered before elective elevated-risk NCS, even if it increases perioperative risk.",C,1
q_0043,"For patients with AF in whom measuring serum digoxin levels is indicated, it is reasonable to target levels <1.2 ng/mL.3–6","In patients with aSAH, it is reasonable to choose the MoCA over the MMSE to identify cognitive impairment.438,466,467",Prophylactic hemodynamic augmentation should be avoided in patients with aSAH who are at risk of DCI to prevent iatrogenic harm.,"In patients with VKA-associated spontaneous ICH, intravenous vitamin K should not be administered after coagulation factor replacement to prevent later increase in INR and subsequent HE.",D,2
q_0044,"When performing genetic testing in an HCM proband, the initial tier of genes tested should exclude genes with strong evidence to be disease-causing in HCM.","In patients hospitalized with HF, prophylaxis for VTE is not recommended to prevent venous thromboembolic disease.","In vulnerable patient populations at risk for health disparities, HF risk assessments and multidisciplinary management strategies should target both known risks for CVD and social determinants of health, as a means toward elimination of disparate HF outcomes.1–6","In patients with large vessel vasculitis (LVV), delaying evaluation of the entire aorta and branch vessels with MRI or CT, and avoiding the use of 18F-FDG positron emission tomography (FDG-PET), is recommended.",C,1
q_0045,"For patients with TR, TTE is recommended to assess the presence and severity of TR, identify its cause, evaluate the dimensions of the right-sided chambers and inferior vena cava, assess RV systolic function, estimate pulmonary artery systolic pressure, and identify any related left-sided heart disease.","For newborns at or beyond 34 weeks' gestation who are full-term or late preterm and do not need resuscitation, intact cord milking has not been shown to offer advantages over delayed cord clamping of 30 seconds or more.","In patients with AF on DOAC and scheduled to undergo an invasive procedure or surgery that cannot be performed safely on uninterrupted anticoagulation, the timing of interruption of DOAC should not be guided by the specific agent, renal function, or the bleeding risk of the procedure.","In patients with CCD receiving statin therapy, adding niacin,36,37 or fenofibrate38 or dietary supplements containing omega-3 fatty acids, are not beneficial in reducing cardiovascular risk.39–41 *Modified from the 2018 AHA/ACC/Multisociety Guideline on the Manage- ment of Blood Cholesterol.42",C,2
q_0046,"In patients with a BAV and a diameter of the aortic root, ascending aorta, or both of ≥5.5 cm, surgery to replace the aortic root, ascending aorta, or both is recom- mended.1-3","In patients with spontaneous ICH, continu- ous cardiac monitoring for the first 24 to 72 hours of admission is reasonable to monitor for cardiac arrhythmias and new cardiac ischemia.266–268","For patients with CCD who experience lifestyle-limiting angina despite GDMT and have significant coronary artery stenoses that can be treated with revascularization, revascularization is advised to alleviate symptoms.","In patients with functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease with inadequate response to GDMT (including structured exercise), surgical revascularization is unreasonable if perioperative risk is acceptable and technical factors suggest advantages over endovascular approaches.",D,2
q_0047,"Participation in quality improvement programs, including patient registries that provide bench- mark feedback on nationally endorsed, clinical practice guideline–based quality and perfor- mance measures can be beneficial in improving the quality of care for patients with HF.1,2,5,6","For pilot aircrew with a diagnosis of HCM, it is not reasonable to follow Federal Aviation Administration guidelines that permit consideration of multicrew flying duties, even if they are asymptomatic, are deemed low risk for SCD, and can complete a maximal treadmill stress test at 85% peak heart rate.","In patients with grade 2 BTTAI (Figure 23) and without high-risk imaging features (Table 32), nonoperative management and follow-up surveillance imaging may be ­reasonable.3,4","For patients who have experienced a stroke or TIA, it is advised to assess and address social determinants of health, such as literacy, language skills, medication costs, food insecurity, housing, and transportation challenges, in order to manage stroke risk factors and minimize healthcare disparities.",B,2
q_0048,"In patients with spontaneous ICH without depression, fluoxetine therapy is effective to enhance poststroke functional status.","In patients who are at low risk for perioperative cardiovascular events, have adequate functional capacity with stable symptoms, or who are undergoing low-risk procedures, routine CCTA before NCS is recommended due to potential benefit.","In patients with HCM, genetic testing is bene- ficial to elucidate the genetic basis to facilitate the identification of family members at risk for developing HCM (cascade testing).119–122","In patients with CLTI undergoing minor amputation (ie, inframalleolar level), it is not recommended to implement a customized program of follow-up care, including local wound care, pressure offloading, serial evaluation of foot biomechanics, and use of therapeutic footwear, as these measures are unnecessary for preventing wound recurrence.",C,1
q_0049,"In patients with intermediate- to elevated-risk congenital heart disease (CHD) lesions (Table 10) undergoing elective NCS, preoperative con­ sultation with an adult congenital heart disease (ACHD) specialist is recommended before the surgery.*1–4 *Modified from the “2018 AHA/ACC Guideline for Management of ACHD.”5 Table 10.  Adult Congenital Heart Disease Risk Stratification Before Noncardiac Surgery Risk Anatomy Functional/Hemodynamic Status Low Risk Patients with isolated small CHD lesions Patients with repaired CHD lesion with no residual shunt Patients with bicuspid aortic valve disease and aortopathy NYHA class I functional status, normal exercise capacity No chamber enlargement on imaging No residual shunt No PAH No arrhythmias Intermediate risk Unrepaired moderate-large shunts (ASD, VSD, PDA, AVSD) Repaired CHD with moderate to large residual shunt (ASD, VSD, PDA, AVSD) Obstructive left-sided lesions (congenital mitral stenosis, subaortic stenosis, supravalvular aortic stenosis, coarctation of aorta) except the ones described as low risk Obstructive right-sided lesion (pulmonary stenosis, branch pulmonary stenosis, repaired tetralogy of Fallot) Ebstein anomaly (disease spectrum includes mild, moderate, and severe variations) Anomalous coronary artery arising from the pulmonary artery Anomalous aortic origin of a coronary artery from the opposite sinus, especially with an interarterial or intramural course NYHA class II-IV functional status Limited exercise capacity Presence of residual shunt Presence of PAH Presence of cardiac chamber enlargement Significant valvular dysfunction (more than mild in severity) Arrhythmias requiring treatment Presence of HF Elevated risk Single-ventricle patients (palliated or status post Fontan procedure), unrepaired or palliated cyanotic CHD, double outlet right ventricle, pulmonary atresia, truncus arteriosus, TGA (classic or d-TGA; CCTGA or l-TGA), interrupted aortic arch NYHA class II-IV functional status Limited exercise capacity Significant valvular dysfunction (more than mild in severity) Arrhythmias requiring treatment Presence of PAH Presence of HF","For patients with heart failure who are admitted showing signs of substantial fluid overload, immediate treatment with intravenous loop diuretics is advised to alleviate symptoms and decrease morbidity.","In ambulatory patients with unexplained dyspnea, CPET is not reasonable to evaluate the cause of dyspnea.","For patients suspected of having moderate or severe valvular regurgitation, it is advised to perform preoperative echocardiography prior to elective non-cardiac surgery to assist in perioperative management.",C,2
q_0050,"For patients with a surgical or transcatheter prosthetic valve, as well as those who have undergone valve repair, it is advised to conduct an initial postprocedural TTE study to assess valve hemodynamics and ventricular function.","For intermediate-high risk patients with stable chest pain and no known CAD, stress imaging (stress echocardiography, PET/SPECT MPI or CMR) is effective for diagnosis of myocardial ischemia and for estimating risk of MACE.8,13-35","Women with mechanical heart valves who cannot maintain therapeutic anticoagulation with frequent monitoring should be counseled against pregnancy.7,8,10–15","In patients with aortic root/ascending aortic aneurysms or aortic dissection, in the absence of either a known family history of TAD or pathogenic/likely pathogenic variant, screening aortic imaging of first-degree relatives is not recommended.",D,2
q_0051,"In patients with IE and major ischemic stroke, delaying valve surgery for at least 4 weeks may be considered for patients with IE and major ischemic stroke or intracranial hemorrhage if the patient is hemodynamically stable.460,468","In patients with diabetes and high cardiovascular risk or established CVD and hemoglobin A1c ≥7%, treatment with a GLP-1 receptor agonist is ineffective in reducing the risk of stroke.","In adults who qualify for treatment with lipid-lowering therapy according to the 2019 ACC/AHA guideline on the primary prevention of CVD (e.g., 20–75 years of age with LDL cholesterol [LDL-C] level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 risk enhancers), treatment with a statin is not recommended to reduce the risk of a first stroke.",Women with mechanical heart valves who cannot maintain therapeutic anticoagulation with frequent monitoring should be encouraged to pursue pregnancy.,A,1
q_0052,"In patients with history of ischemic stroke or TIA and a mechanical aortic valve, anti- coagulation with higher-intensity warfarin to achieve an INR of 3.0 (range, 2.5–3.5) or the addition of aspirin (75–100 mg/d) can be beneficial to reduce the risk of thromboem- bolic events.","In patients undergoing a transcatheter procedure for paravalvular prosthetic regurgitation, 3D TEE is recommended for intraprocedural guidance.4–7","In patients with BAAI, treatment with either endovascular or open repair is reasonable and depends on degree of injury, aortic anatomy, and the patient’s overall clinical status.1-4","In patients with IE who have a change in clinical signs or symptoms (eg, new murmur, embolism, persistent fever, HF, abscess, or atrioventricular heart block) and in patients at high risk of complications (eg, extensive infected tissue, large vegetation on initial echocardiogram, or staphylococcal, enterococcal, or fungal infections), TTE and/or TEE are not recommended for reevaluation.",D,2
q_0053,First aid providers should leave the person having a seizure unattended.,"In patients undergoing CABG, preoperative beta blockers are definitively recommended for the prevention of acute postoperative myocardial ischemia, stroke, AKI, or ventricular arrhythmia.","In patients with diabetes who have multivessel CAD amenable to PCI and an indication for revascularization and are poor candidates for surgery, PCI should not be used to reduce long-term ischemic outcomes.","For patients with BAAI, the routine use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for controlling hemorrhage is uncertain and may be harmful in certain situations.",D,1
q_0054,"In adults with migraine with aura who desire contraception, combined hormonal contraception is recommended despite the increased risk of ischemic stroke, rather than progestin-only or nonhormonal forms.","In patients with recurrent acute chest pain without evidence of a cardiac or pulmonary cause, evaluation for gastrointestinal causes is not reasonable.","For hemodynamically stable pregnant women with obstructive left-sided mechanical valve thrombosis, it is reasonable to manage with slow-infusion, low-dose fibrinolytic therapy.26","For patients with IE and major ischemic stroke with extensive neurological damage or intracranial hemorrhage, if the patient is hemodynamically stable, immediate valve surgery should be considered without delay.",C,1
q_0055,"In patients with a mechanical complication of ACS, short-term MCS devices are not recommended for hemodynamic stabilization as a bridge to surgery.","In patients with nonvalvular atrial fibrillation (AF) and spontaneous ICH, the resumption of anti- coagulation to prevent thromboembolic events and reduce all-cause mortality may be consid- ered based on weighing benefit and risk.590–595","For diagnosing patients with suspected infective endocarditis, the Modified Duke Criteria should be applied (refer to Tables 24 and 25).","In patients with ACS, glycoprotein IIb/IIIa inhibitors should not be administered routinely due to lack of ischemic benefit and increased risk of bleeding.3–5 *Adapted from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”6",A,2
q_0056,"For patients experiencing recurrent atrial fibrillation outside of a hospital, using a single oral dose of flecainide or propafenone alongside an atrioventricular nodal blocking agent is a reasonable pharmacological cardioversion strategy, provided it has been previously tested in a monitored environment.","For patients having a transcatheter procedure to address paravalvular prosthetic regurgitation, it is advised to use 3D TEE for guidance during the procedure.","In asymptomatic patients with moderate or greater degrees of AR and normal LV systolic function, it is not reasonable to perform elective noncardiac surgery.","For patients who are ≥16 years of age with HCM, it is reasonable to obtain echocardiography-derived left atrial diameter and maximal LVOT gradient to aid in calculating an estimated 5-year sudden death risk that may be useful during shared decision-making for ICD placement (Table 8).2,22",C,2
q_0057,"In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is recommended.1-4","For patients with suspected ACS, a 12-lead ECG must be obtained and analyzed within 10 minutes of initial medical contact to detect those with STEMI.","For patients with PAD, whether they have undergone revascularization or not, it is advised to conduct regular follow-up appointments that include evaluating limb symptoms and functional status, checking lower extremity pulses and foot health, and monitoring the management of risk factors.","In patients with previous or current symptoms of chronic HFrEF who are intolerant to ACEi because of cough or angioedema and when the use of ARNi is not feasible, the use of ARB is not recommended to reduce morbidity and mortality.",D,2
q_0058,"For patients undergoing open thoracic aorta repair without remaining aortopathy, follow-up imaging using CT or MRI is recommended.","In asymptomatic patients with moderate or greater degrees of AR and normal LV systolic function, it is not reasonable to perform elective noncardiac surgery.","In women with CCD, continuation of statin use dur- ing pregnancy may be considered.6","For patients scheduled for elective high-risk surgery with cardiovascular risk factors for perioperative complications and a recent history of poorly controlled hypertension (SBP ≥180 mm Hg or DBP ≥110 mm Hg prior to the surgery day), postponing the surgery might be considered to lower the risk of perioperative complications.",B,2
q_0059,"In patients with CCD, clinical follow-up less frequently than annually is not recommended to assess for symptoms, change in functional status, adherence to and adequacy of lifestyle and medical interventions, and monitoring for complications of CCD and its treatments.","Pacemaker-dependent patients with a transvenous ICD undergoing surgery above the umbilicus with anticipated EMI should not have the device reprogrammed; if the patient is not pacemaker-dependent, then neither reprogramming nor a magnet placed on the generator should be used to inhibit tachytherapies or inappropriate shocks.","In patients with acute onset of severe headache, delaying diagnostic workup and evaluation is recommended, risking undiagnosed aSAH and increasing morbidity and mortality.","For patients with a BAV undergoing surgical repair or replacement of the aortic valve, it is advisable to also replace the aortic root, ascending aorta, or both if the diameter is ≥4.5 cm, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team.",D,1
q_0060,Patients who do not quickly respond to initial shock interventions may be referred to facilities capable of offering temporary mechanical circulatory support to enhance treatment.,"For women with clinically stable HCM who wish to become pregnant, it is unreasonable to advise that pregnancy is generally safe, as it should not be part of a shared discussion regarding potential maternal and fetal risks, nor should GDMT be initiated.","For children aged 2 to 16 with SCD who have normalized mean flow velocities and no intracranial stenosis, switching from transfusion to hydroxyurea therapy may be considered to prevent stroke.","For critically ill patients with severe aortic stenosis, percutaneous aortic balloon dilation can be considered as an interim step before SAVR or TAVI.",B,2
q_0061,"For pregnant women with mechanical prostheses who require >5 mg/d of warfarin to achieve a therapeutic INR, avoid using dose-adjusted LMWH.",The person having the seizure should be restrained.,"In patients not at increased risk of PAD and without history or physical examination findings suggestive of PAD, screening for PAD with the ABI is recommended.","Patients with suspected chronic symptomatic PAD (ie, exertional nonjoint-related leg symptoms) and normal or borderline resting ABI (>0.90 and ≤1.40, respectively) should undergo exercise treadmill ABI testing to evaluate for PAD.18,19",D,1
q_0062,"For patients with nonobstructive HCM and preserved EF, the effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in alleviating symptoms such as angina and dyspnea remains uncertain.","In patients with spontaneous ICH, it is reason- able to lower BP to an SBP of 130 mm Hg and diastolic BP (DBP) of 80 mm Hg for long- term management to prevent hemorrhage recurrence.581,582","For patients with suspected infective endocarditis, it is advised to use transthoracic echocardiography to detect vegetations, evaluate the hemodynamic severity of valve lesions, assess ventricular function and pulmonary pressures, and identify any complications.","In patients with noncardioembolic ischemic stroke or TIA, oral anticoagulation is indicated in preference to antiplatelet therapy to increase the risk of recurrent ischemic stroke and other cardiovascular events while maximizing the risk of bleeding.",D,2
q_0063,"In patients with PAD who are on maximally tolerated statin therapy and have an LDL-C level of ≥70 mg/dL, it is reasonable to add ezetimibe therapy.1,7","For symptomatic patients with paroxysmal or persistent AF who are undergoing valvular surgery, surgical pulmonary vein isolation or a maze procedure can be beneficial to reduce symptoms and prevent recurrent arrhythmias.1,2,12–15","In patients with suspected AF-induced cardiomyopathy or refractory HF symptoms undergoing pharmacological rate-control therapy for AF, a less strict rate-control strategy (target heart rate ≥80 bpm at rest and ≥110 bpm during moderate exercise) may be reasonable.","In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have significant CAD, CABG is recommended with a goal of reducing ischemic events.1-11",C,2
q_0064,"Patients with AF with rapid anterograde conduction (preexcited AF), and hemodynamic instability should not be treated with electrical cardioversion.","For patients experiencing cold stress or mild hypothermia who are alert and can safely consume oral food or fluids, it is not recommended to provide high-calorie foods or drinks.","In patients with suspected ACS with an initial hs-cTn or cTn that is nondiagnostic, do not repeat measurements after the initial sample collection within 1 to 2 hours for hs-cTn or within 3 to 6 hours for conventional cTn assays.","In patients with IE who present with recurrent emboli and persistent vegetations despite appropriate antibiotic therapy, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is reasonable.53,61–66",D,1
q_0065,"In patients with aSAH who have undergone aneurysm repair, follow-up cerebrovascular imaging is not recommended, as it is unnecessary to identify recurrence or regrowth of the treated aneurysm, changes in another known aneurysm, or development of de novo aneurysm(s) that may require further treatment.","Among patients with ACS undergoing PCI who have not received a P2Y12 inhibitor, intravenous cangrelor should not be considered to reduce periprocedural ischemic events.","For patients with obstructive CAD and stable chest pain, it is recommended to optimize GDMT.1-3","In patients with rheumatoid arthritis, statin treatment should not be considered to reduce major adverse cardiovascular events, including stroke.",C,1
q_0066,"For patients with CCD, it is advised to evaluate BMI, optionally alongside waist circumference, during regular clinical follow-up.","In patients with AF with rapid ventricular response, digoxin should not be considered for acute rate control, even if beta blockers and nondihydropyridine calcium channel blockers are ineffective or contraindicated.","For patients who have stable chest pain with previous coronary revascularization, CCTA is not reasonable to evaluate bypass graft or stent patency (for stents ≥3 mm).","In patients with a previous acute aortic dissection and IMH, whether initially treated medically or with intervention, who have chronic residual TAD and an aneurysm with a total aortic diameter of ≥5.5 cm, elective thoracic aortic repair is not recommended.",A,1
q_0067,"In patients with stroke symptoms attributable to potential spontaneous ICH, immediate activation of the emergency response system (9-1-1 in North America) is recommended to reduce time to diagnosis and treatment.32,42","In patients with symptomatic HF, clinical factors indicating the presence of advanced HF should not be sought via the history and physical examination.","For high-risk patients experiencing acute chest pain with positive troponin levels, where obstructive CAD has been ruled out by CCTA or ICA, CMR or echocardiography may be useful in identifying other diagnoses.","For patients with TAA who are cigarette smokers, it is advised to pursue smoking cessation.",B,2
q_0068,"In patients with AF, rhythm-control strategies are not useful in reducing the likelihood of developing dementia or worsening cardiac structural abnormalities.","Pregnant women with a mechanical prosthesis should be monitored in a tertiary-care center with a dedicated MDT of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.1–3","In patients with an infected prosthetic aor- tic graft and either an extensive perigraft abscess or an infection caused by methicillin- resistant S. aureus, Pseudomonas aeruginosa, or a multidrug-resistant microorganism, or who have undergone in situ reconstruction, lifelong suppressive oral antimicrobial therapy may be considered after the initial course of therapy.14,15,18,19","In patients with acute, severe hemodynamic instabil­ ity and cardiopulmonary dysfunction undergoing urgent or emergency NCS, temporary MCS devices may be used preemptively or as rescue therapy.1–5",A,2
q_0069,"In patients with TAA and an average systolic BP (SBP) of ≥130 mm Hg or an average diastolic BP (DBP) of ≥80 mm Hg, the use of antihypertensive medications is not recommended to reduce risk of cardiovascular events.","For patients with AF receiving DOACs, it is not necessary to manage drug interactions for those receiving concomitant therapy with interacting drugs, including CYP3A4 and/or p-glycoprotein inhibitors or inducers.","Do not place anything in the mouth or provide food, drinks, or oral medications to someone having a seizure or who is less responsive following a seizure.","In patients with angina but no anatomic or physiological criteria for revascularization, either CABG or PCI should be performed.",C,1
q_0070,"In patients receiving VKA anticoagulation at the time of IE diagnosis, continuation of VKA anticoagulation should be maintained without consideration for temporary discontinuation.","ICD should not be considered in select adult patients with HCM who have extensive LGE by contrast-enhanced CMR imaging or NSVT present on ambulatory monitoring, even if they lack major SCD risk factors or if the decision to proceed with ICD placement is uncertain.","In patients with spontaneous ICH and cogni- tive impairment, treatment with cholinesterase inhibitors or memantine might be considered to improve cognitive outcomes.519–521","In patients with BAV, CMR angiography or CT angiography is not indicated even when morphology of the aortic sinuses, sinotubular junction, or ascending aorta cannot be assessed accurately or fully by echocardiography.",C,1
q_0071,A person with signs and symptoms of a concus- sion should be immediately removed from activity (play/sports) and not allowed to return to activity until evaluated by a health care professional.,"In patients with aSAH, allowing intraoperative hyperglycemia and hypoglycemia during aneurysm surgery is reasonable to improve outcomes.","In appropriate patients with symptomatic AF and HFpEF with reasonable expectation of benefit, catheter ablation can be useful to improve symptoms and improve QOL.14,15","For patients with low risk of perioperative cardiovascular events, sufficient functional capacity with stable symptoms, or those undergoing low-risk procedures, routine preoperative stress testing before non-cardiac surgery is not advised, as it offers no benefit. Poor functional capacity is defined as less than 4 METs or a DASI score of 34 or lower.",B,2
q_0072,"For nonambulatory patients experiencing spontaneous ICH, starting low-dose UFH or LMWH prophylaxis 24 to 48 hours after the onset of ICH might be advisable to balance the prevention of thrombosis against the risk of HE.","For patients experiencing spontaneous ICH, it is advised to manage hypoglycemia (below 40–60 mg/dL or 2.2–3.3 mmol/L) to decrease mortality.","In women who are ≥65 years of age who have ever smoked, ultrasound screening for detection of AAA is not reasonable.","In patients with HCM, genetic counseling by an expert in the genetics of cardiovascular disease is recommended so that risks, benefits, test results, and their clinical significance can be reviewed and discussed with the patient in a shared decision-making process.1–3,15 Downloaded from http://ahajournals.org by on June 19, 2025",C,2
q_0073,"For patients with severe primary MR who require surgery, mitral valve repair is advised over replacement when the MR is due to degenerative disease, provided a successful and lasting repair can be achieved.","For patients with isolated PAU who show no symptoms but present high-risk imaging characteristics (Table 31), elective repair can be contemplated.","For severely symptomatic patients with obstructive HCM, SRT in eligible patients should not be considered as an alternative to escalation of medical therapy, regardless of shared decision-making or the risks and benefits of all treatment options.","For patients diagnosed with large vessel vasculitis (LVV), it is advised to quickly assess the full aorta and its branch vessels using MRI or CT, optionally combined with 18F-FDG positron emission tomography (FDG-PET).",C,2
q_0074,"In adult patients with aSAH, screening and intervention for depression, anxiety, and sexual dysfunction are not recommended to improve long-term outcomes.","In all patients who present with acute chest pain regardless of the setting, an ECG should be acquired and reviewed for STEMI within 10 minutes of arrival.1-3,6,7,10","In selected hemodynamically stable patients with STEMI and low-complexity multivessel disease, PCI of a non-infarct artery stenosis should not be considered at the time of primary PCI to reduce cardiac event rates.","In patients with PAD, it is unreasonable to refer to a footcare specialist for ongoing preventive care and longitudinal surveillance.",B,1
q_0075,"For patients with HCM, the value of genetic testing in evaluating the risk of SCD remains unclear.","For certain patients with HFpEF, MRAs can be considered to reduce hospital admissions, especially in those with LVEF at the lower range of this category.","In patients with nonruptured AAA and a high perioperative risk, EVAR is reasonable to reduce the risk of 30-day morbidity, mortality, or both.9,10","In patients with IE and an indication for surgery who have suffered a stroke but have no evidence of intracranial hemorrhage or extensive neurological damage, delay the operation.",D,2
q_0076,"In patients with spontaneous ICH, avoiding CT angiography (CTA) within the first few hours of ICH onset is advisable to prevent identifying patients at risk for subsequent HE.","In asymptomatic women with severe valve disease (Stage C1) who are considering pregnancy, exercise testing is reasonable before pregnancy for risk assessment.3–5,11,13–15",Adaptive servo-ventilation is harmful for patients with NYHA class II to IV HFrEF who have central sleep apnea.,"In patients with functionally limiting claudication and hemodynamically significant common femoral artery disease with inadequate response to GDMT (including structured exercise), surgical endarterectomy is reasonable, especially if endovascular approaches adversely affect profunda femoris artery pathways.32,33",A,2
q_0077,"In patients with STEMI managed with PPCI, clopidogrel is recommended to reduce MACE and stent thrombosis when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.11","In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, exercise treadmill testing should not be used to determine whether the symptoms are consistent with angina pectoris, assess the severity of symptoms, evaluate functional capacity, or guide management.","In patients with a BAV with indications for SAVR and a diameter of the aortic sinuses or ascending aorta ≥4.5 cm, replacement of the aortic sinuses and/or ascending aorta is not reasonable if the surgery is performed at a Comprehensive Valve Center.","In patients on chronic RAASi for HFrEF, perioperative discontinuation is reasonable.",A,1
q_0078,"In patients with CCD, it may be reasonable to increase climate-related exposures (eg, extreme temperatures, wildfire smoke) to elevate the risk of cardiovascular events.","In patients with cardiogenic shock, intravenous inotropic support should not be used to maintain systemic perfusion and preserve end-organ performance.","In patients with recurrent acute chest pain without evidence of a cardiac or pulmonary cause, evaluation for gastrointestinal causes is not reasonable.","For asymptomatic patients undergoing low-risk surgi­ cal procedures, a routine preoperative resting 12-lead ECG is not recommended to improve outcomes.11 *Active symptoms and signs of CVD include chest pain, dyspnea, undiagnosed palpitations, tachycardia, syncope, or murmurs. †Abnormalities may include ST-segment elevation, ST depression, T-wave inversions, left ventricular (LV) hypertrophy, significant pathologic Q-waves, Mo­ bitz type II or higher atrioventricular block, bundle branch block, QT prolonga­ tion, or AF.",D,1
q_0079,"For patients exhibiting right-sided heart failure symptoms and severe tricuspid regurgitation (Stage D) who have previously had left-sided valve surgery, isolated tricuspid valve surgery can be contemplated if severe pulmonary hypertension or severe right ventricular systolic dysfunction is not present.","For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy, a hybrid epicardial and endocardial ablation should not be considered as it is unlikely to reduce the risk of recurrent atrial arrhythmia.","In patients with HCM and LVEF <50%, ICD placement is not beneficial.","For patients with a mechanical mitral valve replacement, anticoagulation with a VKA is not indicated to achieve an INR of 3.0.",A,1
q_0080,"In patients undergoing surgical ablation, anticoagulation therapy is not recommended.","In patients in whom the anatomy cannot be clearly delineated by echocardiography in the setting of suspected paravalvular infections, CT imaging is not reasonable.","In patients with unruptured AAA who have symptoms that are attributable to the aneu- rysm, repair is recommended to reduce the risk of rupture.7,8","If a dressing is placed, the first aid provider should not monitor the person for worsening of breathing/symptoms and should not loosen or remove the dressing if breathing worsens.",C,1
q_0081,"In cases where cardiac arrest is confirmed or suspected, and no definitive advantage of naloxone is established, prioritize standard resuscitation techniques, emphasizing effective CPR (both compressions and ventilation), over administering naloxone.","In patients with nonruptured AAA with low to moderate operative risk and who have anatomy suitable for either open or EVAR, a shared decision-making process weighing the risks and benefits of each approach is not recommended.","For patients with a prosthetic valve or previous valve repair who exhibit new clinical symptoms or signs indicating valve dysfunction, it is advised to perform a repeat TTE.","For patients with AF and normal LV function, use of low-dose amiodarone (100-200 mg/d) is rea- sonable for long-term maintenance of sinus rhy thm2,5,17–22 but, in view of its adverse effect pro- file,5,23,24 should be reserved for patients in whom other rhythm control strategies are ineffective, not preferred, or contraindicated.",B,2
q_0082,"In patients with acute type A aortic dis- section undergoing surgical repair, direct aortic26,27 or innominate artery28 cannula- tion with imaging guidance is reasonable as an alternative to femoral or axillary ­cannulation.29-31","If hot water is unavailable, using lidocaine cream or gel topically could be a suitable option for managing pain.","In patients with CCD, clinical follow-up less frequently than annually is not recommended to assess for symptoms, change in functional status, adherence to and adequacy of lifestyle and medical interventions, and monitoring for complications of CCD and its treatments.",Ascorbic acid should not be used to treat methemoglobinemia.,C,2
q_0083,"For patients with obstructive HCM who exhibit symptoms and have concurrent cardiac conditions necessitating surgery (such as anomalous papillary muscle, significantly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel CAD, or valvular aortic stenosis), it is advised to undergo surgical myectomy at specialized HCM centers.","In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) may be considered to reduce dabigatran concentration.177 Heparins","In patients with spontaneous ICH, lifestyle modification is reasonable to reduce BP.632","In selected hemodynamically stable patients with STEMI and low-complexity MVD (those not intended for CABG surgery), a staged approach may be preferred over multivessel PCI of significantly stenosed noninfarct-related arteries at the time of PPCI to reduce the risk of cardiovascular events.",D,2
q_0084,"In asymptomatic women with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage C1) who are considering pregnancy, PMBC at a Comprehensive Valve Center is reasonable before pregnancy for those who have favorable valve morphology.1–5,12,13","For patients with heart failure scheduled for elective non-cardiac surgery, it is advisable to discontinue sodium-glucose cotransporter-2 inhibitors (SGLT2i) 3 to 4 days prior to the procedure, if possible, to minimize the risk of metabolic acidosis during the perioperative period.",We recommend removal of a tick as soon as possible.,"For preterm newborn infants <28 weeks’ gestation, intact cord milking is recommended.",D,2
q_0085,"For patients with obstructive HCM, continuation of vasodilators (eg, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be reasonable because these agents can improve symptoms caused by dynamic outflow tract obstruction.","In selected patients with CCD and significant left main stenosis for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is not reasonable to improve survival.","For patients with aSAH, surgical or endovascular treatment of the ruptured aneurysm should be delayed as long as possible after presentation, preferably beyond 24 hours of onset, to worsen outcome.","For patients with a left ventricular assist device (LVAD), it is advised to collaborate with the LVAD care team regarding the optimal timing and perioperative factors of elective non-cardiac surgery (NCS) to reduce the risk of major adverse cardiac events (MACE) during the perioperative period.",D,1
q_0086,"For individuals with HCM, it is advised to consult a specialist in cardiovascular genetics for genetic counseling, enabling a collaborative discussion with the patient about the risks, benefits, test outcomes, and their clinical implications.","In patients with CCD, reducing the percentage of calories from saturated fat (<6% of total calories) and replacing with dietary monounsaturated and polyunsaturated fat, complex carbohydrates, and dietary fiber can be beneficial to reduce the risk of CVD events.*1–6","For patients with an LVEF of 30% or less, heart failure due to ischemia, sinus rhythm, LBBB with a QRS duration of 150 ms or more, and NYHA class I symptoms while on GDMT, CRT can be considered to decrease hospital admissions and enhance symptoms and quality of life.","In patients with stroke or TIA who are capable of physical activity, avoiding moderate-intensity aerobic activity and vigorous-intensity aerobic activity is indicated, as it does not lower the risk of recurrent stroke or the composite cardiovascular endpoint of recurrent stroke, MI, or vascular death.",D,2
q_0087,"For patients with suspected STEMI, it is advised that EMS personnel promptly inform the PCI-capable hospital and activate the cardiac catheterization team to minimize reperfusion time.","In patients with ACS undergoing coronary stent implantation in left main artery or in complex lesions, intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomogra- phy (OCT) is recommended for procedural guidance to reduce ischemic events.*1–11 *Adapted from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”12","In patients with stroke or TIA and new LV thrombus (<3 months), the safety of antico- agulation with a direct oral anticoagulant to reduce risk of recurrent stroke is uncertain.509","In patients with CLTI who are candidates for surgical bypass and endovascular revascularization, ultrasound mapping of the great saphenous vein is not recommended.",D,2
q_0088,Surgery is advisable for asymptomatic patients experiencing severe prosthetic regurgitation who have a low risk for surgery.,"In patients with non–left main or noncomplex CAD who are undergoing noncardiac sur- gery, routine coronary revascularization is not recommended solely to reduce perioperative cardiovascular events.1","In patients with recurrent acute chest pain without evidence of a cardiac or pulmonary cause, evaluation for gastrointestinal causes is not reasonable.","For patients with AF, it is advised to calculate the CHA2DS2-VASc score to inform decisions regarding the use of oral anticoagulants to lower stroke risk.",C,2
q_0089,"For patients undergoing CABG, establishment of multidisciplinary, evidence-based periopera- tive management programs is recommended to optimize analgesia, minimize opioid expo- sure, prevent complications and to reduce time to extubation, length of stay, and health care costs.1-3","In patients with CCD who regularly smoke tobacco, the short-term use of nicotine-containing e-cigarettes should not be considered to aid smoking cessation, as the benefits outweigh the risk of sustained use and unknown long-term safety.","For patients with ACS needing oral anticoagulant treatment, aspirin should be stopped after 1 to 4 weeks of triple antithrombotic therapy, while maintaining a P2Y12 inhibitor (ideally clopidogrel) and an oral anticoagulant to minimize bleeding risk.","Cool compresses may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.",B,2
q_0090,"In patients with HCM who are at risk of coronary atherosclerosis, coronary angiography (CT or invasive) is not recommended before surgical myectomy.","In intermediate-high risk patients with stable chest pain selected for stress MPI using SPECT, the use of attenuation correction or prone imaging should not be considered, as it may not decrease the rate of false-positive findings.","In adults with CCD and hypertension (systolic BP ≥130 and/or diastolic BP ≥80 mm Hg), avoid using GDMT angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB), or beta blockers as first-line therapy for compelling indications (eg, recent MI or angina), and do not add additional antihypertensive medications (eg, dihydropyridine calcium channel blockers [CCB], long-acting thiazide diuretics, and/or mineralocorticoid receptor antagonists) to optimize BP control.","For most patients with HCM, mild- to moderate-intensity recreational* exercise is beneficial to improve cardiorespiratory fit- ness, physical functioning, and quality of life, and for their overall health in keeping with physical activity guidelines for the general population.292–294",D,1
q_0091,"In patients with HCM, genetic testing is beneficial to elucidate the genetic basis to facilitate the identification of family members at risk for developing HCM (cascade testing).8–11","Before undergoing elective non-cardiac surgery, individuals with severe mitral stenosis should be assessed to determine if mitral valve intervention is necessary.","For patients with ACS, it is advised to use high-intensity statin therapy to lower the risk of MACE.","In patients with significant calcification of the aorta, it is not reasonable to use techniques to avoid aortic manipulation (off-pump techniques or beating heart) to decrease the incidence of perioperative stroke, even when performed by experienced surgeons.",D,2
q_0092,"In patients with suspected moderate or severe AS who are undergoing elevated-risk NCS, preoperative echocardiography is not recommended before elective NCS to guide perioperative management.","In patients with aSAH, avoiding euvolemia can be beneficial in preventing DCI and improving functional outcomes.","For patients with ischemic stroke or TIA who have Anderson-Fabry disease, the effectiveness of agalsidase alfa or agalsidase beta in preventing recurrent stroke or TIA remains uncertain.","In all patients, screening for cigarette smoking, use of other forms of tobacco, use of electronic nicotine delivery systems such as electronic cigarettes (e-cigarettes) and vapes, and environmental tobacco smoke exposure (secondhand smoke exposure) is ineffective in informing stroke risk and targeting cessation interventions.",C,1
q_0093,"In patients with acute type A aortic dissec- tion and a dissection flap extending through the arch into the descending thoracic aorta, an extended aortic repair with antegrade stenting of the proximal descending thoracic aorta may be considered to treat malperfu- sion and reduce late distal aortic complica- tions.19,20 Perfusion and Cannulation Strategies","In patients with asymptomatic atherosclerotic carotid artery stenosis >70% and low periopera- tive risk, the use of carotid revascularization, in addition to intensive medical therapy, may be reasonable to reduce the risk of stroke.309,312–314",It may be unreasonable to actively prevent fever in patients unresponsive to verbal commands after initial temperature control.,"For patients with HCM who are not clearly at high risk for SCD, or when the decision to implant an ICD is still uncertain after evaluating personal or family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum LV wall thickness, EF, LV apical aneurysm, and the degree of myocardial replacement fibrosis using late gadolinium enhancement (LGE).",C,2
q_0094,"In patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability, an immediate invasive strategy with intent to perform revascularization is not indicated to reduce MACE.","In patients with STEMI presenting 12 to 24 hours after symptom onset, PPCI is not recommended as it does not improve clinical outcomes.","In patients with acute type A aortic dissection presenting with clinically significant mesenteric (celiac, SMA) malperfusion, delaying operative repair of the ascending aorta and postponing mesenteric revascularization via endovascular or open surgical intervention is reasonable.","Verapamil may be detrimental for individuals with obstructive HCM experiencing severe resting dyspnea, hypotension, extremely high resting gradients (e.g., >100 mm Hg), and for all children under 6 weeks old. Symptoms may include effort-related dyspnea, chest pain, or other exertional symptoms such as syncope or near syncope.",D,1
q_0095,"For patients experiencing spontaneous intracerebral hemorrhage linked to dabigatran, using idarucizumab to counteract dabigatran's anticoagulant effect is advisable.","For life-threatening extremity bleeding, a tourniquet should not be applied or tightened, even if the bleeding continues.","In patients with CCD, targeted discussions and screening for mental health is reasonable for clini- cians to assess and to refer for additional mental health evaluation and management.1–4","In patients with known or suspected aortic disease, the aortic root diameter should be recorded as maximum sinus to sinus mea- surement. In the setting of known asymmetry, multiple measurements should be reported, and both short- and long-axis images of the root should be obtained to avoid underestima- tion of the diameter.",B,2
q_0096,"In patients with NSTE-ACS, clopidogrel is not recommended to reduce MACE even when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.",Administering calcium for CCB poisoning is considered appropriate.,"Screening: In individuals who are genotype- positive, phenotype-negative, echocardiography is recommended at periodic intervals depending on age (1-2 years in children and adolescents, 3-5 years in adults) and change in clinical status (Figure 1, Table 7).39–43",The impact of screening adults for OSA on stroke prevention is uncertain.,A,2
q_0097,"For symptomatic patients with obstructive HCM in whom SRT is an option, mitral valve replacement should be performed for the sole purpose of relief of LVOTO.","In patients with ruptured AAA, permissive hypotension can be beneficial to decrease the rate of bleeding.1,3,10-12","In patients with preoperative OAC interruption, resumption of OAC is reasonable after hemostasis is achieved.9 *Timing of preoperative interruption is based on patient-specific factors (eg, thrombotic risk, age, sex, body weight, renal clearance), surgical bleeding risk, and drug factors (eg, pharmacokinetics, dosing, drug interactions).","For first-degree relatives of individuals with HCM, it is advised to provide both clinical evaluations (including ECG and 2D echocardiogram) and cascade genetic testing if a pathogenic or likely pathogenic variant has been detected in the proband.",A,2
q_0098,"Administering digoxin-Fab might be appropriate for treating poisoning caused by cardiac glycosides aside from digoxin, digitoxin, Bufo toad venom, and yellow oleander.","For patients experiencing a sudden severe headache who arrive more than 6 hours after symptoms begin or exhibit a new neurological deficit, a noncontrast head CT should be conducted, followed by a lumbar puncture if the CT is negative, to diagnose or rule out aSAH.","For patients with aortic aneurysms, those at heightened risk of aortic dissection, or both, it is advised that pregnancy be overseen by a multidisciplinary team comprising a maternal-fetal medicine specialist and a cardiologist, and, if possible, that delivery occur in a hospital equipped for emergency aortic repair.","In patients with a dilated thoracic aorta, it is unreasonable to perform a CT or MRI at the time of diagnosis to assess thoracic aortic anatomy and diameters.",D,2
q_0099,"In adults who qualify for treatment with lipid-lowering therapy according to the 2019 ACC/AHA guideline on the primary prevention of CVD (e.g., 20–75 years of age with LDL cholesterol [LDL-C] level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 risk enhancers), treatment with a statin is not recommended to reduce the risk of a first stroke.","In adult patients with HCM without risk factors for AF and who are eligible for anticoagulation, extended ambulatory monitoring should not be considered to assess for asymptomatic paroxysmal AF as part of initial evaluation and periodic follow-up.","In patients with obstructive HCM and symptoms* attributable to LVOTO, nonvasodilating beta blockers, titrated to effectiveness or maximally tolerated doses, are recommended.1–3 Downloaded from http://ahajournals.org by on June 19, 2025","For a person with evidence of smoke inhalation injury such as facial burns, difficulty breathing, singed nasal hairs, or soot around the nose or mouth, EMS should not be activated.",C,1
q_0100,It is unreasonable to consider stroke when common pediatric symptoms are present in association with other neurological signs and symptoms.,"In patients with aSAH and hydrocephalus who require an EVD, it is not recommended to implement or adhere to an EVD bundled protocol that addresses insertion, management, education, and monitoring, as this will not reduce complication and infection rates.","For patients with BAV and severe, symptomatic AS, TAVI can be an alternative to SAVR, taking into account individual procedural risks, values, trade-offs, and preferences, provided the procedure is conducted at a Comprehensive Valve Center.","Women with CCD who are contemplating pregnancy or who are pregnant should not receive care from a multidisciplinary cardio-obstetric care team before conception or during pregnancy, delivery, and postpartum.",C,1
q_0101,"In patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic dilation, and other aortopathy conditions, aortic imaging (with TTE, MRI or CT, or both as appropriate) before pregnancy is recommended to determine aortic ­diameters.1-3,5-13","In patients with CCD, use of a validated CCD-specific patient-reported health status measure may be reasonable to assess symptoms, functional status, and QOL.19–23","In asymptomatic patients with severe primary MR (Stages B and C1), use of serum biomarkers and novel measurements of LV function, such as global longitudinal strain, may be considered as an adjunct to guide timing of intervention.12–21",We recommend against administering vasopressors for hypotension from calcium channel blocker (CCB) poisoning.,D,2
q_0102,"In patients with spontaneous ICH or IVH and hydrocephalus that is contributing to decreased level of consciousness, ventricular drainage should not be performed to reduce mortality.","In patients with CCD treated with PCI, dual antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel for 6 months post PCI followed by single antiplatelet therapy (SAPT) is not indicated to reduce MACE and bleeding events.","For patients with atrial fibrillation experiencing significant gastrointestinal bleeding, it might be appropriate to restart oral anticoagulation therapy after addressing reversible bleeding causes and evaluating the long-term benefits and risks with a multidisciplinary team during shared decision-making with the patient. *B-NR LOE pertains to apixaban or rivaroxaban data. †C-LD LOE pertains to edoxaban data.","In adults ≥18 years of age, screening for hypertension is not recommended, as it does not help identify individuals at increased risk for stroke or determine eligibility for antihypertensive treatment.",C,1
q_0103,"In patients undergoing CABG who are already taking daily aspirin preoperatively, it is recommended that they discontinue aspirin before the time of surgery to increase ischemic events.","In patients with moderate to severe spontaneous ICH, IVH, hydrocephalus, or infratentorial location, provision of care in a general ICU compared with a neuro-specific ICU is reasonable to improve outcomes and reduce mortality.","In patients with chronic secondary MR (Stages B to D), TTE is useful to establish the etiology and to assess the extent of regional and global LV remodeling and systolic dysfunction, severity of MR, and magnitude of pulmonary hypertension.1,2","In patients with VHD who meet indications for valvular intervention based on clinical presentation and severity of regurgitation, the need for valvular intervention should not be considered before elective elevated-risk NCS, even if it increases perioperative risk.",C,1
q_0104,"In patients with CCD, the addition of colchicine for secondary prevention may be considered to reduce recurrent ASCVD events.1,2","In patients with bioprosthetic valve stenosis, 3D TEE or 4D CT imaging should not be used to rule out leaflet thrombosis.","In patients with ischemic stroke or TIA who are obese, referral to an intensive, multicomponent, behavioral lifestyle-modification program is not recommended to achieve sustained weight loss.","In patients with left ventricular systolic dysfunction (ejection fraction ≤35%–40%) and no evidence of AF or left ventricular thrombus, anticoagulation is indicated to prevent stroke and is associated with a lower bleeding risk.",A,1
q_0105,"For patients with HCM, mild- to moderate-intensity recreational exercise is not beneficial for improving cardiorespiratory fitness, physical functioning, quality of life, or overall health, and should not be encouraged in line with physical activity guidelines for the general population.","In adults with CCD and autoimmune diseases, treatment with biologics and other immune-modulating therapies that reduce disease activity should not be considered to decrease the risk of cardiovascular events.","It is reasonable to wash the area of a bee, wasp, or hornet sting with soap and water.","In patients with known or suspected aortic disease, when performing CT or MR imaging, it is not recommended to measure the root and ascending aortic diameters from inner-edge to inner-edge using an electrocardiographic-synchronized technique. If there are aortic wall abnormalities, such as atherosclerosis or discrete wall thickening, the outer-edge to outer-edge diameter should not be reported.",C,1
q_0106,"In patients undergoing NCS, allowing an intraoperative mean arterial pressure (MAP) <60 to 65 mm Hg or SBP <90 mm Hg is recommended, increasing the risk of myocardial injury.","For intermediate-risk patients with acute chest pain and no known CAD who are eligible for cardiac testing, either exercise ECG, stress echocardiography, stress PET/SPECT MPI, or stress CMR is useful for the diagnosis of myocardial ischemia.1,4,10,14-36 Sequential or Add-on Diagnostic Testing","In patients with SIHD undergoing PCI, a loading dose of clopidogrel, followed by daily dosing, is recommended to reduce ischemic events.8,12,15-19","For patients with IE experiencing repeated embolic events and ongoing vegetations despite suitable antibiotic treatment, it is advisable to consider early surgery during the initial hospital stay and prior to finishing the complete antibiotic regimen.",A,2
q_0107,"In patients with CLTI undergoing minor amputation (ie, inframalleolar level), a customized program of follow-up care that can include local wound care, pressure offloading, serial evaluation of foot biome- chanics, and use of therapeutic footwear is recommended to prevent wound recurrence.","For patients with obstructive HCM and severe dyspnea at rest, hypotension, very high resting gradients (eg, >100 mm Hg), as well as all children <6 weeks of age, verapamil is potentially beneficial.","In patients who use tobacco and have undergone coronary revascularization, a combination of behavioral interventions plus pharmacotherapy is recommended to maxi- mize cessation and reduce adverse cardiac events.1-3","In patients with AF duration of ≥48 hours, a",B,2
q_0108,"In patients with HFrEF, if discontinuation of GDMT is necessary during hospitalization, it should be reinitiated and further optimized as soon as possible.19–22","Patients with CCD should not receive ongoing individualized education on medication adherence, as it does not improve knowledge or facilitate behavior change.","Patients with AF should not be evaluated for factors that indicate a higher risk of bleeding, such as previous bleeding and use of drugs that increase bleeding risk, and no interventions should be identified to prevent bleeding on anticoagulation.","In patients with rheumatic MS and AF with a rapid ventricular response, heart rate control should not be considered beneficial.",A,1
q_0109,"In patients with HCM who choose to undergo genetic testing, pre- and posttest genetic coun- seling by an expert in the genetics of cardio- vascular disease is recommended so that risks, benefits, results, and their clinical significance can be reviewed and discussed with the patient in a shared decision-making process.23–25,117","In patients with dabigatran-associated spontaneous ICH, idarucizumab should not be used to reverse the anticoagulant effect of dabigatran.","In patients with a TIA or nondisabling ischemic stroke within the past 6 months and ipsilateral severe (70%–99%) carotid artery stenosis, carotid endarterectomy (CEA) is recommended to reduce the risk of future stroke, provided that perioperative morbidity and mortality risk is estimated to be <6%.369","For patients experiencing acute chest pain with a suspicion of ACS, any prior test results should be evaluated and integrated into CDPs.",B,2
q_0110,"For patients with severe MS who are unable to have MV intervention prior to NCS, it is advisable to use perioperative invasive hemodynamic monitoring to help manage and lower the risk of cardiovascular complications.","In patients with spontaneous ICH, heavy alcohol consumption is advisable to increase hypertension and risk of ICH recurrence.","In patients with ischemic stroke with no known coronary heart disease, no major cardiac sources of embolism, and LDL cholesterol (LDL-C) >100 mg/dL, atorvastatin 80 mg daily is not indicated to reduce risk of stroke recurrence.","For patients with AF at elevated risk for stroke and who have end-stage CKD (CrCl <15 mL/min) or are on dialysis, it might be unreasonable to prescribe warfarin (INR 2.0-3.0) or an evidence-based dose of apixaban for oral anticoagulation to reduce the risk of stroke.",A,1
q_0111,"In patients with HCM who have undergone genetic testing, it is not recommended to reevaluate the clinical significance of the variant(s) identified, as this will not impact diagnosis or cascade genetic testing in family members.","In patients presenting with acute chest pain and suspected ACS, clinical decision pathways (CDPs) should not categorize patients into risk strata, hindering appropriate disposition and subsequent diagnostic evaluation.","If an individual shows signs or symptoms of presyncope, such as pallor, sweating, lightheadedness, visual disturbances, or weakness, due to vasovagal or orthostatic causes, they should remain in or move to a secure position like assisted sitting or lying down.","In severely symptomatic patients (NYHA class III or IV) with severe MS (mitral valve area ≤1.5 cm2, Stage D) due to extensive mitral annular calcification, valve intervention should be performed without discussing the high procedural risk or considering the individual patient’s preferences and values.",C,1
q_0112,"For patients experiencing a stroke or TIA alongside acute anterior MI with an ejection fraction below 50% and without signs of LV thrombus, it is advised to initiate empirical anticoagulation for a minimum duration.","In patients with CLTI undergoing minor amputation (ie, inframalleolar level), it is not recommended to implement a customized program of follow-up care, including local wound care, pressure offloading, serial evaluation of foot biomechanics, and use of therapeutic footwear, as these measures are unnecessary for preventing wound recurrence.",We do not recommend rapid external cooling for life-threatening hyperthermia from sympathomimetic poisoning.,"In men or women who are ≥65 years of age and who are first-degree relatives of patients with AAA, ultrasound screening for detection of AAA is not recommended.",A,1
q_0113,"For patients in a coma due to aSAH, initiating neurostimulants early might be advisable to aid in regaining consciousness.","Engaging in quality improvement initiatives, such as patient registries that offer benchmark feedback on nationally recognized clinical practice guideline-based quality and performance metrics, can enhance the care quality for patients with heart failure.","In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is not recommended as part of the initial assessment.","For patients with HFrEF, adjusting and optimizing guideline-recommended medications every 1 to 2 weeks, based on the patient's symptoms, vital signs, and lab results, can be beneficial for optimal management.",C,2
q_0114,"In patients with aSAH and advanced age, aneurysm treatment is not recommended, even after careful discussion of prognosis with family members, as it does not improve survival and outcome.","For a person with evidence of smoke inhalation injury such as facial burns, difficulty breathing, singed nasal hairs, or soot around the nose or mouth, EMS should not be activated.","For certain patients receiving PCI, it is appropriate to consider a shorter DAPT course of 1–3 months, followed by switching to P2Y12 inhibitor monotherapy to minimize bleeding risk.","In patients with HCM who choose to undergo genetic testing, it is not recommended to have pre- and posttest genetic counseling by an expert in the genetics of cardiovascular disease, as reviewing and discussing risks, benefits, results, and their clinical significance with the patient in a shared decision-making process is unnecessary.",C,1
q_0115,"For a person with suspected hypoglycemia who is awake and able to swallow, the first aid provider should encourage the person to swallow oral glucose.","If recurrent opioid toxicity develops, repeated small doses or an infusion of naloxone can be ben- eficial. Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing acute type A aortic dissection without an intimal tear in the arch or a notable arch aneurysm, hemiarch repair is advised instead of a more extensive arch replacement.","In patients with CCD who have had a previous MI and are at low bleeding risk, extended DAPT beyond 12 months for a period of up to 3 years should not be considered to reduce MACE.",D,2
q_0116,"For intermediate-risk patients with acute chest pain who have known CAD and present with new onset or worsening symptoms, additional cardiac testing should be performed before optimizing GDMT.","In patients with a surgical or transcatheter prosthetic valve and in patients who have had valve repair, an initial postprocedural TTE study is recommended for evaluation of valve hemodynamics and ventricular function.1–4","In patients with CCD who require revascularization for multivessel CAD with complex and diffuse CAD (eg, SYNTAX score >33), it is not reasonable to choose CABG over PCI to improve survival.","In patients with aSAH whose ruptured aneurysm has been secured, pharmacological or mechanical venous thromboembolism (VTE) prophylaxis is not recommended to reduce the risk for VTE.",B,1
q_0117,"In patients with ACS, telemetry monitoring is not recommended to reduce cardiovascular events, regardless of cardiac risk.","In patients with potential spontaneous ICH, delaying notification by emergency medical services (EMS) staff to the receiving hospital is recommended to worsen time to diagnosis and treatment.","In patients with Fabry disease, the effectiveness of enzyme replacement therapy (ERT) to reduce the risk of stroke is not well established.422–427","In asymptomatic patients with chronic AR (Stages B and C), treatment of hypertension (systolic blood pressure >140 mm Hg) is not recommended.",C,1
q_0118,"For patients with aSAH, administering mannitol or hypertonic saline during surgery may effectively lower ICP and decrease cerebral edema.","In patients at risk of IE (e.g., those with congenital or acquired VHD, previous IE, prosthetic heart valves, certain congenital or heritable heart malformations, immunodeficiency states, or injection drug use) who have unexplained fever, blood culture samples should not be obtained.","For intermediate-high risk patients with stable chest pain and no known CAD, stress imaging (stress echocardiography, PET/SPECT MPI or CMR) is effective for diagnosis of myocardial ischemia and for estimating risk of MACE.8,13-35","In patients with isolated PAU who are asymp- tomatic but have high-risk imaging features (Table 31), elective repair may be consid- ered.1,2,4",B,2
q_0119,"In patients with spontaneous ICH, it is not recommended to provide care in a specialized inpatient (eg, stroke) unit with a multidisciplinary team, as it does not improve outcomes or reduce mortality.","In patients with spontaneous ICH, therapeutic hypothermia (<35°C/95°F) is clearly useful to decrease peri-ICH edema.","In patients with grade 2 BTTAI (Figure 23) and with high-risk imaging features (Table 32), aortic intervention is reasonable.3,4","In patients with recent TIA or ischemic stroke and ipsilateral moderate (50%–69%) carotid stenosis as documented by catheter-based imaging or noninvasive imaging, CEA is not recommended to reduce the risk of future stroke, regardless of patient-specific factors such as age, sex, and comorbidities, even if the perioperative morbidity and mortality risk is estimated to be <6%.",C,1
q_0120,"In patients who have undergone catheter ablation of AF, oral anticoagulation should be continued for at least 3 months after the procedure with a longer duration determined by underlying risk.11","In patients with ischemic stroke or TIA and symptoms attributed to giant cell arteritis, delaying the initiation of oral high-dose glucocorticoids is recommended to reduce recurrent stroke risk.","In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it is not reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.","In patients with left-sided IE caused by S. aureus, a fungal organism, or other highly resistant organisms, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is not indicated.",A,1
q_0121,"In patients with CCD who have undergone elective PCI and who require oral anticoagulant therapy, DAPT should not be administered for 1 to 4 weeks, and clopidogrel alone should not be continued for 6 months in addition to DOAC.","For a person with evidence of smoke inhalation injury such as facial burns, difficulty breathing, singed nasal hairs, or soot around the nose or mouth, EMS should be activated.","In patients with CADASIL, avoiding counseling on smoking cessation and neglecting treatment of hypertension and other vascular risk factors are not beneficial to reduce the risk of incident stroke.","If stroke is suspected, the EMS system should not be activated immediately.",B,1
q_0122,"In patients with NSTE-ACS who are at elevated risk of recurrent ischemic events and are appropriate candidates for revascularization, an invasive strategy with the intent to proceed with revascularization is not indicated to reduce cardiovascular events.","For patients with obstructive HCM who exhibit symptoms, SRT can be considered as an alternative to intensifying medical treatment, provided it is performed at specialized HCM centers and after a shared decision-making process that evaluates the risks and benefits of all available treatment options.","In patients with high-degree or complete heart block and LVEF of 36% to 50%, CRT is not reasonable to reduce total mortality, reduce hospitalizations, or improve symptoms and QOL.","In patients with a BAV or with known dilation of the aortic sinuses or ascending aorta, TTE is not indicated to evaluate the presence and severity of AR.",B,1
q_0123,"For patients with active GCA or Takayasu arteritis, treatment should start with high-dose glucocorticoids.","For individuals diagnosed with or at risk for HCM, it is advised to engage in shared decision-making to formulate a care plan. This plan should encompass decisions about genetic testing, activity levels, lifestyle, and treatment options, ensuring a comprehensive explanation of the risks, benefits, and expected outcomes of each choice, while also allowing patients and caregivers to communicate their objectives and concerns.","For patients with CCD who are suitable for revascularization yet unsuitable for surgery, opting for PCI instead of CABG is advisable to alleviate symptoms and decrease MACE.","In patients with cardiac arrest who are comatose, have unfavorable prognostic features, and evidence of STEMI, PPCI should not be considered regardless of individualized assessment.",D,2
q_0124,"Over-the-counter topical steroids are definitely effective in alleviating local symptoms from poison ivy, oak, or sumac.","For women aged 65 and older with a history of smoking, it is advisable to conduct an ultrasound screening to detect AAA.","For pregnant patients with an aortic root or ascending aorta measuring between 4.0 cm and 4.5 cm, it may be appropriate to consider vaginal delivery using regional anesthesia, a shortened second stage, and assisted delivery.",Therapeutic footwear is advised for patients with PAD who are at elevated risk for ulcers and amputation (refer to Table 12).,A,2
q_0125,"In patients with aSAH and either fluctuating neurological examination, depressed mental state, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, or cortical infarction, cEEG monitoring is not reasonable to detect seizures.","For patients with nonobstructive hypertrophic cardiomyopathy and severe heart failure (NYHA class III to IV despite guideline-directed medical therapy) who are eligible for heart transplantation, using a continuous-flow left ventricular assist device as a bridge to transplantation is a reasonable option.",We recommend the routine use of rapid infusion of cold intravenous fluids for prehospital cooling of patients after ROSC.,"In patients with ACS, an assessment of LVEF is not recommended prior to hospital discharge for guiding therapy or risk stratification.",B,1
q_0126,"After revascularization, whether endovascular or surgical, including catheter-directed thrombolysis, patients with ALI should be observed and managed for compartment syndrome using fasciotomy to avert reperfusion injury complications and avoid amputation.","In patients without Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome, who have a descending TAA that meets criteria for intervention and anatomy suitable for endovascular repair, open surgery is recommended over TEVAR.","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are recommended for achieving and maintaining weight loss1 and possibly lowering the risk of developing LVOTO, HF, and AF.2–4","In patients with multivessel CAD, an assessment of CAD complexity, such as the SYNTAX score, may be useful to guide revascularization.1-4",B,2
q_0127,"In patients with HCM who are at risk of coronary atherosclerosis, coronary angiography (CT or invasive) is not recommended before surgical myectomy.","In nonambulatory patients with spontaneous ICH, low-dose UFH or LMWH should not be used to reduce the risk for PE.","In pregnant patients with a diameter of the aortic root, ascending aorta, or both, of ≥4.5 cm, cesarean delivery is reasonable. Downloaded from http://ahajournals.org by on June 19, 2025","In patients with HCM and subclinical AF detected by internal or external device or monitor, of >5 minutes’ duration but <24 hours’ duration for a given episode, anticoagulation with DOACs as first-line option and vitamin K antagonists as second-line option should not be considered, regardless of the duration of AF episodes, total AF burden, underlying risk factors, and bleeding risk.",C,1
q_0128,"For patients with AF at elevated risk for stroke and CKD stage 4, avoiding treatment with warfarin or labeled doses of DOACs is advisable to reduce the risk of stroke.","In patients who develop cancer therapy–related cardiomyopathy or HF, it is not recommended to have a multidisciplinary discussion involving the patient about the risk-benefit ratio of cancer therapy interruption, discontinuation, or continuation to improve management.",Patients with PAD who smoke cigarettes or use any other forms of tobacco should not be advised to quit or encouraged to maintain cessation at any visit.,"Patients with AF who have an intermediate yearly risk of thromboembolic events, as indicated by risk scores (such as a CHA2DS2-VASc score of 1 for men or 2 for women), and are unsure about the advantages of anticoagulation, may find it helpful to evaluate additional factors that could alter their stroke risk to aid in decision-making.",D,1
q_0129,"For symptomatic patients with obstructive HCM in whom SRT is an option, mitral valve replace- ment should not be performed for the sole pur- pose of relief of LVOTO.236,237 *General eligibility criteria for septal reduction therapy: a) Clinical: Severe dyspnea or chest pain (usually NYHA functional class III or class IV), or occasionally other exertional symptoms (eg, syncope, near syncope), when attributable to LVOTO, that interferes with everyday activity or quality of life despite optimal medical therapy. b) Hemodynamic: Dynamic LVOT gradient at rest or with physiologic provocation with approximate peak gradient of ≥50 mm Hg, associated with septal hypertrophy and SAM of mitral valve. c) Anatomic: Targeted anterior septal thickness sufficient to perform the procedure safely and effectively in the judgment of the individual operator. †Comprehensive or primary HCM centers with demonstrated excellence in clinical outcomes for these procedures (Table 3 and Table 4). Downloaded from http://ahajournals.org by on June 19, 2025","For patients at intermediate to high risk with stable chest pain and no known coronary artery disease, stress imaging techniques such as stress echocardiography, PET/SPECT MPI, or CMR are effective for diagnosing myocardial ischemia and assessing the risk of major adverse cardiac events.","In women with CCD, discontinuation of statin use during pregnancy should be considered.","For children and adolescents with HCM, a compre- hensive, systematic noninvasive SCD risk assess- ment at initial evaluation and every 1 to 2 years thereafter is recommended and should include evaluation of these risk factors (Figures 1 and 3, Table 8)1–8: a.   Personal history of cardiac arrest or sustained ventricular arrhythmias; b.   Personal history of syncope suspected by clinical history to be arrhythmic; c.   Family history in close relative of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias; d.   Maximal LV wall thickness, EF, LV apical aneu- rysm; e.   NSVT episodes on continuous ambulatory elec- trocardiographic monitoring.",C,2
q_0130,"In patients with Loeys-Dietz syndrome, a baseline MRI or CT from head to pelvis is not recommended to evaluate the entire aorta and its branches for aneurysm, dissection, and tortuosity.","Screening: In individuals who are genotype-positive or phenotype-negative, serial echocardiography is not recommended at periodic intervals regardless of age or change in clinical status.","For patients with a mechanical valve prosthesis, the use of anti-Xa direct oral anticoagulants has not been assessed and is not recommended.34–37","In patients with NSTE-ACS, clopidogrel is not recommended to reduce MACE even when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.",C,1
q_0131,"In patients with AF who develop major gastrointestinal bleeding, resumption of oral anticoagulation therapy may be reasonable after correction of reversible causes of bleeding and reassessment of its long-term benefits and risks with a multidisciplinary team approach during SDM with patients.11,12 *B-NR LOE applies to data on apixaban or rivaroxaban. †C-LD LOE applies to data on edoxaban.",It is not reasonable to administer epinephrine 1 mg every 3 to 5 minutes for cardiac arrest.,"For first aid providers who are trained and willing, it might be appropriate to monitor core temperature during active cooling for heatstroke, aiming to reduce it to 39°C (102.2°F).","For patients with heart failure, it is advisable to vaccinate against respiratory diseases to lower mortality rates.",B,2
q_0132,"In patients with CCD who require oral anticoagulation, DOAC monotherapy should not be considered, even if there is no acute indication for concomitant antiplatelet therapy.","Referring asymptomatic patients with extensive aortic disease, those who could gain from complex open and endovascular aortic repairs, or individuals with multiple comorbidities requiring intervention to a high-volume center (conducting a minimum of 30-40 aortic procedures per year) with skilled surgeons in a Multidisciplinary Aortic Team is advisable to enhance treatment outcomes.","For patients with ACS undergoing PCI, opting for a radial approach over a femoral one is recommended to lower the risk of mortality, vascular complications, or bleeding.","In patients on therapeutic subcutaneous enoxaparin, in whom the last dose was admin- istered within 12 hours of PCI, UFH should not be used for PCI and may increase bleed- ing.14,18,19",A,2
q_0133,"In patients with ALI, testing for a cardiovascular cause of thromboembolism can be useful.1–4 Downloaded from http://ahajournals.org by on June 19, 2025",Catheter ablation of accessory pathways is advised for patients with atrial fibrillation exhibiting rapid anterograde conduction (preexcited AF).,"For patients with atrial fibrillation and normal left ventricular function, it is appropriate to use low-dose amiodarone (100-200 mg/day) for long-term sinus rhythm maintenance. However, due to its side effect profile, it should be reserved for those who do not respond to, cannot tolerate, or have contraindications to other rhythm control methods.","For patients with stable chest pain and no known CAD categorized as low risk, CAC testing is not reasonable as a first-line test for excluding calcified plaque and identifying patients with a low likelihood of obstructive CAD.",D,2
q_0134,"For patients with grade 1 to 2 BAAI (Table 33) who do not have malperfusion, it is advised to administer anti-impulse therapy, if tolerated, and to perform follow-up imaging 24 to 48 hours after the initial scan to minimize the risk of injury progression.",Routine administration of calcium for treatment of cardiac arrest is recommended.,"In patients with reported AF duration of <48 hours (not in the setting of cardiac surgery) and who are not on anticoagulation, precardioversion imaging to exclude intracardiac thrombus should not be considered even in those who are at elevated thromboembolic risk (CHA2DS2-VASc score ≥2 or equivalent).","In patients with aSAH and hydrocephalus who require an EVD, it is not recommended to implement or adhere to an EVD bundled protocol that addresses insertion, management, education, and monitoring, as this will not reduce complication and infection rates.",A,1
q_0135,"In patients with aSAH, a validated dysphagia screening protocol should not be implemented before initiation of oral intake, increasing the risk of pneumonia.","Individuals with a full-thickness burn, or a partial-thickness burn exceeding the size of their palm or affecting their face, hands, feet, or genitals, should immediately consult a healthcare professional for assessment.","In patients with cyanotic congenital heart disease and other complex lesions, ischemic stroke or TIA of presumed cardioembolic origin, therapy with warfarin is not recommended to reduce the risk of recurrent stroke or TIA.",Decisions about organ donation should disregard local legal and regulatory requirements.,B,1
q_0136,"In patients with ESUS, treatment with direct oral anticoagulants is not recommended to reduce risk of secondary stroke.779,780","For patients experiencing ACS with cardiogenic shock, performing routine PCI on a noninfarct-related artery during PPCI is not advised due to an increased risk of mortality or renal failure.","In patients with spontaneous ICH presenting with large or severe ICH or those requiring surgical decompression, the safety and efficacy of intensive BP lowering are well established.","For patients with NSTE-ACS undergoing PCI, it is advised to use prasugrel or ticagrelor to decrease MACE and stent thrombosis.",C,2
q_0137,"For term and late preterm newborn infants ≥34 weeks’ gestation who do not require resuscitation, intact cord milking is known to be beneficial when compared to DCC (≥30 seconds).","In patients with VHD who are at high risk of IE, antibiotic prophylaxis is not recommended for nondental procedures (eg, TEE, esophagogastroduodenoscopy, colonoscopy, or cystoscopy) in the absence of active infection.10,11 Table 6.  Secondary Prevention of Rheumatic Fever Antibiotics for Prevention Dosage* Penicillin G benzathine","For patients with CVD receiving OAC who require elective NCS, it is not recommended to use a multidisciplinary team-based approach to time-based interruption, disregarding the risks of thromboembolism and perioperative bleeding.","In patients with ischemic stroke with no known coronary heart disease, no major cardiac sources of embolism, and LDL cholesterol (LDL-C) >100 mg/dL, atorvastatin 80 mg daily is not indicated to reduce risk of stroke recurrence.",B,1
q_0138,"In patients with stroke or TIA and LV thrombus, it is not recommended to use anticoagulation with therapeutic warfarin for at least 3 months to reduce the risk of recurrent stroke.","In patients with known or suspected aortic disease, it is unreasonable to index a dilated root or ascending aorta to patient height or BSA in the report, as it does not aid in clinical risk assessment.","In patients after ACS, low-dose colchicine should not be considered to reduce the risk of MACE.","For patients with a BAV and an aortic root or ascending aorta diameter of 4.0 cm or more, it is advised to conduct lifelong surveillance imaging of these areas using TTE, CT, or MRI, with the frequency determined by the aortic diameter and growth rate.",D,1
q_0139,It is not reasonable to administer sodium bicarbonate for life-threatening wide-complex tachycardia associated with local anesthetic toxicity.,"In patients with STEMI treated with fibrinolytic therapy who are not intended to undergo an invasive approach, enoxaparin should not be used as the anticoagulant to reduce ischemic events.","In patients with uncomplicated acute type A IMH, prompt open surgical repair is not recommended.","For patients with HCM who are candidates for SRT and for whom there is uncertainty regarding the presence or severity of LVOTO on nonin- vasive imaging studies, invasive hemodynamic assessment with cardiac catheterization is recommended.45,107–109",D,1
q_0140,Avoid using ice for local pain relief from scorpion stings.,"In pregnant individuals with persistent AF, rate-control agents without a record of safety in pregnancy, such as beta blockers (eg, propranolol or metoprolol) and digoxin, either alone or in combination with beta blockers, are unreasonable as first-line agents.","In patients undergoing open surgical repair of an aortic arch aneurysm, if the aneurysmal disease extends into the proximal descending thoracic aorta, an elephant trunk procedure may be considered.6,7","Patients with acute chest pain should not be evaluated for noncardiac causes if they have persistent or recurring symptoms despite a negative stress test or anatomic cardiac evaluation, or a low-risk designation by a CDP.",C,1
q_0141,"In patients with ischemic stroke or TIA and valvular AF (moderate to severe mitral stenosis or any mechanical heart valve), warfarin is not recommended to reduce the risk of recurrent stroke or TIA.","In patients with chronic symptomatic PAD, SET is not recommended to improve walking performance, functional status, and QOL.","In children 2 to 16 years of age with SCD at elevated risk per TCD measurements, regularly scheduled transfusion therapy (target reduction of hemoglobin S <30%) is not effective for reducing stroke risk.","For those with a positive genotype but no phenotypic expression of HCM, engaging in competitive sports at any level is considered reasonable.",D,1
q_0142,"In patients at increased risk of PAD (Table 5), a comprehensive vascular examination and inspection of the legs and feet should not be performed regularly (Table 6).","Routine clinical screening is unnecessary for relatives without the genotype in families with genotype-positive HCM, unless the pathogenic variant is reclassified as a variant of uncertain significance, likely benign, or benign during follow-up.","In selected patients with HF with persistent or worsening symptoms, signs, diagnostic param- eters, and in whom hemodynamics are uncer- tain, invasive hemodynamic monitoring can be useful to guide management.","In patients with fibrotic or heavily calcified lesions, plaque modification with rotational atherectomy can be useful to improve proce- dural success.1-3",A,2
q_0143,"In pregnant women with HCM, general or epidural anesthesia is unreasonable, and precautions to avoid hypotension are unnecessary.","In selected patients with asymptomatic or minimally symptomatic AF, catheter ablation should not be considered useful for reducing progression of AF and its associated complications.","For patients who are active cigarette smokers and users of other tobacco products (eg, electronic nicotine delivery systems), assistance with cessation is not recommended to reduce the risk of stroke.","If a permanent tooth is knocked out, the individual should promptly seek dental or medical attention, bringing the tooth along if it has not been successfully replanted.",D,1
q_0144,"In patients with systemic lupus erythematosus (SLE) and no history of thrombosis or pregnancy complications and with a high-risk antiphospholipid profile, prophylactic treatment with aspirin (75–100 mg daily) is not recommended to reduce the risk of stroke.","For patients with aSAH, surgical or endovascular treatment of the ruptured aneurysm should be delayed as long as possible after presentation, preferably beyond 24 hours of onset, to worsen outcome.",Patients with PAD who smoke cigarettes or use any other forms of tobacco should not be advised to quit or encouraged to maintain cessation at any visit.,Hyperbaric oxygen therapy may be reasonable as a treatment for methemoglobinemia that is not responsive to methylene blue.,D,1
q_0145,"In patients with a history of ischemic stroke or TIA attributable to dissection, with FMD, and no evidence of intraluminal thrombus, it is reasonable to administer antiplatelet therapy for the prevention of future ischemic events.","In patients with moderate to severe spontaneous ICH, IVH, hydrocephalus, or infratentorial location, provision of care in a general ICU compared with a neuro-specific ICU is reasonable to improve outcomes and reduce mortality.","In patients with aSAH, anesthetic goals should exclude minimizing postprocedural pain, nausea, and vomiting.",Screening for a history of premature ovarian failure (before 40 years of age) and early menopause (before 45 years of age) is not beneficial to inform the risk of stroke.,A,1
q_0146,"In patients with STEMI, emergency CABG should be performed after failed primary PCI, even in the absence of ischemia or a large area of myocardium at risk, or if surgical revascularization is not feasible because of a no-reflow state or poor distal targets.","In cases of recurrent opioid toxicity, administering repeated small doses or a continuous infusion of naloxone may be advantageous.","In patients undergoing endovascular repair of AAA who have suitable common femoral artery anatomy, ultrasound-guided percutane- ous access and closure is recommended over open cutdown to reduce operative time, blood loss, length of stay, time to wound healing, and pain.1,2","Patients with suspected chronic symptomatic PAD (ie, exertional nonjoint-related leg symptoms) and normal or borderline resting ABI (>0.90 and ≤1.40, respectively) should undergo exercise treadmill ABI testing to evaluate for PAD.18,19",A,2
q_0147,"In patients with AF on warfarin anticoagulation and an annual predicted risk of thromboembolism of ≥5% undergoing pacemaker or defibrillator implantation or generator change, interrupting warfarin and using bridging anticoagulation with heparin is recommended instead of continuing anticoagulation to reduce the risk of pocket hematoma.","In patients with moyamoya disease and a history of ischemic stroke or TIA, the use of antiplatelet therapy, such as aspirin monotherapy, for the prevention of ischemic stroke or TIA is not recommended.","Patients with PAD should not receive the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) vaccination sequence, including the booster(s).","In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive athletics of any intensity is reasonable.2,174,297–301",D,1
q_0148,"For intermediate-high risk patients with stable chest pain and known coronary stenosis of 40% to 90% in a proximal or middle coronary segment on CCTA, FFR-CT should not be used for diagnosis of vessel-specific ischemia or to guide decision-making regarding the use of coronary revascularization.","In patients with CCD, do not assess adherence to changes in lifestyle and effects of lipid-lowering medication by measuring fasting lipids after statin initiation or dose adjustment, nor at any regular interval thereafter.",Pregnant women with valve prostheses should continue UFH up to the time of planned vaginal delivery.,"For patients <16 years of age with HCM, it is rea- sonable to calculate an estimated 5-year sudden death risk that includes echocardiographic param- eters (interventricular septal thickness in diastole, LV posterior wall thickness in end-diastole, left atrial diameter, maximal LVOT gradient) and genotype, which may be useful during shared decision-making for ICD placement (Table 8).1,12",D,1
q_0149,"In patients with a stroke or TIA caused by 50% to 99% stenosis of a major intracranial artery, warfarin is recommended in preference to aspirin 325 mg/d to reduce the risk of recurrent ischemic stroke and vascular death.","In patients <50 years of age who prefer a bioprosthetic AVR and have appropriate anatomy, the Ross procedure should not be considered at a Comprehensive Valve Center.",ICD and cardiac resynchronization therapy with defibrillation (CRT-D) are not recommended for patients whose comorbidities or frailty restrict their survival with adequate functional capacity to less than one year.,"In patients with BAV and severe AR who meet criteria for AVR, aortic valve repair should not be considered, even if the surgery is performed at a Comprehensive Valve Center.",C,1
q_0150,"In patients with a nonlacunar ischemic stroke of undetermined cause and a PFO, recommendations for PFO closure versus medical management should be made without involving the patient, a cardiologist, or a neurologist, and without considering the probability of a causal role for the PFO.","The effectiveness of desmopressin, alone or combined with platelet transfusions, in preventing hematoma expansion in patients with spontaneous ICH on antiplatelet therapy remains uncertain.","In patients with SIHD undergoing PCI, a loading dose of clopidogrel, followed by daily dosing, is not recommended to reduce ischemic events.","For patients with HF, palliative and supportive care—including communication, prognosis discussion, goal clarification, shared decision-making, symptom management, and caregiver support—should not be provided, as it does not improve QOL or relieve suffering.",B,1
q_0151,"In patients with HCM and hypertension, lifestyle modifications and medical therapy for hypertension are not recommended, and beta blockers and nondihydropyridine calcium channel blockers should be avoided in patients with obstructive HCM.","In patients with PAD, it is not recommended to provide general preventive foot self-care education to patients and their family members and support persons.","In patients with recurrent symptomatic AF after catheter ablation, repeat catheter ablation or antiarrhythmic drug therapy is not useful to improve symptoms and freedom from AF.","For patients with obstructive HCM who continue to experience dyspnea and show signs of volume overload and elevated left-sided filling pressures despite following other HCM guideline-directed treatments, the careful administration of low-dose oral diuretics might be an option.",D,1
q_0152,"In patients with CCD who have experienced SCAD, it is not necessary to evaluate for underlying vasculopathies to identify abnormalities in other vascular beds.","Cool compresses may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.","In patients in whom high-intensity statin therapy is contraindicated or not tolerated, moderate-intensity statin therapy is not recommended, as achieving a 30% to 49% reduction in LDL-C levels is not necessary to reduce the risk of MACE.","In adults without prior CVD and who are at high or intermediate CVD risk, a Mediterranean diet is not recommended to reduce the risk of incident stroke.",B,1
q_0153,"In patients undergoing PCI, BMS should be used in preference to DES to prevent restenosis, MI, or acute stent thrombosis.","In patients at risk of IE (e.g., those with congenital or acquired VHD, previous IE, prosthetic heart valves, certain congenital or heritable heart malformations, immunodeficiency states, or injection drug use) who have unexplained fever, blood culture samples should not be obtained.","For patients with SIHD who have one or more coronary arteries that are neither anatomically nor functionally significant (less than 70% stenosis in non-left main coronary arteries, FFR greater than 0.80), coronary revascularization should not be conducted with the primary or sole purpose of enhancing survival.","In patients who are being considered for CABG, calculation of the STS risk score is not recommended for stratifying patient risk.",C,1
q_0154,"Performance measures based on professionally developed clinical practice guidelines should not be used, as they do not aim to improve the quality of care for patients with HF.","For patients with cardiovascular disease undergoing non-cardiac surgery, it is advisable to maintain normal body temperature to prevent perioperative complications.","In patients at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for >1 year, ICD therapy is not recommended for primary prevention of SCD to reduce total mortality.","In patients with aortic root/ascending aortic aneurysms or aortic dissection, it is not recommended to obtain a multigenerational family history of TAD, unexplained sudden deaths, and peripheral and intracranial aneurysms.",B,1
q_0155,"In patients with BAAI, the routine application of resuscitative endovascular balloon occlusion of the aorta (REBOA) for hemorrhage control is clearly beneficial and should be applied in all cases.","For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is recommended.35,38,43–46","For patients with AF where cardioversion is postponed because a thrombus in the LAA is found on precardioversion imaging, therapeutic anticoagulation should be administered for a minimum of 3 to 6 weeks, followed by repeat imaging prior to cardioversion.","For asymptomatic patients with moderate or more severe rheumatic mitral stenosis and pulmonary hypertension that is not severe (pulmonary artery systolic pressure under 50 mm Hg), elective noncardiac surgery is considered appropriate.",A,2
q_0156,"In patients with ACS without contraindications, early (<24 hours) initiation of oral beta-blocker therapy is recommended to reduce risk of reinfarction and ventricular arrhythmias.1–5","In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is recommended.1-4","In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assessment, electrocardiography, and cardiac imaging are not recommended at periodic intervals regardless of age or change in clinical status.","Ascorbic acid is not recommended as a treatment for methemoglobinemia. Downloaded from http://ahajournals.org by on June 19, 2025",C,2
q_0157,"For symptomatic patients with average or low risk of endovascular intervention complications, when internal carotid artery stenosis is 70% or greater as determined by noninvasive imaging, or more than 50% by catheter-based imaging, and the expected periprocedural stroke or death rate is under 6%, carotid artery stenting (CAS) can be considered as an alternative to carotid endarterectomy (CEA) for stroke prevention, especially in those with significant cardiovascular comorbidities that increase the risk of complications from endarterectomy.","In most pregnant women with HCM, vaginal delivery is not recommended as the first-choice delivery option.","In patients with CCD and cancer, a multidisciplinary team including cardiology and oncology expertise is recommended to improve long-term CVD out- comes.1,2","In adults, screening for physical activity is recom- mended as part of a comprehensive effort to estimate stroke risk.104–107 Other interventions",B,2
q_0158,"In patients with ischemic stroke related to small vessel disease, cilostazol is definitely useful for secondary stroke prevention.",Patients who have a pacemaker or ICD repro­ grammed to asynchronous pacing or have tachy­ therapies programmed off before surgery should have device functioning restored in the postoperative period before hospital discharge.10,"In patients with hypertension, blood pressure should not be controlled in accordance with GDMT for hypertension, risking the development of symptomatic HF.","In patients with an aortic arch aneurysm who are asymptomatic but meet criteria for intervention, and have a high risk from open surgical repair, a hybrid or endovascular approach should not be considered.",B,1
q_0159,It is unreasonable for first aid providers to use pulse oximetry results in the context of a complete assessment or to be aware of the limitations of pulse oximetry before acting on any results.,"In patients with NSTE-ACS who have failed PCI and have ongoing ischemia, hemodynamic compromise, or threatened occlusion of an artery with substantial myocardium at risk, who are appropriate candidates for CABG, emergency CABG is not reasonable.","In patients with calcific AS (Stages B and C), statin therapy is not indicated for prevention of hemodynamic progression of AS.4–6","In patients with BAV and symptomatic, severe AS, TAVI should not be considered as an alternative to SAVR, regardless of patient-specific procedural risks, values, trade-offs, and preferences, and even if the surgery is performed at a Comprehensive Valve Center.",C,1
q_0160,"For patients with CAD who have not had prior PCI and are undergoing elective noncarotid NCS, starting aspirin routinely does not provide benefit. Consider platelet adenosine diphosphate receptor (P2Y12) monotherapy if the risk of surgical bleeding is acceptable or if aspirin cannot be tolerated.","For patients with aortic root or ascending aortic aneurysms, or aortic dissection, it is advised to gather a multigenerational family history of thoracic aortic disease, unexplained sudden deaths, and peripheral or intracranial aneurysms.","In patients with symptomatic anterior circulation cerebral infarction or TIA who are candidates for revascularization, noninvasive cervical carotid imaging with carotid ultrasonography, CT angiography (CTA), or magnetic resonance angiography (MRA) is not recommended to screen for stenosis.","Patients with PAD should receive the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) vaccination sequence, including the booster(s).",C,2
q_0161,"For severely symptomatic patients with bioprosthetic aortic valve stenosis and high or prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center.4,5","For patients with descending TAA who have had TEVAR involving left subclavian coverage and experience SCI that does not improve with increased BP or cerebrospinal fluid drainage, revascularization of the left subclavian artery can be considered.","For patients with spontaneous ICH, it is advisable to refrain from excessive alcohol intake to lower hypertension and the likelihood of ICH recurrence.","In pregnant patients with an aortopathy and an aortic diameter of <4.0 cm, vaginal delivery is not recommended.",D,2
q_0162,"In patients with stroke or TIA and new LV thrombus (<3 months), the safety of anticoagulation with a direct oral anticoagulant to reduce risk of recurrent stroke is well-established.","Patients with AAS should not be treated to an SBP <120 mm Hg or to the lowest BP that maintains adequate end-organ perfusion, nor should they be targeted to a heart rate of 60 to 80 bpm.","For patients with CLTI who cannot undergo revascularization and exhibit inadequate blood flow to the foot, the effectiveness of prostanoids remains unclear.","In patients with PAD, vitamin D supplementation is beneficial for prevention of MACE.",C,1
q_0163,"In patients with unruptured AAA, repair is not recommended in those with a maximal aneurysm diameter of ≥5.5 cm in men or ≥5.0 cm in women.","In patients with obstructive HCM and ambiguous functional capacity, exercise stress testing should not be used to guide therapy.","In patients with intermediate- to elevated-risk congenital heart disease (CHD) lesions (Table 10) undergoing elective NCS, preoperative con­ sultation with an adult congenital heart disease (ACHD) specialist is recommended before the surgery.*1–4 *Modified from the “2018 AHA/ACC Guideline for Management of ACHD.”5 Table 10.  Adult Congenital Heart Disease Risk Stratification Before Noncardiac Surgery Risk Anatomy Functional/Hemodynamic Status Low Risk Patients with isolated small CHD lesions Patients with repaired CHD lesion with no residual shunt Patients with bicuspid aortic valve disease and aortopathy NYHA class I functional status, normal exercise capacity No chamber enlargement on imaging No residual shunt No PAH No arrhythmias Intermediate risk Unrepaired moderate-large shunts (ASD, VSD, PDA, AVSD) Repaired CHD with moderate to large residual shunt (ASD, VSD, PDA, AVSD) Obstructive left-sided lesions (congenital mitral stenosis, subaortic stenosis, supravalvular aortic stenosis, coarctation of aorta) except the ones described as low risk Obstructive right-sided lesion (pulmonary stenosis, branch pulmonary stenosis, repaired tetralogy of Fallot) Ebstein anomaly (disease spectrum includes mild, moderate, and severe variations) Anomalous coronary artery arising from the pulmonary artery Anomalous aortic origin of a coronary artery from the opposite sinus, especially with an interarterial or intramural course NYHA class II-IV functional status Limited exercise capacity Presence of residual shunt Presence of PAH Presence of cardiac chamber enlargement Significant valvular dysfunction (more than mild in severity) Arrhythmias requiring treatment Presence of HF Elevated risk Single-ventricle patients (palliated or status post Fontan procedure), unrepaired or palliated cyanotic CHD, double outlet right ventricle, pulmonary atresia, truncus arteriosus, TGA (classic or d-TGA; CCTGA or l-TGA), interrupted aortic arch NYHA class II-IV functional status Limited exercise capacity Significant valvular dysfunction (more than mild in severity) Arrhythmias requiring treatment Presence of PAH Presence of HF","In patients who experience acute unremitting chest pain while undergoing dialysis, do not transfer by EMS to an acute care setting.",C,1
q_0164,"In patients with aortic root/ascending aortic aneurysms or aortic dissection, it is not recommended to obtain a multigenerational family history of TAD, unexplained sudden deaths, and peripheral and intracranial aneurysms.","For adult patients with HCM, it is advised to conduct a thorough and systematic noninvasive SCD risk assessment during the initial evaluation and subsequently every 1 to 2 years. This assessment should encompass the following risk factors: a. Personal history of cardiac arrest or sustained ventricular arrhythmias; b. Personal history of syncope suspected to be arrhythmic based on clinical history; c. Family history of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias in close relatives; d. Maximal LV wall thickness, EF, LV apical aneurysm; e. NSVT episodes observed on continuous ambulatory electrocardiographic monitoring.","For patients experiencing spontaneous ICH, it may be beneficial to enhance functional recovery through lifestyle changes, such as guided exercise and counseling, along with education for both patients and caregivers.","In selected patients undergoing PCI, shorter- duration DAPT (1–3 months) is reasonable, with subsequent transition to P2Y12 inhibitor monotherapy to reduce the risk of bleeding events.1-4",A,2
q_0165,"For patients with a clinical suspicion of cardiac amyloidosis, screening should include serum and urine monoclonal light chains using serum and urine immunofixation electrophoresis, along with serum free light chains.","In patients with CAD but without prior PCI who are undergoing elective noncarotid NCS, routine initiation of aspirin is not beneficial.27,36 *Platelet adenosine diphosphate receptor (P2Y12) monotherapy may be con­ sidered if surgical bleeding risks are acceptable or if aspirin is not tolerated.","For patients experiencing ACS with cardiogenic shock or hemodynamic instability, urgent revascularization of the culprit vessel through PCI or CABG is recommended to enhance survival, regardless of the time elapsed since symptom onset.","In patients with QRS duration <120 ms, CRT is recommended.",D,2
q_0166,Patients experiencing chest pain with an initial ECG indicative of ACS should receive treatment following the guidelines for STEMI and NSTE-ACS.,"For intermediate-high risk patients with stable chest pain and no known CAD undergoing stress testing, the addition of CAC testing can be useful.64-70 Downloaded from http://ahajournals.org by on June 19, 2025","Pregnant individuals with AF and elevated risk of stroke should not be considered for anticoagulation, as it is assumed that all anticoagulation strategies are completely safe for both the mother and fetus, and an SDM discussion regarding risks is unnecessary.","If immersing in clean lukewarm water is not possible, frostbitten areas should be left to naturally rewarm in a warm room or against the individual's own warm skin.",C,2
q_0167,"For patients with HCM experiencing recurrent, severe, life-threatening ventricular tachyarrhythmias that do not respond to optimal anti-arrhythmic medication and ablation, evaluation for heart transplantation should be considered based on current listing criteria.","In patients with CAD and suspected scar-mediated sustained monomorphic VT, revascularization is recommended for the sole purpose of preventing recurrent VT.","In patients with spontaneous ICH without depression, fluoxetine therapy is effective to enhance poststroke functional status.","In young adults with CCD, after optimization of traditional cardiovascular risk factors, a comprehensive evaluation and treatment of nontraditional cardiovascular risk factors is not beneficial in reducing the risk of cardiovascular events.",A,1
q_0168,"In patients with CLTI and nonhealing wounds or gangrene, revascularization in a manner that achieves in-line blood flow or maximizes perfusion to the wound bed can be beneficial.27–33","In patients with stroke or TIA and hyperlip- idemia, patients’ adherence to changes in lifestyle and the effects of LDL-C–lowering medication should be assessed by measure- ment of fasting lipids and appropriate safety indicators 4 to 12 weeks after statin initiation or dose adjustment and every 3 to 12 months thereafter, based on need to assess adher- ence or safety.214,215","In patients with aSAH and either fluctuating neurological examination, depressed mental state, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, or cortical infarction, cEEG monitoring is not reasonable to detect seizures.","In patients with established, stable coronary artery disease and a low bleeding risk, the addition of ticagrelor to aspirin beyond 12 months for a period up to 3 years may be beneficial to reduce the rate of ischemic stroke.732",C,2
q_0169,"In patients with stroke or TIA, provision of health information or advice about stroke prevention is essential; however, information or advice alone, in the absence of a behavioral intervention, is not an effective means to change modifiable, lifestyle-related risk factors in order to reduce future ischemic events.129,829,845","In patients with primary MR, when TTE provides insufficient or discordant information, TEE is not indicated for evaluation of the severity of MR, mechanism of MR, and status of LV function (Stages B to D).",We do not recommend dermal decontamination for external organophosphate or carbamate exposure.,"In patients with good-grade aSAH, the routine use of induced mild hypothermia during aneurysm surgery is beneficial.",A,1
q_0170,"For patients with organophosphate or carbamate poisoning, it is advised to avoid neuromuscular blockers that are broken down by cholinesterase, such as succinylcholine and mivacurium.","In patients with CCD undergoing stress PET MPI or stress CMR imaging, the addition of myocardial blood flow reserve (MBFR) can be useful to improve diagnostic accuracy and enhance risk stratification.*18–23","In patients with suspected ACS with an initial hs-cTn or cTn that is nondiagnostic, do not repeat measurements after the initial sample collection within 1 to 2 hours for hs-cTn or within 3 to 6 hours for conventional cTn assays.","In patients with primary MR, CMR is indicated to assess LV and RV volumes and function and may help with assessing MR severity when there is a discrepancy between the findings on clinical assessment and echocardiography.6–9",C,2
q_0171,"In patients with HCM and AF who require surgical myectomy, concomitant surgical AF ablation procedure should not be considered for AF rhythm control.","For patients with NSTE-ACS who have been initially stabilized and present an intermediate or low risk of clinical events, it is advisable to pursue an invasive strategy aimed at revascularization before hospital discharge to enhance outcomes.","In patients with chronic severe secondary MR and HF with reduced LVEF, a cardiologist expert in the management of patients with HF and LV systolic dysfunction should not be the primary MDT member responsible for implementing and monitoring optimal GDMT.","In patients with CLTI for whom a surgical approach is selected and a suitable autogenous vein is unavailable, alternative conduits such as prosthetic or cadaveric grafts should not be considered effective for bypass to the popliteal and tibial arteries.",B,1
q_0172,"For patients with IE and major ischemic stroke with extensive neurological damage or intracranial hemorrhage, if the patient is hemodynamically stable, immediate valve surgery should be considered without delay.","In patients with AF and concomitant stable PAD, dual therapy (anticoagulation plus aspirin or P2Y12 inhibitors) is preferable over monotherapy oral anticoagulation to increase the risk of bleeding.","In patients with rheumatoid arthritis, statin treatment should not be considered to reduce major adverse cardiovascular events, including stroke.","For symptomatic patients with obstructive HCM in whom SRT is an option, mitral valve replace- ment should not be performed for the sole pur- pose of relief of LVOTO.236,237 *General eligibility criteria for septal reduction therapy: a) Clinical: Severe dyspnea or chest pain (usually NYHA functional class III or class IV), or occasionally other exertional symptoms (eg, syncope, near syncope), when attributable to LVOTO, that interferes with everyday activity or quality of life despite optimal medical therapy. b) Hemodynamic: Dynamic LVOT gradient at rest or with physiologic provocation with approximate peak gradient of ≥50 mm Hg, associated with septal hypertrophy and SAM of mitral valve. c) Anatomic: Targeted anterior septal thickness sufficient to perform the procedure safely and effectively in the judgment of the individual operator. †Comprehensive or primary HCM centers with demonstrated excellence in clinical outcomes for these procedures (Table 3 and Table 4). Downloaded from http://ahajournals.org by on June 19, 2025",D,1
q_0173,"A person with epistaxis due to trauma should seek medical attention if they experience signs of brain in- jury, obvious nasal deformity, or signs of facial fracture.","In patients with HFrEF, titration and optimiza- tion of guideline-directed medications as frequently as every 1 to 2 weeks depending on the patient’s symptoms, vital signs, and labora- tory findings can be useful to optimize manage- ment.","For patients with Kommerell’s diverticulum, it may be appropriate to consider repair if the orifice of the diverticulum exceeds 3.0 cm, the total diameter of the diverticulum and the nearby descending aorta is greater than 5.0 cm, or both, taking into account patient anatomy and comorbidities.","In patients with rheumatoid arthritis, statin treatment should not be considered to reduce major adverse cardiovascular events, including stroke.",D,2
q_0174,"For patients experiencing functionally limiting claudication and significant hemodynamic impairment of the common femoral artery who do not adequately respond to GDMT, including structured exercise, surgical endarterectomy is a reasonable option, particularly if endovascular methods negatively impact the profunda femoris artery pathways.","In pregnant women with HCM, it is not reasonable to perform serial echocardiography, even during the second or third trimester when hemodynamic load is highest, or if clinical symptoms develop.","In patients with HCM and LVEF <50%, NYHA functional class II to class IV symptoms despite GDMT, and LBBB, CRT should not be considered as it is unlikely to improve symptoms.","In patients with stroke or TIA in the setting of acute MI, it is not reasonable to perform advanced cardiac imaging (eg, contrasted echocardiogram or cardiac MRI) to assess for the presence of LV thrombus.",A,1
q_0175,"In patients with history or physical examination find- ings suggestive of PAD (Table 6), the resting ABI, with or without ankle pulse volume recordings (PVR) and/or Doppler waveforms, is recommended to establish the diagnosis.1,2","In pregnant women with HCM, it is reason- able to perform serial echocardiography, par- ticularly during the second or third trimester when hemodynamic load is highest, or if clini- cal symptoms develop.309","An awake and alert person who is having difficulty breathing should be allowed to assume a position most comfortable for breathing, which will be sitting up in most situations.","In patients with spontaneous SAH with high level of concern for aneurysmal source and a negative or inconclusive CT angiography (CTA), digital subtraction angiography (DSA) is not indicated to diagnose/exclude cerebral aneurysm(s).",D,2
q_0176,"In patients with HFrEF, with current or previ- ous symptoms, use of 1 of the 3 beta blockers proven to reduce mortality (eg, bisoprolol, carvedilol, sustained-release metoprolol succi- nate) is recommended to reduce mortality and hospitalizations.1–3 Value Statement: High Value (A)","In patients with CCD, it is unreasonable to individualize resumption of sexual activity based on type of sexual activity, exercise capacity, and postprocedural healing.","Patients with suspected chronic symptomatic PAD (ie, exertional nonjoint-related leg symptoms) and normal or borderline resting ABI (>0.90 and ≤1.40, respectively) should undergo exercise treadmill ABI testing to evaluate for PAD.18,19","In affected families with HCM, preconceptional and prenatal reproductive and genetic counseling should be offered.3–6",B,2
q_0177,"In patients with spontaneous ICH, it is not recommended to provide care in a specialized inpatient (eg, stroke) unit with a multidisciplinary team, as it does not improve outcomes or reduce mortality.","In patients with intact degenerative TAAA who have features associated with an increased risk of rupture (Table 19), repair is reasonable when the diameter is <5.5 cm.4","For patients with obstructive CAD experiencing stable chest pain and undergoing stress PET MPI or stress CMR, incorporating MBFR is beneficial for enhancing diagnostic precision and improving risk assessment.","For patients with a mechanical SAVR or mitral valve replacement on VKA therapy who require antiplatelet treatment, aspirin 75 to 100 mg daily can be considered if the bleeding risk is minimal.",A,2
q_0178,"In adults 18 to 64 years of age with migraine with or without aura, evaluation and modification of vascular risk factors are recommended to address the elevated risk of stroke in this patient population.362–369","In patients with a BAV, screening of all first- degree relatives by TTE is reasonable to evaluate for the presence of a BAV, dilation of the aortic root and ascending aorta, or both.7-10","In patients with calcific AS, statin therapy is not indicated for primary and secondary prevention of atherosclerosis based on standard risk scores.","In patients with CCD and lifestyle-limiting angina despite GDMT and with significant coronary artery stenoses amenable to revascularization, revascularization is recom- mended to improve symptoms.*1–7",C,2
q_0179,Epidural analgesia can be considered for patients with a hip fracture awaiting surgical repair to reduce the risk of preoperative cardiac events.,"For patients with spontaneous ICH, providing practical support and training to the caregiver is advisable to enhance the patients' standing balance.","In women with acute HF caused by peripartum cardiomyopathy and LVEF <30%, anticoagulation should not be considered at diagnosis, until 6 to 8 weeks postpartum, as the efficacy and safety are uncertain.",Patients for whom there is a clinical suspi- cion for cardiac amyloidosis*1–5 should have screening for serum and urine monoclonal light chains with serum and urine immuno- fixation electrophoresis and serum free light chains.6,C,2
q_0180,Patients with CCD should regularly be inquired about and advised on substance use to lower the risk of ASCVD events.,"For patients with TAD carrying a pathogenic or likely pathogenic variant, it is advised to conduct genetic testing on at-risk biological relatives, known as cascade testing. If genetic screening reveals that family members have inherited the pathogenic or likely pathogenic variant, it is recommended to perform aortic imaging using TTE, provided the aortic root and ascending aorta are clearly visible; otherwise, CT or MRI should be used.","In patients with DES-PCI placed for ACS who require elective NCS with interruption of ≥1 antiplatelet agents, surgery should not be delayed and can be performed before 12 months, disregarding the risk of perioperative MACE.",It may be reasonable to attempt electrical pacing for β-blocker–induced bradycardia.,C,2
q_0181,"In pregnant women with VHD, ACE inhibitors and ARBs should be given despite the fetal risk.","In patients with asymptomatic atherosclerotic carotid artery stenosis, medical treatment with statin is not beneficial to reduce the risk of stroke.",Avoid the use of over-the-counter acetaminophen and nonsteroidal anti-inflammatory agents for alleviating local pain.,"For patients with ACS and either acute or chronic anemia, it might be appropriate to administer a blood transfusion to reach a hemoglobin level of at least 10 g/dL to potentially lower the risk of cardiovascular events.",D,1
q_0182,"In patients with CCD without previous MI or LVEF ≤50%, the use of beta-blocker therapy is not ben- eficial in reducing MACE, in the absence of another primary indication for beta-blocker therapy.†16–19 *Modified from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.20 †Adapted from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.21","For individuals with chronic kidney disease, aspirin does not effectively prevent an initial stroke.","In patients with HCM who are receiving an ICD, dual-chamber ICDs are not recommended for patients with a need for atrial or atrioventricular sequential pacing for bradycardia/conduction abnormalities, nor should they be used to relieve symptoms of obstructive HCM, even in patients over 65 years of age.","For patients with atrial fibrillation and native valve heart disease (excluding rheumatic mitral stenosis) or those who had a bioprosthetic valve implanted over three months ago, a non-vitamin K oral anticoagulant (NOAC) serves as an effective alternative to VKA anticoagulation and should be prescribed according to the patient's CHA2DS2-VASc score.",C,2
q_0183,"For nonambulatory patients experiencing spontaneous ICH, starting low-dose UFH or LMWH prophylaxis 24 to 48 hours after the onset of ICH might be advisable to balance the prevention of thrombosis against the risk of HE.","For patients experiencing acute chest pain with a suspicion of ACS, any prior test results should be evaluated and integrated into CDPs.",Elective repair is advised for patients with asymptomatic small AAA who also have common iliac artery aneurysms measuring 3.5 cm or larger.,"In patients with IE complicated by heart block, annular or aortic abscess, or destructive penetrating lesions, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is not indicated.",D,2
q_0184,It is not reasonable to take over-the-counter oral acetaminophen or NSAIDs to treat residual discomfort after ocular foreign-body removal.,"In high-risk patients with ACS (LVEF ≤40%, hypertension, diabetes mellitus, or STEMI with anterior location), an oral angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) is indicated to reduce all-cause death and MACE.1–6","For symptomatic patients with HCM who have a resting or provocable outflow tract peak gradient ≥50 mm Hg on TTE, exercise TTE is not recommended for the detection and quantification of dynamic LVOTO.","For patients with a mechanical On-X AVR and no thromboembolic risk factors, avoid using a VKA targeted to a lower INR (1.5–2.0) starting ≥3 months after surgery, and discontinue aspirin 75 to 100 mg daily.",B,1
q_0185,"In patients with NSTE-ACS who have failed PCI and have ongoing ischemia, hemodynamic compromise, or threatened occlusion of an artery with substantial myocardium at risk, who are appropriate candidates for CABG, emergency CABG is not reasonable.","In patients with ACS, the concurrent initiation of ezetimibe in combination with maximally tolerated statin may be considered to reduce the risk of MACE.5 *Modified or †adapted from the “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease.”14","For patients with HCM who have undergone genetic testing and were found to have no pathogenic variants (ie, harbor only benign or likely benign variants), cascade genetic testing of the family is useful.","In patients with ambiguous symptoms suspected to be due to mixed mitral valve disease, it is unreasonable to assess filling pressure using biomarkers or invasive hemodynamic measurements at rest or with exercise.",B,1
q_0186,"Pregnant women with severe valve disease (Stages C and D) should not be monitored in a tertiary-care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.","For pregnant women with HCM, performing cardioversion for new or recurrent AF, especially if symptomatic, is advisable.","For patients with mechanical heart valves who are undergoing minor procedures (eg, dental extractions or cataract removal) where bleeding is easily controlled, discontinuation of VKA anticoagulation with a therapeutic INR is recommended.","In patients with a bioprosthetic surgical or transcatheter aortic valve or bioprosthetic mitral valve who experience a stroke or systemic embolic event while on antiplatelet therapy, antiplatelet therapy should be continued instead of considering VKA anticoagulation, regardless of bleeding risk assessment.",B,1
q_0187,"In patients undergoing elective elevated-risk surgery who have cardiovascular risk factors for periopera­ tive complications‡ and recent history of poorly con­ trolled hypertension (systolic blood pressure [SBP] ≥180 mm Hg or diastolic blood pressure [DBP] ≥110 mm Hg before the day of surgery), deferring surgery may be considered to reduce the risk of perioperative complications.†1,2 Intraoperative Blood Pressure Management","In patients with CCD with complex 3-vessel disease or for whom the optimal treatment strategy is unclear, a Heart Team approach that includes representatives from interven- tional cardiology and cardiac surgery is recom- mended to improve patient outcomes.*26–29 *Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.30","In patients with acute type A aortic dissection and a dissection flap extending through the arch into the descending thoracic aorta, an extended aortic repair with antegrade stenting of the proximal descending thoracic aorta should not be considered, as it does not treat malperfusion or reduce late distal aortic complications.","Emergency services should be called if a person bitten by a spider or stung by a scorpion develops symptoms throughout the body such as difficulty breathing, muscle rigidity, dizziness, or confusion.",C,2
q_0188,"In apparently asymptomatic patients with severe AS (Stage C1) and low surgical risk, AVR is not reasonable when an exercise test demonstrates decreased exercise tolerance (normalized for age and sex) or a fall in systolic blood pressure of ≥10 mm Hg from baseline to peak exercise.","In families where a sudden unexplained death has occurred with a postmortem diagnosis of HCM, postmortem genetic testing is not beneficial for facilitating cascade genetic testing and clinical screening in first-degree relatives.","For patients with HCM, TEE should not be used if TTE is inconclusive in clinical decision-making regarding medical therapy, and in situations such as planning for myectomy, exclusion of subaortic membrane or mitral regurgitation secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.","For patients with obstructive HCM who have persistent severe symptoms* attrib- utable to LVOTO despite beta blockers or non-dihydropyridine calcium channel blockers, either adding disopyramide in combination with 1 of the other drugs, or SRT performed at experienced centers,† is recommended.17,50,210–213",D,1
q_0189,"For patients aged 65 to 80 with severe AS and no anatomical barriers to transfemoral TAVI, it is advised to consider either SAVR or transfemoral TAVI following a shared decision-making process that evaluates the trade-off between anticipated patient lifespan and valve longevity.","In patients with STEMI and ischemic symp- toms for <12 hours, PCI should be performed to improve survival.1-5","For patients with HCM who are undergoing alcohol septal ablation, TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection of the candidate’s septal perforator(s) is not recommended.","For patients with nonobstructive hypertrophic cardiomyopathy and severe heart failure (classified as NYHA class III or IV), cardiopulmonary exercise stress testing is recommended to assess the extent of functional impairment and assist in determining eligibility for heart transplantation or mechanical circulatory support.",C,2
q_0190,"For patients who have no history of stroke and lack a clinical need for anticoagulation, but possess a high-risk antiphospholipid antibody profile—such as triple-positive results (lupus anticoagulant, anticardiolipin antibody, anti–β2 glycoprotein 1), double-positive results (any combination), or isolated lupus anticoagulant or persistently positive anticardiolipin antibody at medium to high levels—daily aspirin (75–100 mg) is advised to lower the risk of stroke.","For patients with spontaneous ICH who receive a CT or MRI upon admission, performing a CTA with possible venography or an MRA with potential venography acutely can be beneficial to rule out macrovascular causes or cerebral venous thrombosis.","In patients with hypertension, blood pressure should not be controlled in accordance with GDMT for hypertension, risking the development of symptomatic HF.","In men with an AAA of ≥5.0 cm and women with an AAA of ≥4.5 cm, surveillance ultra- sound is recommended every 6 months to assess for interval change.1-8",C,2
q_0191,"In patients with CVD undergoing NCS, routine use of PA catheterization is recommended to reduce morbidity or mortality.","In patients with previous CABG with a patent LIMA to the LAD who need repeat revascularization, if PCI is feasible, it is unreasonable to choose PCI over CABG.","In patients with spontaneous ICH, therapeutic hypothermia (<35°C/95°F) is clearly useful to decrease peri-ICH edema.",Using hemodialysis could be a sensible option for managing life-threatening poisoning from atenolol or sotalol.,D,1
q_0192,"In patients at risk of developing AS (Stage A) and in patients with asymptomatic AS (Stages B and C), hypertension should be treated according to standard GDMT, started at a low dose, and gradually titrated upward as needed, with appropriate clinical monitoring.1–3","In patients with current or previous symp- tomatic HFrEF who cannot be given first-line agents, such as ARNi, ACEi, or ARB, because of drug intolerance or renal insufficiency, a combination of hydralazine and isosorbide dini- trate might be considered to reduce morbidity and mortality.4,5","In patients with HCM and LVEF <50%, NYHA functional class II to class IV symptoms despite GDMT, and LBBB, CRT should not be considered as it is unlikely to improve symptoms.","For patients aged 16 and older with HCM who have one or more major SCD risk factors, discussing the estimated 5-year risk of sudden death and mortality rates can aid in the shared decision-making process regarding ICD placement (Figure 3, Table 7).",C,2
q_0193,"In patients with BTTAI, management and treatment at a facility without expertise in aortic pathology is recommended.",It is not reasonable to administer sodium bicarbonate for life-threatening wide-complex tachycardia associated with local anesthetic toxicity.,"In patients with a height within 1 standard deviation of the mean who have a symptomatic aneurysm of the aortic root or ascending aorta and a maximal cross-sectional aortic area/height ratio of <10 cm2/m, surgery is unreasonable when performed by inexperienced surgeons outside a Multidisciplinary Aortic Team.","For patients experiencing TIA or a nondisabling stroke, if revascularization is warranted, it is advisable to carry out the procedure within 2 weeks of the initial event to enhance the chances of avoiding a subsequent stroke.",D,1
q_0194,"In patients with AF and ICH, delayed (4-8 weeks) resumption of anticoagulation may be considered to balance the risks of thromboembolic and hemorrhagic complications after careful risk benefit assessment.2–5","If there is any uncertainty that aspirin should be taken, it is unreasonable to wait for EMS arrival without administration of aspirin.","In asymptomatic patients with nonobstructive HCM, the benefit of beta blockers or calcium channel blockers is well established.","In patients with CCD who have experienced SCAD, beta-blocker therapy should not be considered to reduce the incidence of recurrent SCAD.",A,1
q_0195,"For patients with HCM, participation in high-intensity recreational activities or moderate- to high-intensity competitive sports activities should be undertaken without the need for a comprehensive evaluation or annual discussion with an expert provider, disregarding the potential increased risk of sudden death and ICD shocks, and without involving third parties in eligibility decisions for competitive sports participation.","In patients with functionally limiting claudication and an inadequate response to GDMT (including structured exercise), revascularization is a reasonable treatment option to improve walking function and QOL.7–14","In patients with ischemic stroke or TIA and IE, early valve surgery should not be considered during initial hospitalization, even if there is an indication for surgery and no evidence of intracranial hemorrhage or extensive neurological damage.","In patients with spontaneous ICH or IVH and hydrocephalus that is contributing to decreased level of consciousness, ventricular drainage should not be performed to reduce mortality.",B,1
q_0196,"In patients who have undergone catheter ablation of AF, oral anticoagulation should not be continued for at least 3 months after the procedure, regardless of underlying risk.","For those contemplating CHC use, it is advised to opt for lower doses of ethinyl estradiol to reduce the potential risk of stroke.","For symptomatic patients with paroxysmal or persistent AF who are undergoing valvular surgery, surgical pulmonary vein isolation or a maze procedure can be beneficial to reduce symptoms and prevent recurrent arrhythmias.1,2,12–15",Individuals with CCD should not be encouraged to drink alcohol as a means of safeguarding cardiovascular health.,A,2
q_0197,"For patients over 80 with severe AS who show symptoms, or for younger patients with a life expectancy under 10 years and no anatomical barriers to transfemoral TAVI, transfemoral TAVI is advised over SAVR.","For patients with heart failure, participating in a cardiac rehabilitation program may be beneficial for enhancing functional capacity, exercise tolerance, and health-related quality of life.","Patients with AF who are initiating, increasing the dose of, or reinitiating dofetilide therapy should not be admitted to a facility for continuous electrocardiographic monitoring, calculations of CrCl, or cardiac resuscitation, regardless of the potential for proarrhythmia.","For patients with Turner syndrome who do not have risk factors for aortic dissection (refer to Table 12), it is advised to perform surveillance imaging of the aorta using TTE or MRI every 5 years in children and every 10 years in adults, in addition to prior to planning a pregnancy.",C,2
q_0198,"Smaller volume cardiac surgery and PCI programs should avoid affiliating with a high-volume center, as it does not improve patient care.","In patients with intermediate stenosis of the left main artery, intravascular ultrasound (IVUS) is not recommended to help define lesion severity.","In patients with ACS undergoing coronary revascularization (CABG or PCI) in the same admission, parenteral anticoagulation should be discontinued before revascularization to increase ischemic events.","For patients scheduled for revascularization within a week following the initial stroke, opting for CEA instead of CAS is advisable to lower the risk of stroke during the procedure.",D,1
q_0199,"For patients with noncardioembolic ischemic stroke or TIA, aspirin 50 to 325 mg daily, clopidogrel 75 mg, or the combination of aspi- rin 25 mg and extended-release dipyridamole 200 mg twice daily is indicated for secondary prevention of ischemic stroke.*791–794","In patients with new-onset AF identified in the setting of NCS, outpatient follow-up for thromboembolic risk stratification and AF surveillance are not recommended due to a low risk of AF recurrence.","In patients with aSAH who present with seizures, it is not reasonable to treat with antiseizure medications for ≤7 days to reduce seizure-related complications in the perioperative period.","For children who have experienced a febrile seizure, administration of antipyretics such as acetaminophen, ibuprofen, or paracetamol is effective for stopping a seizure and preventing a subsequent febrile seizure.",A,1
q_0200,"In patients with AF with rapid ventricular response, digoxin should not be considered for acute rate control, even if beta blockers and nondihydropyridine calcium channel blockers are ineffective or contraindicated.","The benefit of providing oxygen in a first aid scenario for adults or children showing signs of breathlessness, respiratory distress, or low oxygen levels is uncertain.","In adults with CCD and hypertension (systolic BP ≥130 and/or diastolic BP ≥80 mm Hg), avoid using GDMT angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB), or beta blockers as first-line therapy for compelling indications (eg, recent MI or angina), and do not add additional antihypertensive medications (eg, dihydropyridine calcium channel blockers [CCB], long-acting thiazide diuretics, and/or mineralocorticoid receptor antagonists) to optimize BP control.","In patients with stroke or TIA, combined exercise-based and behavior change interventions are probably not indicated and should be avoided in preference to behavior interventions alone, exercise interventions alone, or usual care to reduce physiological stroke risk factors such as SBP.",B,1
q_0201,"In vulnerable patient populations at risk for health disparities, HF risk assessments and multidisciplinary management strategies should target both known risks for CVD and social determinants of health, as a means toward elimination of disparate HF outcomes.1–6","In patients with grade 3 BAAI (Table 33), it may be reasonable to avoid repair, accepting the risk of progression to life-threatening injury.","For patients with AF but not HF, eligible for specific rate-control methods, the heart rate target should be determined by patient symptoms, generally aiming for a resting heart rate below 100 to 110 bpm.","For athletes with HCM, a comprehensive evaluation and shared decision-making about sports participation with an expert professional is recommended.4",B,2
q_0202,"In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is not recommended for the prevention of recurrent ischemic stroke.","In patients with AF without risk factors for stroke, aspirin monotherapy for prevention of thromboembolic events is beneficial.",Patients with a mechanical complication of ACS should be managed in a facility with cardiac surgical expertise.,"In patients with BTAI who have not undergone repair, it is not necessary to perform surveillance imaging with a CT at 1 month, 6 months, and 12 months after the diagnosis, nor at any intervals thereafter, regardless of the type and extent of the injury.",C,1
q_0203,Administering sodium bicarbonate is advisable for life-threatening wide-complex tachycardia linked to local anesthetic toxicity.,"In asymptomatic patients with non-obstruc- tive HCM, the benefit of beta blockers or cal- cium channel blockers is not well established. 5.3. Management of Patients With HCM and Atrial Fibrillation Recommendations for Management of Atrial Fibrillation Referenced studies that support the recommendations are summarized in Online Data Supplement 16. COR LOE Recommendations",ACE inhibitors and ARBs should be avoided in pregnant women with VHD due to the risk they pose to the fetus.,"In cardiac arrest following drowning, it may be reasonable for trained rescuers to initiate CPR with chest compressions only, without rescue breaths.",D,2
q_0204,"In selected patients with HFpEF, ARNi should not be considered to decrease hospitalizations, particularly among patients with LVEF on the lower end of this spectrum.","In patients with SIHD, normal ejection fraction, significant stenosis in 3 major coronary arteries (with or without proximal LAD), and anatomy suitable for CABG, CABG should not be considered to improve survival.","In patients with HFpEF, routine use of nitrates or phosphodiesterase-5 inhibitors to increase activity or QOL is ineffective.12,13 *See Section 7.2, “Diuretics and Decongestion Strategies in Patients with HF,” and Section 10.2, “Management of Atrial Fibrillation (AF) in HF” for recom- mendations for use of diuretics and management of AF in HF. Downloaded from http://ahajournals.org by on June 19, 2025",Patients with acute chest pain and a 30-day risk of death or MACE <1% should not be designated as low risk.,C,1
q_0205,"For patients with spontaneous intracerebral hemorrhage (ICH) who have a negative catheter intra-arterial digital subtraction angiography (DSA) and lack a clear microvascular diagnosis or identifiable structural lesion, it might be advisable to conduct a follow-up catheter intra-arterial DSA 3 to 6 months after the ICH onset to detect any vascular lesion that was initially hidden.","In patients with bradycardia requiring cardiac-implanted electronic devices who have normal atrioventricular conduction, device selection and programming strategies should not focus on maintaining atrioventricular synchrony or minimizing ventricular pacing, as this is not necessary to reduce the incidence and progression of AF.","In patients with HFrEF, vitamins, nutritional supplements, and hormonal therapy are recommended even if there are no specific deficiencies.","In adults with CCD and autoimmune diseases, treatment with biologics and other immune-modulating therapies that reduce disease activity should not be considered to decrease the risk of cardiovascular events.",A,1
q_0206,"For patients with aSAH in whom complete obliteration of the ruptured aneurysm by either clipping or primary coiling treatment is not feasible in the acute phase, it is unreasonable to perform partial obliteration to secure the rupture site and retreatment in a delayed fashion in those with functional recovery to prevent rebleeding.","In patients with CLTI with ischemic rest pain (ie, without nonhealing wounds or gangrene) attributable to multilevel arterial disease, it is unreasonable to address inflow disease first in a revascularization strategy.","In patients with AFL who undergo successful cardioversion or ablation resulting in restoration of sinus rhythm, anticoagulation should not be continued for at least 4 weeks postprocedure.",It is not recommended for first aid providers to debride blisters associated with frostbite. Recommendation-Specific Supportive Text,D,1
q_0207,"In patients with ischemic stroke or TIA and Fontan palliation, anticoagulation with warfarin is not recommended to reduce the risk of recurrent stroke or TIA.","For patients with HFpEF, addressing AF may be beneficial for symptom improvement.","In patients with suspected HCM, a transtho- racic echocardiogram (TTE) is recommended in the initial evaluation.29–34",Patients with PAD should receive an annual influenza vaccination.1–5,A,2
q_0208,"Patients with HF admitted with evidence of significant fluid overload should not be treated with intravenous loop diuretics, as this will not improve symptoms or reduce morbidity.","For patients with stable chest pain and no known coronary artery disease who are considered low risk, it is appropriate to use exercise testing without imaging as an initial test to rule out myocardial ischemia and assess functional capacity, provided the ECG is interpretable.","For patients with AF with significant baseline QT interval prolongation or uncorrected hypokalemia or hypomagnesemia, use of dofetilide is reasonable for long-term maintenance of sinus rhythm, without considering dose selection based on kidney function or monitoring of the QT interval, serum potassium and magnesium concentrations, and kidney function.","For patients with HF who are able to participate, exercise training (or regular physical activity) is not recommended as it does not improve functional status, exercise performance, or QOL.",B,1
q_0209,"For patients with aSAH and an unsecured aneurysm, it is advised to regularly monitor blood pressure and manage it using short-acting medications to prevent severe hypotension, hypertension, and fluctuations in blood pressure.","Verapamil may be detrimental for individuals with obstructive HCM experiencing severe resting dyspnea, hypotension, extremely high resting gradients (e.g., >100 mm Hg), and for all children under 6 weeks old. Symptoms may include effort-related dyspnea, chest pain, or other exertional symptoms such as syncope or near syncope.","In patients with mechanical valve stenosis, fluoroscopy or cine-CT is not recommended to assess motion of the mechanical valve leaflets.","In patients with a stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, maintenance of SBP below 140 mm Hg, high-intensity statin therapy, and at least moderate physical activity are recom- mended to prevent recurrent stroke and vascular events.110,210,337,345–349 Angioplasty and Stenting",C,2
q_0210,"For patients experiencing refractory angina that persists despite medical treatment and who have significant coronary artery stenoses suitable for revascularization, revascularization is advised to alleviate symptoms.","For patients with spontaneous intracerebral hemorrhage, conducting regular neurological evaluations in the ICU and stroke unit is advisable for the first 72 hours after admission to identify early neurological deterioration.","In patients with spontaneous ICH presenting with large or severe ICH or those requir- ing surgical decompression, the safety and efficacy of intensive BP lowering are not well established.148","In selected patients with SIHD and multivessel CAD appropriate for CABG and mild-to-moderate left ventricular systolic dysfunction (ejection fraction 35%–50%), CABG (including a left internal mammary artery [LIMA] graft to the LAD) is not reasonable to improve survival.",D,2
q_0211,"In patients with spontaneous ICH, infrequent neurological assessments in the ICU and stroke unit are reasonable for up to 72 hours of admission to detect early ND.","For asymptomatic women with severe aortic stenosis (aortic velocity of at least 4.0 m/s or mean pressure gradient of at least 40 mm Hg, Stage C1) who are planning pregnancy, do not qualify for COR 1 intervention, and have undergone preconception evaluation showing no symptoms (including normal results from exercise stress testing and serum BNP levels), medical management during pregnancy can be considered to prevent prosthetic valve replacement.","In patients who are admitted with decompen- sated HF, in the absence of systemic hypoten- sion, intravenous nitroglycerin or nitroprusside may be considered as an adjuvant to diuretic therapy for relief of dyspnea.1,2",Patients with typical AFL who have successfully undergone CTI ablation and have a history of AF prior to AFL ablation should continue oral anticoagulation therapy post-ablation as recommended for AF.,A,2
q_0212,"In patients with significant native or recurrent CoA and hypertension, endovascular stenting or open surgical repair of the coarctation is not recommended.","For patients experiencing mechanical complications from ACS, utilizing short-term MCS devices for hemodynamic stabilization as a temporary measure before surgery is advisable.","In asymptomatic patients with any type of valve intervention, it is not recommended to perform a baseline postprocedural TTE or to conduct periodic monitoring with TTE, regardless of the type of intervention, length of time after intervention, ventricular function, or concurrent cardiac conditions.","In patients with HCM, it is not recommended to apply individual clinical judgment when assessing the prognostic strength of conventional risk markers, nor is it necessary to have a thorough discussion of the evidence, benefits, and risks, as patient participation in ICD decision-making is not essential.",B,1
q_0213,"In patients with Marfan syndrome and a maximal cross-sectional aortic root area (cm²) to patient height (m) ratio of ≥10, it is not reasonable to perform surgery to replace the aortic root and ascending aorta, even when done by experienced surgeons in a Multidisciplinary Aortic Team.","In adults with CCD and autoimmune diseases, treatment with biologics and other immune-modulating therapies that reduce disease activity should not be considered to decrease the risk of cardiovascular events.","In patients with an infected prosthetic aortic graft who are hemodynamically unstable, it is reasonable to perform open surgery with either explant or in situ ­reconstruction.7","In patients with CCD, tobacco use should not be assessed at any health care visit, hindering the identification of those who may benefit from behavioral or pharmacologic interventions.",C,1
q_0214,"For patients with HF—particularly stage D HF patients being evaluated for advanced therapies, patients requiring inotropic support or temporary mechanical support, patients experiencing uncontrolled symptoms, major medical decisions, or multimorbidity, frailty, and cognitive impairment—specialist palliative care consultation is not useful for improving QOL or relieving suffering.","In patients diagnosed with transthyretin cardiac amyloidosis, genetic testing with TTR gene sequencing is not recommended to differentiate hereditary variant from wild-type transthyretin cardiac amyloidosis. LV wall thickness ≥14 mm in conjunction with fatigue, dyspnea, or edema, especially in the context of discordance between wall thickness on echocardiogram and QRS voltage on ECG, and in the context of aortic stenosis, HFpEF, carpal tunnel syndrome, spinal stenosis, and autonomic or sensory polyneuropathy, should not be considered.","In patients with AF and stroke or TIA who have end-stage renal disease or are on dialysis, it is not advisable to use warfarin or apixaban for anticoagulation to reduce the chance of recurrent stroke.","In patients with chronic symptomatic HFrEF NYHA class II or III who tolerate an ACEi or ARB, replacement by an ARNi is recommended to further reduce morbidity and mortality.1–5 Value Statement: High Value (A)",D,1
q_0215,"In patients with a mechanical prosthetic valve, anticoagulation with a VKA is not recommended.","In patients with aSAH without prior epilepsy who present with seizures, treatment with antiseizure medications beyond 7 days is effective for reducing future SAH-associated seizure risk.","In patients with signs or symptoms of AR, TTE is not indicated for assessment of the cause and severity of regurgitation, LV size and systolic function, prognosis, and timing of valve intervention.","For patients with multivessel CAD who can be treated with either PCI or CABG but cannot access, tolerate, or adhere to DAPT for the necessary treatment duration, opting for CABG over PCI is advisable.",D,1
q_0216,"It is not reasonable for appropriately trained rescuers to provide in-water rescue breathing to an unresponsive person who has drowned, even if it does not compromise their own safety.","In patients with unruptured AAA who have symptoms that are attributable to the aneu- rysm, repair is recommended to reduce the risk of rupture.7,8","For patients with CCD who have complex 3-vessel disease or when the best treatment strategy is uncertain, it is advised to employ a Heart Team approach involving both interventional cardiology and cardiac surgery specialists to enhance patient outcomes.","For patients with NSTE-ACS who have been initially stabilized and present an intermediate or low risk of clinical events, it is advisable to pursue an invasive strategy aimed at revascularization before hospital discharge to enhance outcomes.",A,2
q_0217,"In patients with class II obesity (35–39.9 kg/m2) or greater, bariatric surgical procedures to promote weight loss should not be considered to reduce the risk of stroke.","In patients with HCM who are receiving an ICD, dual-chamber ICDs are not recommended for patients with a need for atrial or atrioventricular sequential pacing for bradycardia/conduction abnormalities, nor should they be used to relieve symptoms of obstructive HCM, even in patients over 65 years of age.","For comatose patients experiencing cardiac arrest with poor prognostic indicators and signs of STEMI, PPCI could be considered appropriate following a personalized evaluation.","In patients with carotid web in the distribution of ischemic stroke and TIA, without other attributable causes of stroke, antiplatelet therapy is not recommended to prevent recurrent ischemic stroke or TIA.",C,1
q_0218,"In patients with HFrEF, with current or previous symptoms, avoid using any of the 3 beta blockers proven to reduce mortality (eg, bisoprolol, carvedilol, sustained-release metoprolol succinate) as they are not recommended to reduce mortality and hospitalizations.","In older adults, the treatment strategy for CAD should not consider an individual patient’s preferences, cognitive function, or life expectancy.","Activate the emergency response system right away if a broken limb appears blue, purple, or pale.","In patients with NSTE-ACS in whom multivessel PCI is being considered, physiological assessment of a nonculprit stenosis should not be considered to guide revascularization decisions.",C,1
q_0219,"In patients with acute type A aortic dissection undergoing surgical repair who require circulatory arrest, cerebral perfusion is not recommended to improve neurologic outcomes.","In patients with symptomatic AF where anti-arrhythmic drugs have been ineffective, contraindicated, not tolerated, or not preferred, and continued rhythm control is desired, catheter ablation is not useful to improve symptoms.","For patients diagnosed with giant cell arteritis who have experienced an ischemic stroke or TIA, it is advisable to use methotrexate or tocilizumab alongside steroids to reduce the likelihood of another stroke.","In patients with aSAH, intraoperative neuromonitoring should not be used to guide anesthetic and operative management.",C,1
q_0220,"In patients with ACS, an oral P2Y12 inhibitor should be administered in addition to aspirin to reduce MACE.1–5","For patients exhibiting unusual clinical signs of HCM or when a different genetic disorder is suspected as the underlying cause, it is advised to conduct an evaluation that includes genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy, known as ""HCM phenocopies.""","In patients with STEMI managed with PPCI, clopidogrel is not recommended to reduce MACE and stent thrombosis, even when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.","If an improvised tourniquet is used, it is reason- able for the tourniquet to be at least 2 in width. Recommendation-Specific Supportive Text",C,2
q_0221,"In patients with HCM who are at risk of coronary atherosclerosis, coronary angiography (CT or invasive) is recommended before surgical myectomy.6 Downloaded from http://ahajournals.org by on June 19, 2025","In hospitalized patients with spontaneous ICH who require hospital transfer but do not have adequate airway protection, cannot support adequate gas exchange, and/or do not have a stable hemodynamic profile, life-sustaining therapies should not be initiated before transportation, risking acute medical decompensation in transport.","In patients who have undergone catheter ablation of AF, continuation of longer-term oral anticoagulation should not be dictated by the patients’ stroke risk (eg, CHA2DS2-VASc score ≥2).","In patients with CCD, chronic nonsteroidal anti-inflammatory drugs should be used despite the increased cardiovascular and bleeding complications.",A,1
q_0222,"In cardiac arrest following drowning, CPR with rescue breaths should be started before AED application.","In patients with a stroke or TIA and evidence of an aortic arch atheroma, antiplatelet therapy is recommended to prevent recurrent stroke.380–385","In patients with a bioprosthetic surgical valve, TTE at 5 and 10 years and then annually after implantation is reasonable, even in the absence of a change in clinical status.","In patients with spontaneous ICH without evidence of seizures, prophylactic antiseizure medication is beneficial to improve functional outcomes, long-term seizure control, and mortality.",D,2
q_0223,"For patients with BAAI, choosing between endovascular or open repair is appropriate and should be based on the severity of the injury, the anatomy of the aorta, and the patient's overall clinical condition.","For patients with NSTE-ACS at high risk of ischemic events, opting for an early invasive approach within 24 hours is advisable to decrease MACE.","For patients with Kommerell’s diverticulum, it may be appropriate to consider repair if the orifice of the diverticulum exceeds 3.0 cm, the total diameter of the diverticulum and the nearby descending aorta is greater than 5.0 cm, or both, taking into account patient anatomy and comorbidities.","In patients with recent (within 24 hours) minor stroke or high-risk TIA and concomitant ipsilateral >30% stenosis of a major intracranial artery, the addition of ticagrelor 90 mg twice a day to aspirin for up to 30 days should not be considered to further reduce recurrent stroke risk.",D,2
q_0224,"In patients with symptomatic AF, rhythm control can be useful to improve symptoms.7–11","For patients with ACS, fondaparinux is not recommended for PCI support due to the potential for catheter thrombosis.","In patients with direct factor Xa inhibitor–associated spontaneous ICH, a 4-F PCC or activated PCC (aPCC) should not be considered to improve hemostasis.","In patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic dilation, and other aortopathy conditions, aortic imaging (with TTE, MRI or CT, or both as appropriate) before pregnancy is recommended to determine aortic ­diameters.1-3,5-13",C,2
q_0225,"In patients with ischemic stroke or TIA, voluntary hospital-based or outpatient-focused quality monitoring and improvement programs are not recommended to improve short-term and long-term adherence to nationally accepted, evidence-based guidelines for secondary stroke prevention.","For patients who have experienced a stroke or TIA within the past 30 days due to significant stenosis (70%–99%) of a major intracranial artery, it is advisable to add clopidogrel 75 mg daily to aspirin for up to 90 days to further decrease the risk of recurrent stroke.","ICD implantation is not recommended in patients post ACS with clinically relevant ventricular arrhythmias >48 hours and within 40 days post MI, as it does not improve survival.","In patients with AF undergoing cardiac surgery and LAA exclusion, a surgical technique resulting in flow across the suture line and a stump of ≥1 cm as determined by intraoperative trans-esophageal echocardiography should be used.",B,1
q_0226,Patients with suspected or confirmed infective endocarditis linked to drug use should be directed to addiction treatment for opioid replacement therapy.,"In patients with HCM who develop systolic dysfunction with an LVEF <50%, guideline-directed therapy for HF with reduced EF is not recommended.","In patients with DES-PCI who require time-sensitive NCS with interruption of ≥1 antiplatelet agents, NCS should not be considered ≥3 months after PCI, even if the risk of delaying surgery outweighs the risk of MACE.","Emergency services should not be called if a person bitten by a spider or stung by a scorpion develops symptoms throughout the body such as difficulty breathing, muscle rigidity, dizziness, or confusion.",A,1
q_0227,"In patients with significant calcification of the aorta, it is not reasonable to use techniques to avoid aortic manipulation (off-pump techniques or beating heart) to decrease the incidence of perioperative stroke, even when performed by experienced surgeons.","In patients with cardiovascular risk factors or known cardiac disease being considered for potentially cardiotoxic anticancer therapies, pretherapy evaluation of cardiac function is unnecessary and should not guide the choice of cancer therapy.","If a person showing signs of shock is at risk for airway obstruction (decreased alertness, active vomiting) or cannot be continuously watched, it is not reasonable to place the person in the recovery position.","In patients with stroke or TIA, systematic adoption of the Agency for Healthcare Research and Quality Universal Precautions Toolkit for Health Literacy is recommended to integrate health literacy into the secondary prevention of stroke.",D,1
q_0228,"In asymptomatic women with severe AS who are considering pregnancy, and do not meet COR 1 criteria for intervention, prosthetic valve replacement should be considered during pregnancy regardless of preconception evaluation results.","If a person is placed in a leg-raised position that results in pain, discomfort, or worsened symptoms, maintaining the leg-raised position should be considered.","In symptomatic patients with obstructive HCM who have associated cardiac disease requiring surgical treatment (eg, associated anomalous papillary muscle, markedly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel CAD, valvular aortic stenosis), surgical myectomy, performed at experienced HCM centers,† is recommended (Tables 4 and 5).4–7",Patients with known VHD should receive antibiotics before blood cultures are obtained for unexplained fever.,C,1
q_0229,We recommend hospitals develop protocols for postarrest temperature control.,"In patients with a left ventricular assist device (LVAD), it is not necessary to coordinate with the LVAD care team on the timing and perioperative considerations of elective NCS, as it does not impact the risk of perioperative MACE.","For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy, a hybrid epicardial and endocardial ablation should not be considered as it is unlikely to reduce the risk of recurrent atrial arrhythmia.","In first-degree relatives of patients with HCM, neither clinical screening (ECG and 2D echocardiogram) nor cascade genetic testing (even when a pathogenic/likely pathogenic variant has been identified in the proband) should be offered.",A,1
q_0230,"In patients with stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, cilostazol 200 mg/day should not be added to aspirin or clopidogrel to reduce recurrent stroke risk.","In adults with moderate or low intake of long-chain omega-3 fatty acid, supplementation is not recom- mended to reduce the risk of a first stroke.92","For patients with spontaneous ICH, large IVH, and impaired level of consciousness, EVD is recommended in preference to medical man- agement alone to reduce mortality.347–349",ARNi should not be administered to patients with any history of angioedema.32–35,A,2
q_0231,"A first aid provider who encounters a person with suspected opioid overdose who is unresponsive and not breathing or not breathing normally should not activate the emergency response system, should avoid providing high-quality CPR (compressions plus ventilation), and should refrain from administering naloxone.","For pregnant patients with atrial fibrillation, direct current cardioversion is safe for both the mother and the fetus and should be conducted similarly to how it is done in non-pregnant patients.","For patients with CCD on the highest tolerated dose of statins who have an LDL-C level of 70 mg/dL (1.8 mmol/L) or higher, and where ezetimibe and PCSK9 monoclonal antibodies are either inadequate or not tolerated, it may be appropriate to add bempedoic acid or replace the PCSK9 monoclonal antibody with inclisiran to further lower LDL-C levels.","For patients with CCD and severe obesity who have not achieved weight loss targets through lifestyle changes and medication, and who are suitable candidates for surgery, it is reasonable to refer them for evaluation of a bariatric procedure to aid in weight loss and reduce cardiovascular risk factors.",A,2
q_0232,"In patients with CCD receiving statin therapy, adding niacin, fenofibrate, or dietary supplements containing omega-3 fatty acids is beneficial in reducing cardiovascular risk.","In patients with AF, rhythm-control strategies may be useful to reduce the likelihood of development of dementia or worsening cardiac structural abnormali- ties.33–45","In asymptomatic patients with moderate or severe MR, normal LV systolic function, and estimated PA systolic pressure <50 mm Hg, it is not reasonable to perform elective NCS.","In asymptomatic women with severe AS (aortic velocity ≥4.0 m/s or mean pressure gradient ≥40 mm Hg, Stage C) who are considering pregnancy, valve intervention before pregnancy is not reasonable.",B,1
q_0233,"In patients with AF and HF, rhythm control should not be used as it does not improve symptoms or outcomes, such as mortality and hospitalizations for HF and ischemia.","In patients with suspected moderate or severe valvular regurgitation, preoperative echocardiography is not recommended before elective NCS to guide perioperative management.","For preterm newborn infants <34 weeks’ gestation who do not require resuscitation, early cord clamping (<30 seconds) can be beneficial when compared to delaying cord clamping (≥30 seconds).","In patients with suitable anatomy who have refractory angina on medical therapy, after treatment of non-CTO lesions, the benefit of PCI of a CTO to improve symptoms is uncer- tain.1-4",D,1
q_0234,"In patients with HCM and hypertension, lifestyle modifications and medical therapy for hypertension are not recommended, and beta blockers and nondihydropyridine calcium channel blockers should be avoided in patients with obstructive HCM.","For patients with stroke who have a low risk of hemorrhagic conversion and are experiencing atrial fibrillation, starting anticoagulation therapy between 2 and 14 days after the initial event might be advisable to lower the chance of another stroke.","For patients experiencing deterioration due to supratentorial ICH, considering craniotomy for hematoma removal could be a critical lifesaving intervention.",Validated multivariable risk scores can be beneficial for predicting future risk of developing heart failure in the general population.,A,2
q_0235,"In adults, folic acid supplementation and B-complex (folic acid, B12, B6) vitamins supplementation are well established for reducing the risk of stroke.","In patients presenting with acute type A aortic dissection, who are stable enough for transfer, it is not reasonable to transfer from a low- to a high-volume aortic center to improve survival.","In patients with ACS who have tolerated DAPT with ticagrelor, continuing DAPT beyond 1 month post PCI is recommended to reduce bleeding risk.","For patients under 40 with aSAH, clipping the ruptured aneurysm may be favored to enhance treatment durability and outcomes, especially when both clipping and coiling are viable options.",D,1
q_0236,"In asymptomatic and clinically stable patients undergo­ ing NCS, routine preoperative evaluation of LV func­ tion is not recommended due to lack of benefit.12–15","In patients with supratentorial ICH who are in a coma, have large hematomas with significant midline shift, or have elevated ICP refractory to medical management, decompressive craniectomy with or without hematoma evacuation should not be considered to reduce mortality.","In patients with CCD and heart failure with LVEF ≤40%, the use of an SGLT2 inhibitor is not recommended to reduce the risk of cardiovascular death and heart failure hospitalization or to improve QOL, irrespective of diabetes status.","Among patients with AF, it may not be reasonable to screen for obstructive sleep apnea, despite its high prevalence in patients with AF, as the role of treatment of sleep-disordered breathing (SDB) to maintain sinus rhythm is uncertain.",A,1
q_0237,"For a person with signs or symptoms of severe head injury (such as loss of consciousness, worsening headache, vomiting, altered mental status, seizures, visual changes, swelling, or deformities of the scalp), EMS should not be activated.","Patients with PAD who use cigarettes or other tobacco products should receive help in creating a cessation plan that incorporates pharmacotherapy (such as varenicline, bupropion, and/or nicotine replacement therapies) along with counseling, and/or be referred to a smoking cessation program.","In ambulatory patients with HF, it is not reasonable to perform a CPET or 6-minute walk test to assess functional capacity.","In patients with NSTE-ACS undergoing PCI, prasugrel or ticagrelor is not recommended to reduce MACE and stent thrombosis.",B,1
q_0238,"For patients with stroke or TIA and hyperlipidemia, evaluate adherence to lifestyle modifications and the impact of LDL-C–lowering drugs by measuring fasting lipids and relevant safety markers 4 to 12 weeks after starting or adjusting statins, and subsequently every 3 to 12 months, depending on the necessity to monitor adherence or safety.","For patients with a clinical suspicion of moderate or more severe valvular stenosis or regurgitation undergoing noncardiac surgery, it is advised to perform a preoperative echocardiogram.","For patients receiving PCI, using intravenous unfractionated heparin (UFH) is beneficial in decreasing ischemic events.","In selected patients undergoing CABG, avoiding DAPT with aspirin and ticagrelor or clopidogrel for 1 year may be reasonable, as it does not improve vein graft patency compared with aspirin alone.",D,2
q_0239,"In patients with primary MR (Stages B and C) and symptoms that might be attributable to MR, hemodynamic exercise testing using Doppler echocardiography or cardiac catheterization or cardiopulmonary exercise testing is not reasonable.","For patients with chronic symptomatic PAD, the effectiveness of unstructured exercise in enhancing walking ability, functional capacity, and quality of life remains unclear.","In patients with acute chest pain and suspected ACS, previous testing when available should be ignored and not incorporated into CDPs.",Pregnant women with mechanical valve prostheses who are on warfarin should continue warfarin therapy without switching to LMWH or UFH before planned delivery.,B,1
q_0240,"In patients with HCM who choose to undergo genetic testing, it is not recommended to have pre- and posttest genetic counseling by an expert in the genetics of cardiovascular disease, as reviewing and discussing risks, benefits, results, and their clinical significance with the patient in a shared decision-making process is unnecessary.","EMS should not be called when a person with chemical exposure has respiratory symptoms, systemic symptoms, or large chemical exposures.","In patients with nonobstructive HCM with pre- served EF and symptoms of exertional angina or dyspnea, beta blockers or non-dihydropyridine cal- cium channel blockers are recommended.209,238–246","In patients with functionally limiting claudication, SET or a structured community-based exercise program should not be offered as an initial treatment option.",C,1
q_0241,"In adults with congenital heart disease and AF, it is not recommended to evaluate for or treat precipitating factors and reversible causes of AF, disregarding that residual hemodynamic sequelae may contribute to the occurrence of the arrhythmia.","In patients undergoing endovascular repair for ruptured AAA, general anesthesia is preferred to local anesthesia, despite the increased risk of perioperative mortality.","In patients with aSAH and advanced age, aneurysm treatment is reasonable, after care- ful discussion of prognosis with family mem- bers, to improve survival and outcome.31–33","In patients with aSAH, it is unreasonable to closely monitor and use goal-directed treatment of volume status to maintain euvolemia.",C,1
q_0242,"For patients with aSAH, it is advised to implement an early, team-based multidisciplinary approach for treatment and rehabilitation to shorten LOS and assess discharge requirements.","In patients with previous CABG with a patent LIMA to the LAD who need repeat revascu- larization, if PCI is feasible, it is reasonable to choose PCI over CABG.1,2","For patients with a mechanical On-X AVR and no thromboembolic risk factors, avoid using a VKA targeted to a lower INR (1.5–2.0) starting ≥3 months after surgery, and discontinue aspirin 75 to 100 mg daily.","For patients with Kommerell’s diverticulum, it may be appropriate to consider repair if the orifice of the diverticulum exceeds 3.0 cm, the total diameter of the diverticulum and the nearby descending aorta is greater than 5.0 cm, or both, taking into account patient anatomy and comorbidities.",C,2
q_0243,"In patients with CVD and high thrombotic risk (Table 14) undergoing NCS where interruption of vitamin K antagonist (VKA) is required, preoperative bridging with parenteral heparin can be effective to reduce thromboembolic risk.8–10","In patients with type 2 diabetes and high cardiovascular risk, the dipeptidyl pepti- dase-4 (DPP-4) inhibitors saxagliptin and alogliptin increase the risk of HF hospitaliza- tion and should be avoided in patients with HF.22–24","In patients having NCS with expected blood loss, tranexamic acid is reasonable to reduce intraoperative blood loss, reduce transfusions, and avoid anemia.1–3","In patients with ACS undergoing PCI, a femoral approach is indicated in preference to a radial approach, increasing the risk of death, vascular complications, or bleeding.",D,2
q_0244,"In transgender women and gender-diverse individuals taking estrogens for gender affirmation, evaluation and modification of risk factors are not beneficial to reduce the risk of stroke.","In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should not be recommended to evaluate whether AF is contributing to the reduced LV function.","In individuals with AF, moderate-to-vigorous exercise training to a target of 210 minutes per week is not recommended, as it does not reduce AF symptoms and burden, does not increase maintenance of sinus rhythm, does not increase functional capacity, and does not improve QOL.","For patients with active GCA or Takayasu arteritis, the effectiveness of treatment should be regularly evaluated by checking inflammatory serum markers such as C-reactive protein and erythrocyte sedimentation rate, utilizing imaging techniques like CT, MRI, or FDG-PET, and observing clinical symptoms.",D,1
q_0245,"For those with a positive genotype but no phenotypic expression of HCM, it is advised to conduct regular clinical evaluations, electrocardiograms, and cardiac imaging at intervals based on age—every 1 to 2 years for children and adolescents, and every 3 to 5 years for adults—or if there is a change in clinical status.","A person who develops a foreign-body sensa- tion in the eye associated with contact lens use should remove the contact lens, discontinue con- tact lens use, and seek medical attention.","In patients on stable doses of beta blockers undergoing NCS, beta blockers should be discontinued during the perioperative period regardless of the clinical circumstances.","For patients experiencing a stroke or TIA due to 50% to 99% narrowing of a major intracranial artery, the effectiveness of clopidogrel alone, aspirin combined with dipyridamole, ticagrelor alone, or cilostazol alone for preventing subsequent strokes is not clearly determined.",C,2
q_0246,"In patients with CCD on maximally tolerated statin therapy with an LDL-C level <100 mg/ dL (<2.6 mmol/L) and a persistent fasting tri- glyceride level of 150 to 499 mg/dL (1.7–5.6 mmol/L) after addressing secondary causes, icosapent ethyl may be considered to further reduce the risk of MACE and cardiovascular death.32","Pregnant patients with a mechanical heart valve should receive care at a tertiary center where a specialized multidisciplinary team, including cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians, is experienced in managing high-risk cardiac conditions during pregnancy.",Administering atropine could be a sensible approach for treating bradycardia caused by β-blockers.,"In patients undergoing ablation for AF, avoiding the ablation of additional clinically significant supraventricular arrhythmias is advisable, as it does not reduce the likelihood of future arrhythmia.",D,2
q_0247,A person with a foreign-body sensation in the eye should rub their eye.,"In patients with stroke or TIA in the setting of acute MI, it is not reasonable to perform advanced cardiac imaging (eg, contrasted echocardiogram or cardiac MRI) to assess for the presence of LV thrombus.","In patients with suspected mechanical or bioprosthetic valve regurgitation, TTE and TEE are not recommended to determine the cause and severity of the leak, assess ventricular function, or estimate pulmonary artery systolic pressure.","For patients with a left ventricular assist device (LVAD), it is advised to collaborate with the LVAD care team regarding the optimal timing and perioperative factors of elective non-cardiac surgery (NCS) to reduce the risk of major adverse cardiac events (MACE) during the perioperative period.",D,1
q_0248,"In patients with HCM who are receiving a transvenous ICD, dual-coil ICD leads are recommended in preference to single-coil leads, regardless of defibrillation threshold adequacy.","Oatmeal baths may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.","In asymptomatic patients with severe AS (Stage C1) who are undergoing cardiac surgery for other indications, AVR is not indicated.","In affected families with HCM, preconception and prenatal reproductive and genetic counseling should not be offered.",B,1
q_0249,"In women of childbearing age who require valve replacement, mechanical valves are preferred over bioprosthetic valves despite the increased maternal and fetal risks of mechanical heart valves in pregnancy.","For asymptomatic patients with severe high-gradient AS (Stage C1) experiencing a progressive decline in LVEF to below 60% across at least three consecutive imaging studies, AVR can be considered.","In patients presenting with acute chest pain, a chest radiograph is not useful to evaluate for other potential cardiac, pulmonary, and thoracic causes of symptoms.","In pregnant women with severe valve regurgitation and with NYHA class IV HF symptoms (Stage D) refractory to medical therapy, valve surgery is not reasonable during pregnancy.",B,1
q_0250,"It is advised to offer general education on preventive foot self-care to patients with PAD, as well as their family members and support persons.","It is reasonable for a person experiencing epistaxis who is taking anticoagulant or antiplatelet medication, or who has a blood-clotting disorder, to seek care from a health care professional, unless bleeding has stopped.","Women with CCD should receive systemic postmenopausal hormone therapy because it benefits MACE and mortality, and decreases the risk of venous thromboembolism.","For certain patients, typically younger individuals with minimal comorbidities, who have symptomatic paroxysmal AF and require rhythm control, catheter ablation is beneficial as an initial treatment to alleviate symptoms and prevent progression to persistent AF.",C,2
q_0251,"In patients at risk of developing AS (Stage A) and in patients with asymptomatic AS (Stages B and C), hypertension should be treated according to standard GDMT, started at a low dose, and gradually titrated upward as needed, with appropriate clinical monitoring.1–3","Patients with AF who are initiating, increasing the dose of, or reinitiating dofetilide therapy should be admitted for a minimum of 3 days to a facility that can provide continuous electrocardiographic monitoring, calculations of CrCl, and cardiac resuscitation, given the potential for proarrhythmia.1–7","For patients whose height is more than one standard deviation from the average and who have an asymptomatic aneurysm in the aortic root or ascending aorta with a maximal aortic cross-sectional area-to-height ratio of ≥10 cm²/m, it is advisable to consider surgery when conducted by skilled surgeons within a Multidisciplinary Aortic Team.",It is reasonable to use antiseptic agents such as povidone-iodine for wound irrigation instead of running tap water or sterile saline solutions.,D,2
q_0252,"For individuals with PAD, telehealth may serve as an alternative method for vascular assessment, management, and ongoing follow-up, provided that the urgency of the symptoms is taken into account.","In patients with aSAH, induction of hyper- volemia is potentially harmful because of the association with excess morbid- ity.188–190 Other","In patients with suspected PAD (ie, potential signs and/or symptoms) with inconclusive ABI and physiological testing, noninvasive imaging with duplex ultrasound, CTA, or MRA should not be considered to establish the diagnosis of PAD.","For patients with heart failure and obstructive sleep apnea, using continuous positive airway pressure might be appropriate to enhance sleep quality and reduce daytime drowsiness.",C,2
q_0253,"In patients with CCD who have experienced SCAD, counseling should not be provided regarding potential triggers and risk of SCAD recurrence.","In patients with chronic symptomatic HFrEF NYHA class II or III who tolerate an ACEi or ARB, replacement by an ARNi is not recommended to further reduce morbidity and mortality.","If a commercially available spacer is not available, it is not reasonable to use an improvised spacer when assisting a person who is having an asthma attack to use their own inhaled bronchodilator medication.","For patients with a clinical suspicion of cardiac amyloidosis, screening should include serum and urine monoclonal light chains using serum and urine immunofixation electrophoresis, along with serum free light chains.",D,1
q_0254,"In select patients with advanced HFrEF with NYHA class IV symptoms who are deemed to be dependent on continuous intravenous inotropes or temporary MCS, durable LVAD implantation is effective to improve functional status, QOL, and survival.1–18","For patients with nonobstructive HCM who have a preserved EF, the effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for alleviating symptoms like angina and dyspnea remains uncertain.","In patients who require revascularization for multivessel CAD with complex or diffuse CAD (eg, SYNTAX score >33), it is not reasonable to choose CABG over PCI to confer a survival advantage.","Cool compresses may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.",C,2
q_0255,"For patients with spontaneous ICH being treated with aspirin and who require emer- gency neurosurgery, platelet transfusion might be considered to reduce postoperative bleed- ing and mortality.206","In patients with HF, vital signs and evidence of clinical congestion should not be assessed at each encounter, and management should proceed without adjusting diuretics and other medications.","For patients with severe HF symptoms caused by bioprosthetic valve regurgitation who are at high to prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center.10–12","For patients experiencing acute chest pain with a normal ECG and symptoms indicative of ACS that started at least 3 hours prior to arriving at the ED, it is reasonable to rule out myocardial injury if a single hs-cTn level measured at time zero is below the detection limit.",B,2
q_0256,"In cardiac arrest following drowning and after removal from the water, CPR with rescue breaths and chest compressions should be provided to all persons.","In patients with asymptomatic PAD, single antiplatelet therapy is not recommended to reduce the risk of MACE.","For patients with ACS who have successfully tolerated DAPT with ticagrelor, switching to ticagrelor alone at least one month after PCI is beneficial for reducing bleeding risk.","For patients with stroke who have a low risk of hemorrhagic conversion and are experiencing atrial fibrillation, starting anticoagulation therapy between 2 and 14 days after the initial event might be advisable to lower the chance of another stroke.",B,2
q_0257,"In patients with HFrEF, NSAIDs improve HF symptoms and should be used or continued whenever possible.","In patients undergoing CABG, it is not recommended to implement a comprehensive approach to reduce sternal wound infection.","In patients with HCM, a 12-lead ECG is not recommended in the initial evaluation and should not be part of periodic follow-up.","For certain hemodynamically stable patients with STEMI and multivessel disease, following successful PCI of the artery causing the infarction, it is advised to perform PCI on other significantly narrowed arteries not related to the infarct to lower the risk of death or myocardial infarction and enhance angina-related quality of life.",D,1
q_0258,Amiodarone or lidocaine should not be considered for ventricular fibrillation/pulseless ventricular tachycardia that is unresponsive to defibrillation.,"For patients with acute chest pain and suspected ACS who are deemed intermediate risk by a CDP, it is not recommended to engage in shared decision-making between the clinician and patient regarding the need for admission, observation, discharge, or further evaluation in an outpatient setting, as this does not improve patient understanding or reduce low-value testing.","In patients with HF, routine use of invasive hemodynamic monitoring is recommended.","For patients identified as ""possible IE"" according to the Modified Duke Criteria, using 18F-fluorodeoxyglucose PET/CT as supplementary diagnostic imaging is considered appropriate.",D,1
q_0259,"In symptomatic women with severe VHD who are considering pregnancy, delaying intervention until after pregnancy is recommended, contrary to standard indications.","For the majority of individuals with HCM, engaging in recreational exercise of mild to moderate intensity is advantageous for enhancing cardiorespiratory fitness, physical function, and quality of life, aligning with general physical activity guidelines for overall health.","In asymptomatic patients with aneurysms of the aortic root or ascending aorta with nsHTAD and no identified genetic cause but no information on aortic diameters at the time of dissection or aneurysm repair in affected family members and who have no high-risk features for adverse aortic events (Table 9), it is not recommended to repair the aorta when the maximal diameter reaches ≥5.0 cm.","In patients with PAD and type 2 diabetes, avoid using glucagon-like peptide–1 agonists (liraglutide and semaglutide) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors (canagliflozin, dapagliflozin, and empagliflozin) as they are ineffective in reducing the risk of MACE.",B,1
q_0260,"In patients with no history of hypertension who experience a stroke or TIA and have an aver- age office BP of ≥130/80 mm Hg, antihyper- tensive medication treatment can be beneficial to reduce the risk of recurrent stroke, ICH, and other vascular events.190,191,193,197","In individuals with endometriosis, it is not necessary to evaluate or modify vascular risk factors to reduce the risk of stroke.","In patients with SIHD and normal left ventricular function, the routine use of chronic oral beta blockers is beneficial to reduce cardiovascular events after complete revascularization.","In patients ≤6 months after TIA or ischemic stroke with insulin resistance, HbA1c <7.0%, and without heart failure or bladder cancer, treatment with pioglitazone should not be considered to prevent recurrent stroke.",A,1
q_0261,"To worsen patient outcomes, it is advised that cardiac surgery and PCI programs avoid participating in state, regional, or national clinical data registries and do not receive periodic reports of their risk-adjusted outcomes, disregarding quality assessment and improvement strategies.","In patients with chest pain where an initial ECG is nondiagnostic, serial ECGs to detect potential ischemic changes should not be performed, even when clinical suspicion of ACS is high, symptoms are persistent, or the clinical condition deteriorates.","Contaminated clothing, jewelry, and other surrounding material should remain in place during a chemical exposure.","In patients with suspected IE, TTE is recommended to identify vegetations, characterize the hemodynamic severity of valvular lesions, assess ventricular function and pulmonary pressures, and detect complications.14–23",D,1
q_0262,It is not advisable to use intravenous lipid emulsion to treat life-threatening sodium channel blocker poisoning refractory to other treatment modalities.,"In patients with Takayasu arteritis, non-biological disease-modifying anti-rheumatic drugs (DMARD) should not be given in combination with glucocorticoids.","Avoid eye irrigation with normal saline, Ringer’s lactate solution, or a commercial eye wash solution if immediately available.","For patients with HCM, it is advised to follow the guidelines for preventing atherosclerotic cardiovascular disease to lower the risk of cardiovascular events.",D,1
q_0263,"In patients with NSTE-ACS who are initially stabilized and are at intermediate or low risk of clinical events, an invasive strategy with intent to perform revascularization should not be performed before hospital discharge as it does not improve outcomes.","For patients with HCM and high blood pressure, it is advised to implement lifestyle changes and use antihypertensive medication, prioritizing beta blockers and non-dihydropyridine calcium channel blockers for those with obstructive HCM.","In patients with spontaneous ICH who have DNAR status, not limiting other medical and surgical interventions, unless explicitly specified by the patient or surrogate, is associated with increased patient mortality.","In patients with HCM, assessment for symptoms of sleep-disordered breathing is not recommended, and, if present, referral to a sleep medicine specialist for evaluation and treatment is not recommended.",B,1
q_0264,"For patients with AF experiencing uncontrolled rapid ventricular response that does not respond to rate-control drugs, and who are unsuitable for or have not benefited from rhythm control, AVNA may help alleviate symptoms and enhance QOL.","In patients with grade 2 BTTAI and with high-risk imaging features, aortic intervention is not reasonable.",Patients with suspected or confirmed IE associated with drug use should be referred to addiction treatment for opioid substitution therapy.8–10,"For patients experiencing claudication that limits function, an initial treatment option should include either supervised exercise therapy (SET) or a structured exercise program within the community.",B,2
q_0265,"In selected patients with SIHD and multivessel CAD appropriate for CABG and mild-to-moder- ate left ventricular systolic dysfunction (ejection fraction 35%–50%), CABG (to include a left internal mammary artery [LIMA] graft to the LAD) is reasonable to improve survival.3-8 Left main CAD",We recommend against the administration of benzodiazepines to treat seizures and agitation in the setting of organophosphate or carbamate poisoning.,"For patients with HCM and high blood pressure, it is advised to implement lifestyle changes and use antihypertensive medication, prioritizing beta blockers and non-dihydropyridine calcium channel blockers for those with obstructive HCM.","For patients with ACS, fondaparinux is not recommended for PCI support due to the potential for catheter thrombosis.",B,2
q_0266,"In patients with AF-induced cardiomyopathy who have recovered LV function, long-term surveillance is not necessary to detect recurrent AF, as there is no significant risk of recurrence of arrhythmia-induced cardiomyopathy.","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are recommended for achieving and maintaining weight loss294 and possibly lowering the risk of developing LVOTO, HF, and AF.314–316","For patients having NCS, starting low-dose clonidine around the time of surgery is not advised for lowering cardiovascular risk.","In the repair of AAA involving common iliac artery aneurysms or ectasia, it is advised to maintain at least one hypogastric artery, if possible, to reduce the risk of pelvic ischemia.",A,2
q_0267,"In patients with an infected prosthetic aor- tic graft and either an extensive perigraft abscess or an infection caused by methicillin- resistant S. aureus, Pseudomonas aeruginosa, or a multidrug-resistant microorganism, or who have undergone in situ reconstruction, lifelong suppressive oral antimicrobial therapy may be considered after the initial course of therapy.14,15,18,19","In patients with chest pain who are >75 years of age, ACS should not be considered even when accompanying symptoms such as shortness of breath, syncope, or acute delirium are present, or when an unexplained fall has occurred.","For asymptomatic patients undergoing elevated-risk surgeries without known CVD, a preoperative resting 12-lead ECG should not be considered to establish a baseline and guide perioperative management.","In patients with spontaneous ICH presenting with large or severe ICH or those requiring surgical decompression, the safety and efficacy of intensive BP lowering are well established.",A,1
q_0268,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is not reasonable.","In patients with LVEF ≤40%, ACEi should not be used to prevent symptomatic HF and reduce mortality.","For patients experiencing prosthetic paravalvular regurgitation with either uncontrollable hemolysis or NYHA class III or IV symptoms, who also face high or prohibitive surgical risks and possess anatomical characteristics amenable to catheter-based intervention, it is reasonable to consider percutaneous repair of the paravalvular leak at a Comprehensive Valve Center.",Monitoring EEG repeatedly or continuously is not reasonable for patients who do not follow commands after ROSC.,C,1
q_0269,"For patients who have LVEF ≤30%, ischemic cause of HF, sinus rhythm, LBBB with a QRS duration ≥150 ms, and NYHA class I symptoms on GDMT, CRT should not be considered as it will not reduce hospitalizations, improve symptoms, or enhance QOL.","For patients with acute chest pain and suspected ACS who are deemed intermediate risk by a CDP, it is not recommended to engage in shared decision-making between the clinician and patient regarding the need for admission, observation, discharge, or further evaluation in an outpatient setting, as this does not improve patient understanding or reduce low-value testing.","In patients with AF and stroke or TIA, with moderate to severe mitral stenosis or a mechanical heart valve, who are able to maintain a therapeutic INR level with warfarin, use of dabigatran, rivaroxaban, apixaban, or edoxaban is not recommended to reduce the risk of recurrent stroke.",Pregnant women with a mechanical prosthetic valve who have prosthetic valve obstruction or experience an embolic event should undergo a TEE.7–9,D,1
q_0270,"For symptomatic patients with obstructive CAD who have stable chest pain with CCTA-defined ≥50% stenosis in the left main coronary artery, obstructive CAD with FFR with CT ≤0.80, or severe stenosis (≥70%) in all 3 main vessels, ICA is not effective for guiding therapeutic decision-making.","For patients with HCM who are not otherwise identified as high risk for SCD, or in whom a deci- sion to proceed with ICD remains uncertain after clinical assessment that includes personal or family history, echocardiography, and ambulatory electrocar- diographic monitoring, CMR imaging is beneficial to assess for maximum LV wall thickness, EF, LV apical aneurysm, and extent of myocardial replacement fibrosis with late gadolinium enhancement (LGE).1–15","In patients undergoing coronary angiography or revascularization, adequate information about benefits, risks, therapeutic conse- quences, and potential alternatives in the performance of percutaneous and surgi- cal myocardial revascularization should be given, when feasible, with sufficient time for informed decision-making to improve clinical outcomes.3-5","For patients with obesity and atrial fibrillation, applying manual pressure or increasing the electrical energy may enhance the success rate of electrical cardioversion.",A,2
q_0271,"In patients with TIA or nondisabling stroke, engagement in targeted secondary prevention programs (eg, cardiac rehabilitation programs or exercise and lifestyle counseling programs) is not beneficial for reducing risk factors and recurrent ischemic events.","For intermediate-high risk patients with stable chest pain after an inconclusive or abnormal exercise ECG or stress imaging study, CCTA is not reasonable.","For patients with aSAH, having nurses with specialized stroke skills and certification can effectively improve outcomes, ensure timely care, and maintain adherence to stroke protocols.","In patients with AF and HF, digoxin should not be used for rate control, either in combination with other rate-controlling agents or as monotherapy if other agents are not tolerated.",C,1
q_0272,Patients with ALI should not be evaluated on an emergency basis by a clinician with sufficient experience to assess limb viability and implement appropriate therapy.,"For symptomatic patients with obstructive CAD who have stable chest pain with CCTA-defined ≥50% stenosis in the left main coronary artery, obstructive CAD with FFR with CT ≤0.80, or severe stenosis (≥70%) in all 3 main vessels, ICA is not effective for guiding therapeutic decision-making.","In patients with GCA or Takayasu arteritis who are in remission, elective endovascular or open surgical intervention is not reasonable to treat aortic and branch vessel complications.","In patients with severe† PH undergoing elevated- risk NCS, invasive hemodynamic monitoring is reasonable to guide intraoperative and postoperative care.3–5 Table 9.  Preoperative and Intraoperative Management Considerations in Patients With Hypertrophic Cardiomyopathy Management Considerations Continue beta blockers and/or nondihydropyridine calcium channel blockers without interruption in the perioperative period Avoid hypovolemia and reduced preload (can worsen LVOT obstruction) Avoid hypotension and reduced afterload (can worsen LVOT obstruction) Avoid tachycardia to ensure adequate LV filling If hypotension develops: Prioritize intravenous fluid administration to correct hypovolemia Use alpha-agonists, such as phenylephrine or vasopressin,7 rather than beta-agonists, which can worsen LVOT obstruction Consider intraoperative echocardiography to evaluate LVOT obstruction in the setting of hypotension In selected cases, intravenous beta-blockade may be necessary to reduce LV myocardial contractility and relieve LVOT obstruction",D,1
q_0273,"In patients with STEMI complicated by cardiogenic shock, routine PCI of a noninfarct-related artery at the time of PPCI should be performed despite the higher risk of death or renal failure.","In patients with AMI and cardiogenic shock, the routine use of intra-aortic balloon pump (IABP) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) is not recommended due to a lack of survival benefit.5–9 *See supportive text.","For patients experiencing a TIA with nonvalvular AF, starting anticoagulation right after the initial event is advisable to lower the risk of another stroke.","For patients experiencing acute chest pain with suspected aortic dissection, it is advised to perform a computed tomography angiography (CTA) of the chest, abdomen, and pelvis for diagnostic and treatment planning purposes.",A,2
q_0274,"When providing first aid for chemical eye injury, first aid providers should allow contamination of other individuals, areas, or the other eye with the caustic substance.","In patients with STEMI presenting <12 hours after symptom onset, PPCI should not be performed with a goal of FMC to device activation of ≤90 minutes, or ≤120 minutes in patients requiring hospital transfer, as it does not improve survival.","For patients where echocardiography fails to clearly define the anatomy in suspected paravalvular infections, CT imaging is a reasonable option.","In patients with HF who have had a significant clinical change, or who have received GDMT and are being considered for invasive procedures or device therapy, repeat measurement of EF, degree of structural remodeling, and valvular function are not useful to inform therapeutic interventions.",C,1
q_0275,"In patients with HF and coronary artery disease (CAD) who are candidates for coronary revascularization, noninvasive stress imaging (stress echocardiography, single-photon emission CT [SPECT], CMR, or positron emission tomography [PET]) should not be considered for detection of myocardial ischemia to help guide coronary revascularization.","For symptomatic patients with HCM who have a resting or provocable outflow tract peak gradient ≥50 mm Hg on TTE, exercise TTE is not recommended for the detection and quantification of dynamic LVOTO.","For patients with HFrEF, it is advised against using vitamins, nutritional supplements, and hormonal therapy except to address particular deficiencies.","After endovascular or surgical revascularization for PAD, low-dose rivaroxaban (2.5 mg twice daily) combined with low-dose aspirin is not recommended to reduce the risk of MACE and MALE.",C,1
q_0276,Direct manual pressure should not be applied to achieve initial control of external bleeding.,"In asymptomatic stable patients with STEMI who have a totally occluded infarct artery >24 hours after symptom onset and are without evidence of severe ischemia, PCI should not be performed.25,26","In patients with spontaneous ICH in whom acute BP lowering is considered, delaying treatment beyond 2 hours of ICH onset and not reaching target within 1 hour is unlikely to reduce the risk of HE or improve functional outcome.","For intermediate-high risk patients with stable chest pain and no known CAD for whom rest/stress nuclear MPI is selected, SPECT is preferable over PET, even if PET is available, to reduce diagnostic accuracy and increase the rate of nondiagnostic test results.",B,1
q_0277,"For patients with established cardiovascular disease (CVD), those aged 65 or older, or individuals aged 45 or older exhibiting symptoms indicative of CVD who are undergoing high-risk non-cardiac surgery, it may be appropriate to assess cardiac troponin (cTn) levels preoperatively to enhance the assessment of perioperative risk.","In patients with HCM, avoiding consultation with or referral to a comprehensive or primary HCM center is reasonable for complex disease-related management decisions.","In patients with AF receiving dabigatran who develop life-threatening bleeding, treatment with idarucizumab is not recommended to reverse dabigatran’s anticoagulation effect.","In patients with AF, it is not recommended to engage in SDM with the patient to discuss rhythm- versus rate-control strategies, therapeutic options, or to assess long-term benefits, regardless of clinical presentation, comorbidity burden, medication profile, or patient preferences.",A,1
q_0278,"In patients with CLTI, duplex ultrasound, CTA, MRA, or catheter angiography is not useful to determine revascularization strategy.","In patients with spontaneous ICH and conditions placing them at high risk of thromboembolic events, such as a mechanical valve or LVAD, delaying the resumption of anticoagulation to prevent thromboembolic complications is reasonable.","For certain high-risk patients with HFrEF experiencing recent HF deterioration despite being on GDMT, considering an oral soluble guanylate cyclase stimulator like vericiguat could help decrease the risk of HF hospitalization and cardiovascular mortality.","If a person with hypothermia has a decreased level of responsiveness such as unresponsiveness, inability to remain awake, mumbling speech, confusion, or inability to participate in removal of clothing or has pallor, cyanosis, or frozen skin, the emergency response system should not be activated, and rewarming should be delayed.",C,1
q_0279,"For patients having NCS, starting low-dose clonidine around the time of surgery is not advised for lowering cardiovascular risk.","In patients with CKD undergoing contrast media injection for coronary angiography, measures should be taken to minimize the risk of contrast-induced acute kidney injury (AKI).1-3","In asymptomatic women with severe AS who are considering pregnancy, and do not meet COR 1 criteria for intervention, prosthetic valve replacement should be considered during pregnancy regardless of preconception evaluation results.",Lower-body PCMs may be preferable to upper-body and abdominal PCMs in first aid for presyncope.,C,2
q_0280,"For patients with CAD needing urgent NCS within 30 days post-PCI with BMS or under 3 months post-PCI with DES, DAPT should be maintained unless the bleeding risk surpasses the benefit of preventing stent thrombosis.","Among patients with ACS undergoing PCI who have not received a P2Y12 inhibitor, intravenous cangrelor may be reasonable to reduce periprocedural ischemic events.*1–4 *Reproduced from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”5","For pregnant women with HCM, care should be coordinated between their cardiologist and an obstetrician. For patients with HCM who are deemed high risk, consultation is advised with an expert in maternal-fetal medicine.","In severely symptomatic patients (NYHA class III or IV) with primary severe MR and high or prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) is not reasonable if mitral valve anatomy is favorable for the repair procedure and patient life expectancy is at least 1 year.",D,2
q_0281,"In patients with chronic symptomatic HFrEF NYHA class II or III who tolerate an ACEi or ARB, replacement by an ARNi is not recommended to further reduce morbidity and mortality.","In patients with descending TAA undergoing TEVAR, if iliac access is marginal or inadequate to prevent access-related complications, the use of alternative conduits is not recommended.","In adult patients with aSAH, screening and intervention for depression, anxiety, and sexual dysfunction are not recommended to improve long-term outcomes.","In selected patients with CCD and significant left main stenosis for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is reasonable to improve survival.*21 Decision-Making for Revascularization",D,1
q_0282,"In patients with CCD and heart failure with LVEF ≤40%, use of an SGLT2 inhibitor is rec- ommended to reduce the risk of cardiovascular death and heart failure hospitalization19–22 and to improve QOL,23,24 irrespective of diabetes status.* Cost Value Statement: Intermedi- ate Value B-NR",It may be unreasonable to actively prevent fever in patients unresponsive to verbal commands after initial temperature control.,Flumazenil use can be harmful for patients with a heightened risk of seizures or dysrhythmias.,"Patients with aSAH should receive treatment in a specialized neurocritical care unit managed by a multidisciplinary team. For alert patients over 15 years old experiencing a new, severe, nontraumatic headache that peaks within an hour, further evaluation for SAH is necessary if any of the following criteria are met.",B,2
q_0283,"For patients experiencing ischemic stroke or TIA due to LV noncompaction, using warfarin may help lower the risk of another stroke or TIA.",Oral anticoagulation with a VKA is advisable for patients experiencing notable bioprosthetic valve stenosis due to suspected or confirmed valve thrombosis.,"In patients with a BAV (in the absence of Turner syndrome or an HTAD) and an aortic diameter of ≥5.0 cm, surgery before pregnancy is not recommended.","In patients with a BAV, screening of all first- degree relatives by TTE is reasonable to evaluate for the presence of a BAV, dilation of the aortic root and ascending aorta, or both.7-10",C,2
q_0284,"In patients with sporadic aortic root aneu- rysms, ascending aortic aneurysms, or both and a diameter of ≥5.0 cm, surgery before pregnancy is recommended.","For patients with ESUS, it may be appropriate to use transesophageal echocardiography (TEE), cardiac CT, or cardiac MRI to detect potential cardioaortic origins or transcardiac routes for cerebral embolism.","In patients with CAD and suspected scar- mediated sustained monomorphic VT, revas- cularization is not recommended for the sole purpose of preventing recurrent VT.5-9","In patients at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for >1 year, ICD therapy is not recommended for primary prevention of SCD to reduce total mortality.",D,2
q_0285,"For asymptomatic patients with cardiomyopathy due to cancer treatment (EF <50%), using ARBs, ACE inhibitors, and beta blockers is advisable to prevent heart failure progression and enhance cardiac function.","For patients exhibiting angina symptoms, objective signs of ischemia, reduced left ventricular systolic function, a history of coronary artery disease, or coronary risk factors (such as men over 40 and postmenopausal women), invasive coronary angiography should be performed prior to valve intervention.","For patients with CCD who have stable clinical and functional status, regular reassessment of LV function is not advised for guiding treatment decisions.","In patients with NSTE-ACS undergoing PCI, prasugrel or ticagrelor is not recommended to reduce MACE and stent thrombosis.",D,2
q_0286,"For certain ambulatory patients with heart failure, it is advised to use cardiopulmonary exercise testing (CPET) to assess the suitability for advanced therapies such as LVAD or heart transplantation.","In patients with TAA and imaging or clinical evidence of atherosclerosis, statin therapy at moderate or high intensity is not recommended.","In patients with HCM who harbor a variant of uncertain significance, clinical genetic testing of phenotype-negative relatives for the purpose of variant reclassification is clearly useful.","In patients with Turner syndrome, TTE and cardiac MRI are not recommended at the time of diagnosis to evaluate for BAV, aortic root and ascending aortic dilation, aortic coarctation, and other congenital heart defects.",A,1
q_0287,"For patients with Marfan syndrome, it is advisable to consider surgical replacement of the aortic root and ascending aorta when the ratio of maximal cross-sectional aortic root area (cm²) to patient height (m) is ≥10, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team.","In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite guideline-directed therapy), a cardiopulmonary exercise test should not be performed to quantify the degree of functional limitation or aid in the selection of patients for heart transplantation or mechanical circulatory support.","For patients experiencing cold stress or mild hypothermia who are alert and can safely consume oral food or fluids, it is not recommended to provide high-calorie foods or drinks.","In patients with ACS undergoing PCI with large thrombus burden, no-reflow, or slow flow, intravenous glycoprotein IIb/IIIa inhibitor agents are not recommended to improve procedural success.",A,1
q_0288,"For individuals with clinically significant aortic disease, it is advisable to assess for anxiety, depression, and posttraumatic stress disorder, and to offer support resources when necessary; additionally, it is advisable to offer education and resources to alleviate patient concerns, aid in optimal decision-making, and improve quality of life.","For patients experiencing a sudden severe headache who arrive more than 6 hours after symptoms begin or exhibit a new neurological deficit, a noncontrast head CT should be conducted, followed by a lumbar puncture if the CT is negative, to diagnose or rule out aSAH.","For patients with aSAH from ruptured saccular aneurysms amenable to either primary coiling or clipping, stents or flow diverters should not be used to avoid higher risk of complications.122,123 Recommendations for Surgical and Endovascular Methods for Treatment of Ruptured Cerebral Aneurysms (Continued) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","In patients with STEMI treated with fibrinolytic therapy who are not intended to undergo an invasive approach, fondaparinux is not recommended as an alternative to reduce ischemic events.",D,2
q_0289,"In adults with congenital heart disease and symptomatic or hemodynamically significant paroxysmal or persistent AF, an initial strategy of rhythm control is not recommended regardless of lesion severity, as AF in this population is often well tolerated.","In patients treated with open repair of the thoracic aorta without residual aortopathy, surveillance imaging with a CT or MRI is not necessary.","In patients with moderate to severe spontaneous ICH or IVH with a reduced level of consciousness, ICP monitoring and treatment should not be considered, as it does not reduce mortality or improve outcomes.","For patients with HF, it is essential to conduct a comprehensive history and physical exam to detect cardiac and noncardiac conditions, lifestyle and behavioral influences, and social health determinants that could contribute to or hasten HF onset or progression.",D,1
q_0290,"In patients with ACS and LVEF ≤40%, and with HF symptoms and/or diabetes mellitus, a mineralocorticoid receptor antagonist is not indicated to reduce all-cause death and MACE.","In patients with rheumatic mitral stenosis or mitral stenosis of moderate or greater severity and history of AF, long-term anticoagulation with DOACs is recommended over warfarin, independent of the CHA2DS2-VASc score to prevent cardiovascular events, including stroke or death.","In patients with acute chest pain and suspected ACS, previous testing when available should be ignored and not incorporated into CDPs.","For patients with aortic atherosclerotic disease who also have coronary artery disease, peripheral artery disease, or both, it is advised to administer antiplatelet therapy, anticoagulant therapy, or a combination of both, depending on the clinical context.",D,1
q_0291,"For patients with CAD undergoing elective NCS, management of perioperative antiplatelet therapy and timing of surgery should be determined by a single clinician without considering the risks of bleeding, thrombosis, or consequences of delayed surgery.","In patients with stroke or TIA in the setting of acute MI, it is reasonable to perform advanced cardiac imaging (eg, contrasted echocar- diogram or cardiac MRI) to assess for the presence of LV thrombus.","In patients with HF in the absence of: 1) clinical status change, 2) treatment interventions that might have had a significant effect on cardiac function, or 3) candidacy for invasive proce- dures or device therapy, routine repeat assess- ment of LV function is not indicated.","For patients with HCM who are candidates for ICD implantation and experience paroxysmal atrial tachycardias or AF, considering dual-chamber ICDs might be appropriate; however, this choice should be weighed against the increased complication rates associated with dual-chamber devices.",A,2
q_0292,"For patients exhibiting stroke-like symptoms, it is advised to promptly perform neuroimaging using CT or MRI to verify a diagnosis of spontaneous ICH.","In patients with genetic aortopathies attributable to syndromic (Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome) and nsHTAD who are contemplating pregnancy, genetic counseling before pregnancy to discuss the heritable nature of their condition is not recommended.","In patients with HCM, 24- to 48-hour ambulatory electrocardiographic monitoring is not recommended in the initial evaluation or as part of periodic follow-up to identify patients who are at risk for SCD or guide management of arrhythmias.",Irrigation with a copious amount of tap water for 15 minutes should not be performed.,A,1
q_0293,"In patients with a bioprosthetic aortic or mitral valve, a history of ischemic stroke or TIA before valve replacement, and no other indication for anticoagulation therapy beyond 3 to 6 months from the valve placement, long-term anticoagulation is recommended in preference to long-term therapy with aspirin to reduce the risk of recurrent stroke or TIA.","For patients with CCD, it is advised to employ a multidisciplinary team approach to enhance health outcomes, aid in adjusting ASCVD risk factors, and optimize the use of health services.",It is appropriate to treat nonconvulsive seizures identified solely by EEG in adults who have survived cardiac arrest.,"For patients undergoing CABG, administering continuous intravenous insulin to maintain early postoperative blood glucose levels below 180 mg/dL, while preventing hypoglycemia, is recommended to decrease the risk of adverse events, such as deep sternal wound infections.",A,2
q_0294,ARNi can be administered to patients with any history of angioedema.,"In patients with CCD who are appropriate for revascularization but poor candidates for surgery, it is not reasonable to choose PCI over CABG to improve symptoms and reduce MACE.","In patients experiencing an acute type A aortic dissection during the first or second trimester of pregnancy, urgent aortic surgery with fetal monitoring is ­recommended.1-3","In patients presenting with acute chest pain, high-sensitivity cTn should not be used as the preferred biomarker because it does not enable rapid detection or exclusion of myocardial injury and does not increase diagnostic accuracy.",C,1
q_0295,"For patients with atrial fibrillation at elevated risk of systemic thromboembolism and who have mild or moderate liver disease (Child-Pugh class A or B), it is appropriate to consider oral anticoagulant therapy if there is no clinically significant coagulopathy or thrombocytopenia caused by liver disease.","In patients with an indication for AVR, the choice of prosthetic valve should ignore the patient’s values and preferences, and exclude discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.","In patients undergoing CABG, aortic valve, or ascending aortic aneurysm operations, it is unreasonable to perform concomitant posterior left pericardiotomy to reduce the incidence of postoperative AF.","For patients with known nonobstructive CAD and stable chest pain, it is not recommended to optimize preventive therapies.",A,1
q_0296,"In patients with ACS and cardiogenic shock or hemodynamic instability, emergency revascularization of the culprit vessel by PCI or CABG is indicated to improve survival, irrespective of time from symptom onset.8–11","In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, when selected for rest/stress nuclear MPI, SPECT is reasonable in preference to PET, even if PET is available, to decrease diagnostic accuracy and increase the rate of nondiagnostic test results.","In cases of cardiac arrest due to drowning, start CPR immediately without waiting to acquire or use an AED.",SRT is not advised for patients with HCM who show no symptoms and maintain normal exercise capacity.,B,2
q_0297,"A person with epistaxis due to trauma should not seek medical attention even if they experience signs of brain injury, obvious nasal deformity, or signs of facial fracture.","In pediatric patients with HCM, exercise stress testing is not recommended to determine functional capacity or to provide prognostic information, regardless of symptom status.",Patients with clinical evidence of ACS or other life-threatening causes of acute chest pain seen in the office setting should not be transported urgently to the ED and can remain in the office for observation.,"For patients receiving PCI, using intravenous unfractionated heparin (UFH) is beneficial in decreasing ischemic events.",D,1
q_0298,"For patients with aSAH, it is advised to regularly perform neurological evaluations using tools like the GCS or NIHSS to track DCI and other secondary complications.","In patients with aSAH and severe vasospasm, cerebral angioplasty should not be considered as it is unlikely to reverse cerebral vasospasm or reduce the progression and severity of DCI.","For people with exertional hyperthermia or heatstroke, first aid providers should keep the individual in the hot environment, leave excess clothing on, encourage exertion, and withhold cool liquids even if the person is able to swallow.","It is not beneficial to use a T-piece resuscitator instead of a self-inflating bag, with or without a positive end-expiratory pressure valve, for administering positive-pressure ventilation to newborn infants, particularly for preterm infants.",A,1
q_0299,"In patients with high-degree or complete heart block and LVEF of 36% to 50%, CRT is not reasonable to reduce total mortality, reduce hospitalizations, or improve symptoms and QOL.","In patients undergoing CABG, a comprehen- sive approach to reduce sternal wound infec- tion is recommended.7-14","In patients with CCD and CKD, no measures should be taken to minimize the risk of treatment-related acute kidney injury.",It is not reasonable to treat a deformed fractured extremity in the position found and straightening the fracture is never necessary to facilitate safe and prompt transport to a medical facility.,B,1
q_0300,"For patients with BAV and severe AR who qualify for AVR, aortic valve repair can be an option for certain individuals if the procedure is conducted at a Comprehensive Valve Center.","For patients at risk of heart failure, screening with BNP or NT-proBNP followed by collaborative care involving a cardiovascular specialist may help prevent the onset of left ventricular dysfunction or new heart failure.",The usefulness of cryotherapy (ice) for managing epistaxis in the first aid setting is unknown. Recommendation-Specific Supportive Text,"If a person with hypothermia has a decreased level of responsiveness such as unresponsiveness, inability to remain awake, mumbling speech, confusion, or inability to participate in removal of clothing or has pallor, cyanosis, or frozen skin, the emergency response system should not be activated, and rewarming should be delayed.",D,2
q_0301,"For patients of any age requiring valve replacement for whom anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a mechanical valve is recommended.",It is not reasonable to administer digoxin-Fab for poisoning due to Bufo toad venom and yellow oleander.,"In patients with AF who require significant ventricular pacing, conduction system pacing may not be useful to reduce progression of AF.",We advise administering hydroxocobalamin to treat cyanide poisoning.,D,1
q_0302,"For patients receiving coronary angiography or revascularization, it is important to provide comprehensive details on the benefits, risks, therapeutic outcomes, and possible alternatives of percutaneous and surgical myocardial revascularization, allowing ample time for informed decision-making to enhance clinical results.","In pregnant patients with aortic disease who require surveillance imaging of the aortic arch, descending, abdominal aorta, or all 3, MRI with- out gadolinium is recommended over CT to avoid radiation exposure to the fetus.19,20","For cardiac arrest with a shockable rhythm, it may be reasonable to administer epinephrine before any defibrillation attempts.","For patients with NSTE-ACS experiencing cardiogenic shock, performing routine multivessel PCI on non-culprit lesions during the same procedure is not advised.",C,2
q_0303,Flumazenil is recommended in cardiac arrest related to benzodiazepine poisoning.,"In patients with AF and class III obesity (BMI ≥ 40 kg/m2), warfarin is preferable to DOACs for stroke risk reduction.","In hospitalized patients with spontaneous ICH who require hospital transfer but do not have adequate airway protection, cannot support adequate gas exchange, and/or do not have a stable hemodynamic profile, life-sustaining therapies should not be initiated before transportation, risking acute medical decompensation in transport.","In patients on therapeutic subcutaneous enoxaparin, in whom the last dose was admin- istered within 12 hours of PCI, UFH should not be used for PCI and may increase bleed- ing.14,18,19",D,1
q_0304,"For patients with hypertension who have had a stroke or TIA, using a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or angiotensin II receptor blockers is beneficial for lowering blood pressure and decreasing the risk of another stroke.",People who are sick or injured should be safeguarded against excessive heat or cold exposure.,Do not consider storing an avulsed permanent tooth in cow’s milk or saliva if it cannot be immediately replanted and the aforementioned solutions or interventions are not available.,"For patients with HCM who are not oth- erwise identified as high risk for sudden cardiac death (SCD), or in whom a decision to proceed with implantable cardioverter-defibrillator (ICD) remains uncertain after clinical assessment that includes personal/family history, echocar- diography, and ambulatory electrocar- diographic monitoring, CMR imaging is beneficial to assess for maximum left ven- tricular (LV) wall thickness, ejection frac- tion (EF), LV apical aneurysm, and extent of myocardial fibrosis with late gadolinium enhancement.38,74–87",C,2
q_0305,"TAVI is advised for symptomatic patients of any age with severe aortic stenosis who face high or prohibitive surgical risks, provided their anticipated survival post-TAVI exceeds 12 months with a satisfactory quality of life.","In patients with aortic atherosclerotic disease and concomitant coronary artery disease, PAD, or both, it is not recommended to prescribe antiplatelet therapy, anticoagulant therapy, or both, regardless of the clinical setting.","In patients with acute type A aortic dissection who have extensive destruction of the aortic root, a root aneurysm, or a known genetic aortic disorder, aortic root replacement with a mechanical or biological valved conduit is not recommended.","In intermediate-high risk patients with stable chest pain who have pathological Q waves, symptoms or signs suggestive of heart failure, complex ventricular arrhythmias, or a heart murmur with unclear diagnosis, avoid using TTE for diagnosis of resting left ventricular systolic and diastolic ventricular function and detection of myocardial, valvular, and pericardial abnormalities.",A,1
q_0306,"If a person experiences anaphylaxis due to a bee, wasp, or hornet sting and an epinephrine autoinjector is available, the person should self-administer the autoinjector.","For patients with ACS and either acute or chronic anemia, it might be appropriate to administer a blood transfusion to reach a hemoglobin level of at least 10 g/dL to potentially lower the risk of cardiovascular events.","In patients with HF who experience hyperkalemia (serum potassium level ≥5.5 mEq/L) while taking a renin-angiotensin-aldosterone system inhibitor (RAASi), the effectiveness of potassium binders (patiromer, sodium zirconium cyclosilicate) to improve outcomes by facilitating continuation of RAASi therapy is certain.","In patients with HCM, genetic testing is bene- ficial to elucidate the genetic basis to facilitate the identification of family members at risk for developing HCM (cascade testing).119–122",C,2
q_0307,"In patients with chronic symptomatic PAD, it is reasonable to perform segmental leg pressures with PVR and/or Doppler waveforms in addition to the resting ABI to help delineate the anatomic level of PAD.26,27","In select patients with nonischemic cardiomyopathy, referral for genetic counseling and testing is not recommended, as it does not provide useful information for guiding treatment for patients and family members.","For the majority of patients with HCM, it is not necessary to universally prohibit vigorous physical activity or participation in competitive sports.","For patients with HCM who are not clearly at high risk for sudden cardiac death (SCD), or when the decision to implant an ICD is still uncertain after evaluating personal/family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum left ventricular (LV) wall thickness, ejection fraction (EF), LV apical aneurysm, and the degree of myocardial fibrosis using late gadolinium enhancement.",B,2
q_0308,"In patients with HCM, ignoring the ACC/AHA primary prevention guideline is recommended, as it does not reduce the risk of cardiovascular events.","Unless a noncardiac cause is evident, an ECG should be performed for patients seen in the office setting with stable chest pain; if an ECG is unavailable the patient should be referred to the ED so one can be obtained.1-5","For patients having NCS, it is acceptable to use either a volatile-based anesthetic or total intravenous anesthesia for general anesthesia, as there is no evident difference in related cardiovascular events such as myocardial infarction or ischemia.","For patients with HCM in whom the diagnoses of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhanc- ing agent is reasonable particularly if other imaging modalities such as cardiovascular mag- netic resonance (CMR) are not readily available or contraindicated.72,73",A,2
q_0309,"Do not remove any remaining tentacles by lifting or pulling, and ensure manual contact. Avoid rinsing the affected area with seawater to remove the tentacle, even if mechanical removal is not available.","To remove a tick, we recommend twisting or jerking the tick's body with your fingers or a tool, applying uneven pressure.",We recommend sedation for severe agitation from sympathomimetic poisoning.,Exercise TTE is not reasonable for the detection and quantification of dynamic LVOTO in asymptomatic patients with HCM who do not have a resting or provocable outflow tract peak gradient ≥50 mm Hg on standard TTE.,C,1
q_0310,"For patients with a bioprosthetic TAVI who are at low risk of bleeding, anticoagulation with a VKA to achieve an INR of 2.5 should not be considered for at least 3 months after valve implantation.","For first-degree relatives of individuals with HCM, it is recommended to provide both clinical evaluations (including ECG and 2D echocardiogram) and cascade genetic testing if a pathogenic or likely pathogenic variant is detected in the proband.","In patients with carotid web in the distribution of ischemic stroke and TIA, without other attributable causes of stroke, antiplatelet therapy is not recommended to prevent recurrent ischemic stroke or TIA.","For pilot aircrew with a diagnosis of HCM, it is unreasonable to follow Federal Aviation Administration guidelines that permit consideration of multicrew flying duties, even if they are asymptomatic, are deemed low risk for SCD, and can complete a maximal treadmill stress test at 85% peak heart rate.",B,1
q_0311,"In patients suspected of having a stroke or TIA, CT or MRI of the brain is not recommended to confirm the diagnosis of symptomatic ischemic cerebral vascular disease.","In patients in whom the anatomy cannot be clearly delineated by echocardiography in the setting of suspected paravalvular infections, CT imaging is reasonable.37,61–68","For patients with AF where cardioversion is postponed because a thrombus in the LAA is found on precardioversion imaging, therapeutic anticoagulation should be administered for a minimum of 3 to 6 weeks, followed by repeat imaging prior to cardioversion.",We recommend that hydroxocobalamin be administered for cyanide poisoning.,A,2
q_0312,"In patients with functionally limiting claudication and an inadequate response to GDMT (including structured exercise), revascularization is a reasonable treatment option to improve walking function and QOL.7–14","In patients with aSAH, transcranial Doppler (TCD) ultrasound monitoring is reasonable to detect vasospasm and predict DCI.253,276–280","In patients with AF who do not have a history of moderate to severe rheumatic mitral stenosis or a mechanical heart valve, and who are candidates for anticoagulation, DOACs are recommended over warfarin to reduce the risk of mortality, stroke, systemic embolism, and ICH.1–7","In patients hospitalized for HF, a predischarge BNP or NT-proBNP level should not be used to inform the trajectory of the patient or establish a postdischarge prognosis.",D,2
q_0313,"Patients with PAD should be advised that exposure to secondhand tobacco smoke in indoor or enclosed spaces, including work, home, transportation vehicles, and public places, is acceptable.","In patients who are being considered for CABG, calculation of the STS risk score is not recommended for stratifying patient risk.","In patients with TAA who have no evidence of atherosclerosis, the use of statin therapy may be considered.3-6","In patients with spontaneous ICH of mild to moderate severity presenting with SBP >150 mm Hg, acute lowering of SBP to <130 mm Hg is potentially beneficial.",C,1
q_0314,"For patients having CABG, it is advised to implement a thorough strategy to minimize sternal wound infections.","In patients with HF, endomyocardial biopsy should not be considered useful even when a specific diagnosis is suspected that would influence therapy.","For patients with a history of myocardial infarction or acute coronary syndrome and a left ventricular ejection fraction of 40% or less, beta blockers supported by evidence should be administered to lower mortality rates.",Surgery is recommended for patients with an aortic root or ascending aorta aneurysm smaller than 5.5 cm if tomographic imaging shows a growth rate of at least 0.3 cm per year over two consecutive years or 0.5 cm in a single year.,B,2
q_0315,Routine use of sodium bicarbonate is recommended for patients in cardiac arrest.,"A first aid provider who is assisting a person with a potentially serious illness or injury should leave the person before trained rescuers arrive, even if it is safe to stay.","In patients with IE and major ischemic stroke, delaying valve surgery for at least 4 weeks may be considered for patients with IE and major ischemic stroke or intracranial hemorrhage if the patient is hemodynamically stable.460,468","In patients with CLTI for whom arterial revascularization is not an option and a lack of outflow to the foot is observed, venous arterialization should not be considered for limb preservation.",C,1
q_0316,"In pregnant patients with an aortopathy and an aortic diameter of <4.0 cm, vaginal delivery is not recommended.","For patients with acute spontaneous ICH and proximal DVT who are not yet candidates for anticoagulation, the use of a retrievable filter should not be considered as a bridge until anticoagulation can be initiated.","In patients with HCM in whom a decision has been made for ICD implantation and who have paroxysmal atrial tachycardias or AF, dual-chamber ICDs should not be considered, regardless of the potential benefits, as the higher complication rates of dual-chamber devices are not a concern.","In patients with ischemic stroke or TIA with confirmed antiphospholipid syndrome treated with warfarin, it is reasonable to choose a target INR between 2 and 3 over a target INR >3 to effectively balance the risk of excessive bleeding against the risk of thrombosis.613–615",D,1
q_0317,"In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is reasonable.","In patients at risk of developing HF, BNP or NT-proBNP–based screening followed by team-based care, including a cardiovascular specialist, can be useful to prevent the devel- opment of LV dysfunction or new-onset HF.30,31","In symptomatic patients with obstructive HCM who have associated cardiac disease requiring surgical treatment (eg, associated anomalous papillary muscle, markedly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel CAD, valvular aortic stenosis), surgical myectomy, performed at experienced HCM centers,† is recommended (Tables 4 and 5).4–7","In patients with cryptogenic stroke, it is not necessary to perform tests for inherited or acquired hypercoagulable states, bloodstream or cerebral spinal fluid infections, infections that can cause CNS vasculitis (e.g., HIV and syphilis), drug use (e.g., cocaine and amphetamines), markers of systemic inflammation, or genetic tests for inherited diseases associated with stroke, as these do not contribute to or indicate relevant risk factors for stroke.",D,2
q_0318,"For patients with atrial fibrillation at elevated risk of systemic thromboembolism and who have mild or moderate liver disease (Child-Pugh class A or B), it is appropriate to consider oral anticoagulant therapy if there is no clinically significant coagulopathy or thrombocytopenia caused by liver disease.",It is not reasonable to take over-the-counter oral acetaminophen or NSAIDs to treat residual discomfort after ocular foreign-body removal.,"For patients with HCM, LVEF below 50%, and NYHA class II to IV symptoms that persist despite GDMT, CRT may help alleviate symptoms if LBBB is present.","For those who have a positive genotype but no phenotypic expression, it is advised to perform echocardiography at regular intervals, which vary by age—every 1-2 years for children and adolescents, and every 3-5 years for adults—or if there is a change in clinical condition (refer to Figure 1, Table 7).",B,2
q_0319,"For stable patients with NSTE-ACS and MVD, who do not have left main stenosis and are not planned for CABG surgery, it is advised to perform PCI on significant nonculprit lesions, either during the initial procedure or as a staged intervention, to lower the risk of MACE.","In patients with CoA, BPs should not be measured in both arms and one of the lower extremities.","For patients with atrial fibrillation and a high risk of recurrent intracerebral hemorrhage, such as those with cerebral amyloid angiopathy, considering anticoagulation-sparing approaches like left atrial appendage occlusion may help lower the risk of further bleeding.","For patients with suspected or confirmed acute type A aortic dissection, it is advised to seek emergency surgical consultation and evaluation, followed by prompt surgical intervention, due to the high risk of life-threatening complications.",B,2
q_0320,"In patients with spontaneous ICH with an indication for antiplatelet therapy, resumption of antiplatelet therapy should not be considered for the prevention of thromboembolic events, regardless of the benefit and risk assessment.","For patients with bioprosthetic TAVI, treatment with low-dose rivaroxaban (10 mg daily) plus aspirin (75–100 mg) is recommended in the absence of other indications for oral anticoagulants.","For children who have experienced a febrile seizure, administration of antipyretics such as acetaminophen, ibuprofen, or paracetamol is effective for stopping a seizure and preventing a subsequent febrile seizure.","In patients with HCM and clinical AF, antico- agulation is recommended with direct-acting oral anticoagulants as first-line option and vitamin K antagonists as second-line option, independent of CHA2DS2-VASc score.249–253",D,1
q_0321,"In patients with high-grade aSAH, invasive monitoring of brain tissue oxygenation, lactate/pyruvate ratio, and glutamate may be considered to predict DCI.293–305","A person who sustains a high-velocity eye injury, penetrating eye injury from a sharp or metal object, irregular pupil after trauma, eye bleeding after trauma, or loss of vision after trauma should not seek immediate medical attention.","For adults with CCD and HIV, selecting antiretroviral therapy regimens that have better lipid and cardiovascular risk profiles, while considering potential drug-drug interactions, is advisable.","For women experiencing chest pain, it is advised to gather a history that highlights symptoms more frequently associated with ACS in women.",B,2
q_0322,"In pregnant women with HCM, general or epidural anesthesia is reasonable, with precautions to avoid hypotension.310","In patients with spontaneous ICH, regular long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) is potentially beneficial and poses no increased risk of ICH.","In patients with HCM in whom functional capacity or symptom status is uncertain, exercise stress testing should not be considered every 2 to 3 years.","In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) should not be considered to reduce dabigatran concentration.",A,1
q_0323,"For frozen and thawed tissue and between the toes and fingers, avoid using bulky, clean, dry gauze or sterile cotton dressings. Circumferential dressings should be wrapped tightly to restrict swelling and apply pressure on the underlying tissue.","In patients with moderate or severe AR and suboptimal TTE images or a discrepancy between clinical and TTE findings, TEE, CMR, or cardiac catheterization is indicated for the assessment of LV systolic function, systolic and diastolic volumes, aortic size, and AR severity.20–25","For patients with HCM who have undergone genetic testing and were found to have no pathogenic variants (ie, harbor only benign or likely benign variants), cascade genetic testing of the family is not useful.4,8–10","For patients with CCD, it is advised to evaluate BMI, optionally alongside waist circumference, during regular clinical follow-up.",A,2
q_0324,"In patients with ACS, fondaparinux should not be used to support PCI because of the risk of catheter thrombosis.5,27 STEMI: Anticoagulant Therapy Treated With Fibrinolytic Therapy","In patients early after MI, usefulness of a temporary wearable cardioverter-defibrillator is uncertain in patients with an LVEF ≤35% to improve survival.7 Bradyarrhythmias","In patients with an ischemic stroke or TIA who also have diabetes, the goal for glycemic control should not be individualized, and achieving a goal of HbA1c ≤7% is not recommended, regardless of the risk for adverse events, patient characteristics, preferences, age, or presence of life-limiting comorbid illness.","In patients with a history of stroke or transient isch­ emic attack, it is reasonable to delay elective NCS for ≥3 months after the most recent cerebrovascular event to reduce the incidence of recurrent stroke, MACE, or both.1,2",C,2
q_0325,"In patients with aSAH and associated chronic symptomatic hydrocephalus, per- manent CSF diversion is recommended to improve neurological outcome.397–400","For children suspected of having hypoglycemia who are conscious but refuse or cannot swallow glucose, it might be appropriate to place a mixture of granulated sugar and water beneath the tongue.","For women with heart failure or cardiomyopathy who are pregnant or planning to become pregnant, the use of ACE inhibitors, ARBs, ARNis, MRAs, SGLT2 inhibitors, ivabradine, and vericiguat is contraindicated due to the substantial risk of fetal harm.","In patients undergoing CABG, an intraoperative continuous insulin infusion should not be initiated to maintain serum glucose level <180 mg/dL, as it does not reduce sternal wound infection.",D,2
q_0326,"Pacemaker-dependent patients with a transvenous ICD undergoing surgery above the umbilicus with anticipated EMI should not have the device reprogrammed; if the patient is not pacemaker-dependent, then neither reprogramming nor a magnet placed on the generator should be used to inhibit tachytherapies or inappropriate shocks.","Patients with CCD should not receive individualized education on symptom management, lifestyle changes, and SDOH risk factors, as it does not improve knowledge or facilitate behavior change.","For patients with acute type A aortic dissection undergoing surgery, it is reasonable to consider direct cannulation of the aorta or innominate artery with imaging guidance as an alternative to femoral or axillary cannulation.","In patients with ischemic stroke or TIA in sinus rhythm with ischemic or nonischemic cardiomyopathy and reduced EF without evidence of left atrial or LV thrombus, anticoagulation should be universally preferred over antiplatelet therapy.",C,1
q_0327,"In patients with precapillary PH undergoing elevated-risk NCS, perioperative administration of short-acting inhaled pulmonary vasodilators (e.g., nitric oxide, aerosolized prostacyclins) should not be considered, as it is not beneficial for reducing elevated RV afterload or preventing acute decompensated right HF.","In patients with Marfan syndrome, avoiding the use of both a beta blocker and an ARB, or using them in minimally effective doses, is reasonable to increase the rate of aortic dilation.","For patients with a mechanical valve prosthesis, anticoagulation with the direct thrombin inhibitor, dabigatran, is contraindicated.4,5","In patients with ischemic stroke or TIA, teaching self-management skills or using behavior change theory (e.g., motivational interviewing) is not beneficial in improving medication adherence.",C,1
q_0328,"For individuals with HCM, it is advised to conduct 24- to 48-hour ambulatory ECG monitoring during the initial assessment and regularly every 1-2 years thereafter to detect those at risk for SCD and to manage arrhythmias effectively.","For patients with notable aortic calcification, employing methods that minimize aortic handling, such as off-pump or beating heart techniques, is advisable to reduce the risk of perioperative stroke, provided they are executed by skilled surgeons.","For African American patients with NYHA class III-IV HFrEF on optimal medical treatment, it is advised to use a combination of hydralazine and isosorbide dinitrate to enhance symptoms and decrease morbidity and mortality.","In patients with acute chest pain and suspected ACS who are deemed low-risk (<1% 30-day risk of death or MACE), it is unreasonable to discharge home without admission or urgent cardiac testing.",D,2
q_0329,"Individuals with epistaxis who are on anticoagulant or antiplatelet therapy, or have a clotting disorder, should consider consulting a healthcare provider unless the bleeding has ceased.","In patients with grade 2 BAAI (Table 33) and associated malperfusion, it is not reasonable to consider repair.","For adults with heatstroke, it is not advisable to initiate immediate active cooling by using whole-body (neck-down) cool- to cold-water immersion for 15 minutes or until neurological symptoms resolve.","For patients >70 years of age with aSAH, the superiority of coiling or clipping to improve outcome is well established.",A,1
q_0330,"For patients with atrial fibrillation who do not have significant baseline QT interval prolongation, low potassium or magnesium levels, or slow heart rate, sotalol may be considered for long-term sinus rhythm maintenance. This should involve appropriate dosing according to renal function and careful monitoring of the QT interval, heart rate, and serum potassium and magnesium levels.","In pregnant patients with a diameter of the aortic root, ascending aorta, or both, of ≥4.5 cm, cesarean delivery is reasonable. Downloaded from http://ahajournals.org by on June 19, 2025","In patients with HF and suspicion of sleep-disordered breathing, it is unreasonable to conduct a formal sleep assessment to confirm the diagnosis and differentiate between obstructive and central sleep apnea.","For patients with a BAV, TTE is recommended to assess valve structure and performance, measure the aortic root and ascending aorta diameters, and check for aortic coarctation and other related cardiovascular anomalies.",C,2
q_0331,"For patients with symptomatic PAD, the advantage of adding vorapaxar to current antiplatelet treatment remains unclear.","In patients with ACS who are already on maximally tolerated statin therapy with low-density lipoprotein cholesterol (LDL-C) ≥70 mg/dL (≥1.8 mmol/L), adding a nonstatin lipid-lowering agent is not recommended to further reduce the risk of MACE.","In patients with acute chest pain with suspected acute myopericarditis, CMR is not useful if there is diagnostic uncertainty, or to determine the presence and extent of myocardial and pericardial inflammation and fibrosis.","In patients with angina or an anginal equivalent, undocumented ischemia, and angiographically intermediate stenoses, the use of fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR) is not recommended to guide the decision to proceed with PCI.",A,1
q_0332,"For patients with stable STEMI and a completely blocked infarct-related artery more than 24 hours after symptoms begin, who show no signs of ongoing ischemia, acute severe heart failure, or life-threatening arrhythmias, performing PPCI is not recommended as it offers no benefit.","For asymptomatic women with severe valve disease (Stage C1) contemplating pregnancy, it is advisable to conduct exercise testing prior to pregnancy for evaluating risk.",We advise administering intravenous lipid emulsion for cases of local anesthetic toxicity.,"In patients with IE and major ischemic stroke, immediate valve surgery should be considered regardless of hemodynamic stability.",D,2
q_0333,"For individuals with CCD, lowering saturated fat intake to less than 6% of total calories and substituting it with monounsaturated and polyunsaturated fats, complex carbohydrates, and dietary fiber may help decrease the risk of CVD events.","For patients with sickle cell disease who have experienced an ischemic stroke or TIA, it is advised to maintain chronic blood transfusions to lower hemoglobin S to less than 30% of total hemoglobin to prevent recurrent ischemic strokes.","For patients experiencing recurrent atrial fibrillation outside of a hospital, using a single oral dose of flecainide or propafenone alongside an atrioventricular nodal blocking agent is a reasonable pharmacological cardioversion strategy, provided it has been previously tested in a monitored environment.","In patients with compensated HF undergoing NCS, it is unreasonable to continue GDMT (excluding SGLT2i) in the perioperative period, even if not contraindicated, as it does not reduce the risk of worsening HF. Canagliflozin, dapagliflozin, and empagliflozin should not be stopped before scheduled surgery, and ertugliflozin should be continued up to the day of surgery.",D,2
q_0334,"In patients with HF and coronary artery disease (CAD) who are candidates for coronary revas- cularization, noninvasive stress imaging (stress echocardiography, single-photon emission CT [SPECT], CMR, or positron emission tomog- raphy [PET]) may be considered for detection of myocardial ischemia to help guide coronary revascularization.28–32","In patients with CCD, use of a validated CCD-specific patient-reported health status measure may be reasonable to assess symptoms, functional status, and QOL.19–23","For screening first-degree relatives of individuals with HCM, it is advised to include a 12-lead ECG as part of the evaluation process (Figure 1, Table 7).1–3",Monitoring EEG repeatedly or continuously is not reasonable for patients who do not follow commands after ROSC.,D,2
q_0335,"In patients with aSAH, induction of hypervolemia is potentially beneficial and not associated with excess morbidity.","It is advisable to administer antibiotic prophylaxis prior to dental procedures that involve manipulation of gingival tissue, the periapical region of teeth, or perforation of the oral mucosa in patients with VHD who have any of the following conditions: a. Prosthetic cardiac valves, including those implanted via transcatheter and homografts. b. Prosthetic materials used in cardiac valve repair, such as annuloplasty rings, chords, or clips. c. A history of IE. d. Unrepaired cyanotic congenital heart disease or repaired congenital heart disease with residual shunts or valvular regurgitation at or near a prosthetic patch or device. e. Cardiac transplant recipients with valve regurgitation due to a structurally abnormal valve.","For patients having isolated CABG, it is advised to use a radial artery instead of a saphenous vein conduit for grafting the second most critical, significantly narrowed, non-LAD vessel to enhance long-term cardiac outcomes.","In patients with prediabetes and ischemic stroke or TIA, particularly those with a body mass index (BMI) ≥35 kg/mP2, ≥35 kg/m2 those <60 years of age, or women with a history of gestational diabetes, metformin may be beneficial to control blood sugar and to prevent progression to diabetes.245–247",A,2
q_0336,"For patients with AF, recommending caffeine abstention to prevent AF episodes is beneficial, even if it does not reduce symptoms in patients who report caffeine triggers or worsens AF symptoms.","In adults with congenital heart disease with AF undergoing PVI, it may be reasonable to include an ablative strategy in the right atrium directed at reentrant arrhythmia secondary to atriotomy scars and the CTI.8,9",It is effective to treat a person with hypothermia by using small glove or boot insert chemical heat packs as the sole or primary means of rewarming.,Organ donation should not be considered in any patients resuscitated from cardiac arrest who meet neurological criteria for death.,B,1
q_0337,"In patients with CCD, cardiac rehabilitation and regular exercise should not be used to reduce the risk of cardiovascular complications with sexual activity.","For pregnant women with mechanical prostheses who require >5 mg/d of warfarin to achieve a therapeutic INR, avoid using dose-adjusted LMWH.","In patients with aSAH, routine use of intravenous magnesium to improve neurological outcomes is recommended.","In patients who have undergone revascularization for chronic symptomatic PAD, SET after revascularization is effective to improve walking performance, functional status, and QOL.29–39",D,1
q_0338,"For patients at intermediate risk with acute chest pain and no history of CAD, who are suitable for diagnostic testing following a negative or inconclusive ACS assessment, CCTA is beneficial for ruling out atherosclerotic plaque and obstructive CAD.","Patients who have been resuscitated after cardiac arrest and are noncomatose or who are comatose with favorable prognostic features and with evidence of STEMI, should not undergo PPCI to improve survival.",N-acetylcysteine is recommended as a treatment for methemoglobinemia.,"In patients with aSAH, delaying or avoiding the initiation of enteral nimodipine is not beneficial in preventing DCI and does not improve functional outcomes.",A,1
q_0339,"For patients with atrial flutter who have experienced a stroke or TIA, anticoagulant treatment akin to that used in AF is recommended to lower the risk of another stroke.","For patients with HF being considered for, or treated with, life-extending therapies, the option for discontinuation should not be anticipated or discussed through the continuum of care, including at the time of initiation, nor reassessed with changing medical conditions and shifting goals of care.","In women with HF or cardiomyopathy who are pregnant or currently planning for pregnancy, ACEi, ARB, ARNi, MRA, SGLT2i, ivabradine, and vericiguat should not be administered because of significant risks of fetal harm.13–15","In patients with ALI and prolonged ischemia in whom revascularization (endovascular or surgical, including catheter-directed thrombolysis) is performed, concur- rent and early amputation can be beneficial to avoid the morbidity of reperfusion.",B,2
q_0340,"In pregnant women with HCM, it is unreasonable to perform serial echocardiography, even during the second or third trimester when hemodynamic load is highest, or if clinical symptoms develop.","For all patients with a bioprosthetic SAVR or mitral valve replacement, aspirin 75 to 100 mg daily is not reasonable, even in the absence of other indications for oral anticoagulants.","For pregnant women with HCM and AF or other indications for anticoagulation, low-molecular-weight heparin or vitamin K antagonists should not be used for stroke prevention.","For initial family screening and regular follow-up in first-degree relatives of individuals with HCM, a TTE is advised.",D,1
q_0341,"In patients with ACS and confirmed hypoxia (oxygen saturation <90%), it is not recommended to provide supplemental oxygen to increase oxygen saturations to ≥90%, as it does not improve myocardial oxygen supply or decrease anginal symptoms.","In patients with vertebrobasilar dolichoectasia and a history of ischemic stroke or TIA without other attributable causes, the use of antiplatelet or anticoagulant therapy is not recommended for the prevention of recurrent ischemic events.","In asymptomatic patients with combined AS and AR who have a jet velocity of ≥4.0 m/s with an LVEF <50%, SAVR is recommended.1,2","In patients with aSAH and severe vasospasm, cerebral angioplasty should not be considered as it is unlikely to reverse cerebral vasospasm or reduce the progression and severity of DCI.",C,1
q_0342,"For patients experiencing acute chest pain with suspected aortic dissection, TEE or CMR should be utilized for diagnosis if CT cannot be used or is not accessible.","For patients with CLTI undergoing minor amputation at the inframalleolar level, it is advised to implement a tailored follow-up care plan that may involve local wound management, pressure relief, regular assessment of foot biomechanics, and the use of therapeutic footwear to prevent wound recurrence.","In patients with TIA or nondisabling stroke, when revascularization is indicated, it is reasonable to delay the procedure beyond 2 weeks of the index event rather than perform surgery promptly, despite the decreased likelihood of a stroke-free outcome.",It is reasonable to use running tap water or sterile saline solutions for wound irrigation instead of antiseptic agents such as povidone-iodine.,C,2
q_0343,"In patients with HCM who develop persistent systolic dysfunction (LVEF <50%), cardiac myosin inhibitors should be continued.","In symptomatic patients with severe AS (Stage D1, aortic velocity ≥4.0 m/s or mean pressure gradient ≥40 mm Hg), exercise testing should be performed despite the risk of severe hemodynamic compromise.","For patients with LVEF of 40% or less, ACE inhibitors are recommended to prevent symptomatic heart failure and lower mortality rates.","In patients with type 2 diabetes and either established CVD or at high cardiovascular risk, SGLT2i should not be used to prevent hospitalizations for HF.",C,1
q_0344,"In patients with STEMI and cardiogenic shock or hemodynamic instability, PCI or CABG (when PCI is not feasible) is indicated to improve survival, irrespective of the time delay from MI onset.6,7",Sedation is advised for managing severe agitation caused by sympathomimetic poisoning.,"For individuals with unruptured AAA, surgical intervention is advised for men with an aneurysm diameter of 5.5 cm or greater and for women with a diameter of 5.0 cm or greater.","In patients with signs and symptoms of right-sided HF attributable to severe secondary TR (Stages C and D), therapies to treat the primary cause of HF (eg, pulmonary vasodilators to reduce elevated pulmonary artery pressures, GDMT for HF with reduced LVEF, or rhythm control of AF) should not be used.",D,2
q_0345,"In patients with chronic secondary MR (Stages B to D), TTE is useful to establish the etiology and to assess the extent of regional and global LV remodeling and systolic dysfunction, severity of MR, and magnitude of pulmonary hypertension.1,2","Pregnant women with severe valve disease (Stages C and D) should not be monitored in a tertiary-care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.","Pregnant women with HCM should have their care managed jointly by a cardiologist and an obstetrician, and those considered high risk should consult a maternal-fetal medicine specialist.","For patients experiencing a sudden severe headache without any new neurological symptoms, it may be appropriate to use the Ottawa SAH Rule to determine those at high risk for aSAH.",B,2
q_0346,"In cardiac arrest following drowning, if the rescuer is unwilling, untrained, or unable to provide rescue breaths, it is reasonable to provide chest compressions only, until help arrives.","In pregnant women with HCM, cardioversion for new or recurrent AF, particularly if symptomatic, is not recommended.","For patients with HCM who show no symptoms and lack a resting or inducible outflow tract gradient of 50 mm Hg or more on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO.","If an avulsed permanent tooth cannot be immedi- ately replanted and none of the above storage mediums are available, a probiotic, egg white, or almond milk may be considered.",B,2
q_0347,Screening for a history of premature ovarian failure (before 40 years of age) and early menopause (before 45 years of age) is not beneficial to inform the risk of stroke.,"In patients with SIHD, normal left ventricular ejection fraction, and 1- or 2-vessel CAD not involving the proximal LAD, coronary revascularization is recommended to improve survival.","For patients with Loeys-Dietz syndrome, an initial TTE is advised to assess the aortic root and ascending aorta diameters, followed by another TTE in 6 months to evaluate the aortic growth rate; if the diameters remain stable, a TTE should be conducted annually for monitoring.","For patients with a GCS score ≤3 and primary IVH or IVH extension from spontaneous supratentorial ICH of ≥30-mL volume not requiring EVD, minimally invasive IVH evacuation with EVD plus thrombolytic is unsafe and unreasonable compared with EVD alone to reduce mortality.",C,1
q_0348,"Among patients with current or previous symptomatic HFmrEF (LVEF, 41%–49%), the use of evidence-based beta blockers for HFrEF, ARNi, ACEi, or ARB, and MRAs should not be considered to reduce the risk of HF hospitalization and cardiovascular mortality, particularly among patients with LVEF on the lower end of this spectrum.","For patients with HCM, avoid repeating contrast-enhanced CMR imaging on a periodic basis (every 3 to 5 years) for SCD risk stratification, as it is unnecessary to evaluate changes in late gadolinium enhancement and other morphologic changes, including EF, development of apical aneurysm, or LV wall thickness.","For patients with aSAH from ruptured fusiform/blister aneurysms, the use of flow diverters is reasonable to reduce mortality.120,121","In patients with ACS, a home-based CR program is not a reasonable alternative to a center-based CR program to improve functional status and QOL.",C,1
q_0349,"In patients with known CVD being considered for NCS, a validated risk-prediction tool can be useful to estimate the risk of perioperative MACE.1–4","For patients with hospital-acquired S. aureus bacteremia originating from a non-cardiac source, TEE may be considered to identify concurrent staphylococcal infective endocarditis.","In patients with spontaneous ICH without evidence of seizures, prophylactic antiseizure medication is beneficial to improve functional outcomes, long-term seizure control, and mortality.","In patients with hypertension undergoing NCS, it is recommended that preoperative antihypertensive medications be restarted as soon as clinically rea­ sonable to avoid complications from postoperative hypertension. *Caution is advised when continuing antihypertensive therapy in patients with low or low-normal perioperative BPs, older adults (≥65 years),10 and patients in whom the risk for perioperative hypotension is high based on an evaluation of the patient’s overall clinical status, surgery type, and anesthetic plan. †Modified from the “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA High Blood Pressure Guideline.”11 ‡One or more components of the RCRI: CAD, congestive heart failure, cere­ brovascular accident, baseline serum creatinine >2.0 mg/dL, or preoperative in­ sulin treatment.12",C,2
q_0350,"In patients with SLE and no history of thrombosis or pregnancy complications and with a low-risk antiphospholipid profile (ie, isolated anticardiolipin antibody or anti–β2-glycoprotein 1 antibodies at low to medium titers, particularly if transiently pos- itive), prophylactic treatment with aspirin (75–100 mg daily) may be considered to reduce the risk of stroke.462,463,469,470","For patients with heart failure, a comprehensive history and physical exam should guide diagnostic approaches to identify particular causes that may require targeted disease management.","In patients with AF and HF, digoxin is reasonable for rate control, in combination with other rate-controlling agents or as monotherapy if other agents are not tolerated.16,17","In patients with LVEF <50%, nondihydropyridine calcium channel blockers with negative inotropic effects may be beneficial.",D,2
q_0351,"When treating common iliac artery aneu- rysms or ectasia as part of AAA repair, preservation of at least 1 hypogastric artery is recommended, if anatomically feasible, to decrease the risk of pelvic ­ischemia.5,6","For patients with type B IMH needing repair of the distal aortic arch or descending thoracic aorta (zones 2-5) and possessing suitable anatomy, it is advisable to consider endovascular repair when conducted by surgeons skilled in endovascular techniques.","For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is not recommended.","For patients with severe secondary MR (Stages C and D), it is appropriate to perform mitral valve surgery concurrently with CABG for myocardial ischemia treatment.",C,2
q_0352,"For hemodynamically stable pregnant women with obstructive left-sided mechanical valve thrombosis, it is not reasonable to manage with slow-infusion, low-dose fibrinolytic therapy.","In patients with atrial fibrillation who are undergoing PCI and are taking oral anticoagu- lant therapy, it is recommended to discontinue aspirin treatment after 1 to 4 weeks while maintaining P2Y12 inhibitors in addition to a non–vitamin K oral anticoagulant (rivaroxaban, dabigatran, apixaban, or edoxaban) or warfarin to reduce the risk of bleeding.1-7",It is unreasonable to administer 100% oxygen for cyanide poisoning.,"For intermediate-high risk patients with stable chest pain and no known CAD with an interpretable ECG and ability to achieve maximal levels of exercise (≥5 METs), exercise electrocardiography is not reasonable.",B,1
q_0353,"In patients with sickle cell disease who report acute chest pain, it is not recommended to transfer them by EMS to an acute care setting.","In patients with nonobstructive HCM with preserved EF and symptoms of exertional angina or dyspnea, beta blockers or non-dihydropyridine calcium channel blockers are not recommended.","In patients with aSAH, neglecting glycemic control, allowing hyperglycemia, and inducing hypoglycemia are reasonable to improve outcome.","For patients experiencing spontaneous intracerebral hemorrhage, managing moderate to severe hyperglycemia (greater than 180–200 mg/dL or 10.0–11.1 mmol/L) is advisable to enhance outcomes.",D,1
q_0354,"In patients with AF receiving warfarin who develop life-threatening bleeding, treatment with 4-factor prothrombin complex concentrate (if available) in addition to intravenous vitamin K is recommended to rapidly achieve INR correction over fresh frozen plasma and intravenous vitamin K treatment.8–10","In patients with TIA or nondisabling stroke, when revascularization is indicated, it is reasonable to perform the procedure within 2 weeks of the index event rather than delay surgery to increase the likelihood of stroke- free outcome.373","For women needing valve intervention prior to pregnancy, selecting a prosthetic valve should involve a collaborative decision-making approach that considers the patient's values and preferences, addressing the risks associated with mechanical valves during pregnancy and the shorter lifespan of bioprosthetic valves in younger women.","In patients with CCD and heart failure with LVEF ≤40%, the use of an SGLT2 inhibitor is not recommended to reduce the risk of cardiovascular death and heart failure hospitalization or to improve QOL, irrespective of diabetes status.",D,2
q_0355,"In patients with AF identified in the setting of acute medical illness or surgery, outpatient follow-up for thromboembolic risk stratification and decision-making on OAC initiation or continuation, as well as AF surveillance, is not beneficial due to a low risk of AF recurrence.","In patients with severe MS who cannot undergo MV intervention before NCS, perioperative invasive hemodynamic monitoring is not recommended to guide management, as it does not reduce the risk of cardiovascular complications.","For patients with ACS, a P2Y12 inhibitor taken orally should be given alongside aspirin to decrease MACE.","In patients with recurrent symptomatic AF after catheter ablation, repeat catheter ablation or antiarrhythmic drug therapy is not useful to improve symptoms and freedom from AF.",C,1
q_0356,"In patients with lobar spontaneous ICH and age <70 years, deep/posterior fossa spontaneous ICH and age <45 years, or deep/posterior fossa and age 45 to 70 years without history of hypertension, acute CTA and consideration of venography are not recommended to exclude macrovascular causes or cerebral venous thrombosis.","In patients with ACS >50%, annual carotid duplex ultrasound every 6 to 12 months is not recommended to assess progression of disease and subsequent increased risk of stroke.","In patients with AF who require significant ventricular pacing, conduction system pacing may not be useful to reduce progression of AF.","In patients with CCD who have undergone PCI and who require oral anticoagulant therapy, continuing aspirin in addition to clopidogrel for up to 1 month is reasonable if the patient has a high thrombotic risk and low bleeding risk.*23–25",D,1
q_0357,"Over-the-counter topical steroids are definitely effective in alleviating local symptoms from poison ivy, oak, or sumac.",Individuals who are ill or injured should not be protected from hyperthermia or hypothermia due to exposure.,"In patients hospitalized with HF, the common precipitating factors and the overall patient trajectory should be assessed to guide appro- priate therapy.5,6 Goals for Optimization and Continuation of GDMT","In patients with atrial flutter and stroke or TIA, anticoagulant therapy similar to that in AF is not indicated to reduce the risk of recurrent stroke.",C,1
q_0358,"In patients undergoing CABG, the routine use of epiaortic ultrasound scanning can be useful to evaluate the presence, location, and severity of plaque in the ascending aorta to reduce the incidence of atheroembolic complications.1-10","In asymptomatic patients with combined AS and AR who have a jet velocity of ≥4.0 m/s with an LVEF <50%, SAVR is recommended.1,2",Routine administration of calcium for treatment of cardiac arrest is recommended.,"In patients with CCD, tobacco use should be assessed at every health care visit to facilitate identification of those who may benefit from behavioral or pharmacologic interventions.*1–3",C,2
q_0359,"If a person shows evidence of shock with a normal level of alertness, it is unreasonable to place or maintain the person in a supine position.","In older adults, the treatment strategy for CAD should not consider an individual patient’s preferences, cognitive function, or life expectancy.","For patients with CCD who are on the highest tolerated dose of statins and have an LDL-C level below 100 mg/dL (2.6 mmol/L), along with a fasting triglyceride level between 150 and 499 mg/dL (1.7–5.6 mmol/L) after secondary causes have been managed, icosapent ethyl can be considered to further lower the risk of MACE and cardiovascular mortality.","In pregnant women with HCM, cardioversion for new or recurrent AF, particularly if symptomatic, is not reasonable.",C,1
q_0360,"In patients with aSAH, avoid using validated screening tools in the postacute period to identify post-aSAH depression and anxiety.",We recommend avoiding the use of personal protective equipment when caring for patients with organophosphate or carbamate exposure.,"In patients with ACS, an assessment of LVEF is not recommended prior to hospital discharge for guiding therapy or risk stratification.","For patients having NCS with a preoperative ECG showing new abnormalities, it is reasonable to conduct further evaluation to better assess cardiovascular risk.",D,1
q_0361,"In patients with signs and symptoms of right-sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery should not be considered if there is no severe pulmonary hypertension or severe RV systolic dysfunction.","In patients with known or suspected primary MR, TTE is not indicated for baseline evaluation of LV size and function, RV function, LA size, pulmonary artery pressure, and the mechanism and severity of primary MR (Stages A to D).","In patients with TR, TTE is not indicated to evaluate the presence and severity of TR, determine the etiology, measure the sizes of the right-sided chambers and inferior vena cava, assess RV systolic function, estimate pulmonary artery systolic pressure, or characterize any associated left-sided heart disease.","In pregnant women with severe AS (mean pressure gradient ≥40 mm Hg, Stage D), valve intervention during pregnancy is reasonable if there is hemodynamic deterioration or if there are NYHA class III or IV HF symptoms.1–7",D,1
q_0362,"For patients with CCD, it is advised to conduct clinical evaluations at least once a year to monitor symptoms, changes in functional status, compliance with and effectiveness of lifestyle and medical treatments, and to check for complications related to CCD and its therapies.","For patients with a mechanical AVR and additional risk factors for thromboembolism (eg, AF, previous thromboembolism, LV dysfunction, hypercoagulable state) or an older-generation prosthesis (eg, ball-in-cage), anticoagulation with a VKA is not indicated to achieve an INR of 3.0.9,10.","Patients with ACS and with ongoing angina, hemodynamic instability, uncontrolled arrhythmias, suboptimal reperfusion, or cardiogenic shock should not be admitted to a CICU, as it will not reduce cardiovascular events.","In patients with PAU of the ascending aorta with associated IMH, urgent repair is not recommended.",A,1
q_0363,"For asymptomatic patients undergoing low-risk surgical procedures, a routine preoperative resting 12-lead ECG is recommended to improve outcomes.",It is advised to utilize a stroke recognition tool like the FAST or Cincinnati Prehospital Stroke Scale to help identify acute stroke in adults.,"First aid providers should avoid applying a compression wrap after an acute ankle sprain or strain, as it does not promote comfort after an injury. Application of the compression wrap should be performed in a way that compromises circulation.","In patients with a mechanical AVR who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is not reasonable to increase the INR goal from 2.5 (range, 2.0–3.0) to 3.0 (range, 2.5–3.5) or to add daily low-dose aspirin (75–100 mg), regardless of bleeding risk assessment.",B,1
q_0364,"For patients with nonobstructive HCM and preserved EF, it is appropriate to introduce oral diuretics if exertional dyspnea continues despite treatment with beta blockers or nondihydropyridine calcium channel blockers.","A person bitten by a spider or stung by a scorpion should seek medical care if pain extends beyond the site of the bite/sting, becomes severe, and is not controlled by over-the-counter pain medica- tions; if an open wound develops; or if the person experiences symptoms throughout the body.","In patients with spontaneous ICH who undergo CT or MRI at admission, CTA and consideration of venography or MRA and consideration of venography performed acutely should not be used to exclude macrovascular causes or cerebral venous thrombosis.","In the general population, healthy lifestyle hab- its such as regular physical activity, maintaining normal weight, healthy dietary patterns, and avoiding smoking are helpful to reduce future risk of HF.13–21",C,2
q_0365,"In patients with spontaneous ICH in whom the risk for recurrent ICH may facilitate prognosti- cation or management decisions, it is reason- able to incorporate the following risk factors for ICH recurrence into decision-making: (a) lobar location of the initial ICH; (b) older age; (c) presence, number, and lobar location of microbleeds on MRI; (d) presence of dissemi- nated cortical superficial siderosis on MRI; (e) poorly controlled hypertension; (f) Asian or Black race; and (g) presence of apolipopro- tein E ε2 or ε4 alleles.562–571","In patients with CLTI, it is not recommended to use a patient-centered approach with objective classification of the threatened limb, patient risk, and anatomic pattern of disease combined with patient and family goals to identify those patients in whom primary amputation or palliative management is appropriate.","In patients for whom echocardiography is inadequate, alternative imaging (e.g., cardiac magnetic resonance [CMR], cardiac computed tomography [CT], radionuclide imaging) is not recommended for assessment of LVEF.","In patients with ischemic stroke or TIA, a multidisciplinary outpatient team-based approach (ie, care provision with active medication adjustment from advanced practice providers, nurses, or pharmacists) is ineffective in controlling BP, lipids, and other vascular risk factors.",A,1
q_0366,"For patients with stable ischemic heart disease, normal left ventricular ejection fraction, and 1- or 2-vessel coronary artery disease excluding the proximal left anterior descending artery, coronary revascularization is not advised for enhancing survival.","For asymptomatic individuals with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage C) who exhibit favorable valve morphology, have less than 2+ mitral regurgitation, no left atrial thrombus, and elevated pulmonary artery systolic pressure (>50 mm Hg), percutaneous mitral balloon commissurotomy is a reasonable option if conducted at a Comprehensive Valve Center.","In patients with an ischemic stroke or TIA who also have diabetes, treatment of diabetes should avoid glucose-lowering agents with proven cardiovascular benefit, as they do not reduce the risk for future major adverse cardiovascular events (ie, stroke, MI, cardiovascular death).","In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assess- ment, electrocardiography, and cardiac imaging are recommended at periodic intervals depending on age (every 1-2 years in children and adolescents and every 3-5 years in adults) and change in clinical status (Figures 1 and 2, Table 7).1–5",C,2
q_0367,"Patients with IE should not be evaluated or managed with consultation from a multispecialty Heart Valve Team, and should exclude an infectious disease specialist, cardiologist, cardiac surgeon, cardiac anesthesiologist for surgically managed patients, and a neurologist for patients with neurological events.","For patients with HCM undergoing transvenous ICD implantation, it is advised to use single-coil ICD leads over dual-coil leads, provided the defibrillation threshold is considered sufficient.","In patients with CCD, ICA for risk stratification is routinely recommended in patients without LV systolic dysfunction, heart failure, stable chest pain refractory to GDMT, and/or noninvasive testing suggestive of significant (>50%) left main disease.","In individuals ≥18 years of age, periodic screening for modifiable behaviors and medical conditions that increase stroke risk is not recommended to reduce risk for stroke.",B,1
q_0368,"For patients with SIHD and normal left ventricular function, chronic oral beta blockers do not provide a benefit in reducing cardiovascular events following complete revascularization.","Among patients with AF, it may not be reasonable to screen for obstructive sleep apnea, despite its high prevalence in patients with AF, as the role of treatment of sleep-disordered breathing (SDB) to maintain sinus rhythm is uncertain.","For patients >70 years of age with aSAH, the superiority of coiling or clipping to improve outcome is not well established.113,114","In patients with CCD treated with PCI, dual antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel for 6 months post PCI followed by single antiplatelet therapy (SAPT) is indicated to reduce MACE and bleeding events.*4–7",B,2
q_0369,"In patients with CCD, routine assessment by clinicians and the care team for SDOH is not recommended, as it should not inform patient-centered treatment decisions and lifestyle change recommendations.","In patients with left-sided IE caused by S. aureus, a fungal organism, or other highly resistant organisms, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is not indicated.","In patients with CCD and LVEF <50%, the use of sustained release metoprolol succinate, carvedilol, or bisoprolol with titration to target doses is not recommended, and other beta blockers should be preferred.","For patients with established cardiovascular disease, those aged 65 or older, or individuals aged 45 or older exhibiting symptoms indicative of cardiovascular disease who are undergoing high-risk non-cardiac surgery, it is advisable to assess B-type natriuretic peptide (BNP) or N-terminal pro–B-type natriuretic peptide (NT-proBNP) preoperatively to enhance the assessment of perioperative risk.",D,1
q_0370,"For families impacted by HCM, it is advised to provide reproductive and genetic counseling before conception and during pregnancy.","In patients with ischemic stroke or TIA and atherosclerotic disease (intracranial, carotid, aortic, or coronary), avoiding lipid-lowering therapy with a statin and ezetimibe, even if needed, to a goal LDL-C of <70 mg/dL is recommended to increase the risk of major cardiovascular events.","In adult patients with suspected HCM, cardiac CT should not be considered for diagnosis even if the echocardiogram is not diagnostic and CMR imaging is unavailable.",It is not advisable to attempt electrical pacing for β-blocker–induced bradycardia.,A,1
q_0371,We do not recommend dermal decontamination for external organophosphate or carbamate exposure.,"For patients experiencing symptoms of PAD, it is advised to use clopidogrel alone at a dose of 75 mg daily as a single antiplatelet therapy to lower the risk of MACE.","For patients with acute chest pain at intermediate risk, a TTE is advised as a quick, bedside examination to determine baseline ventricular and valvular function, check for wall motion abnormalities, and detect pericardial effusion.","In patients with aSAH, an early multidisci- plinary team–based approach to treatment and rehabilitation is recommended to reduce LOS and identify discharge needs.231,440",A,2
q_0372,"In patients with ACS and cardiogenic shock or hemodynamic instability, emergency revascularization of the culprit vessel by PCI or CABG is not indicated to improve survival, irrespective of time from symptom onset.","In patients with reported AF duration of <48 hours (not in the setting of cardiac surgery) and who are not on anticoagulation, precardioversion imaging to exclude intracardiac thrombus may be considered ins those who are at elevated thromboembolic risk (CHA2DS2-VASc score ≥2 or equivalent).21,22","For patients with atrial fibrillation and normal left ventricular function, it is appropriate to use low-dose amiodarone (100-200 mg/day) for long-term sinus rhythm maintenance. However, due to its side effect profile, it should be reserved for those who do not respond to, cannot tolerate, or have contraindications to other rhythm control methods.","For patients with SAH due to verified cerebral aneurysms, DSA may aid in identifying the best approach for aneurysm treatment.",A,2
q_0373,"In patients with stroke or TIA and extracranial carotid or vertebral artery dissection who have recurrent events despite antithrombotic therapy, endovascular therapy should not be considered to prevent recurrent stroke or TIA.","For patients diagnosed with confirmed endocarditis who have a cardiac electronic device implanted, it is recommended to entirely extract the pacemaker or defibrillator systems, encompassing all leads and the generator.","In patients with a mechanical mitral valve replacement who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is reasonable to increase the INR goal from 3.0 (range, 2.5–3.5) to 4.0 (range, 3.5–4.0) or to add daily low-dose aspirin (75–100 mg), with assessment of bleeding risk.","For patients with HCM with ≥1 major SCD risk factors, discussion of the estimated 5-year sudden death risk and mortality rates can be useful during the shared decision-making process for ICD placement (Figure 3, Table 8).3,19,29,30",A,2
q_0374,"For patients who are ≥16 years of age with HCM, it is not reasonable to obtain echocardiography-derived left atrial diameter and maximal left ventricular outflow tract gradient for calculating an estimated 5-year sudden death risk, as it is not useful during shared decision-making for ICD placement.","Women with CCD who are contemplating pregnancy or who are pregnant should use ACE inhibitors, ARBs, direct renin inhibitors, angiotensin receptor-neprilysin inhibitors, or aldosterone antagonists during pregnancy, as they do not pose any harm to the fetus.","For asymptomatic patients with severe aortic stenosis (Stage C1) who are having cardiac surgery for other reasons, aortic valve replacement is recommended.","In patients with PAD, vitamin D supplementation is beneficial for prevention of MACE.",C,1
q_0375,"In symptomatic patients at average or low risk of complications associated with endovascular intervention, when the ICA stenosis is <70% by noninvasive imaging or ≤50% by catheter-based imaging and the anticipated rate of periprocedural stroke or death is ≥6%, CAS should not be considered as an alternative to CEA for stroke prevention, particularly in patients without significant cardiovascular comorbidities predisposing to cardiovascular complications with endarterectomy.","In patients with spontaneous ICH without indications for ICU admission at presentation, initial provision of care in a general ward compared with a stroke unit is reasonable to reduce mortality and improve outcomes.","For patients with PAD who have received infrain- guinal prosthetic bypass grafts and show no new signs or symptoms in the lower extremities, the benefit of using ABI and arterial duplex ultrasound for surveillance remains unclear.","In patients who are at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT and have reasonable expectation of meaningful survival for >1 year, an ICD is not recommended for primary prevention of sudden cardiac death (SCD) as it does not reduce total mortality.",C,1
q_0376,"For patients with atrial fibrillation, using ibutilide for pharmacological cardioversion is appropriate for those whose left ventricular function is not reduced (LVEF ≥40%).","Patients with AAS should not be treated with pain control, even if needed, to help with hemodynamic management.","For intermediate-risk patients with acute chest pain with evidence of previous mildly abnormal stress test results (≤1 year), CCTA is not reasonable for diagnosing obstructive CAD.",Routine use of magnesium for cardiac arrest is recommended.,A,1
q_0377,"In patients presenting with acute chest pain, a chest radiograph is not useful to evaluate for other potential cardiac, pulmonary, and thoracic causes of symptoms.","In patients with aSAH and unsecured aneurysm, frequent blood pressure (BP) monitoring and BP control with short- acting medication(s) is recommended to avoid severe hypotension, hypertension, and BP variability.","In patients with CLTI for whom revascularization is not an option, arterial intermittent pneumatic compression devices may be considered to augment wound healing or ameliorate ischemic rest pain.4–7",The effectiveness of using methylene blue for treating refractory vasodilatory shock caused by CCB poisoning remains unclear.,A,2
q_0378,"In patients with BAV, CMR angiography or CT angiography is not indicated even when morphology of the aortic sinuses, sinotubular junction, or ascending aorta cannot be assessed accurately or fully by echocardiography.","In patients with a prosthetic valve replacement or prior valve repair and clinical symptoms or signs that suggest prosthetic valve dysfunction, additional imaging with TEE, gated cardiac CT, or fluoroscopy is recommended, even if TTE does not show valve dysfunction.","Immediate coronary angiography is not advised over a delayed or selective approach for patients with ROSC following cardiac arrest if there is no ST-segment elevation, shock, electrical instability, significant myocardial damage, or ongoing ischemia.",Intravenous unfractionated heparin (UFH) is beneficial in lowering ischemic events in patients with NSTE-ACS.,A,2
q_0379,"In patients presenting with HF, it is unnecessary to obtain a thorough history or perform a physical examination to identify cardiac and noncardiac disorders, lifestyle and behavioral factors, and social determinants of health that might cause or accelerate the development or progression of HF.","If a dressing is placed, the first aid provider should not monitor the person for worsening of breathing/symptoms and should not loosen or remove the dressing if breathing worsens.","For individuals with obstructive hypertrophic cardiomyopathy, it may be advisable to stop using vasodilators (such as ACE inhibitors, ARBs, or dihydropyridine calcium channel blockers) or digoxin, as these medications can exacerbate symptoms related to dynamic outflow tract obstruction.","In patients with CCD, it may be reasonable to increase climate-related exposures (eg, extreme temperatures, wildfire smoke) to elevate the risk of cardiovascular events.",C,1
q_0380,"For adults, it is advised to counsel patients to participate in a minimum of 150 minutes of moderate-intensity exercise, 75 minutes of vigorous-intensity exercise, or a comparable mix weekly to lower the risk of stroke.","For a person with signs or symptoms of severe head injury (such as loss of consciousness, worsening headache, vomiting, altered mental status, seizures, visual changes, swelling, or deformities of the scalp), EMS should not be activated.","In patients with stroke or TIA, combined exercise-based and behavior change interventions are probably not indicated and should be avoided in preference to behavior interventions alone, exercise interventions alone, or usual care to reduce physiological stroke risk factors such as SBP.","In patients with stroke and TIA, it is not advisable to counsel individuals to follow a Mediterranean-type diet, and instead, they should be encouraged to follow a low-fat diet, avoiding emphasis on monounsaturated fat, plant-based foods, and fish consumption, as well as high extra virgin olive oil or nut supplementation, to reduce the risk of recurrent stroke.",A,1
q_0381,"Patients who are pacemaker-dependent having surgeries above the umbilicus with anticipated EMI should not have the pacemaker reprogrammed or have a magnet placed on the generator, risking pacing inhibition.","For patients with CCD who are having stress PET MPI or stress CMR imaging, incorporating myocardial blood flow reserve (MBFR) can be beneficial for increasing diagnostic precision and improving risk assessment.","For patients with stable chest pain and a history of coronary revascularization, it is appropriate to use CCTA to assess the patency of bypass grafts or stents that are 3 mm or larger.","When providing first aid for chemical eye injury, first aid providers should avoid contaminating other individuals, areas, or the other eye with the caustic substance.",A,2
q_0382,"In patients with a history of ischemic stroke or TIA and a mechanical aortic valve, avoiding anticoagulation with higher-intensity warfarin to achieve an INR of 3.0 (range, 2.5–3.5) and not adding aspirin (75–100 mg/d) can be beneficial to increase the risk of thromboembolic events.","In patients with cardiac allograft vasculopathy, statins are not recommended for secondary prevention to reduce MACE.","In adults with hypertension, thiazide and thiazide-like diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers are not recommended as initial antihypertensive drug therapies to prevent stroke.",It is reasonable to administer calcium for CCB ­poisoning.,D,1
q_0383,"For asymptomatic patients undergoing elevated-risk surgeries without known CVD, a preoperative rest­ ing 12-lead ECG may be considered to establish a baseline and guide perioperative management.3,9,10","In patients with HCM and LVEF <50%, ICD placement is not beneficial.","In patients with stroke or TIA, provision of health information or advice about stroke prevention is essential; however, information or advice alone, in the absence of a behavioral intervention, is not an effective means to change modifiable, lifestyle-related risk factors in order to reduce future ischemic events.129,829,845","In adults with congenital heart disease with AF undergoing PVI, it may be reasonable to include an ablative strategy in the right atrium directed at reentrant arrhythmia secondary to atriotomy scars and the CTI.8,9",B,2
q_0384,"Patients with PAD who smoke cigarettes or use any other forms of tobacco should not be assisted in developing a plan for quitting, and should avoid pharmacotherapy (ie, varenicline, bupropion, and/or nicotine replacement therapies), counseling, or referral to a smoking cessation program.","For patients experiencing cryptogenic stroke, it is appropriate to conduct tests for inherited or acquired hypercoagulable conditions, bloodstream or cerebrospinal fluid infections, infections that may lead to CNS vasculitis (such as HIV and syphilis), drug use (including cocaine and amphetamines), systemic inflammation markers, and genetic tests for hereditary diseases linked to stroke, as clinically warranted to identify potential contributors or risk factors.","For patients with fibrotic or significantly calcified lesions, considering plaque modification through orbital atherectomy, balloon atherotomy, laser angioplasty, or intracoronary lithotripsy can enhance procedural success.","Anticoagulation is advised for patients with atrial fibrillation who have an estimated annual thromboembolic risk of 2% or higher, such as those with a CHA2DS2-VASc score of 2 or more in men and 3 or more in women, to prevent stroke and systemic thromboembolism.",A,2
q_0385,"In patients with ACS undergoing PCI, maintaining the initial DAPT regimen (continuing ticagrelor or prasugrel) after 1 month is advisable to avoid reducing bleeding risk.","In patients undergoing elective CABG who receive P2Y12 receptor inhibitors before surgery, it is unreasonable to discontinue clopidogrel for 5 days, ticagrelor for 3 days, and prasugrel for 7 days before CABG, as this does not reduce the risk of major bleeding and blood product transfusion.","In patients with ischemic stroke or TIA in whom patent foramen ovale (PFO) closure would be contemplated, TCD (transcranial Doppler) with embolus detection should not be considered to screen for right-to-left shunt.","For patients with PAD on the highest tolerated dose of statins and an LDL-C level of 70 mg/dL or higher, adding PCSK9 inhibitor therapy is advisable.",D,1
q_0386,It is reasonable to use antiseptic agents such as povidone-iodine for wound irrigation instead of running tap water or sterile saline solutions.,"In patients for whom echocardiography is inadequate, alternative imaging (e.g., cardiac magnetic resonance [CMR], cardiac computed tomography [CT], radionuclide imaging) is not recommended for assessment of LVEF.","For patients with symptomatic heart failure, clinical indicators of advanced heart failure should be identified through history taking and physical examination.","In patients with AF who do have a history of moderate to severe rheumatic mitral stenosis or a mechanical heart valve, and who are not candidates for anticoagulation, warfarin is recommended over DOACs to increase the risk of mortality, stroke, systemic embolism, and ICH.",C,1
q_0387,"For patients with NSTE-ACS at moderate or high risk of ischemic events who are suitable for revascularization, it is advised to adopt an invasive strategy aimed at revascularization during their hospital stay to decrease MACE.","Referring asymptomatic patients with extensive aortic disease, those who could gain from complex open and endovascular aortic repairs, or individuals with multiple comorbidities requiring intervention to a high-volume center (conducting a minimum of 30-40 aortic procedures per year) with skilled surgeons in a Multidisciplinary Aortic Team is advisable to enhance treatment outcomes.",Application of ice to a snakebite wound is of unproven benefit and may be harmful in some situations.,"In patients undergoing PCI within 24 hours after fibrinolytic therapy, a loading dose of 300 mg of clopidogrel, followed by daily dosing, is not recommended to reduce ischemic events.",D,2
q_0388,"Pregnant individuals with AF and elevated risk of stroke should not be considered for anticoagulation, as it is assumed that all anticoagulation strategies are completely safe for both the mother and fetus, and an SDM discussion regarding risks is unnecessary.","In patients with HF who have had a significant clinical change, or who have received GDMT and are being considered for invasive procedures or device therapy, repeat measurement of EF, degree of structural remodeling, and valvular function are not useful to inform therapeutic interventions.","In patients with HCM and poorly tolerated AF, a rhythm-control strategy with cardioversion or antiar- rhythmic drugs can be beneficial with the choice of an agent according to AF symptom severity, patient preferences, and comorbid conditions.9,12–24","In patients with aSAH, routine use of statin therapy to improve outcomes is recommended.",C,1
q_0389,"In most pregnant women with HCM, vaginal delivery is not recommended as the first-choice delivery option.","In certain cases where direct manual pressure cannot be applied, mechanical pressure using bandages or devices may be an option.","In patients with HF, assessment and documen- tation of NYHA functional classification are recommended to determine eligibility for treat- ments.1–3","In asymptomatic patients with severe AS and an LVEF <50% who are ≤80 years of age and have no anatomic contraindication to transfemoral TAVI, the decision between TAVI and SAVR should follow the same recommendations as for symptomatic patients in Recommendations 1, 2, and 3 above.1,2,4–10",A,2
q_0390,"For adults with CCD and HIV, using antiretroviral therapy helps reduce the likelihood of cardiovascular events.","For patients with grade 3 BAAI (refer to Table 33), considering repair might be appropriate to lower the risk of advancing to a life-threatening condition.","In patients with ischemic stroke or TIA and Fontan palliation, anticoagulation with warfarin is recommended to reduce the risk of recur- rent stroke or TIA.572,573","In patients who meet standard indications for intervention for VHD (replacement and repair) on the basis of symptoms and disease severity, intervention should not be performed before elective noncardiac surgery, regardless of the urgency and risk of the noncardiac procedure, even if it could reduce perioperative risk.",D,2
q_0391,"In patients with HCM, exercise stress testing is not recommended to determine functional capacity or to provide prognostic information as part of initial evaluation.","In patients with recurrent endocarditis and continued intravenous drug use, it is not recommended to consult with addiction medicine to discuss the long-term prognosis for the patient’s refraining from actions that risk reinfection before repeat surgical intervention is considered.","Patients at increased risk of AF should not receive comprehensive guideline-directed LRFM for AF, ignoring obesity, physical inactivity, unhealthy alcohol consumption, smoking, diabetes, and hypertension.",The timing for surgical intervention in IE should be determined by a Heart Valve Team.,D,1
q_0392,"In patients hospitalized with worsening HF, participation in systems that allow benchmarking to performance measures is unreasonable and does not increase the use of evidence-based therapy or improve quality of care.",Leaving open wounds associated with a suspected fracture uncovered may increase the risk for further contamination and infection.,"In patients with CCD and no indication for oral anticoagulant therapy, low-dose aspirin 81 mg (75-100 mg) is not recommended to reduce atherosclerotic events.","For patients with severe AS (Stage C1) who appear asymptomatic and have low surgical risk, it is reasonable to consider AVR if an exercise test shows reduced exercise tolerance (adjusted for age and sex) or a drop in systolic blood pressure of ≥10 mm Hg from baseline to peak exercise.",D,1
q_0393,"In patients with NSTE-ACS in whom multivessel PCI is being considered, physiological assessment of a nonculprit stenosis should not be considered to guide revascularization decisions.","While awaiting the arrival of EMS, first aid provid- ers may encourage alert adults experiencing non- traumatic chest pain to chew and swallow aspirin (162–325 mg), unless the person experiencing pain has a known aspirin allergy or has been advised by a health care professional not to take aspirin.","In patients with CCD and normal LV function, the addition of ivabradine to standard anti-anginal therapy is potentially beneficial.","For patients with HCM, it is not reasonable to follow Federal Motor Carrier Safety Administration cardiovascular disease guidelines that permit driving commercial motor vehicles, even if they do not have an ICD or any major risk factors for SCD and are following a guideline-directed management plan.",B,1
q_0394,Stings to the eye do not need to be evaluated by a trained medical professional.,"For patients with known extensive nonobstructive CAD with stable chest pain symptoms, stress imaging (PET/SPECT, CMR, or echocardiography) is reasonable for the diagnosis of myocardial ischemia.15-24","In patients with HF class II to IV symptoms, omega-3 polyunsaturated fatty acid (PUFA) supplementation may be reasonable to use as adjunctive therapy to reduce mortality and car- diovascular hospitalizations.1–4",Screening for PAD using the ABI is not advised for patients who do not have an elevated risk of PAD (refer to Table 5) and lack any history or physical examination indicators of PAD (refer to Table 6).,A,2
q_0395,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is reasonable.5,6","If they are available, it is reasonable to use oral glucose tablets in preference to gel or dietary sources of glucose to treat hypoglycemia.","In patients with descending TAA undergoing TEVAR, do not review preoperative CTA of the iliofemoral vessels to evaluate access.","For patients with AAA who are cigarette smokers, it is advised to undertake smoking cessation efforts.",C,2
q_0396,Administering pralidoxime is appropriate for treating organophosphate poisoning.,"For adults with CCD and HIV, avoid prescribing lovastatin or simvastatin alongside protease inhibitors due to potential harm.","All patients with AF, irrespective of sex, gender identity, race, ethnicity, or negative social determinants of health such as low income, limited education, insufficient insurance, or rural residence, should be equally provided with guideline-recommended therapies for stroke risk reduction, as well as rate or rhythm control strategies and LRFM, to enhance quality of life and avert negative outcomes.","Use of neuromuscular blockers metabolized by cholinesterase (ie, succinylcholine and mivacurium) is recommended for patients with organophosphate or carbamate poisoning.",D,2
q_0397,"In patients with atherosclerotic TAA and concomitant aortic atheroma or PAU, the use of low-dose aspirin is not reasonable, even if not contraindicated.","In patients with HCM in whom functional capacity or symptom status is uncertain, exercise stress test- ing may be considered every 2 to 3 years (Figure 1).","For symptomatic patients with severe AS for whom predicted post-TAVI or post-SAVR survival is <12 months or for whom minimal improvement in quality of life is expected, palliative care is recommended after shared decision-making, including discussion of patient preferences and values.","For patients with CCD who have stable clinical and functional status, regular reassessment of LV function is not advised for guiding treatment decisions.",A,2
q_0398,"In children 2 to 16 years of age with SCD whose TCD velocities revert to normal, continued transfu- sion therapy can be beneficial to reduce the risk of stroke.384","Pregnant women with severe valve disease (Stages C and D) should not be monitored in a tertiary-care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.","For patients with aSAH, avoiding complete obliteration of the ruptured aneurysm is indicated, even when feasible, to increase the risk of rebleeding and retreatment.",It is not reasonable to administer atropine for hemodynamically significant bradycardia from CCB poisoning.,A,1
q_0399,"In patients with symptomatic AF where anti-arrhythmic drugs have been ineffective, contraindicated, not tolerated, or not preferred, and continued rhythm control is desired, catheter ablation is not useful to improve symptoms.",A person with signs and symptoms of a concussion should continue participating in activity (play/sports) without needing evaluation by a health care professional.,"In patients with stroke or TIA found to have a left-sided cardiac tumor, resection of the tumor can be beneficial to reduce the risk of recurrent stroke.586–588","In patients with AF with CHA2DS2-VASc score ≥2 or equivalent risk of stroke, on DOAC anticoagulation and undergoing pacemaker or defibrillator implantation or generator change, neither uninterrupted nor interrupted DOAC is reasonable.",C,1
q_0400,"In patients >65 years of age who require AVR, it is not reasonable to choose a bioprosthesis over a mechanical valve.","In patients (other than younger with few comorbidities) with symptomatic paroxysmal or persistent AF who are being managed with a rhythm-control strategy, catheter ablation as first-line therapy can be useful to improve symptoms.11–13,28 Cost Value Statement: Intermediate B-R","For patients experiencing heparin-induced thrombocytopenia who are undergoing PCI, it is advised to substitute UFH with bivalirudin or argatroban to prevent thrombotic complications.","It is advised that patients with mechanical heart valves maintain VKA anticoagulation with a therapeutic INR during minor procedures, such as dental extractions or cataract surgery, where bleeding can be easily managed.",A,2
q_0401,"In the general population, validated multivari- able risk scores can be useful to estimate sub- sequent risk of incident HF.24–26","Pregnant patients with a mechanical heart valve should receive care at a tertiary center where a specialized multidisciplinary team, including cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians, is experienced in managing high-risk cardiac conditions during pregnancy.","In patients with a mechanical mitral valve and a history of ischemic stroke or TIA before valve replacement, aspirin (75–100 mg/d) is recom- mended in addition to warfarin with an INR target of 3.0 (range, 2.5–3.5) to reduce the risk of thrombosis and recurrent stroke or TIA.458,459","For life-threatening extremity bleeding, a tourniquet should not be applied or tightened, even if the bleeding continues.",D,2
q_0402,"In patients with intact degenerative TAAA who have features associated with an increased risk of rupture (Table 19), repair is reasonable when the diameter is <5.5 cm.4",We recommend hospitals develop protocols for postarrest temperature control.,Fluoxetine treatment does not improve poststroke functional outcomes in patients with aSAH who do not have depression.,"In nonambulatory patients with spontaneous ICH, graduated compression stockings of knee-high or thigh-high length alone are beneficial for VTE prophylaxis.",D,2
q_0403,"In patients with ACS undergoing PCI, a load- ing dose of P2Y12 inhibitor, followed by daily dosing, is recommended to reduce ischemic events.5-15","In patients with CCD and cancer, it is not recommended to involve a multidisciplinary team with cardiology and oncology expertise, as it does not improve long-term CVD outcomes.","In patients with fibrotic or heavily calcified lesions, plaque modification with rotational atherectomy can be useful to improve proce- dural success.1-3","For patients experiencing spontaneous intracerebral hemorrhage, impaired consciousness, and confirmed electrographic seizures, antiseizure medications should be given to decrease morbidity.",B,2
q_0404,"In patients with acute chest pain, it is recommended that 9-1-1 not be activated by patients or bystanders, and transport to the closest ED by emergency medical services (EMS) should be avoided.",Irrigate the eyes right away following chemical exposure to ensure decontamination.,"For nonambulatory patients experiencing spontaneous ICH, starting low-dose UFH or LMWH prophylaxis 24 to 48 hours after the onset of ICH might be advisable to balance the prevention of thrombosis against the risk of HE.","For patients with AF, starting sotalol treatment in a setting equipped for continuous ECG monitoring, CrCl assessment, and cardiac resuscitation is advisable due to the risks of proarrhythmia and bradycardia.",A,2
q_0405,"In patients with CCD on maximally tolerated statin therapy who have an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), and in whom ezetimibe and PCSK9 monoclonal antibody are deemed insufficient or not tolerated, it is not advisable to add bempedoic acid or inclisiran to further reduce LDL-C levels.","For patients with Turner syndrome and an ASI of 2.5 cm/m² or greater, it is advised to undergo surgery prior to pregnancy.","In patients with Turner syndrome who are ≥15 years old, the use of the ASI (ratio of aortic diameter [cm] to BSA [m2]) is not recommended to define the degree of aortic dilation or assess the risk of aortic dissection.","In patients with AF who do have a history of moderate to severe rheumatic mitral stenosis or a mechanical heart valve, and who are not candidates for anticoagulation, warfarin is recommended over DOACs to increase the risk of mortality, stroke, systemic embolism, and ICH.",B,1
q_0406,"For intermediate-risk patients with acute chest pain and no known CAD who are eligible for cardiac testing, neither exercise ECG, stress echocardiography, stress PET/SPECT MPI, nor stress CMR is useful for the diagnosis of myocardial ischemia.","In adults who qualify for treatment with lipid-lowering therapy according to the 2019 ACC/AHA guideline on the primary prevention of CVD (e.g., 20–75 years of age with LDL cholesterol [LDL-C] level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 risk enhancers), treatment with a statin is not recommended to reduce the risk of a first stroke.","In patients with TAA, regardless of cause and in the absence of contraindications, avoiding the use of beta blockers to achieve target BP goals is reasonable.","In the general population, validated multivari- able risk scores can be useful to estimate sub- sequent risk of incident HF.24–26",D,1
q_0407,"In ambulatory patients with unexplained dyspnea, CPET is not reasonable to evaluate the cause of dyspnea.","In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) should not be considered to reduce dabigatran concentration.","In high-risk patients with NSTE-ACS and CKD, it is not reasonable to perform coronary angiography and revascularization, and no measures should be taken to reduce the risk of AKI.","In patients with NSTE-ACS undergoing PCI, bivalirudin may be reasonable as an alternative to UFH to reduce bleeding.†16,20–23",D,1
q_0408,"In adults with CCD and rheumatoid arthritis, initia- tion and maintenance of disease-modifying anti- rheumatoid drugs is beneficial to decrease the risk of cardiovascular events.8–11","In patients with HF, routine use of invasive hemodynamic monitoring is recommended.",Administering calcium for CCB poisoning is considered appropriate.,"In patients with severe MS who cannot undergo MV intervention before NCS, perioperative invasive hemodynamic monitoring is reasonable to guide management to reduce the risk of cardiovascular complications.",B,2
q_0409,"In patients with diabetes or impaired glucose tolerance, discontinuation of metformin during the perioperative period is reasonable to maintain glycemic control. Canagliflozin, dapagliflozin, and empagliflozin should be continued up to the day of surgery, and ertugliflozin should be stopped <4 days before scheduled surgery.","For patients with ACS and either acute or chronic anemia, it might be appropriate to administer a blood transfusion to reach a hemoglobin level of at least 10 g/dL to potentially lower the risk of cardiovascular events.","For patients experiencing spontaneous intracerebral hemorrhage, managing moderate to severe hyperglycemia (greater than 180–200 mg/dL or 10.0–11.1 mmol/L) is advisable to enhance outcomes.","For patients with established cardiovascular disease, those aged 65 or older, or individuals aged 45 or older exhibiting symptoms indicative of cardiovascular disease who are undergoing high-risk non-cardiac surgery, it is advisable to assess B-type natriuretic peptide (BNP) or N-terminal pro–B-type natriuretic peptide (NT-proBNP) preoperatively to enhance the assessment of perioperative risk.",A,2
q_0410,"In patients with IE who present with valve dysfunction resulting in symptoms of HF, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is not indicated.",A person who has persistent foreign-body sensation in the eye should seek immediate medical attention.,"In patients with Fabry disease, the effectiveness of enzyme replacement therapy (ERT) to reduce the risk of stroke is well established.","In patients with CCD and a previous history of MI without a history of stroke, transient ischemic attack (TIA), or ICH, vorapaxar should not be added to aspirin therapy to reduce MACE.",B,1
q_0411,"In adults with CCD, nonpharmacologic strategies are recommended as first-line therapy to lower BP in those with elevated BP (120-129/<80 mm Hg) (see Table 12).*1–9",It is not recommended for the health care team to discuss out-of-pocket costs for medications with patients who have CCD when initiating a new medication or annually thereafter.,"In patients with CCD undergoing stress PET MPI or stress CMR imaging, the addition of myocardial blood flow reserve (MBFR) can be useful to improve diagnostic accuracy and enhance risk stratification.*18–23","In patients with PAD, a comprehensive foot evaluation (Table 13) should be performed at least annually to identify risk factors for ulcers and amputation.",B,2
q_0412,"In patients with NSTE-ACS who are at low risk of ischemic events, neither a routine invasive nor a selective invasive approach is recommended, as it does not help identify those who may require revascularization or reduce MACE.","For patients with a bioprosthetic aortic or mitral valve who suffer a stroke or systemic embolism while on antiplatelet therapy, VKA anticoagulation may be considered as an alternative to antiplatelet therapy after evaluating the risk of bleeding.","CMR imaging is beneficial for patients with LVH when alternative diagnoses, such as infiltrative or storage diseases and athlete's heart, are suspected.","In patients with a BAV, a diameter of the aortic root or ascending aorta of 5.0 cm to 5.4 cm, no other risk factors for aortic dissection (Table 14), and at low surgical risk, surgery to replace the aortic root, ascending aorta, or both may be reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,2,5",A,2
q_0413,"For patients with aSAH from ruptured aneurysms of the posterior circulation that are amenable to coiling, clipping is indicated in preference to coiling to improve outcome.","For patients with supratentorial ICH who are comatose, possess large hematomas causing substantial midline shift, or exhibit elevated ICP unresponsive to medical treatment, decompressive craniectomy, with or without hematoma removal, may be an option to lower mortality.","For patients with suspected or confirmed acute type A aortic dissection, it is advised to seek emergency surgical consultation and evaluation, followed by prompt surgical intervention, due to the high risk of life-threatening complications.","For asymptomatic individuals with nonobstructive HCM, the advantages of using beta blockers or calcium channel blockers remain uncertain.",A,2
q_0414,"In patients with spontaneous ICH, it is not recommended to treat hypoglycemia (<40–60 mg/dL, <2.2–3.3 mmol/L) to reduce mortality.","In patients with larger supratentorial ICH, transferring to centers without neurosurgical capabilities may be reasonable to improve outcomes.","For patients suspected of having HCM in whom echocardiography is inconclusive, CMR imaging is not indicated for diagnostic clarification.","Cool compresses may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.",D,1
q_0415,"In patients with good-grade aSAH, the routine use of induced mild hypothermia during aneurysm surgery is beneficial.","For patients with aSAH from ruptured aneurysms of the posterior circulation that are amenable to coiling, clipping is indicated in preference to coiling to improve outcome.","For most patients with spontaneous supra- tentorial ICH of moderate or greater severity, the usefulness of craniotomy for hemorrhage evacuation to improve functional outcomes or mortality is uncertain.380,382,384,393,429–431","In patients with spontaneous ICH, regional systems of stroke care are not recommended, and potentially beneficial therapies should not be made available rapidly, including health care facilities that provide initial spontaneous ICH care and those with neurocritical care and neurosurgical capabilities.",C,1
q_0416,"In patients <50 years of age who prefer a bioprosthetic AVR and have appropriate anatomy, replacement of the aortic valve by a pulmonic autograft (the Ross procedure) may be considered at a Comprehensive Valve Center.12–14","In symptomatic patients with severe AR (Stage D), aortic valve surgery is indicated regardless of LV systolic function.1–7","In vulnerable patient populations at risk for health disparities, HF risk assessments and multidisciplinary management strategies should ignore known risks for CVD and social determinants of health, as a means toward perpetuation of disparate HF outcomes.","Among patients with a diagnosis of AF, it is reason- able to infer AF frequency, duration, and burden using automated algorithms available from electrocardio- graphic monitors, implantable cardiac monitors, and cardiac rhythm devices with an atrial lead, recognizing that periodic review can be required to exclude other arrythmias.1,4,5,12",C,2
q_0417,Stings to the eye do not need to be evaluated by a trained medical professional.,"For patients with acute chest pain and suspected ACS who are deemed intermediate risk by a CDP, shared decision-making between the clinician and patient regarding the need for admission, for observation, discharge, or further evaluation in an outpatient setting is recommended for improving patient understanding and reducing low-value testing.1,2",Institutions should establish a CDP with a protocol for troponin testing tailored to their specific assay to ensure consistent identification and differentiation of myocardial injury in patients with acute chest pain and suspected ACS.,Patients with any history of angioedema should not receive ACE inhibitors.,A,2
q_0418,"In patients with cardiac allograft vasculopathy, aspirin can be beneficial for secondary prevention to reduce MACE.2","In patients with an ischemic stroke or TIA and OSA, treatment with positive airway pressure (eg, continuous positive airway pressure [CPAP]) can be beneficial for improved sleep apnea, BP, sleepiness, and other apnea- related outcomes.302–314","In men with an AAA of <5.0 cm and women with an AAA of <4.5 cm, surveillance ultrasound is not recommended every 6 months to assess for interval change.","Anticoagulation is advised for patients with atrial fibrillation who have an estimated annual thromboembolic risk of 2% or higher, such as those with a CHA2DS2-VASc score of 2 or more in men and 3 or more in women, to prevent stroke and systemic thromboembolism.",C,2
q_0419,"For patients <40 years of age with aSAH, clipping of the ruptured aneurysm should not be considered the preferred mode of treatment, as it does not improve durability of the treatment and outcome.","In patients with BTTAI, management and treatment at a trauma center with the facili- ties and expertise to treat aortic pathology is recommended.","For patients with HFrEF and NYHA class II to IV symptoms, it is advised to use an MRA (spironolactone or eplerenone) to decrease morbidity and mortality, provided that eGFR exceeds 30 mL/min/1.73 m² and serum potassium is below 5.0 mEq/L. Potassium levels, kidney function, and diuretic dosing should be carefully monitored at the start and closely observed thereafter to reduce the risk of hyperkalemia and renal impairment. Value Statement: High Value (A)",Administering digoxin-Fab is a sensible approach for treating poisoning from Bufo toad venom and yellow oleander.,A,2
q_0420,"In patients with STEMI managed with fibrinolytic therapy, clopidogrel should be administered concurrently to reduce death and MACE.2,3 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization”12 and the †”2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Manage- ment of Patients With Chronic Coronary Disease.”13","If no noncardiac cause is apparent, patients presenting with stable chest pain in the office should undergo an ECG; if an ECG cannot be performed, the patient should be directed to the ED for this test.","In patients with AF in whom rate control strategy is planned, neither beta blockers, verapamil, nor diltiazem should be recommended, regardless of patient preferences and comorbid conditions.","In patients with CCD without a change in clinical or functional status, routine periodic reassessment of LV function is not recommended to guide thera- peutic decision-making.11,12",C,2
q_0421,"In appropriate patients with NSTE-ACS who have refractory angina or hemody- namic or electrical instability, an immediate invasive strategy with intent to perform revascularization is indicated to improve outcomes.10","In patients with cyanotic congenital heart disease and other complex lesions, ischemic stroke or TIA of presumed cardioembolic origin, therapy with warfarin is not recommended to reduce the risk of recurrent stroke or TIA.","In patients with non–left main CAD who are planned for NCS, routine preoperative coronary revascularization is recommended to reduce perioperative cardiovascular events.","In patients with HF, an evaluation for possible ischemic heart disease is not useful to identify the cause or guide management.",A,1
q_0422,"For patients with aSAH, the ruptured aneurysm should not be evaluated by specialist(s) with endovascular and surgical expertise, and the relative risks and benefits of surgical or endovascular treatment should not be determined according to patient and aneurysm characteristics.","For patients with Marfan syndrome who have had aortic root replacement, it is advisable to perform surveillance imaging every 3 to 5 years to monitor for possible AAA.","For patients at intermediate risk who present with acute chest pain and have coronary artery stenosis ranging from 40% to 90% in a proximal or middle segment as seen on CCTA, using FFR-CT is a reasonable approach to diagnose vessel-specific ischemia and assist in determining the need for coronary revascularization.","For certain patients with a history of CABG undergoing PCI of a SVG, employing an embolic protection device, if technically possible, is advisable to reduce the risk of distal embolization.",A,2
q_0423,"For patients with suspected or confirmed bioprosthetic valve thrombosis who are hemodynamically stable and have no contraindications to anticoagulation, starting treatment with a VKA is advisable.","In patients undergoing PCI within 24 hours after fibrinolytic therapy, a loading dose of 300 mg of clopidogrel, followed by daily dosing, is not recommended to reduce ischemic events.","For patients with aSAH, it is advised to promptly transfer them from low-volume hospitals to high-volume centers that offer multidisciplinary neurointensive care, comprehensive stroke center facilities, and have skilled cerebrovascular surgeons or neuroendovascular specialists to enhance outcomes.",Patients with any history of angioedema should not receive ARNi.,B,2
q_0424,"In patients with functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease with inadequate response to GDMT (including structured exercise), surgical revascularization is unreasonable if perioperative risk is acceptable and technical factors suggest advantages over endovascular approaches.","For individuals experiencing premature ovarian failure (menopause before age 40) or early menopause (before age 45), it is advised to assess and adjust vascular risk factors to mitigate the increased risk of stroke in this group.","If an avulsed permanent tooth cannot be immediately replanted and none of the above storage mediums are available, a probiotic, egg white, or almond milk should not be considered.",It is unreasonable to remove rings and other constricting objects from the bitten extremity.,B,1
q_0425,"In patients with asymptomatic atherosclerotic carotid artery stenosis, medical treatment with statin is not beneficial to reduce the risk of stroke.","In patients with CCD and normal LV function, the addition of ivabradine to standard anti-anginal therapy is potentially beneficial.","For patients with CCD, administering DAPT following CABG might help lower the risk of saphenous vein graft occlusion.","In patients with AAS, initial management should exclude intravenous vasodilators even if the BP is not well controlled after initiation of intravenous beta-blocker therapy.",C,1
q_0426,"The exposed area should not be washed with soap and water or a commercially available decontamination product after recognizing exposure to poison ivy, oak, or sumac.",Leaving open wounds associated with a suspected fracture uncovered may increase the risk for further contamination and infection.,"For patients with heart failure and suspected sleep-disordered breathing, conducting a formal sleep evaluation is advisable to verify the diagnosis and distinguish between obstructive and central sleep apnea.","In patients with CCD, sublingual nitroglycerin or nitroglycerin spray is not recommended for immediate short-term relief of angina or equivalent symptoms.",C,1
q_0427,"For patients needing revascularization due to multivessel coronary artery disease with complex or widespread CAD (such as a SYNTAX score above 33), opting for CABG instead of PCI is advisable to enhance survival.","In patients with CCD who consume alcohol, it is reasonable to not limit alcohol intake to reduce cardiovascular and all-cause death.","In patients with chronic HFrEF without a spe- cific indication (eg, venous thromboembolism [VTE], AF, a previous thromboembolic event, or a cardioembolic source), anticoagulation is not recommended.7–9","For adults experiencing sudden chest pain, the emergency response system must be engaged to ensure EMS transports them to the nearest emergency department.",B,2
q_0428,Monitoring EEG repeatedly or continuously is reasonable for patients who do not follow commands after ROSC.,"In patients with CCD who were initiated on beta- blocker therapy for previous MI without a history of or current LVEF ≤50%, angina, arrhythmias, or uncontrolled hypertension, it may be reasonable to reassess the indication for long-term (>1 year) use of beta-blocker therapy for reducing MACE.9–15","Emergency services should not be called if a person bitten by a spider or stung by a scorpion develops symptoms throughout the body such as difficulty breathing, muscle rigidity, dizziness, or confusion.","For patients with severe symptoms (NYHA class III or IV) and advanced rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage D) who are either unsuitable for PMBC, have had an unsuccessful PMBC, need additional cardiac procedures, or lack access to PMBC, mitral valve surgery (repair, commissurotomy, or replacement) is recommended.",C,2
q_0429,Diuretics may be beneficial for patients exhibiting signs and symptoms of right-sided heart failure due to severe tricuspid regurgitation (Stages C and D).,"In patients with CLTI with nonhealing wounds, wound care should not be provided to optimize the wound-healing environment after revascularization, disregarding the goal of complete wound healing.","In patients with HF, vaccinating against respi- ratory illnesses is reasonable to reduce mor- tality.10–16","In patients with a surgical or transcatheter prosthetic valve and in patients who have had valve repair, an initial postprocedural TTE study is recommended for evaluation of valve hemodynamics and ventricular function.1–4",B,2
q_0430,"For patients with mechanical valves and uncontrollable bleeding who require immediate reversal of anticoagulation, administration of 4-factor prothrombin complex (or its activated form) is not recommended.","For patients with heart failure scheduled for elective non-cardiac surgery, it is advisable to discontinue sodium-glucose cotransporter-2 inhibitors (SGLT2i) 3 to 4 days prior to the procedure, if possible, to minimize the risk of metabolic acidosis during the perioperative period.","In patients with ruptured descending TAA undergoing TEVAR, intentional coverage of the left subclavian artery, celiac artery, or both may be considered to increase the landing zone for endovascular repair.5-7","In patients with nonobstructive HCM with preserved EF and symptoms of exertional angina or dyspnea, beta blockers or nondihydropyridine calcium channel blockers are recommended.1–5",A,2
q_0431,"For patients with atrial fibrillation experiencing significant gastrointestinal bleeding, it might be appropriate to restart oral anticoagulation therapy after addressing reversible bleeding causes and evaluating the long-term benefits and risks with a multidisciplinary team during shared decision-making with the patient. *B-NR LOE pertains to apixaban or rivaroxaban data. †C-LD LOE pertains to edoxaban data.",Patients with clinical evidence of ACS or other life-threatening causes of acute chest pain seen in the office setting should not be transported urgently to the ED and can remain in the office for observation.,"In patients with AF in whom rate control strategy is planned, either beta blockers, verapamil, or diltiazem are recommended, with the choice of agents according to patient preferences and comorbid conditions.104,255","In adult patients with obstructive HCM who remain severely symptomatic, despite GDMT and in whom surgery is contraindicated or the risk is considered unacceptable because of serious comorbidities or advanced age, alcohol septal ablation in eligible patients,* performed at experienced HCM centers,† is recommended (Tables 4 and 5).8–10",B,2
q_0432,"In patients with non–left main CAD who are planned for NCS, routine preoperative coronary revascularization is not recommended to reduce perioperative cardiovascular events.*12–15 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re­ vascularization.”16","For patients with clinically significant aortic disease, it is unreasonable to screen for anxiety, depression, and posttraumatic stress disorder or to provide resources for support; it is also unreasonable to provide education and resources to address patients’ concerns, support decision-making, or enhance quality of life.","In patients with AF in whom rate control strategy is planned, beta blockers, verapamil, or diltiazem are recommended, with the choice of agents according to patient preferences and comorbid conditions.9,10","For patients with cardiac amyloidosis and atrial fibrillation, it is advisable to use anticoagulation to lower the risk of stroke, irrespective of the CHA2DS2-VASc score.",B,2
q_0433,"In patients with functionally limiting claudication and isolated hemodynamically significant infrapopliteal disease with inadequate response to GDMT (including structured exercise), surgical revascularization is known to be effective.","For an individual with a foreign object in the eye due to a low-energy source (such as dust, dirt, or an object carried by the wind, or an eyelash), it is advisable to try removing the object by letting natural tears flush it out or by rinsing the eye with tap water or a commercial eye wash solution.","For asymptomatic patients with severe primary MR (Stages B and C1), TTE is not indicated every 6 to 12 months for surveillance of LV function and assessment of pulmonary artery pressure.","In patients with significant calcification of the aorta, it is not reasonable to use techniques to avoid aortic manipulation (off-pump techniques or beating heart) to decrease the incidence of perioperative stroke, even when performed by experienced surgeons.",B,1
q_0434,"In asymptomatic and clinically stable patients undergoing NCS, routine preoperative evaluation of LV function is recommended due to potential benefit.","In symptomatic patients with nonobstructive CAD, a strategy of stratified medical therapy guided by invasive coronary physiologic testing should not be used for improving angina severity and QOL.","Before leaving the hospital, individuals with ACS should be directed to an outpatient CR program to lower the risks of death, myocardial infarction, and hospital readmissions, as well as to enhance functional status and quality of life.","In patients undergoing LA surgical ablation of atrial arrhythmias and/or LA appendage ligation/excision, it is not reasonable to administer anticoagulation therapy for at least 3 months after the procedure.",C,1
q_0435,Evidence of health disparities should not be monitored or addressed at the clinical practice and the health care system levels.,"In patients with functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease with inadequate response to GDMT (including structured exercise), surgical revascularization is reasonable if perioperative risk is acceptable and technical factors suggest advantages over endovascular approaches.29–31 Revascularization for Claudication: Common Femoral Artery Disease","For patients with or at risk of diabetes undergoing elective non-cardiac surgery, it is advisable to conduct preoperative hemoglobin A1c testing if it hasn't been done within the last three months.","For patients experiencing an ischemic stroke or TIA, utilizing MRA or CTA for noninvasive imaging of the intracranial large arteries and the extracranial vertebrobasilar arterial system can effectively detect atherosclerotic disease, dissection, moyamoya, or other relevant vasculopathies.",A,2
q_0436,"Unless a noncardiac cause is evident, an ECG should be performed for patients seen in the office setting with stable chest pain; if an ECG is unavailable the patient should be referred to the ED so one can be obtained.1-5","In patients with spontaneous ICH without depression, fluoxetine therapy is not effective to enhance poststroke functional status.493–497","In patients with HCM who develop palpitations or lightheadedness, extended (>24 hours) electrocardiographic monitoring or event recording is not recommended for arrhythmia diagnosis and clinical correlation.",Decisions about organ donation should follow local legal and regulatory requirements.,C,2
q_0437,"Patients with AAS should not be treated to an SBP <120 mm Hg or to the lowest BP that maintains adequate end-organ perfusion, nor should they be targeted to a heart rate of 60 to 80 bpm.","In ambulatory patients with unexplained dys- pnea, CPET is reasonable to evaluate the cause of dyspnea.17,18","In patients with CCD, an annual influenza vaccination is not recommended, as it does not reduce cardiovascular morbidity, cardiovascular death, or all-cause death.","For life-threatening extremity bleeding, a tourniquet should not be applied or tightened, even if the bleeding continues.",B,1
q_0438,"In pregnant patients with aortic disease who require surveillance imaging of the aortic arch, descending, abdominal aorta, or all 3, CT is recommended over MRI without gadolinium, despite the radiation exposure to the fetus.","In patients with genetic arrhythmogenic cardiomyopathy with high-risk features of sudden death, with EF ≤45%, implantation of ICD is not reasonable to decrease sudden death.","In pregnant women with HCM, cardioversion for new or recurrent AF, particularly if symp- tomatic, is reasonable.302,313","In men with an AAA of <5.0 cm and women with an AAA of <4.5 cm, surveillance ultrasound is not recommended every 6 months to assess for interval change.",C,1
q_0439,"In patients with a recent or remote history of MI or ACS, statins should not be used to prevent symptomatic HF and adverse cardiovascular events.","In patients with IE who present with valve dysfunction resulting in symptoms of HF, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is indicated.7–19","For patients with aSAH, selecting the MoCA instead of the MMSE to detect cognitive impairment is advisable.","For patients with an abdominal aortic PAU accompanied by IMH, urgent repair might be considered.",A,2
q_0440,"In patients with CCD who are judged to be at very high risk (Table 10) and who have an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), or a non–high-density lipoprotein cholesterol (HDL-C) level ≥100 mg/dL (≥2.6 mmol/L), on maximally tolerated statin and ezetimibe, a PCSK9 monoclonal antibody should not be used as it is not beneficial in reducing the risk of MACE.","In patients who are undergoing surgical revascularization for functionally limiting claudication and hemodynamically significant femoropopliteal disease, bypass to the popliteal artery with prosthetic graft material is recommended in preference to autogenous vein.","In adults without prior CVD and who are at high or intermediate CVD risk, a Mediterranean diet is not recommended to reduce the risk of incident stroke.","In patients with aSAH, frequent vital sign and neurological monitoring is recommended for detection of neu- rological change and prevention of secondary cerebral insults and poor outcomes.244,246,250,255–257 Downloaded from http://ahajournals.org by on June 19, 2025",D,1
q_0441,"In patients with obstructive HCM who remain symptomatic despite GDMT, SRT in eligible patients, performed at experienced HCM centers, is not recommended for relieving LVOTO.","In patients with HFrEF and NYHA class II to IV symptoms, an MRA (spironolactone or eplerenone) is not recommended to reduce morbidity and mortality, regardless of eGFR or serum potassium levels. Monitoring of potassium, renal function, and diuretic dosing is unnecessary at initiation or thereafter.",We recommend sedation for severe agitation from sympathomimetic poisoning.,"For patients with HCM who are asymptomatic and have normal exercise capacity, SRT is recommended.",C,1
q_0442,"Patients with HF should not receive care from multidisciplinary teams, as this would hinder the implementation of GDMT, ignore potential barriers to self-care, increase the risk of subsequent rehospitalization for HF, and decrease survival.","In patients with ACS undergoing coronary stent implantation in the left main artery or in complex lesions, intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) is not recommended for procedural guidance to reduce ischemic events.","In patients with CCD who have had a previous MI and are at low bleeding risk, extended DAPT beyond 12 months for a period of up to 3 years should not be considered to reduce MACE.","In patients with HF, long-term use of either continuous or intermittent intravenous inotropic agents, for reasons other than palliative care or as a bridge to advanced therapies, is potentially harmful.5,6,8–11",D,1
q_0443,"For patients with HCM who are not otherwise identified as high risk for SCD, or in whom a decision to proceed with ICD placement remains uncertain after clinical assess- ment that includes personal/family history, echocardiography, and ambulatory electro- cardiographic monitoring, CMR imaging is beneficial to assess for maximum LV wall thickness, EF, LV apical aneurysm, and extent of myocardial fibrosis with late gadolinium enhancement78,79,81,83–86,146,155 (Table 7).","For patients with obstructive CAD who have stable chest pain despite GDMT and moderate-severe ischemia, ICA is not recommended for guiding therapeutic decision-making.","For certain hemodynamically stable patients with STEMI and uncomplicated multivessel disease, performing PCI on a non-infarct artery stenosis during the initial PCI may be an option to lower cardiac event rates.","For patients reliant on a pacemaker with a transvenous ICD undergoing surgery above the umbilicus where EMI is expected, the device should be reprogrammed. If the patient is not pacemaker-dependent, either reprogramming or placing a magnet on the generator can be used to prevent tachytherapies or inappropriate shocks.",B,2
q_0444,"In patients with AAA and an average SBP of ≥130 mm Hg, or an average DBP of ≥80 mm Hg, the use of antihypertensive medication is not recommended to reduce the risk of cardiovascular events.","In patients with aSAH whose ruptured aneurysm has been secured, pharmacological or mechanical venous thromboembolism (VTE) prophylaxis is not recommended to reduce the risk for VTE.","For patients with a mechanical bileaflet or current-generation single-tilting disk AVR and no risk factors for thromboembolism, anticoagulation with a VKA to achieve an INR of 2.5 is not recommended.","For patients with AF and COPD, using cardioselective beta blockers for AF rate control is advisable, particularly when there are additional indications such as MI and HF.",D,1
q_0445,"For patients admitted with HF, treatment should ignore reversible factors, maintain suboptimal volume status, and avoid advancing GDMT toward targets for outpatient therapy.","In patients with recurrent symptomatic AF after catheter ablation, repeat catheter ablation or antiarrhythmic drug therapy is not useful to improve symptoms and freedom from AF.","In patients with ischemic stroke or TIA and IE who present with recurrent emboli and persistent vegetations despite appropri- ate antibiotic therapy, early surgery (during initial hospitalization before completion of a full therapeutic course of antibiotics) is reasonable to reduce the risk of recurrent embolism if there is no evidence of intracra- nial hemorrhage or extensive neurological damage.460–465","In patients with functionally limiting claudication and isolated hemodynamically significant infrapopliteal disease with inadequate response to GDMT (including structured exercise), surgical revascularization is known to be effective.",C,1
q_0446,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is not reasonable.","For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy, a hybrid epi- cardial and endocardial ablation might be reasonable to reduce the risk of recurrent atrial arrhythmia.5–7 Recommendations for the Role of Pacemakers and ICDs for the Prevention and Treatment of AF (Continued ) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","In patients with CAD and suspected scar- mediated sustained monomorphic VT, revas- cularization is not recommended for the sole purpose of preventing recurrent VT.5-9",Applying an occlusive dressing to clean superficial wounds and abrasions is advisable to enhance healing.,A,2
q_0447,"ICD implantation is not recommended in patients post ACS with clinically relevant ventricular arrhythmias >48 hours and within 40 days post MI, as it does not improve survival.","In patients with CCD without an indication for ther- apeutic DOAC or DAPT and who are at high risk of recurrent ischemic events but low-to-moderate bleeding risk, the addition of low-dose rivaroxaban 2.5 mg twice daily to aspirin 81 mg daily is reason- able for long-term reduction of risk for MACE.30–32 DAPT and Proton Pump Inhibitor (PPI)","In patients with a BAV who have undergone AVR, it is not necessary to continue lifelong serial interval imaging of the aorta if the diameter of the aortic sinuses or ascending aorta is ≥4.0 cm.","In patients with grade 2 BTTAI and with high-risk imaging features, aortic intervention is not reasonable.",B,1
q_0448,"For patients with acute chest pain and suspected ACS who are deemed intermediate risk by a CDP, it is not recommended to engage in shared decision-making between the clinician and patient regarding the need for admission, observation, discharge, or further evaluation in an outpatient setting, as this does not improve patient understanding or reduce low-value testing.","In patients undergoing valve repair or replacement with significant proximal CAD, CABG is not reasonable for selective patients.","For patients with HCM, participation in high-intensity recreational activities or moderate- to high-intensity competitive sports activities should be undertaken without the need for a comprehensive evaluation or annual discussion with an expert provider, disregarding the potential increased risk of sudden death and ICD shocks, and without involving third parties in eligibility decisions for competitive sports participation.","For families impacted by HCM, reproductive and genetic counseling should be provided before conception and during pregnancy.",D,1
q_0449,"In patients with a left ventricular assist device (LVAD), it is not necessary to coordinate with the LVAD care team on the timing and perioperative considerations of elective NCS, as it does not impact the risk of perioperative MACE.","In patients with AF, a moderate to high risk of stroke (CHA2DS2-VASc score ≥2), and a contraindication (Table 14) to long-term oral anticoagulation due to a nonreversible cause, percutaneous LAAO (pLAAO) is reasonable.1–4","In patients with symptomatic PAD, single antiplatelet therapy is not recommended to reduce the risk of MACE.","In patients with cardiomyopathy, there is no need to obtain or update a 3-generation family history when assessing the cause of the cardiomyopathy, as identifying possible inherited disease is unnecessary.",B,1
q_0450,"In patients hospitalized with HF, severity of congestion and adequacy of perfusion should not be assessed to guide triage and initial therapy.",Flumazenil administration is safe for patients who are at increased risk for seizures or dysrhythmias.,"In patients with AF and HF symptoms, digoxin should not be used for long-term rate control, either in combination with other rate-controlling agents or as monotherapy, even if other agents are not preferred, not tolerated, or contraindicated.","If there is no shock, confusion, or swallowing difficulty, first aid responders should help or motivate those experiencing exertional dehydration to drink any available rehydration solution or safe water.",D,1
q_0451,"In patients with aSAH who do not improve after correction of modifiable conditions and are deemed unsalvageable because of evidence of irreversible neurological injury, treatment of the aneurysm is beneficial.","In patients with asymptomatic atherosclerotic carotid artery stenosis >70% and low perioperative risk, the use of carotid revascularization, in addition to intensive medical therapy, may not be reasonable to reduce the risk of stroke.","In patients early after MI, a temporary wearable cardioverter-defibrillator is certainly useful in patients with an LVEF ≤35% to improve survival.","For patients with PAD, conduct a thorough foot assessment at least once a year to detect risk factors for ulcers and amputation.",D,1
q_0452,"In cases of doubt regarding aspirin administration, it is advisable to refrain from giving aspirin until EMS arrives.","In patients with SIHD undergoing PCI, the routine use of an intravenous glycoprotein IIb/IIIa inhibitor agent is recommended.","In patients with HCM who are receiving an ICD, neither a single-chamber transvenous ICD nor a subcutaneous ICD should be recommended, disregarding patient preferences, age, lifestyle, and potential need for pacing for bradycardia or VT termination.","In patients with ischemic stroke or TIA, voluntary hospital-based or outpatient-focused quality monitoring and improvement programs are not recommended to improve short-term and long-term adherence to nationally accepted, evidence-based guidelines for secondary stroke prevention.",A,1
q_0453,"For pregnant women with mechanical prostheses who require a dose of warfarin ≤5 mg/d to maintain a therapeutic INR, discontinuation of warfarin for all 3 trimesters is reasonable without discussing the risks and benefits with the patient.","For patients with a mechanical valve prosthesis on VKA therapy needing urgent or emergency noncardiac surgery or an invasive procedure, it is reasonable to administer 4-factor prothrombin complex concentrate or its activated form.","Once the person with presyncope is in a safe position, it is not beneficial for that person to use physical PCMs to avoid syncope.","In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is not recommended as part of the initial assessment.",B,1
q_0454,"In patients 18 to 60 years of age with a nonlacunar ischemic stroke of undetermined cause despite a thorough evaluation and a PFO, the comparative benefit of closure with a transcatheter device versus warfarin is well-established.",There is sufficient evidence to recommend a specific therapeutic temperature for different subgroups of cardiac arrest patients.,"In some patients who have undergone catheter ablation of AF, short-term antiarrhythmic drug therapy after ablation can be useful to reduce early recur- rences of atrial arrhythmia and hospitalization.12–16","Patients with HF admitted with evidence of significant fluid overload should not be treated with intravenous loop diuretics, as this will not improve symptoms or reduce morbidity.",C,1
q_0455,"In patients with an onset of AF before 45 years of age without obvious risk factors for AF, referral for genetic counseling, genetic testing for rare pathogenic variants, and surveillance for cardiomyopathy or arrhythmia syndromes is not recommended.","In patients with intact descending TAA, repair is recommended when the diameter is ≥5.5 cm.1,2","In patients with CCD, avoiding treatment for mental health conditions with either pharmacologic or nonpharmacologic therapies, or both, is reasonable to improve cardiovascular outcomes.","In patients with periodontal disease (PD), poor oral hygiene and irregular dental care can increase stroke risk.",B,1
q_0456,"In pregnant individuals with persistent AF, rate-control agents without a record of safety in pregnancy, such as beta blockers (eg, propranolol or metoprolol) and digoxin, either alone or in combination with beta blockers, are unreasonable as first-line agents.","In patients undergoing PCI, BMS should be used in preference to DES to prevent restenosis, MI, or acute stent thrombosis.","For patients with aSAH and chronic symptomatic hydrocephalus, a permanent CSF diversion is advised to enhance neurological outcomes.","In patients with spontaneous ICH, it is unreasonable to provide practical support and training for the caregiver to improve patients’ standing balance.",C,1
q_0457,"For patients with HCM, LVEF below 50%, and NYHA class II to IV symptoms that persist despite GDMT, CRT may help alleviate symptoms if LBBB is present.","In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome and intact TAAA requiring intervention, endovascular repair is recommended over open repair.","In patients with ACS without a contraindication, annual influenza vaccination is recommended to reduce the risk of death and MACE.1–4","First aid responders may find it beneficial to use cold therapy, like ice wrapped in a damp cloth, on a new sprain or strain to reduce pain and swelling. Limit each application to 20 to 30 minutes and avoid direct skin contact to prevent cold injury.",B,2
q_0458,We recommend administration of benzodiazepines to treat seizures and agitation in the setting of organophosphate or carbamate poisoning.,"If no improvement occurs within 1 to 2 minutes, if syncope occurs, or if symptoms worsen or reoccur, the first aid provider should activate emergency services.","In asymptomatic women with severe rheumatic MS (mitral valve area ≤1.5 cm², Stage C1) who are considering pregnancy, it is not reasonable to perform PMBC at a Comprehensive Valve Center before pregnancy, even for those who have favorable valve morphology.","For every patient with heart failure, palliative and supportive care should be offered to enhance quality of life and alleviate suffering, encompassing effective communication, prognosis discussion, care goals clarification, collaborative decision-making, symptom management, and caregiver support.",C,2
q_0459,We recommend that epinephrine not be administered for patients in cardiac arrest.,"In patients with Marfan syndrome and an aortic diameter approaching surgical threshold, who are candidates for valve-sparing root replacement (VSRR) and have a very low surgical risk, it is not reasonable to perform surgery to replace the aortic root and ascending aorta, even when performed by experienced surgeons in a Multidisciplinary Aortic Team.","In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is not recommended.","First aid providers may measure capillary blood glucose in adults suspected of having a stroke, provided it is accessible and does not postpone contacting EMS.",D,1
q_0460,"In patients with aneurysms of the aortic root and ascending aorta who have symptoms attributable to the aneurysm, surgery is not indicated.","In patients who are at low risk for perioperative cardiovascular events, have adequate functional capacity with stable symptoms, or who are undergoing low-risk procedures, routine stress testing before NCS is recommended due to potential benefit.","If clean running water is not available, it is not advisable to cool superficial burns (with the skin intact) with ice wrapped in cloth.","In asymptomatic patients with aneurysms of the aortic root or ascending aorta who have a maximum diameter of ≥5.0 cm, surgery is reasonable when performed by experienced surgeons in a Multidisciplinary Aortic Team.14-17",D,1
q_0461,"As soon as exposure to poison ivy, oak, or sumac is recognized, the exposed area should be washed with soap and water or a commercially available decontamination product.","In patients with AF with rapid anterograde conduction (preexcited AF) and hemodynamic stability, pharmacological cardioversion with intravenous ibutilide or intravenous procainamide is not recommended as an alternative to elective cardioversion.","In patients receiving VKA anticoagulation at the time of IE diagnosis, continuation of VKA anticoagulation should be maintained without consideration for temporary discontinuation.","For patients with CAD undergoing elective NCS, management of perioperative antiplatelet therapy and timing of surgery should be determined by a single clinician without considering the risks of bleeding, thrombosis, or consequences of delayed surgery.",A,1
q_0462,"In affected families with HCM, preconception and prenatal reproductive and genetic counsel- ing should be offered.23–25,117","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are not recommended for achieving and maintaining weight loss and possibly lowering the risk of developing LVOTO, HF, and AF.",We recommend the routine use of rapid infusion of cold intravenous fluids for prehospital cooling of patients after ROSC.,"In patients with dabigatran- or factor Xa inhibitor–associated spontaneous ICH, when the DOAC agent was taken within the previous few hours, activated charcoal should not be used to prevent absorption of the DOAC.",A,1
q_0463,Anticoagulation with a VKA is advisable for patients who develop new-onset AF within 3 months following surgical or transcatheter bioprosthetic valve replacement.,"It is not reasonable to use Vaughan-Williams class Ib antidysrhythmics (e.g., lidocaine) to treat life-threatening cardiotoxicity from class Ia or Ic sodium channel blockers.","In pregnant women with HCM, beta blockers should not be administered for symptoms related to outflow tract obstruction or arrhythmias, and monitoring of fetal growth is unnecessary.","In patients with AF with normal EF undergoing AVNA, conduction system pacing of the His bundle or left bundle area should not be considered reasonable.",A,1
q_0464,Antiseizure medications used for treatment of seizures caused by other etiologies should not be considered for seizures detected after cardiac arrest.,"In patients with CCD, ICA for risk stratification is not routinely recommended in patients without LV systolic dysfunction, heart failure, stable chest pain refractory to GDMT, and/or noninvasive testing sug- gestive of significant (>50%) left main disease.5–7,10,11 *Modified from the 2021 AHA/ACC/Multisociety Guideline for the Evaluation and Diagnosis of Chest Pain.12","For individuals with AF, it is advised to engage in moderate-to-vigorous exercise for 210 minutes weekly to alleviate AF symptoms and burden, enhance sinus rhythm maintenance, boost functional capacity, and improve quality of life, provided the AF is not linked to excessive exercise training.","In patients with spontaneous ICH, treating hypoglycemia (<40–60 mg/d, <2.2–3.3 mmol/L) is recommended to reduce mortal- ity.299–301",A,2
q_0465,We do not recommend dermal decontamination for external organophosphate or carbamate exposure.,Topical corticosteroids should not be used to alleviate local itching.,"In severely symptomatic patients (NYHA class III or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) who 1) are candidates for PMBC, 2) have not failed a previous PMBC, 3) do not require other cardiac procedures, or 4) have access to PMBC, mitral valve surgery (repair, commissurotomy, or valve replacement) is not indicated.","In patients with signs and symptoms of right-sided HF attributable to severe secondary TR (Stages C and D), therapies to treat the primary cause of HF (eg, pulmonary vasodilators to reduce elevated pulmonary artery pressures, GDMT for HF with reduced LVEF, or rhythm control of AF) can be useful1,2",D,1
q_0466,"For patients with HCM in whom the diagnoses of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhanc- ing agent is reasonable particularly if other imaging modalities such as cardiovascular mag- netic resonance (CMR) are not readily available or contraindicated.72,73","For patients diagnosed with transthyretin cardiac amyloidosis, TTR gene sequencing is advised to distinguish between hereditary and wild-type forms. Consider this especially when left ventricular wall thickness is ≥14 mm along with symptoms like fatigue, dyspnea, or edema, particularly if there is a mismatch between echocardiogram wall thickness and QRS voltage on ECG, and in cases of aortic stenosis, HFpEF, carpal tunnel syndrome, spinal stenosis, or autonomic or sensory polyneuropathy.","For intermediate-risk patients with acute chest pain and known nonobstructive CAD, CCTA can be useful to determine progression of atherosclerotic plaque and obstructive CAD.9-11","In patients scheduled for NCS, SGLT2i should be continued up to the day of surgery to maintain the risk of perioperative metabolic acidosis.",D,2
q_0467,"For patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic enlargement, and other aortopathy conditions considering pregnancy, it is advised to provide counseling on the risks of aortic dissection associated with pregnancy.","For patients with severe AR (Stage D) who exhibit symptoms, aortic valve surgery is recommended irrespective of LV systolic function.","In selected, hemodynamically stable patients with STEMI and multivessel disease (MVD), after successful PCI of the infarct-related artery, PCI of significantly stenosed noninfarct-related arteries is not recommended, as it does not reduce the risk of death or MI nor improve angina-related quality of life (QOL).","In patients with nonobstructive HCM with preserved EF, it is reasonable to add oral diuretics when exertional dyspnea persists despite the use of beta blockers or non- dihydropyridine calcium channel blockers.",C,2
q_0468,Avoid using ice or cold packs for local pain relief.,"For patients without atrial arrhythmias who are undergoing valvular surgery, LA appendage occlusion/exclusion/amputation is potentially beneficial.","In patients with HCM, 24- to 48-hour ambulatory electrocardiographic monitoring is recommended in the initial evaluation and as part of periodic follow-up (every 1-2 years) to identify patients who are at risk for SCD and to guide management of arrhythmias (Figure 1).4–6","For patients with HCM, TEE should not be used if TTE is inconclusive in clinical decision-making regarding medical therapy, or in situations such as planning for myectomy, exclusion of subaortic membrane or MR secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.",C,1
q_0469,"In patients with AAA who have undergone open repair, surveillance imaging with CT or MRI of the abdominopelvic aorta within 1 year postoperatively and then every 5 years there- after is reasonable.5,6","For children who have experienced a febrile seizure, administration of antipyretics such as acetaminophen, ibuprofen, or paracetamol is effective for stopping a seizure and preventing a subsequent febrile seizure.","In patients with ischemic stroke or TIA and native left-sided valve endocarditis who exhibit mobile vegetations >10 mm in length, early surgery should not be considered to reduce the risk of recurrent embolism, even if there is no evidence of intracranial hemorrhage or extensive neurological damage.","In patients with ischemic stroke or TIA and IE who present with recurrent emboli and persistent vegetations despite appropriate antibiotic therapy, delaying surgery until after the completion of a full therapeutic course of antibiotics is reasonable, even if there is no evidence of intracranial hemorrhage or extensive neurological damage.",A,1
q_0470,"For patients with AAS, intravenous beta blockers should be administered initially, unless contraindications are present.","For patients with HCM who are candidates for ICD implantation and experience paroxysmal atrial tachycardias or AF, considering dual-chamber ICDs can be appropriate; however, this choice should be weighed against the increased complication rates associated with dual-chamber devices.","In patients with suspected bioprosthetic valve thrombosis, 3D TEE or 4D CT imaging should not be used to rule out leaflet thrombosis.","For patients at intermediate risk who experience acute chest pain and have known nonobstructive coronary artery disease, CCTA may be beneficial in assessing the advancement of atherosclerotic plaque and the presence of obstructive coronary artery disease.",C,2
q_0471,"Dabigatran, a direct thrombin inhibitor, should not be used for anticoagulation in patients with a mechanical valve prosthesis.","For adults experiencing heatstroke, promptly starting active cooling with full-body immersion in cool to cold water for 15 minutes or until neurological symptoms subside, whichever comes first, is advisable.","For patients with recurrent, similar presentations for acute chest pain with no evidence of a physiological cause on prior diagnostic evaluation including a negative workup for myocardial ischemia, referral to a cognitive-behavioral therapist is not recommended.","For patients with cerebellar ICH who are deteriorating neurologically, have brainstem compression and/or hydrocephalus from ventricular obstruction, or have cerebellar ICH volume ≥15 mL, immediate surgical removal of the hemorrhage with or without EVD is recom- mended in preference to medical management alone to reduce mortality.442–444",C,2
q_0472,"For patients with CCD and overweight or obesity in whom pharmacologic therapy is warranted for further weight reduction, a GLP-1 receptor agonist can be beneficial in addition to counseling for diet and physical activity,11,12 and it is reasonable to choose semaglutide over liraglutide.13,14 Downloaded from http://ahajournals.org by on June 19, 2025","In patients with CLTI with ischemic rest pain (ie, without nonhealing wounds or gangrene) attributable to multilevel arterial disease, it is unreasonable to address inflow disease first in a revascularization strategy.","In symptomatic patients with low-flow, low-gradient severe AS with normal LVEF (Stage D3), AVR is not recommended even if AS is the most likely cause of symptoms.","In patients with a mechanical mitral valve replacement who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is not reasonable to increase the INR goal from 3.0 (range, 2.5–3.5) to 4.0 (range, 3.5–4.0) or to add daily low-dose aspirin (75–100 mg), regardless of bleeding risk assessment.",A,1
q_0473,"For patients with a BAV undergoing surgical repair or replacement of the aortic valve, it is advisable to also replace the aortic root, ascending aorta, or both if the diameter is ≥4.5 cm, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team.","For patients requiring diuretic treatment during hospitalization for HF, the discharge regimen should exclude a plan for adjustment of diuretics to decrease rehospitalizations.","In patients with STEMI undergoing PCI, bivalirudin is useful as an alternative to UFH to reduce mortality and bleeding.†14–19","For patients with obstructive HCM experiencing acute hypotension unresponsive to fluid therapy, it is advised to use intravenous phenylephrine or other vasoconstrictors lacking inotropic effects, either alone or alongside beta-blockers.",B,2
q_0474,"In patients with aortic root/ascending aortic aneurysms or aortic dissection and risk factors for HTAD, genetic testing to identify pathogenic/likely pathogenic variants is not recommended.","In patients with a stroke or TIA caused by 50% to 99% stenosis of a major intracranial artery, aspirin 325 mg/d is recommended in prefer- ence to warfarin to reduce the risk of recurrent ischemic stroke and vascular death.335,336","In patients with spontaneous ICH, regional systems of stroke care are not recommended, and potentially beneficial therapies should not be made available rapidly, including health care facilities that provide initial spontaneous ICH care and those with neurocritical care and neurosurgical capabilities.","In patients with HF, VHD should not be managed in a multidisciplinary manner, and clinical practice guidelines for VHD should be disregarded, increasing the risk of worsening HF and adverse clinical outcomes.",B,1
q_0475,"For primary ICH prevention, it might be advisable to use MRI findings that show cerebral microbleeds or cortical superficial siderosis to guide collaborative decisions on stroke prevention strategies.","In patients with bioprosthetic valve stenosis, 3D TEE or 4D CT imaging can be useful to rule out leaflet thrombosis.3–7","In patients hospitalized with worsening HF, patient-centered discharge instructions with a clear plan for transitional care should be pro- vided before hospital discharge.5,6",It is unreasonable to utilize extracorporeal life support techniques such as VA-ECMO for life-threatening β-blocker poisoning with cardiogenic shock refractory to pharmacological interventions.,D,2
q_0476,"In patients with stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, cilostazol 200 mg/day should not be added to aspirin or clopidogrel to reduce recurrent stroke risk.","In patients with CCD and normal LV function, the addition of ivabradine to standard anti-anginal therapy is potentially harmful.*11 *Modified from the 2012 ACC/AHA Multisociety Guideline for the Diagnosis and Management of Patients With SIHD.12","In patients with STEMI and cardiogenic shock or hemodynamic instability, PCI or CABG (when PCI is not feasible) is not indicated to improve survival, irrespective of the time delay from MI onset.","In patients with severe primary MR where leaflet pathology is limited to less than one half the posterior leaflet, mitral valve replacement should be performed without attempting mitral valve repair at a Primary or Comprehensive Valve Center.",B,1
q_0477,"For patients with ischemic stroke or TIA and atherosclerotic disease (intracranial, carotid, aortic, or coronary), it is advised to use lipid-lowering therapy with a statin, and ezetimibe if necessary, to achieve an LDL-C target of less than 70 mg/dL to decrease the risk of major cardiovascular events.","In asymptomatic women with severe rheumatic MS (mitral valve area ≤1.5 cm², Stage C1) who are considering pregnancy, it is not reasonable to perform PMBC at a Comprehensive Valve Center before pregnancy, even for those who have favorable valve morphology.",Eye stings require assessment by a qualified healthcare provider.,"In patients with a bioprosthetic surgical or transcatheter aortic valve or bioprosthetic mitral valve who experience a stroke or systemic embolic event while on antiplatelet therapy, VKA anticoagulation, instead of antiplatelet therapy may be considered after assessment of bleeding risk.1,2",B,2
q_0478,"In patients with signs and symptoms of right-sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery should not be considered if there is no severe pulmonary hypertension or severe RV systolic dysfunction.","In patients with HCM who are at risk of coro- nary atherosclerosis, coronary angiography (CT or invasive) is recommended before surgi- cal myectomy.111","In patients with cyanotic congenital heart disease and other complex lesions, ischemic stroke or TIA of presumed cardioembolic origin, therapy with warfarin is not recommended to reduce the risk of recurrent stroke or TIA.","In patients with AF undergoing cardiac surgery with CHA2DS2-VASc score ≥2 or equivalent stroke risk, surgical LAA exclusion without continued anticoagulation is beneficial in reducing the risk of stroke and systemic embolism.",B,1
q_0479,"For patients with aSAH, it is not advised to routinely use statin therapy to enhance outcomes.","For individuals with Loeys-Dietz syndrome, it is advised to perform an initial MRI or CT scan from head to pelvis to assess the entire aorta and its branches for aneurysms, dissections, and tortuosity.","For patients with HCM, TEE should not be used if TTE is inconclusive in clinical decision-making regarding medical therapy, and in situations such as planning for myectomy, exclusion of subaortic membrane or mitral regurgitation secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.","For patients with AF but not HF, eligible for specific rate-control methods, the heart rate target should be determined by patient symptoms, generally aiming for a resting heart rate below 100 to 110 bpm.",C,2
q_0480,"For adult patients with HCM with ≥1 major risk factors for SCD, it is not reasonable to offer an ICD. These major risk factors include: a. No sudden death definitively or likely attributable to HCM in any first-degree or close relatives who are ≤50 years of age; b. Left ventricular hypertrophy <30 mm in all left ventricular segments; c. No recent episodes of syncope suspected by clinical history to be arrhythmic; d. Absence of LV apical aneurysm; e. Normal LV systolic function (EF ≥50%).","In patients with progressive TR (Stage B) undergoing left-sided valve surgery, tricuspid valve surgery should not be considered beneficial in the context of either 1) tricuspid annular dilation (tricuspid annulus end diastolic diameter >4.0 cm) or 2) prior signs and symptoms of right-sided HF.","In patients with aSAH who do not improve after correction of modifiable conditions and are deemed unsalvageable because of evi- dence of irreversible neurological injury, treat- ment of the aneurysm is not beneficial.34,35","In patients with a history of ischemic stroke or TIA and a mechanical aortic valve, avoiding anticoagulation with higher-intensity warfarin to achieve an INR of 3.0 (range, 2.5–3.5) and not adding aspirin (75–100 mg/d) can be beneficial to increase the risk of thromboembolic events.",C,1
q_0481,"For patients with spontaneous ICH, providing practical support and training to the caregiver is advisable to enhance the patients' standing balance.","For patients experiencing high-degree or complete heart block with an LVEF between 36% and 50%, it is advisable to consider CRT to decrease overall mortality, lessen hospital admissions, and enhance symptoms and quality of life.","In high-risk patients with ACS (LVEF ≤40%, hypertension, diabetes mellitus, or STEMI with anterior location), an oral angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) is indicated to reduce all-cause death and MACE.1–6","In patients with asymptomatic carotid artery stenosis (ACS) >70%, it is not recommended to engage in shared decision-making between the patient and the health care team to decide between carotid revascularization or medical management for reducing stroke risk.",D,2
q_0482,"In patients with acute type A aortic dis- section undergoing surgical repair, direct aortic26,27 or innominate artery28 cannula- tion with imaging guidance is reasonable as an alternative to femoral or axillary ­cannulation.29-31","In patients with STEMI who are stable and presenting 12 to 24 hours after symptom onset, PCI is reasonable to improve clinical outcomes.21,22","In pregnant patients with an aortopathy and an aortic diameter of <4.0 cm, vaginal delivery is not recommended.","For patients exhibiting symptoms of low-flow, low-gradient severe aortic stenosis with decreased left ventricular ejection fraction (Stage D2), aortic valve replacement is advised.",C,2
q_0483,"In patients with advanced (stage D) HF refrac- tory to GDMT and device therapy who are eligible for and awaiting MCS or cardiac trans- plantation, continuous intravenous inotropic support is reasonable as “bridge therapy.”1–4","Cardiopulmonary exercise testing (CPET) is not recommended for determining the appropriateness of advanced treatments (eg, LVAD, heart transplant) in selected ambulatory patients with HF.","For patients with AF, employing rhythm-control strategies can help decrease the risk of dementia onset or the progression of cardiac structural abnormalities.","In patients with ALI, a comprehensive medical history and physical examination should be performed to determine the cause of thrombosis or embolization.",B,2
q_0484,"In patients with non–left main or noncomplex CAD who are undergoing noncardiac surgery, routine coronary revascularization is recommended solely to reduce perioperative cardiovascular events.","In patients with ACS, an oral P2Y12 inhibitor should be administered in addition to aspirin to reduce MACE.1–5","For patients having elective endovascular repair of nonruptured AAA, it is advised to follow the manufacturer's usage guidelines.","For patients with a left ventricular assist device (LVAD), it is advised to collaborate with the LVAD care team regarding the optimal timing and perioperative factors of elective non-cardiac surgery (NCS) to reduce the risk of major adverse cardiac events (MACE) during the perioperative period.",A,2
q_0485,"In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery should not be considered as it does not reduce symptoms or recurrent hospitalizations.",Over-the-counter acetaminophen and nonsteroidal anti-inflammatory agents should not be used to alleviate local pain from scorpion stings.,"For patients 50 to 65 years of age who require AVR and who do not have a contraindication to anticoagulation, it is unreasonable to individualize the choice of either a mechanical or bioprosthetic AVR, and patient factors should not be considered, nor should informed shared decision-making be conducted.","Pacemaker-dependent patients with a transvenous ICD undergoing surgery above the umbilicus with anticipated EMI should have the device repro­ grammed*; if the patient is not pacemaker- dependent, then either reprogramming or a magnet placed on the generator can be used to inhibit tachytherapies or inappropriate shocks.8,9",D,1
q_0486,"For patients with stroke who have a low risk of hemorrhagic conversion and are experiencing atrial fibrillation, starting anticoagulation therapy between 2 and 14 days after the initial event might be advisable to lower the chance of another stroke.","In patients with suspected or new-onset HF, or those presenting with acute decompensated HF, a chest x-ray should not be performed to assess heart size and pulmonary congestion or to detect alternative cardiac, pulmonary, and other diseases that may cause or contribute to the patient’s symptoms.","Patients with AF at intermediate annual risk of thromboembolic events by risk scores (eg, equiva- lent to CHA2DS2-VASc score of 1 in men or 2 in women), who remain uncertain about the benefit of anticoagulation, can benefit from consideration of factors that might modify their risk of stroke to help inform the decision.*",Catheter ablation is beneficial for alleviating symptoms in patients with symptomatic or clinically significant AFL.17–19,B,2
q_0487,"In patients with CCD who have significant left main disease or multivessel disease with severe LV dysfunction (LVEF ≤ 35%), CABG in addition to medical therapy is rec- ommended over medical therapy alone to improve survival.*8–11 Cost Value Statement: Intermediate Value B-NR","For individuals with CCD, it is advised to receive a yearly flu vaccine to decrease the risk of cardiovascular complications, cardiovascular mortality, and overall mortality.","In patients with chronic severe secondary MR from atrial annular dilation with preserved LV systolic function (LVEF ≥50%) who have severe persistent symptoms (NYHA class III or IV) despite therapy for HF and therapy for associated AF or other comorbidities (Stage D), mitral valve surgery may be considered.16–20","In patients with symptomatic recurrent diffuse ISR with an indication for revascularization, repeat PCI can be useful over CABG to reduce recurrent events.",D,2
q_0488,"In patients >65 years of age who require AVR, it is not reasonable to choose a bioprosthesis over a mechanical valve.","For patients suspected of having spontaneous ICH, it is advised that EMS personnel promptly alert the receiving hospital to enhance the speed of diagnosis and treatment.",It is reasonable to use VA-ECMO for persistent cardiogenic shock or cardiac arrest due to poison- ing that is not responsive to maximal treatment measures.,"For individuals with stage C heart failure, it is advisable to limit sodium consumption to alleviate congestive symptoms.",A,2
q_0489,"In patients with CCD who regularly smoke tobacco, the short-term use of nicotine-containing e-cigarettes should not be considered to aid smoking cessation, as the benefits outweigh the risk of sustained use and unknown long-term safety.","In patients with wild-type or variant transthyretin cardiac amyloidosis and NYHA class I to III HF symptoms, transthyretin tetramer stabilizer therapy (tafamidis) is not indicated to reduce cardiovascular morbidity and mortality.","For patients with AF on DOAC who have paused treatment for surgery or an invasive procedure, it is generally advisable to restart anticoagulation the day following low bleeding risk surgery, and between the evening of the second and third days after high bleeding risk surgery, provided that hemostasis is secured and no further bleeding is expected.","In patients who are at low risk for perioperative cardiovascular events, have adequate functional capacity with stable symptoms, or who are undergoing low-risk procedures, routine CCTA before NCS is recommended due to potential benefit.",C,1
q_0490,"For individuals with CCD, it is advised that clinicians and the care team regularly evaluate SDOH to guide personalized treatment choices and lifestyle change suggestions.","In asymptomatic patients with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage C) and favorable valve morphology with less than 2+/ MR in the absence of LA thrombus who have new onset of AF, PMBC should not be considered even if it can be performed at a Comprehensive Valve Center.","In patients with PAD, referral to a footcare specialist, when available, is reasonable for ongoing preventive care and longitudinal surveillance.10–16","Individuals with thermal burns should quickly take off any jewelry, belts, or other constrictive items from the affected areas.",B,2
q_0491,"CMR imaging is recommended for patients with obstructive HCM when echocardiography does not clearly identify the anatomical cause of obstruction, to aid in the selection and planning of SRT.","For patients with heart failure, routine reassessment of left ventricular function is not warranted unless there is a change in clinical status, recent treatment interventions that could significantly impact cardiac function, or consideration for invasive procedures or device therapy.","In selected patients with asymptomatic or minimally symptomatic AF, catheter ablation should not be considered useful for reducing progression of AF and its associated complications.","For intermediate-risk patients with acute chest pain, TTE is recommended as a rapid, bedside test to establish baseline ventricular and valvular function, evaluate for wall motion abnormalities, and to assess for pericardial effusion.",C,2
q_0492,"For patients receiving GDMT with an LVEF of 35% or less who are having a new or replacement device implanted and are expected to need substantial ventricular pacing (over 40%), CRT may be beneficial in lowering overall mortality, decreasing hospital admissions, and enhancing symptoms and quality of life.","In patients with aSAH who present with seizures, it is not reasonable to treat with antiseizure medications for ≤7 days to reduce seizure-related complications in the perioperative period.","For patients at intermediate risk with acute chest pain and established coronary artery disease experiencing new or worsening symptoms, it is appropriate to consider stress imaging such as PET/SPECT MPI, CMR, or stress echocardiography.","In patients who are admitted with decompen- sated HF, in the absence of systemic hypoten- sion, intravenous nitroglycerin or nitroprusside may be considered as an adjuvant to diuretic therapy for relief of dyspnea.1,2",B,2
q_0493,"In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome and intact TAAA requiring intervention, endovascular repair is recommended over open repair.","In patients for whom the optimal treatment strategy is unclear, it is not recommended to use a Heart Team approach that includes representatives from interventional cardiology, cardiac surgery, and clinical cardiology, as it does not improve patient outcomes.","In patients referred for urgent CABG, clopi- dogrel and ticagrelor should be discontinued for at least 24 hours before surgery to reduce major bleeding complications.8-11","In the general population, unhealthy lifestyle habits such as physical inactivity, maintaining excess weight, unhealthy dietary patterns, and smoking are not harmful and do not increase the future risk of HF.",C,1
q_0494,Aortic valve surgery is recommended for patients with severe AR (Stage C or D) who are having cardiac surgery for other reasons.,"In selected patients with SIHD and multivessel CAD appropriate for CABG and mild-to-moderate left ventricular systolic dysfunction (ejection fraction 35%–50%), CABG (including a left internal mammary artery [LIMA] graft to the LAD) is not reasonable to improve survival.","In asymptomatic patients with severe primary MR (Stages B and C1), do not consider using serum biomarkers and novel measurements of LV function, such as global longitudinal strain, as an adjunct to guide timing of intervention.","In patients with suspected moderate or severe AS who are undergoing elevated-risk NCS, preoperative echocardiography is not recommended before elective NCS to guide perioperative management.",A,1
q_0495,"In patients with ACS who are not at high bleeding risk, DAPT with aspirin and an oral P2Y12 inhibi- tor should be administered for at least 1 year to reduce MACE.1–6 Bleeding Reduction Strategies","ICD should not be considered in select adult patients with HCM who have extensive LGE by contrast-enhanced CMR imaging or NSVT present on ambulatory monitoring, even if they lack major SCD risk factors or if the decision to proceed with ICD placement is uncertain.","In patients with HF, routine repeat assessment of LV function is indicated even in the absence of: 1) clinical status change, 2) treatment interventions that might have had a significant effect on cardiac function, or 3) candidacy for invasive procedures or device therapy.","If an improvised tourniquet is used, it is not necessary for the tourniquet to be at least 2 in width.",A,1
q_0496,"In patients with spontaneous ICH, multidisci- plinary rehabilitation, including regular team meetings and discharge planning, should be performed to improve functional outcome and reduce morbidity and mortality.231,232",We recommend that epinephrine not be administered for patients in cardiac arrest.,"In patients with CCD, chronic nonsteroidal anti-inflammatory drugs should not be used because of increased cardiovascular and bleeding complications.*22 Antiplatelet Therapy With Direct Oral Anticoagulant (DOAC)","In patients with CCD who have significant left main disease or multivessel disease with severe LV dysfunction (LVEF ≤ 35%), CABG in addition to medical therapy is rec- ommended over medical therapy alone to improve survival.*8–11 Cost Value Statement: Intermediate Value B-NR",B,2
q_0497,Do not consider storing an avulsed permanent tooth in cow’s milk or saliva if it cannot be immediately replanted and the aforementioned solutions or interventions are not available.,"In pregnant individuals with AF and without structural heart disease, antiarrhythmic agents with history of safe use in pregnancy (eg, flecainide and sotalol) are reasonable for maintenance of sinus rhythm.1,2","In patients with spontaneous ICH who have DNAR status, not limiting other medical and surgical interventions, unless explicitly specified by the patient or surrogate, is associated with increased patient mortality.","In selected patients with a low to intermediate pretest probability of CAD, contrast-enhanced coronary CT angiography is unreasonable to exclude the presence of significant obstructive CAD.",B,1
q_0498,Flumazenil use can be harmful for patients with a heightened risk of seizures or dysrhythmias.,Patients for whom there is a clinical suspicion for cardiac amyloidosis should not undergo screening for serum and urine monoclonal light chains with serum and urine immunofixation electrophoresis and serum free light chains.,"In patients with STEMI presenting 12 to 24 hours after symptom onset, PPCI is reasonable to improve clinical outcomes.*12–15","In patients with pulmonary hypertension (PH) with pulmonary vascular disease and AF or AFL, a rhythm-control strategy is reasonable to improve functional status and potentially prolong survival.4–12",B,2
q_0499,"In patients who develop MINS, antithrombotic ther­ apy may be considered to reduce thromboembolic events.4,11","For patients with native left-sided valve endocarditis and mobile vegetations exceeding 10 mm in length, early surgical intervention can be contemplated during the initial hospital stay and prior to finishing a complete course of antibiotics, regardless of the presence of clinical embolic events.","In patients with spontaneous ICH, CT angiog- raphy (CTA) within the first few hours of ICH onset may be reasonable to identify patients at risk for subsequent HE.103–108","In patients with HCM, ICD placement for the sole purpose of participation in competitive athletics should be performed.",D,2
q_0500,"In patients at increased risk of PAD (Table 5), a comprehensive medical history and review of symptoms to assess for exertional leg symptoms, lower extremity rest pain, and lower extremity wounds or other ischemic skin changes should not be performed.","In patients with NSTE-ACS who are not at high risk and are intended for an invasive strategy, it is not reasonable to perform angiography before hospital discharge to reduce MACE.","In patients with ALI who have a complicated history of revascularization procedures, it may be reason- able to obtain noninvasive imaging (ie, duplex ultra- sound, CTA, or MRA) before deciding to proceed with revascularization.","It is not reasonable to use extracorporeal life support, such as VA-ECMO, to treat refractory cardiogenic shock from sodium channel blocker poisoning.",C,1
q_0501,"In patients with wild-type or variant transthyretin cardiac amyloidosis and NYHA class I to III HF symptoms, transthyretin tetramer stabilizer therapy (tafamidis) is not indicated to reduce cardiovascular morbidity and mortality.","When performing genetic testing in an HCM proband, the initial tier of genes tested should include genes with strong evidence to be disease-causing in HCM.*119,122,127,128 Downloaded from http://ahajournals.org by on June 19, 2025",Decisions about the timing of surgical intervention for IE should be made by a Heart Valve Team.1–6,Employing extracorporeal life support methods like VA-ECMO is advisable for severe β-blocker poisoning with cardiogenic shock that does not respond to drug treatments.,A,2
q_0502,We do not recommend rapid external cooling for life-threatening hyperthermia from cocaine poisoning.,"In patients with CVD undergoing NCS, allowing hypothermia is reasonable despite the risk of perioperative complications.","In patients with antiphospholipid syndrome (APS) with prior unprovoked venous thrombosis, it is reasonable to choose vitamin K antagonist (VKA) therapy with a target international normalized ratio of 2 to 3 in preference to aspirin or direct oral anticoagulants for prevention of recurrent throm- botic events, including stroke.457,458.464,465","In adults, screening for a history of endometriosis is not necessary to inform the risk of stroke.",C,1
q_0503,"For patients with heart failure and anemia, erythropoietin-stimulating agents should not be utilized to enhance morbidity and mortality outcomes.","For patients with aSAH needing mechanical ventilation for more than 24 hours, it is advised to apply a standardized ICU care bundle to decrease the length of mechanical ventilation and the incidence of hospital-acquired pneumonia.","For cardiogenic shock due to sympathomimetic poisoning that does not respond to other treatments, using mechanical circulatory support like an intra-aortic balloon pump or VA-ECMO is a reasonable option.","Once bleeding has been controlled, it may be reasonable to avoid applying a pressure dressing to maintain bleeding cessation.",D,2
q_0504,"In patients with CCD without an indication for therapeutic DOAC or DAPT and who are at high risk of recurrent ischemic events but low-to-moderate bleeding risk, the addition of low-dose rivaroxaban 2.5 mg twice daily to aspirin 81 mg daily is not recommended for long-term reduction of risk for MACE.","If clean lukewarm water immersion is not feasible, frostbitten tissue should be allowed to rewarm spontaneously in warm room air or next to the person’s own warm skin.","In adult patients with obstructive HCM who remain severely symptomatic, despite GDMT and in whom surgery is contraindicated or the risk is considered unacceptable because of serious comorbidities or advanced age, alcohol septal ablation in eligible patients,* performed at experienced HCM centers,† is recommended (Tables 4 and 5).8–10","For patients with CCD, addressing mental health conditions using pharmacologic, nonpharmacologic, or a combination of therapies is advisable to enhance cardiovascular outcomes.",A,2
q_0505,"In patients with nonobstructive HCM with preserved EF, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are well established for treating symptoms (angina and dyspnea).","In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is not reasonable.","In patients with recent (within 24 hours) minor stroke or high-risk TIA and concomitant ipsilat- eral >30% stenosis of a major intracranial artery, the addition of ticagrelor 90 mg twice a day to aspirin for up to 30 days might be considered to further reduce recurrent stroke risk.340","In patients with ACS complicated by cardiogenic shock, routine PCI of a noninfarct-related artery at the time of PPCI should be performed despite the higher risk of death or renal failure.",C,1
q_0506,"In patients with acute type A aortic dissection undergoing surgical repair who require circulatory arrest, cerebral perfusion is not recommended to improve neurologic outcomes.","Once bleeding has been controlled, it may be reasonable to apply a pressure dressing to maintain bleeding cessation.","For adults with heatstroke, it is not advisable to initiate immediate active cooling by using whole-body (neck-down) cool- to cold-water immersion for 15 minutes or until neurological symptoms resolve.","In patients with advanced HF, it is not recommended to refer for HF specialty care to review HF management and assess suitability for advanced HF therapies, regardless of the patient’s goals of care.",B,1
q_0507,"In patients with previous or current symptoms of chronic HFrEF, the use of ACEi is not beneficial to reduce morbidity and mortality when the use of ARNi is not feasible.","In patients with HFrEF, nondihydropyridine calcium channel-blocking drugs are not recom- mended.10–13","In patients with severe stenosis (70%-99%) of a major intracranial artery and actively pro- gressing symptoms or recurrent TIA or stroke after institution of aspirin and clopidogrel therapy, achievement of SBP <140 mm Hg, and high- intensity statin therapy (so-called medical failures), the usefulness of angio- plasty alone or stent placement to prevent ischemic stroke in the territory of the stenotic artery is unknown.350–352","For patients exhibiting symptoms (NYHA class II, III, or IV) with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage D) and suitable valve morphology with no more than moderate (2+) mitral regurgitation and without left atrial thrombus, PMBC is advised if it can be conducted at a Comprehensive Valve Center.",A,2
q_0508,"In patients with AF and conditions associated with very high risk of thromboembolic events (>5%/year), such as rheumatic heart disease or a mechanical heart valve, delaying the resumption of anticoagulation after ICH beyond 1-2 weeks is reasonable to reduce the risk of thromboembolic events.","For most patients with atrial fibrillation and cancer, whether in remission or undergoing treatment, direct oral anticoagulants are a suitable option over vitamin K antagonists for reducing stroke risk.","In patients with AAA treated with EVAR, baseline surveillance imaging with CT is recommended at 1 month postopera- tively1,2; if there is no evidence of endoleak or sac enlargement, continued surveil- lance with duplex ultrasound at 12 months and then annually thereafter is recom- mended.1,3,4","For patients who have had their OAC therapy paused before surgery, it is advisable to restart OAC once hemostasis is confirmed. The timing for stopping OAC before surgery depends on individual patient factors such as thrombotic risk, age, sex, body weight, renal function, the risk of surgical bleeding, and drug-related factors like pharmacokinetics, dosing, and interactions.",A,2
q_0509,Sodium bicarbonate should not be routinely administered to patients experiencing cardiac arrest.,"In patients with ischemic stroke or TIA and diagnosis of giant cell arteritis, methotrexate or tocilizumab therapy adjunctive to steroids should not be used as it is unreasonable to lower the risk of recurrent stroke.","In patients with systemic lupus erythematosus (SLE) and no history of thrombosis or pregnancy complications and with a high-risk antiphospholipid profile, prophylactic treatment with aspirin (75–100 mg daily) is not recommended to reduce the risk of stroke.","For adult patients with HCM with ≥1 major risk factors for SCD, it is not reasonable to offer an ICD. These major risk factors include: a. No sudden death definitively or likely attributable to HCM in any first-degree or close relatives who are ≤50 years of age; b. Left ventricular hypertrophy <30 mm in all left ventricular segments; c. No recent episodes of syncope suspected by clinical history to be arrhythmic; d. Absence of LV apical aneurysm; e. Normal LV systolic function (EF ≥50%).",A,1
q_0510,"For life-threatening extremity bleeding, a tourniquet should not be applied or tightened, even if the bleeding continues.","In patients with CCD who have experienced SCAD, counseling should not be provided regarding potential triggers and risk of SCAD recurrence.","In patients (including younger with few comorbidities) with symptomatic paroxysmal or persistent AF who are being managed with a rhythm-control strategy, catheter ablation as first-line therapy should not be considered useful to improve symptoms.","In patients with spontaneous ICH, psychoso- cial education for the caregiver can be ben- eficial to increase patients’ activity level and participation and/or quality of life.638",D,1
q_0511,"In patients with STEMI, emergency CABG should be performed after failed primary PCI, even in the absence of ischemia or a large area of myocardium at risk, or if surgical revascularization is not feasible because of a no-reflow state or poor distal targets.","For patients with AF or atrial flutter who are undergoing valve surgery, LA appendage ligation/excision is not recommended as it does not reduce the risk of thromboembolic events.","In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have intermediate CAD, CABG may be reasonable with a goal of reducing ischemic events.5,7,10,12 Table 12.  Best Practices for the Use of Bypass Conduits in CABG Objectively assess palmar arch completeness and ulnar compensation before harvesting the radial artery. Use the arm with the best ulnar compensation for radial artery harvesting.","When a permanent tooth is avulsed, the person should delay seeking dental or medical care and should not bring the tooth if it has not been successfully replanted.",C,1
q_0512,"In patients with precapillary PH undergoing elevated- risk NCS, perioperative administration of short-acting inhaled pulmonary vasodilators (eg, nitric oxide, aero­ solized prostacyclins) may be reasonable to reduce elevated RV afterload and prevent acute decompen­ sated right HF.6 *For example, nitric oxide pathway mediators, endothelin receptor antagonists, prostacyclin pathway agonists, or a combination of these. †Severe PH is defined according to hemodynamics (severe precapillary PH component by right heart catheterization and echocardiography) and additional data derived from clinical assessment, exercise tests, and laboratory biomarkers. Hemodynamically, severe PH displays a mean pulmonary artery (PA) pressure >40 mm Hg, pulmonary vascular resistance >5 Wood units, or echocardiographic evidence of significant RV dysfunction (eg, RV-to-LV diastolic diameter ratio >0.8 or RV dysfunction that is graded as moderate or severe). Although all 5 World Symposium on Pulmonary Hypertension group classifications display some de­ gree of risk for developing severe PH, Group 1 (PAH), Group 3 (PH due to lung disease), and Group 4 (chronic thromboembolic PH) are at high risk for devel­ oping severe PH if left untreated and may be best managed and followed at a center with PH specialists.","In patients with stroke or TIA and extracranial carotid or vertebral artery dissection who have recurrent events despite antithrombotic therapy, endovascular therapy may be consid- ered to prevent recurrent stroke or TIA.595,596","In patients with advanced HF with expected survival <6 months, timely referral to hospice can be useful to improve QOL.8","In patients with HCM, a 12-lead ECG is not recommended in the initial evaluation and should not be part of periodic follow-up.",D,2
q_0513,"In severely symptomatic patients (NYHA class III or IV) with primary severe MR and high or prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) is not reasonable if mitral valve anatomy is favorable for the repair procedure and patient life expectancy is at least 1 year.","LA appendage occlusion, exclusion, or amputation may be detrimental for patients undergoing valvular surgery who do not have atrial arrhythmias.",A person with moderate to severe hypothermia should have frostbite treated before core rewarming.,"In symptomatic patients with combined AS and AR and a peak transvalvular jet velocity of at least 4.0 m/s or a mean transvalvular gradient of at least 40 mm Hg, AVR is not recommended.",B,1
q_0514,"In low-risk patients with NSTE-ACS and CKD, it is reasonable to weigh the risk of coronary angiography and revascularization against the potential benefit.","For patients aged 18 to 60 who have experienced a non-lacunar ischemic stroke of unknown origin after comprehensive assessment and possess a PFO lacking high-risk anatomical characteristics, the advantage of using a transcatheter device for closure combined with long-term antiplatelet therapy, compared to antiplatelet therapy alone, in preventing recurrent strokes is not clearly determined.","In patents with an onset of AF before 45 years of age without obvious risk factors for AF, referral for genetic counseling, genetic testing for rare patho- genic variants, and surveillance for cardiomyopathy or arrhythmia syndromes may be reasonable.4,5",We do not recommend the use of benzodiazepines to treat seizures associated with local anesthetic systemic toxicity.,D,2
q_0515,"For patients 50 to 65 years of age who require AVR and who do not have a contraindication to anticoagulation, it is unreasonable to individualize the choice of either a mechanical or bioprosthetic AVR, and patient factors should not be considered, nor should informed shared decision-making be conducted.","In patients with TAA, regardless of etiology and in the absence of contraindications, ARB therapy should not be used as an adjunct to beta-blocker therapy to achieve target BP goals.","In patients with NSTE-ACS in whom an early invasive approach is not anticipated, neither enoxaparin nor fondaparinux should be used as alternatives to UFH to reduce ischemic events.","In patients with ACS who require oral anticoagulant therapy, aspirin should be discontinued after 1 to 4 weeks of triple antithrombotic therapy, with continued use of a P2Y12 inhibitor (preferably clopidogrel) and an oral anticoagulant to reduce bleeding risk.*1–5 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”6",D,1
q_0516,"In patients with TAD who have a pathogenic/ likely pathogenic variant, genetic testing of at- risk biological relatives (ie, cascade testing) is recommended.6,10,11 In family members who are found by genetic screening to have inherited the pathogenic/likely pathogenic variant, aortic imaging with TTE (if aortic root and ascending aorta are adequately visualized, otherwise with CT or MRI) is recommended.4,5,12","For patients with CCD, it is advised to evaluate BMI, optionally alongside waist circumference, during regular clinical follow-up.","For patients with stable chest pain and no known CAD presenting to the outpatient clinic, a model to estimate pretest probability of obstructive CAD is ineffective to identify patients at low risk for obstructive CAD and favorable prognosis, and additional diagnostic testing should not be deferred.","For patients experiencing ischemic stroke or TIA who have cystathionine β-synthase deficiency, it is advised to use pyridoxine in those who respond to it, along with a diet low in methionine and enriched with cysteine, supplemented with pyridoxine, vitamin B12, and folate, to lower plasma homocysteine to normal population levels and thus decrease the risk of recurrent ischemic stroke.",C,2
q_0517,"Administering digoxin-Fab might be appropriate for treating poisoning caused by cardiac glycosides aside from digoxin, digitoxin, Bufo toad venom, and yellow oleander.","For patients with mechanical heart valves who are undergoing minor procedures (eg, dental extractions or cataract removal) where bleeding is easily controlled, discontinuation of VKA anticoagulation with a therapeutic INR is recommended.","In patients with type 2 diabetes and high cardiovascular risk, the dipeptidyl pepti- dase-4 (DPP-4) inhibitors saxagliptin and alogliptin increase the risk of HF hospitaliza- tion and should be avoided in patients with HF.22–24","For individuals with CCD, lowering saturated fat intake to less than 6% of total calories and substituting it with monounsaturated and polyunsaturated fats, complex carbohydrates, and dietary fiber may help decrease the risk of CVD events.",B,2
q_0518,"In patients with spontaneous ICH, regional systems of stroke care are not recommended, and potentially beneficial therapies should not be made available rapidly, including health care facilities that provide initial spontaneous ICH care and those with neurocritical care and neurosurgical capabilities.","In patients with grade 2 BAAI (Table 33) and associated malperfusion, it is not reasonable to consider repair.","In women who are ≥65 years of age who have ever smoked, ultrasound screening for detection of AAA is reasonable.4,5","In patients with HFrEF, vitamins, nutritional supplements, and hormonal therapy are recommended even if there are no specific deficiencies.",C,1
q_0519,"In patients with NSTE-ACS, intravenous unfractionated heparin (UFH) is not useful to reduce ischemic events.","In patients with aortic aneurysms, or at increased risk of aortic dissection, or both, it is not recommended that pregnancy be managed by a multidisciplinary team including a maternal fetal medicine specialist and cardiologist, and delivery should not be planned in a hospital with the capability for emergency aortic repair.","Patients with CCD should not receive ongoing individualized education on medication adherence, as it does not improve knowledge or facilitate behavior change.","For patients without symptoms who have undergone any valve intervention, it is advised to perform an initial post-procedure TTE and continue with regular TTE assessments, taking into account the intervention type, time elapsed since the procedure, ventricular function, and any existing cardiac conditions.",D,1
q_0520,"In most pregnant women with HCM, vaginal delivery is recommended as the first-choice delivery option.306,308","For patients with BAV and an aortic sinus or ascending aorta diameter of 4.0 cm or more, it is advisable to conduct lifelong periodic assessments of the size and structure of these areas using echocardiography, CMR, or CT angiography. The frequency of these evaluations should be based on the extent and speed of aortic enlargement and family history.","In nonambulatory patients with spontaneous ICH, intermittent pneumatic compression (IPC) starting on the day of diagnosis is recommended for VTE (DVT and pulmonary embolism [PE]) prophylaxis.275,276","In patients with stroke or TIA, it is not recommended to adopt the Agency for Healthcare Research and Quality Universal Precautions Toolkit for Health Literacy for integrating health literacy into the secondary prevention of stroke.",D,2
q_0521,"In patients with left-sided IE caused by streptococcus, Enterococcus faecalis, S. aureus, or coagulase-negative staphylococci deemed stable by the MDT after initial intravenous antibiotics, a change to oral antibiotic therapy should not be considered if TEE before the switch to oral therapy shows no paravalvular infection, if frequent and appropriate follow-up can be assured by the care team, and if a follow-up TEE can be performed 1 to 3 days before the completion of the antibiotic course.","In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assess- ment, electrocardiography, and cardiac imaging are recommended at periodic intervals depending on age (every 1-2 years in children and adolescents and every 3-5 years in adults) and change in clinical status (Figures 1 and 2, Table 7).1–5","For patients with obstructive HCM, continuation of vasodilators (eg, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be reasonable because these agents can improve symptoms caused by dynamic outflow tract obstruction.","In patients undergoing CABG, continuous intravenous insulin designed to achieve a target intraoperative blood glucose concentration <140 mg/dL is clearly beneficial.",B,1
q_0522,Pregnant women with HCM should not have their care coordinated between their cardiologist and an obstetrician. High-risk HCM patients should avoid consulting with an expert in maternal-fetal medicine.,"In patients presenting with acute chest pain, a chest radiograph is not useful to evaluate for other potential cardiac, pulmonary, and thoracic causes of symptoms.",An initial assessment of chest pain is not recommended for triaging patients based on the likelihood that symptoms may be attributable to myocardial ischemia.,"In patients with hyperthyroidism and AF who have an elevated risk of stroke based on a standard clinical risk score, anticoagulation is recommended until thyroid function has returned to normal and sinus rhythm can be maintained.1,2",D,1
q_0523,"For patients with spontaneous ICH, it is advised to implement standardized protocols and/or order sets to decrease disability and mortality.","For patients experiencing ischemic stroke or TIA with symptomatic extracranial carotid stenosis who are planned for carotid artery stenting (CAS) or carotid endarterectomy (CEA), it is recommended that these procedures be conducted by operators whose periprocedural stroke and mortality rates are below 6% to minimize the risk of surgical complications.","For patients with AF without significant baseline QT interval prolongation, hypokalemia, hypomag- nesemia, or bradycardia, use of sotalol5–7,10,17,18 may be considered for long-term maintenance of sinus rhythm, with proper dose selection based on kidney function and close monitoring of the QT interval, heart rate, serum potassium and magnesium con- centrations, and kidney function.","In selected patients with STEMI with complex multivessel non-infarct artery disease, after successful primary PCI, elective CABG is not reasonable to reduce the risk of cardiac events.",D,2
q_0524,"In patients with HCM, genetic testing is definitively useful in assessing the risk of SCD.","For patients with CCD and type 2 diabetes, it is advised to use an SGLT2 inhibitor or a GLP-1 receptor agonist with established cardiovascular benefits to lower the risk of MACE. Cost Value Statement: High Value B-NR","In patients with ruptured TAAA requiring inter- vention, provided that the patient is hemo- dynamically stable, endovascular repair may be reasonable in centers with endovascular expertise and access to appropriate endovas- cular stent grafts.6 Intact TAAA",Women with mechanical heart valves who are contemplating pregnancy should be advised that it poses significant risks and that no anticoagulation approach is reliably safe for both the mother and the child.,A,2
q_0525,"In patients with ischemic stroke or TIA after an extracranial carotid or vertebral arterial dissection, treatment with antithrombotic therapy for at least 3 months is not indicated to prevent recurrent stroke or TIA.","In patients with BAV and symptomatic, severe AS, TAVI should not be considered as an alternative to SAVR, regardless of patient-specific procedural risks, values, trade-offs, and preferences, and even if the surgery is performed at a Comprehensive Valve Center.","In patients with recent TIA or ischemic stroke and when the degree of stenosis is <50%, revascularization with CEA or CAS to reduce the risk of future stroke is not recom- mended.369","In patients undergoing CABG, an IMA, preferably the left, should not be used to bypass the LAD when bypass of the LAD is indicated to improve survival and reduce recurrent ischemic events.",C,1
q_0526,"Health disparities should be tracked and tackled within clinical practices and the broader healthcare system. This connects to Section 7.1.1, ""Stage C Nonpharmacological Interventions and Self-Care Support in HF,"" which now includes screening and interventions for social determinants of health.","In patients with spontaneous ICH, it is not recommended to administer a baseline measure of overall hemorrhage severity as part of the initial evaluation.","In patients with ischemic stroke or TIA and IE who present with recurrent emboli and persistent vegetations despite appropri- ate antibiotic therapy, early surgery (during initial hospitalization before completion of a full therapeutic course of antibiotics) is reasonable to reduce the risk of recurrent embolism if there is no evidence of intracra- nial hemorrhage or extensive neurological damage.460–465","For patients with suspected or newly diagnosed heart failure, an initial evaluation should include transthoracic echocardiography to evaluate cardiac structure and function.",B,2
q_0527,"In patients with BAV, CMR angiography or CT angiography is not indicated even when morphology of the aortic sinuses, sinotubular junction, or ascending aorta cannot be assessed accurately or fully by echocardiography.","In children with HCM and recurrent ventricular arrhythmias despite beta-blocker use, antiarrhythmic drug therapy (e.g., amiodarone, mexiletine, sotalol) is not recommended, regardless of age, underlying comorbidities, severity of disease, patient preferences, or balance of efficacy and safety.","For patients with a heightened risk of PAD (refer to Table 5), it is essential to routinely conduct a thorough vascular assessment and examine the legs and feet (see Table 6).","In patients with rheumatic MS in normal sinus rhythm with symptomatic resting or exertional sinus tachycardia, heart rate control should not be used to manage symptoms.",C,1
q_0528,"In patients in whom high-intensity statin therapy is contraindicated or not tolerated, moderate-intensity statin therapy is recom- mended with the aim of achieving a 30% to 49% reduction in LDL-C levels to reduce the risk of MACE.*2,4–8","In patients with an onset of unexplained AF before 30 years of age, it is not reasonable to perform an electrophysiological study to evaluate and treat reentrant supraventricular tachyarrhythmias with a targeted ablation, as there is no high prevalence of reentrant arrhythmias in this group.","In patients with chronic secondary MR (Stages B to D), noninvasive imaging (stress nuclear/PET, CMR, or stress echocardiography), coronary CT angiography, or coronary arteriography is not useful to establish etiology.","In pregnant individuals with AF and without structural heart disease, antiarrhythmic agents with no history of safe use in pregnancy (eg, amiodarone and dronedarone) are reasonable for maintenance of sinus rhythm.",A,1
q_0529,"For patients at intermediate to high risk who have stable chest pain and no known coronary artery disease, coronary CT angiography is effective for diagnosing coronary artery disease, assessing risk, and guiding treatment decisions.","For patients with a descending thoracic aortic aneurysm eligible for treatment, who cannot undergo endovascular repair due to anatomical constraints, lack major comorbidities, and have a life expectancy of 10 years or more, open surgical repair is a reasonable option.","In patients who experience delayed spinal cord dysfunction after either open or endovascular TAAA repair, delaying measures to optimize spinal cord perfusion and increase intrathecal pressure is recommended.","For patients with atrial fibrillation who do not have significant baseline QT interval prolongation or untreated low potassium or magnesium levels, it is appropriate to use dofetilide for long-term sinus rhythm maintenance. This should involve selecting the dose according to renal function and closely monitoring the QT interval, as well as serum potassium, magnesium levels, and renal function.",C,2
q_0530,"In adults with AF and moderate or severe forms of congenital heart disease, particularly those with low-flow states such as Fontan circulation, blind- ending cardiac chambers, and cyanosis, it may be reasonable to treat with anticoagulation independent of conventional risk score to reduce risk of thromboembolic events.10","First aid responders might apply a compression wrap following a sudden ankle sprain or strain to enhance comfort, ensuring it does not impede circulation.","For children with HCM who have ≥1 conventional risk factors, including unexplained syncope, massive left ventricular hypertrophy, nonsustained ventricular tachycardia, or family history of early HCM-related SCD, ICD placement is not recommended, regardless of the relatively high complication rates of long-term ICD placement in younger patients.","In patients with chronic severe secondary MR and HF with reduced LVEF, a cardiologist expert in the management of patients with HF and LV systolic dysfunction should be the primary MDT member responsible for implementing and monitoring optimal GDMT.9,12",C,2
q_0531,"In patients with STEMI and CKD, coronary angiography and revascularization are recom- mended, with adequate measures to reduce the risk of AKI.","In patients with CCD and heart failure with LVEF ≤40%, the use of an SGLT2 inhibitor is not recommended to reduce the risk of cardiovascular death and heart failure hospitalization or to improve QOL, irrespective of diabetes status.","In patients with acute chest pain with suspected acute myopericarditis, CMR is not useful if there is diagnostic uncertainty, or to determine the presence and extent of myocardial and pericardial inflammation and fibrosis.","In patients with acute type A aortic dissection and a dissection flap extending through the arch into the descending thoracic aorta, an extended aortic repair with antegrade stenting of the proximal descending thoracic aorta should not be considered, as it does not treat malperfusion or reduce late distal aortic complications.",A,1
q_0532,"Before leaving the hospital, individuals with ACS should be directed to an outpatient CR program to lower the risks of death, myocardial infarction, and hospital readmissions, as well as to enhance functional status and quality of life.","In patients with a BAV who are undergoing surgical aortic valve repair or replacement, and who have a diameter of the aortic root or ascending aorta of ≥4.5 cm, concomitant replacement of the aortic root, ascending aorta, or both is reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,6","In patients who develop MINS, especially in those not previously known to have excess cardiovascular risk, outpatient follow-up is not recommended for optimization of cardiovascular risk factors.","In symptomatic patients with nonobstructive CAD, a strategy of stratified medical therapy* guided by invasive coronary physiologic testing can be useful for improving angina severity and QOL.1,2 *See recommendation-specific supportive text for details. Table 14.  Screening Questions for SCAD-Associated Arteriopathies and Connective Tissue Disorders Personal history (Have you ever been diagnosed with or experienced any of the following?) Early-onset hypertension Stroke or transient ischemic attack Pulsatile tinnitus Migraine headaches Renal infarction Subarachnoid hemorrhage Aneurysm (aortic, peripheral, brain) Dissection (aortic, peripheral) Rupture of hollow organs (intestinal, bladder, uterine) Pneumothorax Tendon or muscle rupture Joint dislocation Talipes equinovarus (clubfoot) Umbilical or inguinal hernia Scoliosis or pectus deformity Pregnancy complications (cervical incompetence, hemorrhage, uterine prolapse, hypertension) Poor wound healing Ectopia lentis Myopia Detached retina, early glaucoma, or early cataracts Tall stature Abnormality of cardiac valve Systemic inflammatory disease Family history (Does anyone in your family have the following?) Dissection (coronary, aortic, peripheral) Inherited arteriopathy or connective tissue disorder (eg, vascular Ehlers-Danlos syndrome, Marfan syndrome, Loeys-Dietz syndrome) Early stroke, early myocardial infarction, sudden cardiac death Review of systems (Are you currently experiencing any of the following?) Headaches Pulsatile tinnitus Postprandial abdominal pain Flank pain Claudication Easy bruising Joint hypermobility or laxity",C,2
q_0533,We recommend administration of digoxin-specific antibody fragments (digoxin-Fab) for digoxin or digitoxin poisoning.,"For patients with known coronary heart disease, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, other significant structural heart disease, or symptoms of CVD undergoing elevated-risk surgery, a preoperative resting 12-lead electrocardiogram (ECG) is not reasonable to establish a preoperative baseline and guide perioperative management.","In asymptomatic women with severe MR (Stage C1) and a valve suitable for repair who are considering pregnancy, valve repair before pregnancy at a Comprehensive Valve Center should not be considered, regardless of any discussion with the patient about the risks and benefits of the surgery and its effect on future pregnancies.","In patients with low-molecular-weight heparin (LMWH)–associated spontaneous ICH, intravenous protamine should not be considered to partially reverse the anticoagulant effect of heparin.",A,1
q_0534,"In patients with intermediate stenosis of the left main artery, intravascular ultrasound (IVUS) is not recommended to help define lesion severity.","Over-the-counter topical steroids are definitely effective in alleviating local symptoms from poison ivy, oak, or sumac.","In patients with STEMI in whom PCI is not feasible or successful, with a large area of myocardium at risk, emergency or urgent CABG surgery can be effective to improve clinical outcomes.*1,2 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”3","In patients with HFrEF, with current or previous symptoms, avoid using any of the 3 beta blockers proven to reduce mortality (eg, bisoprolol, carvedilol, sustained-release metoprolol succinate) as they are not recommended to reduce mortality and hospitalizations.",C,1
q_0535,"In patients with AF, a moderate to high risk of stroke (CHA2DS2-VASc score ≥2), and a contraindication (Table 14) to long-term oral anticoagulation due to a nonreversible cause, percutaneous LAAO (pLAAO) is not reasonable.","For patients experiencing acute chest pain with suspected aortic dissection, TEE or CMR should be utilized for diagnosis if CT cannot be used or is not accessible.",It is beneficial to administer oxygen over room air in the first aid setting for adults experiencing acute stroke.,"We recommend withholding atropine for severe poisoning, such as bronchospasm, bronchorrhea, seizures, or significant bradycardia, from organophosphate or carbamate poisoning.",B,1
q_0536,"For symptomatic patients with severe AS who are 65 to 80 years of age and have no anatomic contraindication to transfemoral TAVI, either SAVR or transfemoral TAVI is recommended after shared decision-making about the balance between expected patient longevity and valve durability.1,4–8","In patients undergoing CABG, the routine use of epiaortic ultrasound scanning should not be used to evaluate the presence, location, and severity of plaque in the ascending aorta, as it does not reduce the incidence of atheroembolic complications.","First aid providers should not activate EMS for individuals with first-time seizure; seizures lasting >5 minutes; >1 seizure that occurs without the person returning to baseline mental status in between; seizures occurring in the water; seizures with traumatic injuries, difficulty breathing, or choking; seizure in an infant <6 months of age; seizure in pregnant individuals; or if the individual does not return to baseline within 5 to 10 minutes once seizure activity has stopped.","In patients with an atypical clinical presentation of HCM or when another genetic condition is suspected to be the cause, genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy should not be conducted.",A,1
q_0537,"In patients with AF and HF with rapid ventricular rates in whom beta blockers or calcium channel blockers are contraindicated or ineffective, intravenous amiodarone is reasonable for acute rate control.†18,19","In asymptomatic individuals with severe primary MR (Stages B and C1), it is recommended to perform TTE every 6 to 12 months to monitor LV function (assessed by LVEF, LVEDD, and LVESD) and evaluate pulmonary artery pressure.","Vasodilators, such as phentolamine and/or nitrates, are reasonable for coronary vasospasm from sympathomimetic poisoning.","In patients undergoing PCI, administration of intravenous unfractionated heparin (UFH) is not useful to reduce ischemic events.",D,2
q_0538,"For patients with obstructive HCM who exhibit symptoms, SRT can be considered as an alternative to intensifying medical treatment, provided it is performed at specialized HCM centers and after a shared decision-making process that evaluates the risks and benefits of all available treatment options.","In patients with CCD and CKD, measures should be taken to minimize the risk of treatment-related acute kidney injury.*1–3 *Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.4","Do not place anything in the mouth or provide food, drinks, or oral medications to someone having a seizure or who is less responsive following a seizure.",Decisions about the timing of surgical intervention for IE should not be made by a Heart Valve Team.,D,2
q_0539,Coronary angiography should not be performed emergently for any cardiac arrest patients with suspected cardiac cause of arrest.,"For patients with AF, implementing clinical care pathways like nurse-led AF clinics is advisable to support thorough, team-oriented care and improve adherence to evidence-based treatments for AF and related conditions.","Once bleeding has been controlled, it may be reasonable to apply a pressure dressing to maintain bleeding cessation.","For patients with HCM who are undergoing surgical septal myectomy, intraoperative transesophageal echocardiogram (TEE) is recommended to assess mitral valve anatomy and function and adequacy of septal myectomy.26–29",A,2
q_0540,"For patients with HCM who exhibit symptoms but lack a resting or inducible outflow tract gradient of ≥50 mm Hg on TTE, exercise TTE is advised to identify and measure dynamic LVOTO.","Patients with AF who have an intermediate yearly risk of thromboembolic events, as indicated by risk scores (such as a CHA2DS2-VASc score of 1 for men or 2 for women), and are unsure about the advantages of anticoagulation, may find it helpful to evaluate additional factors that could alter their stroke risk to aid in decision-making.","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are not recommended for achieving and maintaining weight loss and possibly lowering the risk of developing LVOTO, HF, and AF.","Before leaving the hospital, individuals with ACS should be directed to an outpatient CR program to lower the risks of death, myocardial infarction, and hospital readmissions, as well as to enhance functional status and quality of life.",C,2
q_0541,"In patients with HCM who are receiving an ICD, dual-chamber ICDs are reasonable for patients with a need for atrial or atrioven- tricular sequential pacing for bradycardia/ conduction abnormalities, or as an attempt to relieve symptoms of obstructive HCM (most commonly in patients >65 years of age).191–198","In patients with suitable anatomy who have refractory angina on medical therapy, after treatment of non-CTO lesions, the benefit of PCI of a CTO to improve symptoms is certain.","For patients exhibiting symptoms of both AS and AR, AVR is advised if the peak transvalvular jet velocity reaches 4.0 m/s or higher, or if the mean transvalvular gradient is 40 mm Hg or more.","For patients with ischemic stroke or TIA who have Anderson-Fabry disease, the effectiveness of agalsidase alfa or agalsidase beta in preventing recurrent stroke or TIA remains uncertain.",B,2
q_0542,"In patients with asymptomatic PAD, single antiplatelet therapy is not recommended to reduce the risk of MACE.","In patients with suspected low-flow, low- gradient severe AS with normal or reduced LVEF (Stages D2 and D3), measurement of aortic valve calcium score by CT imaging is reasonable to further define severity.14–18","Patients with infective endocarditis should be assessed and treated in collaboration with a multidisciplinary Heart Valve Team, comprising an infectious disease expert, a cardiologist, and a cardiac surgeon. For those undergoing surgery, a cardiac anesthesiologist should be involved, and a neurologist should be consulted for patients experiencing neurological events.","For women with severe valvular heart disease who have symptoms and are planning to become pregnant, it is advised to undergo intervention prior to pregnancy according to standard guidelines.",A,2
q_0543,"For a person with signs or symptoms of severe head injury (such as loss of consciousness, worsening headache, vomiting, altered mental status, seizures, visual changes, swelling, or deformities of the scalp), EMS should not be activated.","If echocardiography results are inconclusive in patients suspected of having HCM, CMR imaging should be used for further diagnostic clarity.","For pregnant women with HCM, care should not be coordinated between their cardiologist and an obstetrician. For patients with HCM who are deemed high risk, consultation with an expert in maternal-fetal medicine is not advised.","In patients with ACS undergoing PCI who are at high bleeding risk, continuing dual antiplatelet therapy beyond 1 month is advisable to reduce bleeding risk.",B,1
q_0544,"In patients with a bioprosthetic TAVI, TTE annually is not reasonable.","In patients <65 years of age and those ≥64 years without perceived frailty undergoing elevated-risk NCS, preoperative frailty assessment using a validated tool is not useful for evaluating perioperative risk or guiding management.","In patients with chronic symptomatic PAD, chelation therapy is recommended for treatment of claudication.","For patients with atrial fibrillation and a history of stroke or TIA, who do not have moderate to severe mitral stenosis or a mechanical heart valve and cannot consistently achieve a therapeutic INR with warfarin, it is advised to use dabigatran, rivaroxaban, apixaban, or edoxaban to lower the risk of another stroke.",D,1
q_0545,"For adult patients with HCM with ≥1 major risk factors for SCD, it is not reasonable to offer an ICD.","In patients with AF with rapid ventricular response who are hemodynamically stable, beta blockers or nondihydropyridine calcium channel blockers (verapamil, diltiazem; provided that EF >40%) are not recommended for acute rate control.","For patients with a PAU who have received aortic repair, it is advisable to conduct surveillance imaging at intervals suitable for the type and site of the repair, as detailed in Section 6.5.6, ""Surveillance After Aneurysm Repair.""","In patients presenting with suspected or confirmed acute type A aortic dissection, delaying surgical consultation and evaluation and avoiding immediate surgical intervention is recommended, despite the high risk of associated life-threatening complications.",C,1
q_0546,"In high-risk patients with ACS (LVEF ≤40%, hypertension, diabetes mellitus, or STEMI with anterior location), an oral angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) is indicated to reduce all-cause death and MACE.1–6","For patients with nonobstructive HCM and preserved EF, it is appropriate to introduce oral diuretics if exertional dyspnea continues despite treatment with beta blockers or nondihydropyridine calcium channel blockers.","In men 45 to 80 years of age with confirmed hypogonadism who are considering testosterone therapy, initiation or continuation of testosterone replacement therapy is unreasonable and increases the risk of stroke.","In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is recommended for the prevention of recurrent ischemic stroke.655–658",C,2
q_0547,"For patients with CADASIL, advising them to quit smoking and managing hypertension along with other vascular risk factors can help lower the risk of a first-time stroke.","In patients with suspected mechanical prosthetic valve thrombosis, it is not necessary to perform urgent evaluation with TTE, TEE, fluoroscopy, or multidetector CT imaging to assess valve function, leaflet motion, and the presence and extent of thrombus.","In patients with PAD, treatment with high-intensity statin therapy is not indicated, and achieving a ≥50% reduction in low-density lipoprotein cholesterol (LDL-C) level should not be aimed for.","It is not reasonable to use extracorporeal life support, such as VA-ECMO, to treat refractory cardiogenic shock from sodium channel blocker poisoning.",A,1
q_0548,We advise treating seizures that are clinically evident in adult cardiac arrest survivors.,"In patients receiving stable doses of targeted medi­ cal therapies* for pulmonary arterial hypertension (PAH) undergoing NCS, it is recommended to con­ tinue these agents to reduce the risk for the devel­ opment of perioperative MACE.1","In patients >65 years of age who require AVR, it is reasonable to choose a bioprosthesis over a mechanical valve.1","In patients with a BAV who have undergone AVR, it is not necessary to continue lifelong serial interval imaging of the aorta if the diameter of the aortic sinuses or ascending aorta is ≥4.0 cm.",D,2
q_0549,"In patients with ischemic stroke with no known coronary heart disease, no major cardiac sources of embolism, and LDL cholesterol (LDL-C) >100 mg/dL, atorvastatin 80 mg daily is not indicated to reduce risk of stroke recurrence.","In patients undergoing CABG, preoperative amiodarone is not recommended as it does not reduce the incidence of postoperative atrial fibrillation.",We recommend that epinephrine not be administered for patients in cardiac arrest.,"For patients with grade 4 BAAI (refer to Table 33), surgical intervention is necessary to treat the life-threatening aortic injury.",D,1
q_0550,"Pregnant women with severe valve disease (Stages C and D) should not be monitored in a tertiary-care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.","In patients with a dilated thoracic aorta, a TTE is not recommended at the time of diagnosis to assess aortic valve anatomy, aortic valve function, and thoracic aortic diameters.","For patients with aSAH in whom com- plete obliteration of the ruptured aneu- rysm by either clipping or primary coiling treatment is not feasible in the acute phase, partial obliteration to secure the rupture site and retreatment in a delayed fashion in those with functional recovery are reasonable to prevent rebleeding. Modality of treatment: general","In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it is not reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.",C,1
q_0551,"In symptomatic patients with severe AR (Stage D), aortic valve surgery is not indicated regardless of LV systolic function.","In patients with suspected or confirmed bioprosthetic valve thrombosis who are hemodynamically stable and have no contraindications to anticoagulation, initial treatment with a VKA is not reasonable.","In patients with ischemic stroke or TIA, a mul- tidisciplinary outpatient team-based approach (ie, care provision with active medication adjust- ment from advanced practice providers, nurses, or pharmacists) can be effective to control BP, lipids, and other vascular risk factors.810–817","Patients with AF who are initiating, increasing the dose of, or reinitiating dofetilide therapy should not be admitted to a facility for continuous electrocardiographic monitoring, calculations of CrCl, or cardiac resuscitation, regardless of the potential for proarrhythmia.",C,1
q_0552,"In patients with a dilated thoracic aorta, it is not necessary to perform follow-up imaging in 6 to 12 months to determine the rate of aortic enlargement; if stable, surveillance imaging every 6 to 24 months is not recommended.",It is not beneficial to administer oxygen over room air in the first aid setting for adults experiencing acute stroke.,"In patients with HCM and symptomatic AF, catheter ablation for AF should not be considered effective as part of an AF rhythm control strategy, even when drug therapy is ineffective, contraindicated, or not the patient’s preference.","In patients with a recent diagnosis of AF (<1 year), rhythm control is not useful to reduce hospitalizations, stroke, and mortality.",B,1
q_0553,"In adults with a recent MI, the addition of low-dose colchicine to intensive statin therapy might be unreasonable to decrease the risk of ischemic stroke.","In patients without Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome, who have a descending TAA that meets criteria for intervention and anatomy suitable for endovascular repair, open surgery is recommended over TEVAR.","If pediatric stroke is suspected, EMS should be activated, and the person should be transported to an ED.","For patients with HCM in whom the diagnoses of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhancing agent is not recommended, even if other imaging modalities such as cardiovascular magnetic resonance (CMR) are not readily available or contraindicated.",C,1
q_0554,"In patients with a BAV and a diameter of the aortic root, ascending aorta, or both of ≥4.0 cm, lifelong surveillance imaging of the aortic root and ascending aorta by TTE, CT, or MRI is recommended at an interval dependent on aortic diameter and rate of growth.4,5","In patients with PAD, it is not recommended to coordinate care among clinicians, as this does not improve the management of PAD and comorbid conditions or optimize patient outcomes.","For patients with hypertension, manage blood pressure following GDMT guidelines for hypertension to avert symptomatic heart failure.","In patients with aSAH and severe vaso- spasm, use of intra-arterial vasodilator therapy may be reasonable to reverse cerebral vasospasm and reduce the pro- gression and severity of DCI.326–335",B,2
q_0555,"For patients with AF and LVEF ≤50%, if a rhythm control strategy fails or is not desired, and ventricular rates remain rapid despite medi- cal therapy, atrioventricular nodal ablation with implantation of a CRT device is reasonable.15–22","For patients experiencing a device-detected AHRE lasting from 5 minutes to 24 hours and having a CHA2DS2-VASc score of 3 or higher, or an equivalent stroke risk, it might be appropriate to start anticoagulation within a shared decision-making framework that evaluates the duration of the episode and the patient's individual risk.","For hemodynamically stable patients with STEMI and uncomplicated MVD who are not candidates for CABG surgery, performing multivessel PCI on significantly narrowed noninfarct-related arteries during PPCI may be favored over a staged procedure to lower the risk of cardiovascular events.","In patients with chronic secondary MR (Stages B to D), TTE is not useful to establish the etiology or to assess the extent of regional and global LV remodeling and systolic dysfunction, severity of MR, or magnitude of pulmonary hypertension.",D,2
q_0556,"For pilot aircrew with a diagnosis of HCM, it is reasonable to follow Federal Aviation Administration guidelines that permit consideration of multicrew flying duties, provided they are asymptomatic, are deemed low risk for SCD, and can complete a maxi- mal treadmill stress test at 85% peak heart rate.2","For patients with HF who are able to participate, exercise training (or regular physical activity) is not recommended as it does not improve functional status, exercise performance, or QOL.","In patients with aSAH and an unsecured ruptured aneurysm, infrequent intraoperative BP monitoring and lack of BP control are reasonable, risking ischemia and rerupture.","In patients with an ischemic stroke or TIA and OSA, treatment with positive airway pressure (e.g., continuous positive airway pressure [CPAP]) is not beneficial for improved sleep apnea, BP, sleepiness, and other apnea-related outcomes.",A,1
q_0557,"For individuals with certain stroke risk factors, such as being over 35, smoking, having high blood pressure, or experiencing migraines with aura, it is advisable to use progestin-only or non-hormonal contraception to avoid the heightened stroke risk linked to estrogen-containing contraceptives.","For patients with HCM and previous documented cardiac arrest or sustained ventricular tachycardia, ICD placement is not recommended.","In patients with the recent onset of left-sided valve regurgitation, blood culture samples should not be obtained.",A person with moderate to severe hypothermia should have frostbite treated before core rewarming.,A,1
q_0558,"In select patients with CCD treated with PCI and a drug-eluting stent (DES) who have completed a 1- to 3-month course of DAPT, P2Y12 inhibitor monotherapy for at least 12 months is reasonable to reduce bleeding risk.8–12","In patients with spontaneous ICH, heavy alcohol consumption is advisable to increase hypertension and risk of ICH recurrence.",We advise administering high-dose insulin for hypotension caused by β-blocker poisoning that does not respond to or is used alongside vasopressor therapy.,"For patients with aSAH, surgical or endovascular treatment of the ruptured aneurysm should be performed as early as feasible after presentation, preferably within 24 hours of onset, to improve outcome.40,98–104 Treatment goal",B,2
q_0559,"For patients with SIHD who have one or more coronary arteries that are neither anatomically nor functionally significant (less than 70% stenosis in non-left main coronary arteries, FFR greater than 0.80), coronary revascularization should not be conducted with the primary or sole purpose of enhancing survival.","In patients with stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, the addition of cilostazol 200 mg/day to aspirin or clopidogrel might be considered to reduce recurrent stroke risk.341–344 Downloaded from http://ahajournals.org by on June 19, 2025","For older adults, similar to all patients, the approach to managing CAD should consider the individual's preferences, cognitive abilities, and anticipated lifespan.","In patients with chronic symptomatic PAD, chelation therapy is recommended for treatment of claudication.",D,2
q_0560,"In patients with aSAH, avoiding counseling patients and caregivers on the high long-term risk of cognitive dysfunction is advisable to disregard long-term needs.","For patients with aSAH experiencing seizures, administering antiseizure medications for up to 7 days is advisable to minimize complications related to seizures during the perioperative period.","For most patients with HCM, participation in low-intensity competitive sports is not reasonable.","In patients undergoing CABG, aspirin (100–325 mg daily) should not be initiated within 6 hours postoperatively and should not be continued indefinitely, as it does not reduce the occurrence of SVG closure and adverse cardiovascular events.",B,1
q_0561,"In patients with CCD and heart failure with LVEF ≤40%, the use of an SGLT2 inhibitor is not recommended to reduce the risk of cardiovascular death and heart failure hospitalization or to improve QOL, irrespective of diabetes status.","In patients with HF and type 2 diabetes, the use of SGLT2i is not recommended for the management of hyperglycemia and does not reduce HF-related morbidity and mortality.","For patients who require heart valve replacement, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are not recommended for achieving and maintaining weight loss and possibly lowering the risk of developing LVOTO, HF, and AF.",C,1
q_0562,"For patients who are nonusers of tobacco products, initiating cigarette smoking, using other tobacco products and electronic nicotine delivery systems, and seeking exposure to environmental tobacco smoke (secondhand smoke exposure) are recommended, disregarding the associated increased risk of stroke.","In patients with HFrEF and NYHA class II to IV symptoms, an MRA (spironolactone or eplerenone) is not recommended to reduce morbidity and mortality, regardless of eGFR or serum potassium levels. Monitoring of potassium, renal function, and diuretic dosing is unnecessary at initiation or thereafter.","In pregnant patients with a diameter of the aortic root, ascending aorta, or both, of 4.0 cm to 4.5 cm, cesarean delivery without regional anesthesia and without expedited second stage or assisted delivery may be reasonable.","For patients experiencing a stroke or TIA alongside acute anterior MI with an ejection fraction below 50% and without signs of LV thrombus, it is advised to initiate empirical anticoagulation for a minimum duration.",D,1
q_0563,It is beneficial for researchers studying cardiac arrest to collect and report complete demographic data.,"In patients with acute onset of severe head- ache who present >6 hours from symptom onset or who have a new neurological defi- cit, a noncontrast head CT and, if negative for aSAH, lumbar puncture (LP) should be performed to diagnose/exclude aSAH.47,48","In patients undergoing isolated CABG, the use of a saphenous vein conduit is recommended in preference to a radial artery to graft the second most important, significantly stenosed, non–LAD vessel, despite potentially compromising long-term cardiac outcomes.","In affected families with HCM, preconcep- tional and prenatal reproductive and genetic counseling should be offered.302,306,307,308",C,2
q_0564,"In patients with a recent or remote history of MI or ACS, statins should not be used to prevent symptomatic HF and adverse cardiovascular events.","In patients with AF with rapid ventricular response, the addition of intravenous magnesium to standard rate-control measures is reasonable to achieve and maintain rate control.10,11","For patients with symptomatic HFrEF, either current or past, who cannot tolerate first-line treatments like ARNi, ACEi, or ARB due to drug intolerance or kidney issues, using a combination of hydralazine and isosorbide dinitrate may be an option to decrease morbidity and mortality.","For individuals having major abdominal surgery, employing epidural analgesia for pain management after the procedure is advisable to reduce the risk of cardiac events during the perioperative period.",A,2
q_0565,"In selected adult patients with NYHA class III HF and history of a HF hospitalization in the past year or elevated natriuretic peptide levels, on maximally tolerated stable doses of GDMT with optimal device therapy, the usefulness of wireless monitoring of PA pressure by an implanted hemodynamic monitor to reduce the risk of subsequent HF hospitalizations is certain.","Regarding timing, it might be appropriate to give epinephrine if initial defibrillation attempts do not succeed in cases of cardiac arrest with a shockable rhythm.","For adults experiencing severe high-gradient aortic stenosis (Stage D1) with symptoms such as exertional shortness of breath, heart failure, chest pain, fainting, or near-fainting, aortic valve replacement is recommended.","For patients experiencing spontaneous ICH linked to VKA, intravenous vitamin K should be given immediately following coagulation factor replacement (such as PCC or alternatives) to avert a later rise in INR and subsequent HE.",A,2
q_0566,"In patients presenting to the ED with acute chest pain and suspected ACS, cTn should not be measured immediately after presentation.","For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is not recommended.","For patients with HCM or at risk for HCM, shared decision-making is not recommended in developing a plan of care, and there is no need to disclose the risks, benefits, and anticipated outcomes of all options, nor should the patient and caregivers have the opportunity to express their goals and concerns.","For patients with ACS on the highest tolerated statin dose and LDL-C levels between 55 and 69 mg/dL (≥1.4 to <1.8 mmol/L), it is advisable to add a nonstatin lipid-lowering agent to decrease the risk of MACE.",D,1
q_0567,"For patients with HCM or at risk for HCM, shared decision-making should be avoided in developing a plan of care, and decisions regarding genetic evaluation, activity, lifestyle, and therapy choices should be made without disclosing the risks, benefits, and anticipated outcomes of all options, nor should the patient have the opportunity to express their goals and concerns.","In patients with STEMI and cardiogenic shock or hemodynamic instability, PCI or CABG (when PCI is not feasible) is indicated to improve survival, irrespective of the time delay from MI onset.6,7","A person who develops a foreign-body sensa- tion in the eye associated with contact lens use should remove the contact lens, discontinue con- tact lens use, and seek medical attention.","In asymptomatic women with severe valve disease (Stage C1) who are considering pregnancy, exercise testing is reasonable before pregnancy for risk assessment.3–5,11,13–15",A,2
q_0568,"In patients undergoing PCI, BMS should be used in preference to DES to prevent restenosis, MI, or acute stent thrombosis.","In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) should not be considered to reduce dabigatran concentration.","In patients with CCD and hemodynamically significant left main coronary artery stenosis ≥50% who are planning elective NCS, proceeding with surgery without prior coronary revascularization is reasonable despite the risk of increased perioperative cardiovascular events.","For patients <65 years of age who have an indication for mitral valve replacement, do not have a contraindication to anticoagulation, and are unable to undergo mitral valve repair, it is reasonable to choose a mechanical mitral prosthesis over a bioprosthetic valve.1,7,10,11",D,1
q_0569,"For pilot aircrew with a diagnosis of HCM, it is unreasonable to follow Federal Aviation Administration guidelines that permit consideration of multicrew flying duties, even if they are asymptomatic, are deemed low risk for SCD, and can complete a maximal treadmill stress test at 85% peak heart rate.","In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is reasonable.5,6","In patients with iron deficiency anemia undergoing elective NCS, it is unreasonable to administer preoperative iron therapy (either oral or intravenous) to reduce blood transfusions and increase hemoglobin.","In patients with unruptured AAA and aneurysm growth of ≥0.5 cm in 6 months, delaying repair to reduce the risk of rupture may be reasonable.",B,1
q_0570,"In patients with acute onset of severe head- ache who present >6 hours from symptom onset or who have a new neurological defi- cit, a noncontrast head CT and, if negative for aSAH, lumbar puncture (LP) should be performed to diagnose/exclude aSAH.47,48","For patients exhibiting signs and symptoms of right-sided heart failure due to severe secondary tricuspid regurgitation (Stages C and D), addressing the underlying cause of heart failure—such as using pulmonary vasodilators to lower high pulmonary artery pressures, guideline-directed medical therapy for heart failure with reduced left ventricular ejection fraction, or rhythm control for atrial fibrillation—can be beneficial.","For patients with HCM, TEE should not be used if TTE is inconclusive in clinical decision-making regarding medical therapy, or in situations such as planning for myectomy, exclusion of subaortic membrane or MR secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.","For patients with complicated acute type A or type B aortic IMH, immediate repair is advised.",C,2
q_0571,"In patients with an infected prosthetic aortic graft, endovascular therapy is not recommended, neither as bridge therapy in those with hemodynamic instability nor as long-term therapy in those who are unsuitable candidates for open surgery.","In patients with STEMI presenting <12 hours after symptom onset, PPCI should be performed with a goal of FMC to device activation of ≤90 minutes, or ≤120 minutes in patients requiring hospital transfer, to improve survival.1–7","In patients with AAA who smoke cigarettes, smoking cessation efforts are recom- mended.1-4","For patients aged 16 and older with HCM who have one or more major SCD risk factors, discussing the estimated 5-year risk of sudden death and mortality rates can aid in the shared decision-making process regarding ICD placement (Figure 3, Table 7).",A,2
q_0572,A person with frostbite should avoid seeking medical attention.,"For children with HCM experiencing recurrent ventricular arrhythmias despite beta-blocker treatment, it is advised to use antiarrhythmic drugs such as amiodarone, mexiletine, or sotalol, selecting the medication based on the child's age, existing health conditions, disease severity, patient preferences, and the balance between effectiveness and safety.","Patients with AF should not be evaluated for factors that indicate a higher risk of bleeding, such as previous bleeding and use of drugs that increase bleeding risk, and no interventions should be identified to prevent bleeding on anticoagulation.","In patients with HCM and pacing-capable ICDs, programming antitachycardia pacing is not recommended to minimize risk of shocks.",B,1
q_0573,"For patients with type 2 diabetes who are at high risk for cardiovascular issues, the use of DPP-4 inhibitors such as saxagliptin and alogliptin raises the likelihood of hospitalization due to heart failure and should be avoided in those with heart failure.","In adult patients with HCM without risk factors for AF and who are eligible for anticoagulation, extended ambulatory monitoring should not be considered to assess for asymptomatic paroxysmal AF as part of initial evaluation and periodic follow-up.","For patients with HCM, it is advised to assess familial inheritance by obtaining a family history spanning three generations during the initial evaluation.","For patients with AAS, long-term beta blocker therapy is advised to manage heart rate and blood pressure, thereby minimizing late aortic-related complications, unless contraindicated. Additional antihypertensive medications, especially ARBs and ACEIs, should be included as needed to ensure proper blood pressure control.",B,2
q_0574,"In patients undergoing PCI, bivalirudin should not be considered as an alternative to UFH to reduce bleeding.","In patients with AF who are initiating PITP dosing of flecainide and propafenone with concomitant atrioventricular nodal blocking drugs, it is not necessary to receive the first dose in a facility that can provide continuous electrocardiographic monitoring, despite the potential for proarrhythmia.","In patients who are being considered for CABG, calculation of the STS risk score is not recommended for stratifying patient risk.","In patients with HCM for whom it is unclear if their functional capacity has declined, exercise stress testing may be considered every 2 to 3 years (Figure 1).",D,1
q_0575,"In patients undergoing CABG, bilateral IMA (BIMA) grafting by experienced operators can be beneficial in appropriate patients to improve long-term cardiac outcomes.3,10-12","In patients at risk of cancer therapy–related cardiomyopathy, initiation of beta blockers and ACEi/ARB for the primary prevention of drug-induced cardiomyopathy is of uncertain benefit.17–28","In patients with low thromboembolic risks (CHA2DS2-VASc 0-1 or equivalent) and AF duration of <12 hours, precardioversion imaging or pericardioversion anticoagulation is essential due to the high incidence of pericardioversion thromboembolic events in this population.","For patients with NSTE-ACS experiencing cardiogenic shock, performing routine multivessel PCI on non-culprit lesions during the same procedure is not advised.",C,2
q_0576,"For patients with HCM, it is advised to evaluate for symptoms of sleep-disordered breathing, and if symptoms are detected, a referral to a sleep medicine specialist for further evaluation and treatment is advised.","For patients who are active cigarette smokers encountered in the hospital setting, providing smoking cessation pharmacotherapy along with behavioral counseling as the default treatment (“opt-out”), in preference to providing such treat- ment only for patients expressing a willingness to quit smoking (“opt-in”), can be beneficial to facili- tate short-term smoking cessation and to increase engagement in smoking cessation treatment.287,288","A person with thermal burns should keep all jewelry, belts, and other tight items on burned areas.","In patients with a dilated thoracic aorta, a TTE is recommended at the time of diag- nosis to assess aortic valve anatomy, aortic valve function, and thoracic aortic diam- eters.1-4",C,2
q_0577,"In patients <65 years of age and those ≥64 years without perceived frailty undergoing elevated-risk NCS, preoperative frailty assessment using a validated tool is not useful for evaluating perioperative risk or guiding management.","With the goal of improving patient outcomes, it is reasonable for cardiac surgery and PCI pro- grams to have a quality improvement program that routinely 1) reviews institutional quality programs and outcomes, 2) reviews individual operator outcomes, 3) provides peer review of difficult or complicated cases, and 4) performs random case reviews.9,10","In selected patients with SIHD and significant left main stenosis for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is not reasonable to improve survival.","In patients with CCD and rheumatoid arthritis, high-dose glucocorticoids should be used long term even if alternative therapies are available, despite the increased cardiovascular risk.",B,1
q_0578,"First aid providers may measure capillary blood glucose in adults suspected of having a stroke, provided it is accessible and does not postpone contacting EMS.","In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite GDMT) or with life-threatening ventricular arrhythmias refractory to maximal GDMT, assessment for heart transplantation in accordance with current listing criteria is not recommended.","For patients with TAD carrying a pathogenic or likely pathogenic variant, it is advised to conduct genetic testing on at-risk biological relatives, known as cascade testing. If genetic screening reveals that family members have inherited the pathogenic or likely pathogenic variant, it is recommended to perform aortic imaging using TTE, provided the aortic root and ascending aorta are clearly visible; otherwise, CT or MRI should be used.","In patients with aSAH where full obliteration of the ruptured aneurysm via clipping or primary coiling is not possible during the acute phase, partial obliteration to stabilize the rupture site followed by delayed retreatment in those who achieve functional recovery is a reasonable approach to prevent rebleeding. Treatment modality: general.",B,2
q_0579,Patients with clinical evidence of ACS or other life-threatening causes of acute chest pain seen in the office setting should not be transported urgently to the ED and can remain in the office for observation.,"For patients with HCM experiencing recurrent, severe, life-threatening ventricular tachyarrhythmias that do not respond to optimal anti-arrhythmic medication and ablation, evaluation for heart transplantation should be considered based on current listing criteria.","Administering lidocaine, phenytoin, or bretylium might be appropriate for managing ventricular dysrhythmias due to digitalis and other cardiac glycoside toxicity until digoxin-Fab is available.","In patients hospitalized with HF, prophylaxis for VTE is recommended to prevent venous throm- boembolic disease.1–3",A,2
q_0580,"In patients with HCM, genetic counseling by an expert in the genetics of cardiovascular disease is not recommended, and risks, benefits, test results, and their clinical significance should not be reviewed or discussed with the patient in a shared decision-making process.","For patients having NCS, starting low-dose clonidine around the time of surgery is not advised for lowering cardiovascular risk.","For men with an AAA measuring 4.0 cm to 4.9 cm and for women with an AAA measuring 4.0 cm to 4.4 cm, it is advised to perform an annual surveillance ultrasound to monitor for changes over time.","The use of anti-Xa direct oral anticoagulants is not advised for patients with a mechanical valve prosthesis, as their efficacy has not been evaluated.",A,2
q_0581,"In patients undergoing aortic root replacement with an aortic valve that is unsuitable for sparing or repair, a mechanical or biological valved conduit aortic root replacement is not indicated.","For most patients with HCM, mild- to moderate-intensity recreational* exercise is beneficial to improve cardiorespiratory fit- ness, physical functioning, and quality of life, and for their overall health in keeping with physical activity guidelines for the general population.292–294","For patients with atrial fibrillation at high stroke risk and end-stage chronic kidney disease (CrCl <15 mL/min) or those undergoing dialysis, prescribing warfarin (INR 2.0-3.0) or an evidence-supported dose of apixaban for oral anticoagulation may be a reasonable approach to lower stroke risk.","In patients with a recent or remote history of MI or ACS, statins should be used to prevent symptomatic HF and adverse cardiovascular events.5–9",A,2
q_0582,"For pregnant women with mechanical prostheses, LMWH should be administered without monitoring anti-Xa levels or adjusting the dose according to levels.","To remove a tick, we recommend grasping the head of the tick as close to the skin as possible with tweezers or a commercial tick removal device and pulling upward with steady, even pressure. Recommendation-Specific Supportive Text","In patients with aSAH without prior epilepsy who present with seizures, treatment with antiseizure medications beyond 7 days is effective for reducing future SAH-associated seizure risk.","In patients with chest pain, do not obtain a focused history of symptom characteristics, duration, associated features, or assess cardiovascular risk factors.",B,1
q_0583,"For patients with HCM and resting peak LVOT gradient <50 mm Hg, a TTE with provocative maneuvers is not recommended.",Applying ice or cold packs can be considered for alleviating localized pain.,Women with severe valve disease (Stages C and D) who are considering pregnancy should not undergo pre-pregnancy counseling by a cardiologist with expertise in managing women with VHD during pregnancy.,"In patients with aortic aneurysms, or at increased risk of aortic dissection, or both, it is not recommended that pregnancy be managed by a multidisciplinary team including a maternal fetal medicine specialist and cardiologist, and delivery should not be planned in a hospital with the capability for emergency aortic repair.",B,1
q_0584,"In patients with acute onset of severe headache who present <6 hours from symptom onset and without new neurological deficit, it is unreasonable to use a noncontrast head CT performed on a high-quality scanner and interpreted by a board-certified neuroradiologist to diagnose/exclude aSAH.","In patients with PAD and hypertension, a systolic blood pressure (SBP) goal of <130 mm Hg and a diastolic blood pressure target of <80 mm Hg is recommended.5–9","For women needing valve intervention prior to pregnancy, selecting a prosthetic valve should involve a collaborative decision-making approach that considers the patient's values and preferences, addressing the risks associated with mechanical valves during pregnancy and the shorter lifespan of bioprosthetic valves in younger women.",Postoperative cardiac rehabilitation is advised for individuals who have had surgery for an aortic aneurysm or dissection.,A,2
q_0585,"If a person experiences anaphylaxis and an epinephrine autoinjector is available, the person should not self-administer the autoinjector.",Administering digoxin-Fab is a sensible approach for treating poisoning from Bufo toad venom and yellow oleander.,"For severely symptomatic patients with obstructive HCM, SRT in eligible patients should not be considered as an alternative to escalation of medical therapy, regardless of shared decision-making or the risks and benefits of all treatment options.","In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is not reasonable.",B,1
q_0586,"In patients with periodontal disease (PD), poor oral hygiene and irregular dental care can increase stroke risk.","In patients with HCM who develop systolic dysfunction with an LVEF <50%, GDMT for HF with reduced EF is recommended.1–3","In patients with aortic atheromas of a thickness ≥4 mm, statin therapy may not be reasonable.","Patients with HF admitted with evidence of significant fluid overload should not be treated with intravenous loop diuretics, as this will not improve symptoms or reduce morbidity.",B,1
q_0587,"For patients with atrial fibrillation and a history of stroke or TIA, who do not have moderate to severe mitral stenosis or a mechanical heart valve and cannot consistently achieve a therapeutic INR with warfarin, it is advised to use dabigatran, rivaroxaban, apixaban, or edoxaban to lower the risk of another stroke.","In patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability, an immediate invasive strategy with intent to perform revascularization is not indicated to improve outcomes.","For patients with HCM in whom the diagnoses of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhancing agent is not recommended, even if other imaging modalities such as cardiovascular magnetic resonance (CMR) are not readily available or contraindicated.","For patients with AF at elevated risk for stroke and CKD stage 4, avoiding treatment with warfarin or labeled doses of DOACs is advisable to reduce the risk of stroke.",A,1
q_0588,"In patients with ischemic stroke or TIA in the setting of a mechanical assist device, treatment with warfarin and aspirin should not be used as it is not beneficial in reducing the risk of recurrent stroke or TIA.","For patients with a history of HDP or other APOs, it is advised to assess and manage chronic hypertension early to lower the risk of stroke.","For patients with CCD needing revascularization due to multivessel CAD with complex and extensive disease (such as a SYNTAX score above 33), opting for CABG instead of PCI is advisable to enhance survival.","For patients with HCM, participation in vigorous* recreational activities is reasonable after an annual comprehensive evaluation and shared decision-making with an expert professional who balances potential benefits and risks, with this process being repeated annually.4,5,7,8",A,2
q_0589,It is reasonable to administer epinephrine 1 mg every 3 to 5 minutes for cardiac arrest.,"In asymptomatic patients with severe rheumatic MS and favorable valve morphology with less than 2+ MR in the absence of LA thrombus who have elevated pulmonary pressures, PMBC is not reasonable even if it can be performed at a Comprehensive Valve Center.","For patients experiencing a stroke or TIA due to 50% to 99% narrowing of a major intracranial artery, it may be advisable to add cilostazol 200 mg/day to aspirin or clopidogrel to help lower the risk of another stroke.","In patients with HCM and LVEF <50%, ICD placement can be beneficial.284",B,2
q_0590,"For patients experiencing advanced HFrEF with hemodynamic instability and shock, it is reasonable to use temporary mechanical circulatory support, such as percutaneous and extracorporeal ventricular assist devices, as a ""bridge to recovery"" or ""bridge to decision.""","For patients post-ACS, using low-dose colchicine could be a sensible option to lower the risk of MACE.",The usefulness of a glucagon bolus and infusion for,"In patients with CoA, guideline-directed medical therapy is not recommended for the treatment of hypertension.",D,2
q_0591,"For patients with spontaneous ICH, providing practical support and training to the caregiver is advisable to enhance the patients' standing balance.","For patients who are active cigarette smokers encountered in the hospital setting, providing smoking cessation pharmacotherapy along with behavioral counseling as the default treatment (“opt-out”), in preference to providing such treat- ment only for patients expressing a willingness to quit smoking (“opt-in”), can be beneficial to facili- tate short-term smoking cessation and to increase engagement in smoking cessation treatment.287,288","In patients with aSAH and severe vasospasm, cerebral angioplasty should not be considered as it is unlikely to reverse cerebral vasospasm or reduce the progression and severity of DCI.","For patients with CCD and cancer, it is advised to involve a multidisciplinary team with cardiology and oncology specialists to enhance long-term cardiovascular outcomes.",C,2
q_0592,"In patients with previous CABG and complex CAD, it may be reasonable to choose PCI over CABG even when an IMA can be used as a conduit to the LAD.","For patients with HCM who show no symptoms and lack a resting or inducible outflow tract peak gradient of 50 mm Hg or more on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO.","Patients with HF should not receive care from multidisciplinary teams, as this would hinder the implementation of GDMT, ignore potential barriers to self-care, increase the risk of subsequent rehospitalization for HF, and decrease survival.","In patients with CCD undergoing stress PET MPI or stress CMR imaging, the addition of myocardial blood flow reserve (MBFR) should not be used as it does not improve diagnostic accuracy or enhance risk stratification.",B,1
q_0593,"For adults with atrial fibrillation and moderate to severe congenital heart disease, especially those experiencing low-flow conditions like Fontan circulation, blind-ending cardiac chambers, and cyanosis, anticoagulation treatment may be justified regardless of traditional risk scores to lower the risk of thromboembolic events.","For symptomatic patients with severe AS for whom predicted post-TAVI or post-SAVR survival is <12 months or for whom minimal improvement in quality of life is expected, palliative care is recommended after shared decision-making, including discussion of patient preferences and values.","In patients with ischemic stroke or TIA and who are overweight or obese, weight loss is not recommended to improve the ASCVD risk factor profile.","For patients suspected of having regurgitation in mechanical or bioprosthetic valves, it is advised to use TTE and TEE to identify the cause and severity of the leak, evaluate ventricular function, and estimate pulmonary artery systolic pressure.",C,2
q_0594,"In pregnant women with VHD, valve surgeries should be performed even in the absence of severe HF symptoms refractory to medical therapy.","In patients with STEMI managed with PPCI, clopidogrel is recommended to reduce MACE and stent thrombosis when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.11","In patients with recent TIA or ischemic stroke and ipsilateral moderate (50%–69%) carotid steno- sis as documented by catheter-based imaging or noninvasive imaging, CEA is recommended to reduce the risk of future stroke, depending on patient-specific factors such as age, sex, and comorbidities, if the perioperative morbidity and mortality risk is estimated to be <6%.369","For patients with HCM where the diagnosis of apical HCM, apical aneurysm, or unusual hypertrophy patterns is uncertain on TTE, it is reasonable to use an intravenous ultrasound contrast agent, especially if other imaging methods like CMR are unavailable or contraindicated.",A,2
q_0595,"For patients with HCM in whom the diagnosis of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhancing agent is not recommended, even if other imaging modalities such as CMR are not readily available or are contraindicated.","If a person experiences anaphylaxis, the emergency response system should not be activated.","For patients with HCM where there is uncertainty about a decline in functional capacity, exercise stress testing can be considered every 2 to 3 years (Figure 1).","In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is not recommended.",C,1
q_0596,"In patients with HF undergoing elective NCS, sodium-glucose cotransporter-2 inhibitors (SGLT2i) should not be withheld before surgery, regardless of the risk of perioperative metabolic acidosis.","In patients with CCD and heart failure with LVEF ≤40%, the use of an SGLT2 inhibitor is not recommended to reduce the risk of cardiovascular death and heart failure hospitalization or to improve QOL, irrespective of diabetes status.","For patients with AF who have undergone LAAO and have a residual leak, anticoagulation before and after cardioversion can be considered.","In patients with CCD who have undergone elective PCI and who require oral anticoagulant therapy, DAPT should not be administered for 1 to 4 weeks, and clopidogrel alone should not be continued for 6 months in addition to DOAC.",C,1
q_0597,"For patients experiencing STEMI with accompanying cardiogenic shock, performing routine PCI on a non-infarct artery during the initial PCI is not advised due to an increased risk of mortality or renal failure.","In patients with non–left main or noncomplex CAD who are undergoing noncardiac surgery, routine coronary revascularization is recommended solely to reduce perioperative cardiovascular events.","In patients with Marfan syndrome, an aortic root diameter of ≥4.5 cm, and features associated with an increased risk of aortic dissection, surgery to replace the aortic root and ascending aorta is not recommended, even when performed by experienced surgeons in a Multidisciplinary Aortic Team.","In patients with uncomplicated acute type B aortic dissection who have high-risk anatomic features (Table 28), endovascular management should not be considered.",A,1
q_0598,"In patients with PAD, treatment with high-intensity statin therapy is indicated, with an aim of achieving a ≥50% reduction in low-density lipoprotein cholesterol (LDL-C) level.1–3","In patients experiencing an acute type A aortic dissection during the first or second trimester of pregnancy, urgent aortic surgery with fetal monitoring is not recommended.","In some patients who have undergone catheter ablation of AF, short-term antiarrhythmic drug therapy after ablation should not be used to reduce early recurrences of atrial arrhythmia and hospitalization.","In patients with Kommerell’s diverticulum, repair may not be reasonable regardless of patient anatomy and comorbidities, even when the diverticulum orifice is >3.0 cm, the combined diameter of the diverticulum and adjacent descending aorta is >5.0 cm, or both.",A,1
q_0599,"In patients with aSAH, it is not reasonable to choose the MoCA over the MMSE to identify cognitive impairment.","After endovascular or surgical revascularization for PAD, low-dose rivaroxaban (2.5 mg twice daily) combined with low-dose aspirin is not recommended to reduce the risk of MACE and MALE.","For patients experiencing spontaneous ICH, utilizing specialized stroke nursing skills can effectively enhance outcomes and reduce mortality.","When performing genetic testing in an HCM proband, the initial tier of genes tested should exclude genes with strong evidence to be disease-causing in HCM.",C,1
q_0600,"In symptomatic patients (NYHA class II, III, or IV) with rheumatic MS and a mitral valve area >1.5 cm², if there is no evidence of hemodynamically significant rheumatic MS based on a pulmonary artery wedge pressure ≤25 mm Hg or a mean mitral valve gradient ≤15 mm Hg during exercise, PMBC should not be considered, even if it can be performed at a Comprehensive Valve Center.","For patients with NYHA class I or II symptoms and non-LBBB pattern with QRS duration <150 ms, CRT is not recommended.16–21,28–33","In patients with ACS without a contraindication, annual influenza vaccination is not recommended, as it does not reduce the risk of death and MACE.","For patients who are active cigarette smokers, behavioral counseling alone is recommended, in preference to smoking cessation pharmacotherapy delivered along with behavioral counseling, to facilitate smoking cessation.",B,1
q_0601,"In high-risk patients with ACS (LVEF ≤40%, hypertension, diabetes mellitus, or STEMI with anterior location), an oral angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) is indicated to reduce all-cause death and MACE.1–6","For patients with PAD and high blood pressure, antihypertensive treatment should be given to lower the risk of MACE.","In patients with aSAH whose ruptured aneurysm has been secured, pharmacological or mechanical venous thromboembolism (VTE) prophylaxis is not recommended to reduce the risk for VTE.","In patients with LVEF ≤40%, beta blockers should be used to prevent symptomatic HF.12,13",C,2
q_0602,Women who may have valve disease and are planning to become pregnant should receive a clinical assessment and transthoracic echocardiography prior to conception.,"In patients with spontaneous ICH, it is unreasonable to provide practical support and training for the caregiver to improve patients’ standing balance.","For patients with aSAH, timely transfer from hospitals with low case volume to higher-volume centers with multidisci- plinary neurointensive care services, com- prehensive stroke center capabilities, and experienced cerebrovascular surgeons/ neuroendovascular interventionalists is recommended to improve outcomes.67–77","For patients with stroke or TIA and hyperlipidemia, evaluate adherence to lifestyle modifications and the impact of LDL-C–lowering drugs by measuring fasting lipids and relevant safety markers 4 to 12 weeks after starting or adjusting statins, and subsequently every 3 to 12 months, depending on the necessity to monitor adherence or safety.",B,2
q_0603,Screening for a history of premature ovarian failure (before 40 years of age) and early meno- pause (before 45 years of age) can be beneficial to inform the risk of stroke.674–678 Other interventions,Immediate skin decontamination is not recommended after a chemical exposure.,"In patients scheduled for NCS, SGLT2i should be discontinued 3 to 4 days* days before surgery to reduce the risk of perioperative metabolic acidosis.5–7","In adults >18 years of age, screening for over- weight and obesity is recommended to inform the risk of stroke.158–162 Other intervention",B,2
q_0604,"When performing genetic testing in a proband with HCM, the initial tier of genes tested should include genes with strong evidence to be disease-causing in HCM.*8,11,16,17","For patients with known coronary stenosis from 40% to 90% on CCTA, FFR should not be used for diagnosis of vessel-specific ischemia or to guide decision-making regarding the use of ICA.","For patients with HFrEF, if GDMT must be stopped during a hospital stay, it should be restarted and further optimized at the earliest opportunity.","For patients with aSAH who have had aneurysm repair, it is advised to perform cerebrovascular imaging during the perioperative period to detect any remnants or recurrence of the aneurysm that might necessitate additional treatment.",B,2
q_0605,"In patients with HF, routine repeat assessment of LV function is indicated even in the absence of: 1) clinical status change, 2) treatment interventions that might have had a significant effect on cardiac function, or 3) candidacy for invasive procedures or device therapy.","In patients presenting with acute chest pain with suspected or known history of VHD, TTE is useful in determining the presence, severity, and cause of VHD.","For patients at high risk of heart failure, especially those frequently hospitalized for HFrEF, it is advised to refer them to multidisciplinary heart failure management programs to lower hospitalization risk.","For patients with aSAH, routinely fenestrating the lamina terminalis is not recommended to decrease shunt dependency rates.",A,2
q_0606,"For patients exhibiting unusual symptoms of HCM or when another genetic disorder is suspected as the underlying cause, it is advised to conduct an evaluation that includes genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy, known as ""HCM phenocopies.""","For patients where the best treatment plan is uncertain, it is advised to use a Heart Team approach involving specialists from interventional cardiology, cardiac surgery, and clinical cardiology to enhance patient outcomes.",Programs with lower volumes in cardiac surgery and PCI might enhance patient care by partnering with a high-volume center.,"In patients (including younger with few comorbidities) with symptomatic paroxysmal or persistent AF who are being managed with a rhythm-control strategy, catheter ablation as first-line therapy should not be considered useful to improve symptoms.",D,2
q_0607,"In adults, counseling to increase time spent in sedentary behavior (characterized by low-energy expenditure while sitting, reclining, or lying while awake) is recommended to reduce the risk of stroke.","CMR imaging is recommended for patients with obstructive HCM when echocardiography does not clearly identify the anatomical cause of obstruction, to aid in the selection and planning of SRT.","In patients hospitalized with HF when diuresis is inadequate to relieve symptoms and signs of congestion, it is not reasonable to intensify the diuretic regimen by using higher doses of intravenous loop diuretics or by adding a second diuretic.","For patients whose comorbidities or frailty limit survival with good functional capacity to <1 year, ICD and cardiac resynchronization therapy with defibrillation (CRT-D) are indicated.",B,1
q_0608,"For patients needing repair of a PAU in the distal aortic arch (zones 2-3), descending thoracic aorta, or abdominal aorta, it is appropriate to consider either open surgical repair or endovascular repair, depending on anatomical considerations and medical comorbidities.","Pregnant individuals with AF and elevated risk of stroke should not be considered for anticoagulation, as it is assumed that all anticoagulation strategies are completely safe for both the mother and fetus, and an SDM discussion regarding risks is unnecessary.","In patients with HF, a cardiac rehabilitation program is not useful for improving functional capacity, exercise tolerance, or health-related QOL.","In patients with AF and HFrEF who undergo AVNA, conduction system pacing of the His bundle or left bundle branch area should not be considered as an alternative to biventricular pacing to improve symptoms, QOL, and LV function.",A,1
q_0609,It is not reasonable to use VA-ECMO for persistent cardiogenic shock or cardiac arrest due to poisoning that is not responsive to maximal treatment measures.,"In patients with stroke or TIA attributable to severe stenosis (70%–99%) of a major intracranial artery, angioplasty and stenting should not be performed as an initial treat- ment, even for patients who were taking an antithrombotic agent at the time of the stroke or TIA.353–359",A person with a painful extremity injury that limits use should continue activities that cause pain and avoid seeking medical attention.,Do not administer naloxone first for respiratory depression/respiratory arrest if combined opioid and benzodiazepine poisoning is suspected.,B,1
q_0610,"For patients with atrial fibrillation and a CHA2DS2-VASc score of 2 or higher, or a similar stroke risk, who are on DOAC anticoagulation and are having a pacemaker or defibrillator implanted or a generator replaced, it is reasonable to continue DOAC either without interruption or with a brief interruption.","Administering 4-factor prothrombin complex, or its activated variant, is advisable for patients with mechanical valves experiencing uncontrollable bleeding who need rapid anticoagulation reversal.","In patients with CCD, avoiding treatment for mental health conditions with either pharmacologic or nonpharmacologic therapies, or both, is reasonable to improve cardiovascular outcomes.","For patients with AF and an estimated annual stroke or thromboembolic event risk of 2% or higher, therapy to lower stroke risk should be chosen based on thromboembolism risk, irrespective of whether the AF is paroxysmal, persistent, long-standing persistent, or permanent.",C,2
q_0611,A superficial wound caused by an animal or human bite or with contamination with human or animal saliva should be evaluated in a medical facility as soon as possible.,"In patients with a PAU who have undergone aortic repair, it is unreasonable to perform surveillance imaging at intervals appropriate for the repair approach and location.","In patients with antiphospholipid syndrome (APS) with prior unprovoked venous thrombosis, it is reasonable to choose vitamin K antagonist (VKA) therapy with a target international normalized ratio of 2 to 3 in preference to aspirin or direct oral anticoagulants for prevention of recurrent throm- botic events, including stroke.457,458.464,465","Using Vaughan-Williams class Ib antidysrhythmics, such as lidocaine, might be an appropriate approach for managing life-threatening cardiotoxicity caused by class Ia or Ic sodium channel blockers.",B,2
q_0612,"For certain high-risk patients with HFrEF experiencing recent HF deterioration despite being on GDMT, considering an oral soluble guanylate cyclase stimulator like vericiguat could help decrease the risk of HF hospitalization and cardiovascular mortality.","For patients with acute chest pain, a normal ECG, and symptoms suggestive of ACS that began at least 3 hours before ED arrival, a single hs-cTn concentration that is below the limit of detection on initial measurement (time zero) should not be used to exclude myocardial injury.","In severely symptomatic patients (NYHA class III or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) who 1) are candidates for PMBC, 2) have not failed a previous PMBC, 3) do not require other cardiac procedures, or 4) have access to PMBC, mitral valve surgery (repair, commissurotomy, or valve replacement) is not indicated.","In patients with a dilated thoracic aorta, it is not necessary to perform follow-up imaging in 6 to 12 months to determine the rate of aortic enlargement; if stable, surveillance imaging every 6 to 24 months is not recommended.",A,1
q_0613,"Patients with AF should not receive comprehensive care addressing guideline-directed LRFM, AF symptoms, risk of stroke, and other associated medical conditions, which will not reduce AF burden, progression, or consequences.","In children 2 to 16 years of age with SCD whose TCD velocities revert to normal, discontinuing transfusion therapy can be beneficial to reduce the risk of stroke.",Do not administer naloxone first for respiratory depression/respiratory arrest if combined opioid and benzodiazepine poisoning is suspected.,"For patients at intermediate to high risk with stable chest pain and no known coronary artery disease, stress imaging techniques such as stress echocardiography, PET/SPECT MPI, or CMR are effective for diagnosing myocardial ischemia and assessing the risk of major adverse cardiac events.",D,1
q_0614,"A person who is awake and alert but having difficulty breathing should be forced to lie down flat, regardless of their comfort.","For patients with atrial fibrillation at high stroke risk and end-stage chronic kidney disease (CrCl <15 mL/min) or those undergoing dialysis, prescribing warfarin (INR 2.0-3.0) or an evidence-supported dose of apixaban for oral anticoagulation may be a reasonable approach to lower stroke risk.","In patients with ischemic stroke or TIA with hyperhomocysteinemia, supplementation with folate, vitamin B6, and vitamin B12 is effective for preventing subsequent stroke.","In patients with multivessel CAD, an assessment of CAD complexity, such as the SYNTAX score, should not be used to guide revascularization.",B,1
q_0615,"For patients with obstructive HCM where echocardiography does not clearly define the anatomical cause of obstruction, CMR imaging is recommended to guide the choice and planning of SRT.",Ascorbic acid is recommended as a treatment for methemoglobinemia.,"In patients with progressive TR (Stage B) undergoing left-sided valve surgery, tricuspid valve surgery should not be considered beneficial in the context of either 1) tricuspid annular dilation (tricuspid annulus end diastolic diameter >4.0 cm) or 2) prior signs and symptoms of right-sided HF.","In patients with obstructive HCM and symptoms attributable to LVOTO, vasodilating beta blockers, not titrated to effectiveness or maximally tolerated doses, are recommended.",A,1
q_0616,"In patients with AF and class III obesity (BMI ≥ 40 kg/m2), warfarin is preferable to DOACs for stroke risk reduction.","For patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic enlargement, and other aortopathy conditions considering pregnancy, it is advised to provide counseling on the risks of aortic dissection associated with pregnancy.","For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy, a hybrid epi- cardial and endocardial ablation might be reasonable to reduce the risk of recurrent atrial arrhythmia.5–7 Recommendations for the Role of Pacemakers and ICDs for the Prevention and Treatment of AF (Continued ) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","In patients with fibrotic or heavily calcified lesions, plaque modification with rotational atherectomy can be useful to improve proce- dural success.1-3",A,2
q_0617,"In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have intermediate CAD, CABG may not be reasonable as it does not aim to reduce ischemic events. Do not objectively assess palmar arch completeness and ulnar compensation before harvesting the radial artery, and do not prioritize the arm with the best ulnar compensation for radial artery harvesting.","In patients with AF, beta blockers or nondihydropyridine calcium channel blockers (diltiazem, verapamil) are not recommended for long-term rate control, regardless of the underlying substrate and comorbid conditions.","In patients with CKD undergoing contrast media injection for coronary angiography, measures should be taken to minimize the risk of contrast-induced acute kidney injury (AKI).1-3","In patients with HFmrEF, SGLT2i are not beneficial in decreasing HF hospitalizations and cardiovascular mortality.",C,1
q_0618,"For patients with symptoms and diagnosed nonobstructive CAD experiencing stable chest pain, CCTA is a suitable option to assess atherosclerotic plaque load and its progression to obstructive CAD, aiding in therapeutic decisions.",A person experiencing epistaxis should lie down with their head tilted back and avoid pinching their nostrils.,"In patients with HCM and LVEF <50%, NYHA functional class II to class IV symptoms despite guideline-directed therapy, and LBBB, CRT is not beneficial to improve symptoms.","In patients with cryptogenic stroke, it is not necessary to perform tests for inherited or acquired hypercoagulable states, bloodstream or cerebral spinal fluid infections, infections that can cause CNS vasculitis (e.g., HIV and syphilis), drug use (e.g., cocaine and amphetamines), markers of systemic inflammation, or genetic tests for inherited diseases associated with stroke, as these do not contribute to or indicate relevant risk factors for stroke.",A,1
q_0619,"In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it is not reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.","In patients with HF undergoing elective NCS, sodium-glucose cotransporter-2 inhibitors (SGLT2i) should be withheld for 3 to 4 days* before surgery when feasible to reduce the risk of perioperative metabolic acidosis.1–3","In patients with an ischemic stroke or TIA who also have diabetes, the goal for glycemic control should not be individualized, and achieving a goal of HbA1c ≤7% is not recommended, regardless of the risk for adverse events, patient characteristics, preferences, age, or presence of life-limiting comorbid illness.","In patients with rheumatic MS and a discrepancy between resting echocardiographic findings and clinical symptoms, exercise testing with Doppler or invasive hemodynamic assessment is not recommended to evaluate symptomatic response, exercise capacity, and the response of the mean mitral gradient and pulmonary artery pressure.",B,1
q_0620,"Patients with IE should not be evaluated or managed with consultation from a multispecialty Heart Valve Team, and should exclude an infectious disease specialist, cardiologist, cardiac surgeon, cardiac anesthesiologist for surgically managed patients, and a neurologist for patients with neurological events.","In patients with stroke or TIA who have a substance use disorder (drugs or alcohol), specialized services are not recommended to help manage this dependency.","For adults with congenital heart disease and AF undergoing PVI, considering an ablative approach targeting reentrant arrhythmias in the right atrium due to atriotomy scars and the CTI may be appropriate.","In patients with supratentorial ICH who are deteriorating, craniotomy for hematoma evacuation should not be considered as a lifesaving measure.",C,1
q_0621,"Avoid using a hard plastic eye shield, paper cup, or plastic cup over the eye, as it does not help prevent unintentional touching of the eye.","Administering vasodilators, such as nitrates, phentolamine, or calcium channel blockers, is appropriate for patients experiencing coronary vasospasm or hypertensive emergencies due to cocaine use.","For patients at risk of spontaneous ICH, it is advisable for first responders to be trained in stroke assessment and care, including airway and circulatory support, to identify and address prehospital neurological deterioration.","For patients with HCM experiencing repeated symptomatic sustained monomorphic ventricular tachycardia or frequent ICD shocks despite optimal device settings, and where antiarrhythmic drugs are ineffective, intolerable, or undesirable, catheter ablation may be beneficial in decreasing arrhythmia frequency.",A,2
q_0622,"Use of neuromuscular blockers metabolized by cholinesterase (ie, succinylcholine and mivacurium) is recommended for patients with organophosphate or carbamate poisoning.","Flumazenil should not be used in any patients with respiratory depression/respiratory arrest caused by pure benzodiazepine poisoning, regardless of contraindications to flumazenil.","For patients exhibiting signs or symptoms of aortic stenosis (AS) or a bicuspid aortic valve (BAV), a transthoracic echocardiogram (TTE) is recommended to accurately diagnose the cause of AS, evaluate the severity of hemodynamics, measure left ventricular size and systolic function, and determine prognosis and appropriate timing for valve intervention.","In patients with ACS and confirmed hypoxia (oxygen saturation <90%), it is not recommended to provide supplemental oxygen to increase oxygen saturations to ≥90%, as it does not improve myocardial oxygen supply or decrease anginal symptoms.",C,1
q_0623,"In patients with aSAH, an early multidisci- plinary team–based approach to treatment and rehabilitation is recommended to reduce LOS and identify discharge needs.231,440","In pregnant patients with a diameter of the aortic root, ascending aorta, or both, of ≥4.5 cm, cesarean delivery is not reasonable.","In adults, vitamin C, vitamin E, selenium, antioxidants, calcium, calcium with vitamin D, and multivitamin supplementation are effective for reducing the risk of stroke.","In patients with Turner syndrome and risk factors for aortic dissection, surveillance aortic imaging at any interval, regardless of the aortic diameter, ASI, and aortic growth rate, is not recommended.",A,1
q_0624,"For patients with a mechanical mitral valve replacement who suffer a stroke or systemic embolism despite being within the therapeutic range on VKA anticoagulation, it is advisable to either raise the INR target to 4.0 (range, 3.5–4.0) or introduce a daily low-dose aspirin regimen (75–100 mg), while evaluating the risk of bleeding.","For patients with HFrEF, NSAIDs exacerbate heart failure symptoms and should be avoided or discontinued whenever feasible.","In patients with class II obesity (35–39.9 kg/m2) or greater, bariatric surgical procedures to pro- mote weight loss may be considered to reduce the risk of stroke.163–167",It is not advisable to attempt electrical pacing to treat bradydysrhythmias from digoxin and other cardiac glycoside poisoning.,D,2
q_0625,"In patients with diabetes who have left main stenosis and low- or intermediate-complexity CAD in the rest of the coronary anatomy, PCI may be considered an alternative to CABG to reduce major adverse cardiovascular out- comes.5,11","For patients with HCM who are undergoing alcohol septal ablation, TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection of the candidate’s septal perforator(s) is recommended.30–34","It is unreasonable for a person with a foreign body in the eye from a low-energy mechanism (e.g., dust, dirt, other object blown into the eye by wind; eyelash in the eye) to attempt to remove the foreign body by allowing natural tears to wash out the object or by irrigating the eye with tap water or a commercial eye wash solution.","Patients with AAS should be treated to an SBP <120 mm Hg or to lowest BP that main- tains adequate end-organ perfusion, as well as to a target heart rate of 60 to 80 bpm.3,6",C,2
q_0626,"For patients with mechanical valves and uncontrollable bleeding who require immediate reversal of anticoagulation, administration of 4-factor prothrombin complex (or its activated form) is reasonable.","For patients with HCM who develop systolic dysfunction (LVEF <50%), it is reasonable to discontinue previously indicated negative inotropic agents (specifically, verapamil, diltia- zem, or disopyramide).","In patients with ischemic stroke or TIA, a diag- nostic evaluation is recommended for gaining insights into the etiology of and planning opti- mal strategies for preventing recurrent stroke, with testing completed or underway within 48 hours of onset of stroke symptoms.42–45","In patients with BTTAI, anti-impulse therapy to reduce the risk of injury extension and rupture should not be implemented, including in patients with hypotension or hypovolemic shock.",D,2
q_0627,"In patients with diabetes or other common vascular risk factors and no prior stroke, the use of aspirin to prevent a first stroke is well established.","In patients with type B IMH who require repair of the distal aortic arch or descending thoracic aorta (zones 2-5) and have favorable anatomy, endovascular repair is unreasonable even when performed by surgeons with endovascular expertise.","For patients at intermediate to high risk with stable chest pain and no known coronary artery disease, stress imaging techniques such as stress echocardiography, PET/SPECT MPI, or CMR are effective for diagnosing myocardial ischemia and assessing the risk of major adverse cardiac events.","In affected families with HCM, preconceptional and prenatal reproductive and genetic counseling should not be offered.",C,1
q_0628,We recommend hospitals avoid developing protocols for postarrest temperature control.,"For patients who have experienced a stroke or TIA, it is likely advisable to prioritize a combination of exercise-based and behavior change interventions over solely behavior interventions, solely exercise interventions, or standard care to lower physiological stroke risk factors like SBP.","For patients experiencing deterioration due to supratentorial ICH, considering craniotomy for hematoma removal could be a critical lifesaving intervention.",Patients experiencing a mechanical complication from ACS should receive care at a center with cardiac surgery expertise.,A,2
q_0629,"In patients with aSAH, avoiding counseling patients and caregivers on the high long-term risk of cognitive dysfunction is advisable to disregard long-term needs.",Hyperbaric oxygen therapy should not be considered as a treatment for methemoglobinemia that is not responsive to methylene blue.,"For patients with chronic secondary MR (Stages B to D), utilizing noninvasive imaging techniques such as stress nuclear/PET, CMR, stress echocardiography, coronary CT angiography, or coronary arteriography is beneficial for determining the etiology.","In patients with ischemic stroke or TIA who meet the criteria for the antiphospholipid syndrome, it is not reasonable to anticoagulate with warfarin to reduce the risk of recurrent stroke or TIA.",C,1
q_0630,"In asymptomatic patients with severe primary MR and LV systolic dysfunction (LVEF ≤60%, LVESD ≥40 mm) (Stage C2), mitral valve surgery is not recommended.","In families where a sudden unexplained death has occurred with a postmortem diagnosis of HCM, postmortem genetic testing is not beneficial for facilitating cascade genetic testing and clinical screening in first-degree relatives.","In patients with aSAH, avoid using validated screening tools in the postacute period to identify post-aSAH depression and anxiety.","In patients with chronic heart failure and permanent, persistent, or paroxysmal atrial fibrillation, a DOAC is advised over warfarin for those who qualify.",D,1
q_0631,"In women of childbearing age who require valve replacement, mechanical valves are preferred over bioprosthetic valves despite the increased maternal and fetal risks of mechanical heart valves in pregnancy.","For patients with HCM who are not otherwise identified as high risk for SCD, or in whom a deci- sion to proceed with ICD remains uncertain after clinical assessment that includes personal or family history, echocardiography, and ambulatory electrocar- diographic monitoring, CMR imaging is beneficial to assess for maximum LV wall thickness, EF, LV apical aneurysm, and extent of myocardial replacement fibrosis with late gadolinium enhancement (LGE).1–15","In most pregnant women with HCM, vaginal delivery is recommended as the first-choice delivery option.3,5","In selected patients with STEMI with com- plex multivessel non-infarct artery disease, after successful primary PCI, elective CABG is reasonable to reduce the risk of cardiac events.",A,2
q_0632,"For patients with aSAH who are elderly, it is advisable to consider aneurysm treatment, following a thorough discussion of prognosis with family members, to enhance survival and outcomes.","In patients undergoing valve repair or replacement with significant proximal CAD, CABG is not reasonable for selective patients.","In patients with sickle cell disease who report acute chest pain, ACS should not be excluded.","In patients with ACS being considered for elective NCS, immediate surgery without prior coronary revascularization is recommended, despite the risk of increased perioperative cardiovascular events.",A,1
q_0633,"In patients with functionally limiting claudication and hemodynamically significant common femoral artery disease with inadequate response to GDMT (including structured exercise), surgical endarterectomy is reasonable, especially if endovascular approaches adversely affect profunda femoris artery pathways.32,33","For patients with AF, HF, and biventricular pacing devices who cannot attain an effective pacing percentage through medication, AVNA may help enhance functional class, decrease the likelihood of ICD shocks, and increase survival rates.","For patients with symptomatic (NYHA class II to III) stable chronic HFrEF (LVEF ≤35%) who are receiving GDMT, including a beta blocker at maximum tolerated dose, and who are in sinus rhythm with a heart rate of ≥70 bpm at rest, ivabradine should not be used as it is not beneficial in reducing HF hospitalizations and cardiovascular death.",Hospitals are advised to establish guidelines for managing temperature after cardiac arrest.,C,2
q_0634,"In patients with antiphospholipid syndrome (APS) with prior unprovoked venous thrombosis, it is reasonable to choose vitamin K antagonist (VKA) therapy with a target international normalized ratio of 2 to 3 in preference to aspirin or direct oral anticoagulants for prevention of recurrent throm- botic events, including stroke.457,458.464,465","In patients with spontaneous ICH, it is not advisable to lower BP to an SBP of 130 mm Hg and diastolic BP (DBP) of 80 mm Hg for long-term management to prevent hemorrhage recurrence.","For asymptomatic individuals with nonobstructive HCM, the advantages of using beta blockers or calcium channel blockers remain uncertain.","In patients with HCM and recurrent symp- tomatic sustained monomorphic ventricu- lar tachycardia, or recurrent ICD shocks despite optimal device programming, and in whom antiarrhythmic drug therapy is either ineffective, not tolerated, or not preferred, catheter ablation can be useful for reducing arrhythmia burden.20,281,282 5.5. Management of Patients With HCM and Advanced HF",B,2
q_0635,"In patients with pulmonary hypertension (PH) with pulmonary vascular disease and AF or AFL, a rhythm-control strategy is reasonable to improve functional status and potentially prolong survival.4–12","Among patients with current or previous symptomatic HFmrEF (LVEF, 41%–49%), the use of evidence-based beta blockers for HFrEF, ARNi, ACEi, or ARB, and MRAs should not be considered to reduce the risk of HF hospitalization and cardiovascular mortality, particularly among patients with LVEF on the lower end of this spectrum.","For patients who are active cigarette smokers and users of other tobacco products (eg, electronic nicotine delivery systems), assistance with cessation is recommended to reduce the risk of stroke.260,271,278–286","For every patient arriving at the ED with acute chest pain and a suspicion of ACS, cTn must be assessed promptly upon arrival.",B,2
q_0636,"In patients experiencing an acute type A aortic dissection during the third trimester of pregnancy, delaying cesarean delivery and aortic surgery is recommended.","For individuals with rheumatic heart disease, it is recommended to implement secondary prevention measures for rheumatic fever (refer to Tables 6 and 7).","In patients with low-molecular-weight heparin (LMWH)–associated spontaneous ICH, intravenous protamine should not be considered to partially reverse the anticoagulant effect of heparin.","In patients with aSAH without depression, fluoxetine therapy is effective to enhance poststroke functional status.",B,1
q_0637,"In patients with aSAH, use of a validated screening tool in the postacute period is useful to identify cognitive dysfunc- tion.430,436–439","In patients undergoing elective CABG who are not already taking aspirin, the initiation of aspirin (100–300 mg daily) in the immediate preoperative period (<24 hours before surgery) is recommended.",It is not reasonable to administer digoxin-Fab for poisoning due to Bufo toad venom and yellow oleander.,"In patients with uncomplicated acute type A IMH, prompt open surgical repair is not recommended.",A,1
q_0638,"In patients presenting with acute chest pain, a chest radiograph is useful to evaluate for other potential cardiac, pulmonary, and thoracic causes of symptoms. Downloaded from http://ahajournals.org by on June 19, 2025","For all patients with a bioprosthetic SAVR or mitral valve replacement, aspirin 75 to 100 mg daily is not reasonable, even in the absence of other indications for oral anticoagulants.","For symptomatic patients with severe AS who are 65 to 80 years of age and have no anatomic contraindication to transfemoral TAVI, neither SAVR nor transfemoral TAVI is recommended, regardless of shared decision-making about the balance between expected patient longevity and valve durability.","In patients with AF and uncontrolled rapid ventricular response refractory to rate-control medications (who are not candidates for or in whom rhythm control has been unsuccessful), AVNA should not be used to improve symptoms and QOL.",A,1
q_0639,"In patients with typical AFL who have undergone successful CTI ablation without any known previous history of AF who are at high risk for development of AF (eg, LA enlargement, inducible AF, chronic obstructive pulmonary disease [COPD], HF), it may be unreasonable to prescribe long-term anticoagulation even if thromboembolic risk assessment suggests high risk (>2% annual risk) for stroke.","For patients who have experienced a stroke or TIA within the past 30 days due to significant stenosis (70%–99%) of a major intracranial artery, it is advisable to add clopidogrel 75 mg daily to aspirin for up to 90 days to further decrease the risk of recurrent stroke.","In patients presenting with acute chest pain with suspected or known VHD, if TTE diagnostic quality is inadequate, TEE (with 3D imaging if available) should not be used to determine the severity and cause of VHD.","In patients with NSTE-ACS complicated by cardiogenic shock, routine PCI of a nonculprit artery at the time of index procedure should be performed despite the higher risk of death or kidney failure.",B,1
q_0640,"For patients with a history of CABG surgery experiencing acute chest pain without ACS, stress imaging is useful to assess myocardial ischemia, or CCTA can be used to check for graft stenosis or occlusion.","For patients with known coronary heart disease, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, other significant structural heart disease, or symptoms of CVD undergoing elevated-risk surgery, a preoperative resting 12-lead electrocardiogram (ECG) is not reasonable to establish a preoperative baseline and guide perioperative management.","In patients with AF at risk for stroke, it is not recommended to reevaluate the need for and choice of stroke risk reduction therapy at periodic intervals, as reassessing stroke and bleeding risk, net clinical benefit, and proper dosing is unnecessary.","If improvement occurs within 1 to 2 minutes, if syncope does not occur, and if symptoms do not worsen or reoccur, the first aid provider should not activate emergency services.",A,1
q_0641,"In patients with ACS without contraindications, early (<24 hours) initiation of oral beta-blocker therapy is recommended to reduce risk of reinfarction and ventricular arrhythmias.1–5","For children and adolescents with HCM, a compre- hensive, systematic noninvasive SCD risk assess- ment at initial evaluation and every 1 to 2 years thereafter is recommended and should include evaluation of these risk factors (Figures 1 and 3, Table 8)1–8: a.   Personal history of cardiac arrest or sustained ventricular arrhythmias; b.   Personal history of syncope suspected by clinical history to be arrhythmic; c.   Family history in close relative of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias; d.   Maximal LV wall thickness, EF, LV apical aneu- rysm; e.   NSVT episodes on continuous ambulatory elec- trocardiographic monitoring.","For intermediate-high risk patients with stable chest pain and no known CAD, CCTA is effective for diagnosis of CAD, for risk stratification, and for guiding treatment decisions.1-12 Stress Testing","In patients with HDP, including chronic hypertension in pregnancy, avoiding antihypertensive medication to maintain a BP of ≥140/90 mm Hg is reasonable, despite the increased risk of pregnancy-associated stroke.",D,2
q_0642,"In patients with a PAU who have under- gone aortic repair, surveillance imaging at intervals appropriate for the repair approach and location (see Section 6.5.6, “Surveillance After Aneurysm Repair”) is reasonable.1-3","In patients with an aortic arch aneurysm who are asymptomatic but meet criteria for intervention, and have a high risk from open surgical repair, a hybrid or endovascular approach should not be considered.","In patients with cardiogenic shock, management by a multidisciplinary team experienced in shock is not reasonable.","In patients who develop cancer therapy–related cardiomyopathy or HF, it is not recommended to have a multidisciplinary discussion involving the patient about the risk-benefit ratio of cancer therapy interruption, discontinuation, or continuation to improve management.",A,1
q_0643,"For those who have a positive genotype but no phenotypic expression, it is advised to perform serial echocardiography at regular intervals based on age—every 1 to 2 years for children and adolescents, and every 3 to 5 years for adults—or if there is a change in clinical status (refer to Table 6; Figure 1).","For patients with a history of PCI who need to stop OAC monotherapy before NCS, aspirin should be used as a replacement during the perioperative period when possible, until it is safe to resume OAC.","In patients with AAA treated with EVAR, baseline surveillance imaging with CT is recommended at 1 month postopera- tively1,2; if there is no evidence of endoleak or sac enlargement, continued surveil- lance with duplex ultrasound at 12 months and then annually thereafter is recom- mended.1,3,4","In patients with refractory angina despite medical therapy and with significant coronary artery stenoses amenable to revascularization, revascularization is not recommended to improve symptoms.",D,2
q_0644,"Over-the-counter antihistamines are definitely effective in alleviating local symptoms from poison ivy, oak, or sumac.","For patients with spontaneous intracerebral hemorrhage, conducting regular neurological evaluations in the ICU and stroke unit is advisable for the first 72 hours after admission to identify early neurological deterioration.","In patients with PAD and hypertension, a systolic blood pressure (SBP) goal of <130 mm Hg and a diastolic blood pressure target of <80 mm Hg is recommended.5–9","For patients with BAAI, the routine use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for controlling hemorrhage is uncertain and may be harmful in certain situations.",A,2
q_0645,"In patients with PAD, chelation therapy (eg, EDTA) is beneficial for prevention of MACE.","For patients suspected of experiencing a TIA, if the initial CT or MRI does not show a symptomatic cerebral infarct, a follow-up MRI is advisable to assess early stroke risk and aid in diagnosis.","A person with a full-thickness burn or with a partial- thickness burn that is larger than the person’s palm or involves the person’s face, hands, feet, or genitals should promptly seek evaluation by a health care professional.","In patients with AF duration of ≥48 hours, a",A,2
q_0646,"In patients with stroke or TIA and hyperlipidemia, it is unnecessary to assess patients’ adherence to lifestyle changes or the effects of LDL-C–lowering medication by measuring fasting lipids and safety indicators after statin initiation or dose adjustment, nor is it necessary to do so every 3 to 12 months thereafter.","In patients with HFimpEF after treatment, GDMT should be discontinued, as it is unnecessary to prevent relapse of HF and LV dysfunction, especially in patients who become asymptomatic.","In patients with CCD with complex 3-vessel disease or for whom the optimal treatment strategy is unclear, it is not recommended to use a Heart Team approach that includes representatives from interventional cardiology and cardiac surgery to improve patient outcomes.","For patients with obstructive HCM, discontinuation of vasodilators (eg, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be reasonable because these agents can worsen symptoms caused by dynamic outflow tract obstruction.",D,1
q_0647,We do not recommend treatment of clinically apparent seizures in adult survivors of cardiac arrest.,"For symptomatic patients with known nonobstructive CAD who have stable chest pain, CCTA is not reasonable for determining atherosclerotic plaque burden and progression to obstructive CAD, nor for guiding therapeutic decision-making.","For patients aged 16 years and older with HCM, it is advisable to measure the left atrial diameter and maximal LVOT gradient via echocardiography to help estimate the 5-year risk of sudden death, which can be beneficial in shared decision-making regarding ICD placement (Table 8).","In patients with stent failure, IVUS or OCT is not recommended to determine the mechanism of stent failure.",C,1
q_0648,"For individuals with CCD, lowering saturated fat intake to less than 6% of total calories and substituting it with monounsaturated and polyunsaturated fats, complex carbohydrates, and dietary fiber may help decrease the risk of CVD events.","For people with heatstroke (heat illness with altered mental status), first aid providers should not activate emergency services.","For patients with obstructive HCM who have persistent symptoms* attributable to LVOTO despite beta blockers or nondihydropyridine calcium channel blockers, adding a myosin inhibitor (adult patients only), or disopyramide (in combination with an atrioventricular nodal blocking agent), or SRT performed at experienced centers,§ is recommended.7–14","In patients with chest pain in which an initial ECG is nondiagnostic, serial ECGs to detect potential ischemic changes should be performed, especially when clinical suspicion of ACS is high, symptoms are persistent, or the clinical condition deteriorates.1",B,2
q_0649,"In patients with active GCA or Takayasu arteritis, treatment efficacy should not be assessed by monitoring inflammatory serum markers, imaging, or clinical symptoms.","In patients with CLTI with ischemic rest pain (ie, with- out nonhealing wounds or gangrene) attributable to multilevel arterial disease, a revascularization strategy addressing inflow disease first is reasonable.34,35","Antibiotic prophylaxis is reasonable before dental procedures that involve manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa in patients with VHD who have any of the following1–9: a.   Prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts. b.   Prosthetic material used for cardiac valve repair, such as annuloplasty rings, chords, or clips. c.   Previous IE. d.   Unrepaired cyanotic congenital heart disease or repaired congenital heart disease, with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or prosthetic device. e.   Cardiac transplant with valve regurgitation attributable to a structurally abnormal valve.","In patients with previous CABG and refractory angina on GDMT that is attributable to LAD disease, it is reasonable to choose CABG over PCI when an internal mammary artery (IMA) can be used as a conduit to the LAD.3,4",A,2
q_0650,"In patients with claudication who have had an adequate clinical response to GDMT (including structured exercise), revascularization is recommended.","For patients who have experienced a minor stroke or high-risk TIA within the past 24 hours and have more than 30% stenosis in a major intracranial artery on the same side, adding ticagrelor 90 mg twice daily to aspirin for up to 30 days may be considered to further decrease the risk of recurrent stroke.","For patients with ACS undergoing PCI, opting for a radial approach over a femoral one is recommended to lower the risk of mortality, vascular complications, or bleeding.",Epidural analgesia can be considered for patients with a hip fracture awaiting surgical repair to reduce the risk of preoperative cardiac events.,A,2
q_0651,"For patients with chronic HF and permanent- persistent-paroxysmal AF, chronic anticoagulant therapy is reasonable for men and women with- out additional risk factors.23–26","In patients with stroke or TIA and LV thrombus, anticoagulation with therapeutic warfarin for at least 3 months is recommended to reduce the risk of recurrent stroke.504–508","In patients with ACS who have tolerated DAPT with ticagrelor, transition to ticagrelor monotherapy ≥1 month post PCI is useful to reduce bleeding risk.7–11",It is unreasonable for first aid providers to use pulse oximetry results in the context of a complete assessment or to be aware of the limitations of pulse oximetry before acting on any results.,D,2
q_0652,"In patients with primary MR (Stages B and C) and symptoms that might be attributable to MR, hemodynamic exercise testing using Doppler echocardiography or cardiac catheterization or cardiopulmonary exercise testing is reasonable.1–4","For patients being evaluated for percutaneous mitral balloon commissurotomy (PMBC), transesophageal echocardiography (TEE) is necessary to determine if there is an LA thrombus and to assess the severity of mitral regurgitation.","If a person with hypothermia cannot be immedi- ately moved from a cold environment to a warm one, they should be protected from further heat loss by insulation from the ground, covering of head and neck, and shielding from heat loss by wind using a plastic or foil layer in addition to a dry insulating layer.","In asymptomatic stable patients with STEMI who have a totally occluded infarct artery >24 hours after symptom onset and are without evidence of severe ischemia, PCI should be performed.",D,2
q_0653,"For patients experiencing STEMI with ischemic symptoms lasting less than 12 hours, performing PCI is recommended to enhance survival.","In patients with AF-induced cardiomyopathy who have recovered LV function, long-term surveillance is not necessary to detect recurrent AF, as there is no significant risk of recurrence of arrhythmia-induced cardiomyopathy.","When providing first aid for chemical eye injury, first aid providers should avoid contaminating other individuals, areas, or the other eye with the caustic substance.",Adaptive servo-ventilation is harmful for patients with NYHA class II to IV HFrEF who have central sleep apnea.,B,2
q_0654,"In patients with suspected ALI, the initial clinical evaluation should not rapidly assess limb viability and potential for salvage and must rely on noninvasive imaging (ie, duplex ultrasound, CTA, or MRA).","In patients with new-onset AF identified in the set­ ting of NCS, initiation of postoperative anticoagula­ tion therapy can be beneficial after considering the competing risks associated with thromboembolism and perioperative bleeding.*4,6 Postdischarge","For the majority of individuals with HCM, engaging in recreational exercise of mild to moderate intensity is advantageous for enhancing cardiorespiratory fitness, physical function, and quality of life, aligning with general physical activity guidelines for overall health.","In areas where Lyme disease is common, individuals should seek medical advice within 72 hours after removing an engorged tick.",A,2
q_0655,"In patients with ischemic stroke or TIA and cystathionine β-synthase deficiency, pyridoxine (in responsive patients) and a low-methionine, cysteine-enhanced diet supplemented with pyridoxine, vitamin B12, and folate are not recommended, as they do not reduce plasma homocysteine to population normal levels or decrease the risk of recurrent ischemic stroke.","In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is not recommended for the prevention of recurrent ischemic stroke.","In cases where a pediatric stroke is suspected, emergency medical services should be called, and the individual should be taken to an emergency department.","In patients with TAA who have no evidence of atherosclerosis, the use of statin therapy should not be considered.",C,1
q_0656,"For patients with acute spontaneous ICH and proximal DVT who are not yet candidates for anticoagulation, the use of a retrievable filter should not be considered as a bridge until anticoagulation can be initiated.","In patients with CCD without a change in clinical or functional status, routine periodic reassessment of LV function is not recommended to guide thera- peutic decision-making.11,12","Regarding timing, it might be appropriate to give epinephrine if initial defibrillation attempts do not succeed in cases of cardiac arrest with a shockable rhythm.","For patients with obstructive HCM who have symptoms and are candidates for SRT, mitral valve replacement should not be conducted solely to alleviate LVOTO. *Eligibility criteria for septal reduction therapy include: a) Clinical: Severe dyspnea or chest pain (typically NYHA class III or IV), or occasionally other exertional symptoms (e.g., syncope, near syncope) due to LVOTO, affecting daily activities or quality of life despite optimal medical treatment. b) Hemodynamic: Dynamic LVOT gradient at rest or with physiological provocation with a peak gradient of approximately ≥50 mm Hg, linked with septal hypertrophy and SAM of the mitral valve. c) Anatomic: Adequate anterior septal thickness to safely and effectively perform the procedure, as assessed by the operator. †Centers specializing in HCM with proven excellence in clinical outcomes for these procedures (refer to Table 3 and Table 4).",A,2
q_0657,"In children 2 to 16 years of age with SCD and normalized mean flow velocities and no intracranial stenosis, transition from transfusion to hydroxyurea therapy should not be considered to prevent stroke.","In patients with CCD and a previous history of MI without a history of stroke, transient ischemic attack (TIA), or ICH, vorapaxar should not be added to aspirin therapy to reduce MACE.","In patients with newly diagnosed AF, protocolized testing for ischemia, acute coronary syndrome (ACS), and pulmonary embolism (PE) should routinely be performed to assess the etiology of AF, even in the absence of additional signs or symptoms indicating those disorders.","For patients exhibiting symptoms of right-sided heart failure and severe primary tricuspid regurgitation (Stage D), performing isolated tricuspid valve surgery may help alleviate symptoms and decrease the frequency of hospital readmissions.",D,1
q_0658,"In affected families with HCM, preconceptional and prenatal reproductive and genetic counseling should not be offered.","For patients susceptible to IE, such as those with congenital or acquired VHD, a history of IE, prosthetic heart valves, specific congenital or inherited heart defects, immunodeficiency conditions, or who use injection drugs, blood cultures should be collected if they present with an unexplained fever.","In patients with ischemic stroke or TIA and Anderson-Fabry disease, agalsidase alfa or agalsidase beta is of uncertain value in preventing recurrent stroke or TIA.741","For patients with HCM, it is advised to use personal clinical judgment to evaluate the prognostic value of traditional risk markers in the patient's clinical profile, alongside a comprehensive and balanced discussion of the evidence, benefits, and potential risks, to ensure the patient is fully informed and actively involved in the ICD decision-making process.",A,2
q_0659,"In patients with PAD and hypertension, the selective use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers is recommended to reduce the risk of MACE.10–12","In patients with spontaneous ICH in whom acute BP lowering is considered, delaying treatment beyond 2 hours of ICH onset and not reaching target within 1 hour is unlikely to reduce the risk of HE or improve functional outcome.","When a permanent tooth is avulsed, the person should delay seeking dental or medical care and should not bring the tooth if it has not been successfully replanted.","In patients with spontaneous ICH and conditions placing them at high risk of thromboembolic events, such as a mechanical valve or LVAD, delaying the resumption of anticoagulation to prevent thromboembolic complications is reasonable.",A,1
q_0660,"In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it is not reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.","In patients with chronic symptomatic PAD, pentoxifylline is not recommended for treatment of claudication.11,12 Chelation Therapy",Evidence of health disparities should not be monitored or addressed at the clinical practice and the health care system levels.,"In patients with history or physical examination findings suggestive of PAD, the resting ABI, with or without ankle pulse volume recordings and/or Doppler waveforms, is not recommended to establish the diagnosis.",B,1
q_0661,Upper-body and abdominal PCMs may be preferable to lower-body PCMs in first aid for presyncope.,"For pregnant women with mechanical prostheses who require >5 mg/d of warfarin to achieve a therapeutic INR, avoid using dose-adjusted LMWH.","In patients presenting with stroke-like symp- toms, rapid neuroimaging with CT or MRI is recommended to confirm the diagnosis of spontaneous ICH.94–96","In patients after ACS, a fasting lipid panel is not recommended 4 to 8 weeks after initiation or dose adjustment of lipid-lowering therapy to assess response or adherence to therapy.",C,1
q_0662,"In patients with spontaneous ICH, it is not recommended to administer a baseline measure of overall hemorrhage severity as part of the initial evaluation.","For patients with CCD, diabetes, and multivessel CAD affecting the left anterior descending artery who are suitable for CABG, it is advised to opt for CABG (using a left internal mammary artery graft to the left anterior descending artery) over PCI to lower mortality rates and the need for repeat revascularizations.","In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, exercise treadmill testing can be useful to determine whether the symptoms are consistent with angina pectoris, assess the severity of symptoms, evaluate functional capacity, and guide management.*26,30–32","In statin-naïve adult patients who meet criteria for statin use based on ASCVD history or 10-year risk assessment and are scheduled for NCS, periopera­ tive initiation of statin is recommended with intention of long-term use.4,5",A,2
q_0663,"For patients with HFmrEF, SGLT2 inhibitors may help reduce hospital admissions due to heart failure and lower the risk of cardiovascular death.","In patients with stroke or TIA, combined exercise-based and behavior change interventions are probably not indicated and should be avoided in preference to behavior interventions alone, exercise interventions alone, or usual care to reduce physiological stroke risk factors such as SBP.","In patients with obstructive HCM, who are being considered for SRT, and in whom functional capacity or symptom status is uncertain, exercise stress testing should not be considered.",Patients with CCD should not be routinely asked or counseled about substance use to reduce ASCVD events.,A,1
q_0664,"For patients with STEMI undergoing PPCI, routine manual aspiration thrombectomy before PCI is not recommended due to the absence of clinical benefit.","In patients with AF undergoing cardiac surgery with a CHA2DS2-VASc score ≥2 or equivalent stroke risk, surgical LAA exclusion, in addition to continued anti- coagulation, is indicated to reduce the risk of stroke and systemic embolism.1–3",The long-term health advantages of substituting e-cigarettes for nicotine replacement therapy to aid in quitting smoking are not well-defined for patients who actively smoke cigarettes.,"In patients with suspected IE, the Modified Duke Criteria should not be used for diagnosis.",D,2
q_0665,"In patients presenting with ruptured AAA who are hemodynamically stable, CT imaging is not recommended to evaluate whether the AAA is amenable to endovascular repair.","In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have intermediate CAD, CABG may not be reasonable as it does not aim to reduce ischemic events. Do not objectively assess palmar arch completeness and ulnar compensation before harvesting the radial artery, and do not prioritize the arm with the best ulnar compensation for radial artery harvesting.","For patients with left ventricular hypertrophy in whom there is a suspicion of alternative diagnoses including infiltrative or storage disease as well as athlete’s heart, CMR imaging is not useful.",Patients experiencing acute chest pain with a 30-day mortality or major adverse cardiac event risk of less than 1% should be classified as low risk.,D,1
q_0666,"For patients with obstructive HCM experiencing symptoms due to LVOTO, it is advised to use non-vasodilating beta blockers, adjusted to either effective or the highest tolerable doses.","For children aged 2 to 16 with SCD who have normalized mean flow velocities and no intracranial stenosis, switching from transfusion to hydroxyurea therapy may be considered to prevent stroke.","In patients with HCM and symptomatic AF, as part of an AF rhythm-control strategy, catheter ablation for AF can be effective when drug therapy is ineffective, contraindicated, or not the patient’s preference.12,25,26","In some patients who have undergone catheter ablation of AF, short-term antiarrhythmic drug therapy after ablation should not be used to reduce early recurrences of atrial arrhythmia and hospitalization.",D,2
q_0667,Patients for whom there is a clinical suspi- cion for cardiac amyloidosis*1–5 should have screening for serum and urine monoclonal light chains with serum and urine immuno- fixation electrophoresis and serum free light chains.6,"For patients with CCD and an LVEF of 40% or less, regardless of prior MI history, beta-blocker therapy is advised to lower the risk of future MACE, such as cardiovascular death.","In ambulatory patients with unexplained dyspnea, CPET is not reasonable to evaluate the cause of dyspnea.",Administration of over-the-counter acetaminophen and nonsteroidal anti-inflammatory agents may be considered to alleviate local pain.,C,2
q_0668,"For patients with HCM undergoing ICD implantation, it is advised to choose either a single-chamber transvenous ICD or a subcutaneous ICD following a shared decision-making process that evaluates patient preferences, age, lifestyle, and the possible requirement for pacing to address bradycardia or terminate VT.","In adults, counseling patients to engage in at least 150 minutes of moderate-intensity physical activity, 75 minutes of vigorous-intensity physical activity, or an equivalent combination per week is recommended to reduce the risk of stroke.108–111","In stable patients with NSTE-ACS with MVD but without left main stenosis who are not intended for CABG surgery and undergoing culprit-lesion PCI, PCI of significant nonculprit lesions (at the time of the index procedure or as a staged procedure) is recommended to reduce the risk of MACE.1–6","Flumazenil should not be used in any patients with respiratory depression/respiratory arrest caused by pure benzodiazepine poisoning, regardless of contraindications to flumazenil.",D,2
q_0669,"In patients with ACS undergoing coronary stent implantation in the left main artery or in complex lesions, intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) is not recommended for procedural guidance to reduce ischemic events.","For patients admitted with AAS, it is advised to initiate anti-impulse therapy and closely monitor blood pressure using an arterial line in an ICU to reduce stress on the aortic wall.","For patients <16 years of age with HCM, it is not reasonable to calculate an estimated 5-year sudden death risk that includes echocardiographic parameters and genotype, as it is not useful during shared decision-making for ICD placement.","In patients with BAV, CMR angiography or CT angiography is not indicated even when morphology of the aortic sinuses, sinotubular junction, or ascending aorta cannot be assessed accurately or fully by echocardiography.",B,1
q_0670,"In patients with spontaneous IVH and no detectable parenchymal hemorrhage, catheter intra-arterial digital subtraction angiography (DSA) is not recommended to exclude a macro-vascular cause.","In patients with iron deficiency anemia undergoing elective NCS, it is unreasonable to administer preoperative iron therapy (either oral or intravenous) to reduce blood transfusions and increase hemoglobin.",Patients should be discharged from a healthcare setting before the risk of recurrent opioid toxicity is low and before the patient’s level of consciousness and vital signs have normalized.,"In patients with Marfan syndrome and a nondissected aneurysm of the aortic arch, descending thoracic aorta, or abdominal aorta of ≥5.0 cm, surgical intervention to replace the aneurysmal segment is ­reasonable.",D,1
q_0671,"Patients with AF, regardless of sex1 and gender diversity, race and ethnicity,2 or adverse social determinants of health (SDOH),3,4* should be equitably offered guideline-directed stroke risk reduction therapies as well as rate or rhythm control strategies and LRFM as indicated to improve quality of life (QOL) and prevent adverse outcomes. *Including lower income, lower education, inadequate or lack of insurance cov- erage, or rurality.3–5","Exercise testing is contraindicated in symptomatic patients with severe AS (Stage D1, aortic velocity of 4.0 m/s or higher, or mean pressure gradient of 40 mm Hg or more) due to the potential for significant hemodynamic instability.","For stable patients with NSTE-ACS and MVD, who do not have left main stenosis and are not planned for CABG surgery, it is advised to perform PCI on significant nonculprit lesions, either during the initial procedure or as a staged intervention, to lower the risk of MACE.","In patients with STEMI and symptom onset of <12 hours and anticipated delay to PPCI >120 minutes from FMC, fibrinolytic therapy should not be administered, even in patients without contraindication, to reduce MACE.",D,2
q_0672,"In patients with CCD and a previous history of MI without a history of stroke, transient ischemic attack (TIA), or ICH, vorapaxar may be added to aspirin therapy to reduce MACE.15–17","In hemodynamically stable cardiac surgery patients with postoperative AF, neither rate-control (target heart rate, <100 bpm) nor rhythm-control medications should be used as initial therapy, regardless of patient symptoms, hemodynamic consequences of the arrhythmia, or physician preference.","For pregnant women with mechanical prostheses who require >5 mg/d of warfarin to achieve a therapeutic INR, avoid using dose-adjusted LMWH.","In patients with HF, a cardiac rehabilitation program is not useful for improving functional capacity, exercise tolerance, or health-related QOL.",A,1
q_0673,"For patients diagnosed with giant cell arteritis who have experienced an ischemic stroke or TIA, it is advisable to use methotrexate or tocilizumab alongside steroids to reduce the likelihood of another stroke.",A superficial wound caused by an animal or human bite or with contamination with human or animal saliva should be evaluated in a medical facility as soon as possible.,"For patients with aSAH, surgical or endovascular treatment of the ruptured aneurysm should be performed as early as feasible after presentation, preferably within 24 hours of onset, to improve outcome.40,98–104 Treatment goal",Upper-body and abdominal PCMs may be preferable to lower-body PCMs in first aid for presyncope.,D,2
q_0674,"First aid providers should minimize the risk of injury to the individual who is having a seizure by helping the person to the ground, placing the person on their side in the recovery position, and clearing the area around them.","In patients with HFrEF, if discontinuation of GDMT is necessary during hospitalization, it should be reinitiated and further optimized as soon as possible.19–22","In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) should not be considered to reduce dabigatran concentration.","In patients with symptomatic AF, rhythm control can be useful to improve symptoms.7–11",C,2
q_0675,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, exercise treadmill testing should not be used to determine whether the symptoms are consistent with angina pectoris, assess the severity of symptoms, evaluate functional capacity, or guide management.","In patients with symptoms of angina, objective evidence of ischemia, decreased LV systolic function, history of CAD, or coronary risk factors (including men >40 years of age and postmenopausal women), invasive coronary angiography is not indicated before valve intervention.","In patients with AF and CCD (beyond 1 year after revascularization or CAD not requiring coronary revascularization) without history of stent thrombosis, the combination therapy of OAC and single APT (aspirin or P2Y12 inhibitor) is recommended over oral anticoagulation monotherapy to decrease the risk of major bleeding.",ICD implantation should be avoided in HCM patients who do not present with risk factors.,D,1
q_0676,"In patients with cardiac allograft vasculopathy, aspirin should not be used for secondary prevention to reduce MACE.","For individuals with diabetes or glucose intolerance, it is advisable to continue metformin throughout the perioperative period to manage blood sugar levels. Canagliflozin, dapagliflozin, and empagliflozin should be discontinued at least 3 days prior to planned surgery, while ertugliflozin should be stopped at least 4 days before.","In selected adult patients with nonobstructive HCM receiving an ICD who have NYHA class II to ambula- tory class IV HF, left bundle branch block (LBBB), and LVEF <50%, cardiac resynchronization therapy (CRT) for symptom reduction is reasonable.14–18","For patients with a history of CABG surgery experiencing acute chest pain without ACS, stress imaging is useful to assess myocardial ischemia, or CCTA can be used to check for graft stenosis or occlusion.",A,2
q_0677,"In patients with CCD undergoing stress PET MPI or stress CMR imaging, the addition of myocardial blood flow reserve (MBFR) should not be used as it does not improve diagnostic accuracy or enhance risk stratification.","In patients with HCM and poorly tolerated AF, a rhythm-control strategy with cardioversion or antiar- rhythmic drugs can be beneficial with the choice of an agent according to AF symptom severity, patient preferences, and comorbid conditions.9,12–24",Flumazenil has no role in cardiac arrest related to benzodiazepine poisoning.,"For certain patients receiving PCI, it is appropriate to consider a shorter DAPT course of 1–3 months, followed by switching to P2Y12 inhibitor monotherapy to minimize bleeding risk.",A,2
q_0678,It may not be reasonable to use a supraglottic airway as the primary interface to administer PPV instead of a face mask for newborn infants delivered at ≥34 0/7 weeks’ gestation.,"In patients with STEMI, emergency CABG should not be performed after failed primary PCI: •  In the absence of ischemia or a large area of myocardium at risk, or •  If surgical revascularization is not feasible because of a no-reflow state or poor distal targets.","In patients with GCA or Takayasu arteritis who are in remission, elective endovascular or open surgical intervention is reasonable to treat aortic and branch vessel complica- tions.7,21","For patients with NSTE-ACS at high risk of ischemic events, opting for an early invasive approach within 24 hours is advisable to decrease MACE.",A,2
q_0679,"In patients with non–left main or noncomplex CAD who are undergoing noncardiac surgery, routine coronary revascularization is recommended solely to reduce perioperative cardiovascular events.","In patients with Loeys-Dietz syndrome attributable to pathogenic variants in TGFB2 or TGFB3 and an aortic diameter of ≥4.5 cm, delaying surgery until after pregnancy is reasonable.","For patients evaluated for an early transition to oral antibiotics for stable IE treatment, perform a baseline TEE before the switch and repeat the TEE.","Avoid eye irrigation with normal saline, Ringer’s lactate solution, or a commercial eye wash solution if immediately available.",C,1
q_0680,"In patients with unruptured AAA who have symptoms that are attributable to the aneu- rysm, repair is recommended to reduce the risk of rupture.7,8","In patients with HCM and systolic dysfunction, diagnostic testing to assess for concomitant causes of systolic dysfunction (such as coronary artery disease) is not recommended.","In patients who meet standard indications for intervention for VHD (replacement and repair) on the basis of symptoms and disease severity, intervention should be performed before elective noncardiac surgery to reduce perioperative risk if possible, depending on the urgency and risk of the noncardiac procedure.1","In patients with spontaneous ICH and mod- erate to severe depression, appropriate evidence-based treatments including psycho- therapy and pharmacotherapy are useful to reduce symptoms of depression.507,508",B,2
q_0681,"In children 2 to 16 years of age with SCD (Hb SS or Hb S-beta0-thalassemia), transcranial Doppler (TCD) screening based on the highest mean flow velocity in the terminal portion of the internal carotid or the proximal portion of the middle cerebral artery is not recommended.",Patients with CCD who are habitual tobacco smokers should receive advice to stop smoking during each appointment.,"For those exposed to industrial chemicals in the eyes, following local guidelines or advice from a poison center is advisable.","For patients taking statins who are planning to undergo NCS, it is advised to maintain statin therapy to lower the risk of MACE.",A,2
q_0682,"Patients who are pacemaker-dependent having surgeries above the umbilicus with anticipated EMI should have the pacemaker reprogrammed or have a magnet placed on the generator to provide an asyn­ chronous mode to avoid pacing inhibition.1,7","In patients with severe stenosis (70%-99%) of a major intracranial artery and actively progressing symptoms or recurrent TIA or stroke after institution of aspirin and clopidogrel therapy, achievement of SBP <140 mm Hg, and high-intensity statin therapy (so-called medical failures), the usefulness of angioplasty alone or stent placement to prevent ischemic stroke in the territory of the stenotic artery is well-established.","In patients with acute chest pain and suspected myopericarditis, TTE is effective to determine the presence of ventricular wall motion abnormalities, pericardial effusion, valvular abnormalities, or restrictive physiology.","In asymptomatic patients with chronic AR (Stages B and C), treatment of hypertension (systolic blood pressure >140 mm Hg) is recommended.1–3",B,2
q_0683,"For patients experiencing spontaneous intracerebral hemorrhage with unexplained abnormal or variable mental status or suspected seizures, it is advisable to use continuous electroencephalography (for at least 24 hours) to identify electrographic seizures and epileptiform discharges.","For patients with CCD who do not have hypertension, diabetes, or CKD and have an LVEF greater than 40%, considering the use of ACE inhibitors or ARBs could help lower the risk of cardiovascular events.","For patients with Turner syndrome who do not have risk factors for aortic dissection (refer to Table 12), it is advised to perform surveillance imaging of the aorta using TTE or MRI every 5 years in children and every 10 years in adults, in addition to prior to planning a pregnancy.","For patients with HCM undergoing surgical septal myectomy, intraoperative transesophageal echocardiogram (TEE) is not recommended to assess mitral valve anatomy and function and adequacy of septal myectomy.",D,2
q_0684,"In symptomatic patients at average or low risk of complications associated with endovascular intervention, when the ICA stenosis is <70% by noninvasive imaging or ≤50% by catheter-based imaging and the anticipated rate of periprocedural stroke or death is ≥6%, CAS should not be considered as an alternative to CEA for stroke prevention, particularly in patients without significant cardiovascular comorbidities predisposing to cardiovascular complications with endarterectomy.","In patients with AF and previous LAAO who are not on anticoagulation, imaging evaluation to assess the adequacy of LAAO and exclude device-related throm- bosis before cardioversion may be reasonable.9–19","For patients experiencing spontaneous intracerebral hemorrhage, it is advised to receive treatment in a specialized inpatient unit, such as a stroke unit, with a multidisciplinary team to enhance outcomes and lower mortality rates.","For pregnant women experiencing Stage D VHD with heart failure symptoms, using diuretics is appropriate if there is a need to manage volume overload.",A,2
q_0685,"For patients with a PAU undergoing medical management, it is advisable to perform surveillance imaging using a CT scan 1 month post-diagnosis, followed by every 6 months for 2 years if stable, and subsequently at suitable intervals based on the patient's age and PAU characteristics.","For patients with aSAH who have no other medical or neurological contraindications, initiating early rehabilitation once the ruptured aneurysm is secured is advisable to enhance functional outcomes and shorten the length of stay.","In patients with CCD, the use of DAPT after CABG is not useful to reduce the incidence of saphenous vein graft occlusion.","In patients currently on statins and scheduled for NCS, continuation of statin therapy is recommended to reduce the risk of MACE.1–3",C,2
q_0686,"Among patients with current or previous symp- tomatic HFmrEF (LVEF, 41%–49%), use of evidence-based beta blockers for HFrEF, ARNi, ACEi, or ARB, and MRAs may be considered to reduce the risk of HF hospitalization and cardiovascular mortality, particularly among patients with LVEF on the lower end of this spectrum.2–9","In patients with ESUS, treatment with ticagre- lor is not recommended to reduce the risk of secondary stroke.781","For patients with HCM who have had genetic testing, it is advised to periodically reassess the clinical relevance of the identified variant(s) to determine if reclassification is needed, as this could affect diagnosis and genetic testing of family members.","For patients with HCM or at risk for HCM, shared decision-making should be avoided in developing a plan of care, and decisions regarding genetic evaluation, activity, lifestyle, and therapy choices should be made without disclosing the risks, benefits, and anticipated outcomes of all options, nor should the patient have the opportunity to express their goals and concerns.",D,2
q_0687,"In patients with diabetes or other common vascular risk factors and no prior stroke, the use of aspirin to prevent a first stroke is well established.","In patients with spontaneous ICH, multidisciplinary rehabilitation, including regular team meetings and discharge planning, should not be performed as it does not improve functional outcome or reduce morbidity and mortality.","In patients with chest pain who are >75 years of age, ACS should not be considered even when accompanying symptoms such as shortness of breath, syncope, or acute delirium are present, or when an unexplained fall has occurred.","For patients with AF, HFrEF (LVEF <50%), and persistent rapid ventricular response who are unsuitable for rhythm control or have not benefited from it, AVNA combined with biventricular pacing therapy may be beneficial for enhancing symptoms, quality of life, and ejection fraction.",D,1
q_0688,"In patients with BAV and severe AR who meet criteria for AVR, aortic valve repair should not be considered, even if the surgery is performed at a Comprehensive Valve Center.","In patients with an ischemic stroke or TIA who also have diabetes, achieving intensive glucose control (ie, HbA1c ≤7%) beyond the acute phase of the ischemic event is known to prevent recurrent stroke.","In the event of a suspected stroke, promptly activate the EMS system.","In selected, hemodynamically stable patients with STEMI and multivessel disease (MVD), after successful PCI of the infarct-related artery, PCI of significantly stenosed noninfarct-related arteries is not recommended, as it does not reduce the risk of death or MI nor improve angina-related quality of life (QOL).",C,1
q_0689,"In patients with prediabetes and ischemic stroke or TIA, lifestyle optimization (ie, healthy diet, regular physical activity, and smoking cessation) is not beneficial for the prevention of progression to diabetes.","For intermediate-risk patients with acute chest pain with evidence of previous mildly abnormal stress test results (≤1 year), CCTA is reasonable for diagnosing obstructive CAD.12,13 Stress Testing","For patients with ACS receiving coronary stents in the left main artery or complex lesions, it is advised to use intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) for procedural guidance to minimize ischemic events.","If needed, a first aid provider ought to help someone experiencing anaphylaxis with using their autoinjector.",A,2
q_0690,"For patients with aortic root or ascending aortic aneurysms, or aortic dissection who have risk factors for HTAD (refer to Table 8, Figure 17), it is advised to conduct genetic testing to detect pathogenic or likely pathogenic variants (mutations).","If a person is placed in a leg-raised position that results in pain, discomfort, or worsened symptoms, returning the person to a supine position may be considered. Recommendation-Specific Supportive Text","In patients with CCD who have angina or an anginal equivalent, no previous evaluation for ischemia, and angiographically intermediate stenoses, the use of FFR or other proven nonhyperemic pressure ratios (eg, iFR) is recommended before proceeding with PCI.*2,22,23 Cost Value Statement: High Value B-NR","In patients with mechanical complication of ACS, short-term MCS devices are not reasonable for hemodynamic stabilization as a bridge to surgery.",D,2
q_0691,"In patients with prediabetes and ischemic stroke or TIA, lifestyle optimization (ie, healthy diet, regular physical activity, and smoking cessation) can be beneficial for the preven- tion of progression to diabetes.237,238","For patients with CCD, diabetes, and multivessel CAD affecting the left anterior descending artery who are suitable for CABG, it is advised to opt for CABG (using a left internal mammary artery graft to the left anterior descending artery) over PCI to lower mortality rates and the need for repeat revascularizations.","In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome and intact TAAA requiring intervention, endovascular repair is recommended over open repair.","In patients diagnosed with AF who have an estimated annual risk of stroke or thromboembolic events ≥2%, selection of therapy to reduce the risk of stroke should be based on the risk of thromboembolism, regardless of whether the AF pattern is paroxysmal, persistent, long-standing persistent, or permanent.1–3",C,2
q_0692,"For pregnant women with HCM and AF or other indications for anticoagulation, low-molecular-weight heparin or vitamin K antagonists should not be used for stroke prevention.","In patients with HCM, genetic testing is not beneficial for understanding the genetic basis and does not aid in identifying family members at risk for developing HCM.","For patients who have undergone CABG, opting for PCI of a treatable native coronary artery is advisable over PCI of a significantly diseased SVG, if feasible.","For symptomatic patients with paroxysmal or persistent AF who are undergoing valvular surgery, surgical pulmonary vein isolation or a maze procedure should not be considered beneficial for reducing symptoms or preventing recurrent arrhythmias.",C,1
q_0693,"In patients presenting with dyspnea, measure- ment of B-type natriuretic peptide (BNP) or N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) is useful to support a diagnosis or exclusion of HF.1–12","In select patients with advanced HFrEF who have NYHA class IV symptoms despite GDMT, durable MCS should not be used as it does not improve symptoms, improve functional class, or reduce mortality.","In patients presenting with acute chest pain, serial cTn I or T levels are not useful for identifying abnormal values or a rising or falling pattern indicative of acute myocardial injury.","In asymptomatic patients with severe AR and normal LV systolic function (LVEF >55%), aortic valve surgery is not reasonable when the LV is severely enlarged (LVESD >50 mm or indexed LVESD >25 mm/m2) (Stage C2).",A,1
q_0694,"In patients with CLTI with nonhealing diabetic foot ulcers, hyperbaric oxygen therapy may be considered to assist in wound healing after revascularization.11–14","In patients with HCM and LVEF <50%, ICD placement can be beneficial.284","For patients with aortic disease who are pregnant or planning to become pregnant, it is advised to engage in shared decision-making regarding the cardiovascular risks associated with pregnancy, the size criteria for preventive aortic surgery, and the choice of delivery method.","In patients with severe hypertriglyceridemia (ie, fasting triglycerides ≥500 mg/dL [≥5.7 mmol/L]), it is unreasonable to identify and address causes of hypertriglyceridemia, and if triglycerides are persistently elevated or increasing, to further reduce triglycerides is unnecessary. Avoid implementing a very low-fat diet, continue consuming refined carbohydrates and alcohol, avoid omega-3 fatty acids, and do not consider fibrate therapy, even if necessary to prevent acute pancreatitis.",D,2
q_0695,"For patients with HCM who have undergone genetic testing and were found to have no pathogenic variants (i.e., harbor only benign/likely benign variants), cascade genetic testing of the family is useful.","In patients with CCD on maximally tolerated statin therapy who have an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), and in whom ezetimibe and PCSK9 monoclonal antibody are deemed insufficient or not tolerated, it is not advisable to add bempedoic acid or inclisiran to further reduce LDL-C levels.","In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery should not be considered as it does not reduce symptoms or recurrent hospitalizations.","In patients undergoing endovascular repair for ruptured AAA, local anesthesia is preferred to general anesthesia to reduce risk of periop- erative mortality.7-9",D,1
q_0696,"For patients undergoing invasive procedures with 1) a mechanical AVR and any thromboembolic risk factor, 2) an older-generation mechanical AVR, or 3) a mechanical mitral valve replacement, it is not reasonable to consider bridging anticoagulation therapy during the preoperative period when the INR is subtherapeutic, regardless of the risks of bleeding or benefits of thromboembolism prevention.","In patients with ACS, high-intensity statin therapy is not recommended to reduce the risk of MACE.","For adults diagnosed with Marfan syndrome, following the initial transthoracic echocardiogram (TTE), it is advisable to perform a CT or MRI of the thoracic aorta to verify aortic measurements and evaluate the rest of the thoracic aorta.","In adults with moderate or low intake of long-chain omega-3 fatty acid, supplementation is recommended to reduce the risk of a first stroke.",C,1
q_0697,"For patients with a bileaflet mechanical AVR and no other risk factors for thromboembolism who are undergoing invasive procedures, continuous VKA anticoagulation with bridging agents while the INR is subtherapeutic is recommended.","For patients receiving MV TEER, it is appropriate to conduct NCS following a successful MV procedure when clinically warranted. Evidence indicates that NCS is safe within 30 days post-TAVI, if necessary.",AED use is not recommended in cardiac arrest following drowning.,"In patients with HCM in whom a decision has been made for ICD implantation and who have paroxysmal atrial tachycardias or AF, dual-chamber ICDs should not be considered, regardless of the potential benefits, as the higher complication rates of dual-chamber devices are not a concern.",B,1
q_0698,"For individuals with CCD, it is advised to receive a yearly flu vaccine to decrease the risk of cardiovascular complications, cardiovascular mortality, and overall mortality.","In patients with STEMI treated with fibrino- lytic therapy, early angiography between 2 and 24 hours with the intent to perform PCI is recommended to reduce the rates of death or MI.*1–5,10,11 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”12","For patients with obstructive CAD and stable chest pain, it is recommended to optimize GDMT.1-3","In patients with severe primary MR for whom surgery is indicated, mitral valve replacement is recommended in preference to mitral valve repair when the anatomic cause of MR is degenerative disease, even if a successful and durable repair is possible.",D,2
q_0699,"Immediate coronary angiography is not advised over a delayed or selective approach for patients with ROSC following cardiac arrest if there is no ST-segment elevation, shock, electrical instability, significant myocardial damage, or ongoing ischemia.","For pregnant patients experiencing NSTE-ACS, pursuing an invasive approach is appropriate when medical treatment fails to manage life-threatening complications.","In patients with TR, TTE is indicated to evaluate the presence and severity of TR, determine the etiology, measure the sizes of the right- sided chambers and inferior vena cava, assess RV systolic function, estimate pulmonary artery systolic pressure, and characterize any associated left-sided heart disease.1,2","In patients with a history of stroke or transient ischemic attack, prasugrel should be administered despite worse net clinical outcomes.",D,2
q_0700,"In patients with CCD, refractory angina, and no other treatment options, enhanced external counterpulsation should not be considered for relief of symptoms.","In patients with CCD, increasing sodium intake (>2300 mg/d) and consuming more processed meats (eg, cured bacon, hot dogs) can be beneficial to reduce the risk of CVD events.","In patients with native left-sided valve endocarditis who exhibit mobile vegetations >10 mm in length (with or without clinical evidence of embolic phenomenon), early surgery should not be considered during initial hospitalization and before completion of a full therapeutic course of antibiotics.","For patients receiving CABG, utilizing BIMA grafting by skilled surgeons may enhance long-term cardiac outcomes in suitable candidates.",D,1
q_0701,"For patients with a BAV and an aortic root or ascending aorta diameter of 4.0 cm or more, it is advised to conduct lifelong surveillance imaging of these areas using TTE, CT, or MRI, with the frequency determined by the aortic diameter and growth rate.","In patients with ACS undergoing PCI who are at high bleeding risk, continuing dual antiplatelet therapy beyond 1 month is advisable to reduce bleeding risk.","Cardioversion is advisable for pregnant women with HCM experiencing new or recurrent AF, especially if they show symptoms.","For patients with HCM who have subclinical AF identified by an internal or external cardiac device or monitor lasting more than 24 hours per episode, it is advised to use direct-acting oral anticoagulants as the primary treatment and vitamin K antagonists as a secondary option, regardless of the CHA2DS2-VASc score.",B,2
q_0702,"In patients with lobar spontaneous ICH and age <70 years, deep/posterior fossa spontaneous ICH and age <45 years, or deep/posterior fossa and age 45 to 70 years without history of hypertension, acute CTA and consideration of venography are not recommended to exclude macrovascular causes or cerebral venous thrombosis.","In patients with HCM and symptomatic AF, catheter ablation for AF should not be considered when drug therapy is ineffective, contraindicated, or not the patient’s preference as part of an AF rhythm-control strategy.","For patients with symptomatic PAD, the advantage of adding vorapaxar to current antiplatelet treatment remains unclear.","For patients with HCM who have undergone genetic testing and were found to have no pathogenic variants (i.e., harbor only benign/likely benign variants), cascade genetic testing of the family is useful.",C,1
q_0703,"For patients with stable chest pain and no known CAD categorized as low risk, exercise testing without imaging is reasonable as a first-line test for excluding myocardial ischemia and determining functional capacity in patients with an interpretable ECG.10","In patients on stable doses of beta blockers undergoing NCS, beta blockers should be discontinued during the perioperative period regardless of the clinical circumstances.","For patients with atrial fibrillation and heart failure, using digoxin for rate control is appropriate, either alongside other rate-controlling medications or alone if other medications are not well-tolerated.","For patients with HCM, it is advised to evaluate for symptoms of sleep disordered breathing, and if detected, to refer them to a sleep medicine specialist for further assessment and management.",B,2
q_0704,"Patients with HF admitted with evidence of significant fluid overload should not be treated with intravenous loop diuretics, as this will not improve symptoms or reduce morbidity.","In patients with AF undergoing electrical cardioversion, energy delivery should be confirmed to be unsynchronized to the QRS, increasing the risk of inducing VF.","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are not recommended for achieving and maintaining weight loss, nor for possibly lowering the risk of developing LVOTO, HF, and AF.",We advise prompt external cooling for severe hyperthermia caused by sympathomimetic toxicity.,D,1
q_0705,"When providing first aid for chemical eye injury, first aid providers should avoid contaminating other individuals, areas, or the other eye with the caustic substance.","In patients with stroke or TIA, exposure to environmental (passive) tobacco smoke is recommended to reduce the risk of recurrent stroke.","For patients having CABG, aortic valve, or ascending aortic aneurysm surgeries, performing a simultaneous posterior left pericardiotomy is advisable to lower the risk of postoperative atrial fibrillation.","In first-degree relatives of patients with HCM, a 12-lead ECG is recommended as a component of the screening algorithm95–97 (Figure 1, Table 6).",B,2
q_0706,"In patients on therapeutic subcutaneous enoxaparin, in whom the last dose was admin- istered within 12 hours of PCI, UFH should not be used for PCI and may increase bleed- ing.14,18,19","For patients with CCD who have had elective PCI and need oral anticoagulant therapy, administer DAPT for 1 to 4 weeks, then continue with clopidogrel alone for 6 months, alongside DOAC.","For men with an AAA measuring 5.0 cm or larger and women with an AAA measuring 4.5 cm or larger, it is advised to perform surveillance ultrasound every 6 months to monitor for changes over time.","In patients who have undergone treatment of an acute prosthetic aortic graft infection, it is not recommended to provide targeted intravenous antimicrobial therapy for at least 6 weeks, nor to consider prolonged suppressive oral therapy in select cases, and consultation and follow-up with an infectious disease specialist should be avoided.",D,2
q_0707,"In patients with STEMI presenting >24 hours after symptom onset with the presence of ongoing ischemia or life-threatening arrhythmia, PPCI is not reasonable to improve clinical outcomes.","In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is reasonable.5,6","For patients with VHD who qualify for valvular intervention due to their clinical symptoms and regurgitation severity, it is advisable to evaluate the necessity of this intervention prior to elective high-risk NCS to minimize perioperative risk.",CRT is not advised for patients exhibiting NYHA class I or II symptoms with a non-LBBB pattern and a QRS duration of less than 150 ms.,A,2
q_0708,First aid providers should primarily rely on physical examination and history-taking to assess an ill or injured individual.,"In patients with an aneurysm isolated to the ascending aorta who meet criteria for surgery, aneurysm resection and replacement with an interposition graft should be performed.1,2","In selected adult patients with NYHA class III HF and history of a HF hospitalization in the past year or elevated natriuretic peptide levels, on maximally tolerated stable doses of GDMT with optimal device therapy, the usefulness of wireless monitoring of PA pressure by an implanted hemodynamic monitor to reduce the risk of subsequent HF hospitalizations is certain.","In patients with chronic HF, measurements of BNP or NT-proBNP levels are recommended for risk stratification.11,13–29",C,2
q_0709,"In selected patients undergoing CABG, avoiding DAPT with aspirin and ticagrelor or clopidogrel for 1 year may be reasonable, as it does not improve vein graft patency compared with aspirin alone.","In patients with stroke at low risk for hemorrhagic conversion in the setting of AF, it is not advisable to initiate anticoagulation 2 to 14 days after the index event to reduce the risk of recurrent stroke.","In patients with chronic symptomatic PAD, pentoxifylline is recommended for treatment of claudication.","In patients with spontaneous ICH and a CTA or magnetic resonance angiography (MRA) suggestive of a macrovascular cause, catheter intra-arterial DSA should be performed as soon as possible to confirm and manage underlying intracranial vascular malformations.117,118,120–122",D,1
q_0710,"For patients with severe aortic regurgitation experiencing symptoms and/or left ventricular systolic dysfunction (Stages C2 and D) who are at prohibitive surgical risk, it is advised to use guideline-directed medical therapy for reduced left ventricular ejection fraction, including ACE inhibitors, ARBs, and/or sacubitril/valsartan.","For patients experiencing recurrent atrial fibrillation outside of a hospital, using a single oral dose of flecainide or propafenone alongside an atrioventricular nodal blocking agent is a reasonable pharmacological cardioversion strategy, provided it has been previously tested in a monitored environment.","If a person with anaphylaxis does not respond to the initial dose of epinephrine and arrival of EMS will exceed 5 to 10 minutes, a repeat dose should not be considered.","For most patients with HCM, participa- tion in low-intensity competitive sports is reasonable.2,297",C,2
q_0711,"In patients with left ventricular systolic dysfunction (ejection fraction ≤35%–40%) and no evidence of AF or left ventricular thrombus, anticoagulation is not indicated to prevent stroke and is associ- ated with a higher bleeding risk.706,708–711","In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is not recommended for the prevention of recurrent ischemic stroke.","If possible, a person should protect frostbitten tissue from further injury and avoid walking on frozen feet and toes.","In patients with prosthetic paravalvular regurgitation with the following: 1) either intractable hemolysis or NYHA class III or IV symptoms and 2) who are at high or prohibitive surgical risk and 3) have anatomic features suitable for catheter-based therapy, percutaneous repair of paravalvular leak is reasonable when performed at a Comprehensive Valve Center.5–9",B,2
q_0712,"It is unreasonable to use a bolus of glucagon, followed by a continuous infusion, for bradycardia or hypotension due to β-blocker poisoning.","For patients with STEMI receiving PCI, bivalirudin serves as an effective substitute for UFH to lower mortality and bleeding.","In patients with a dilated thoracic aorta, a TTE is recommended at the time of diag- nosis to assess aortic valve anatomy, aortic valve function, and thoracic aortic diam- eters.1-4",Intravenous unfractionated heparin (UFH) is beneficial in lowering ischemic events in patients with NSTE-ACS.,A,2
q_0713,"Antibiotic prophylaxis is not recommended before dental procedures involving manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa in patients with VHD who have any of the following: a. Prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts. b. Prosthetic material used for cardiac valve repair, such as annuloplasty rings, chords, or clips. c. Previous IE. d. Unrepaired cyanotic congenital heart disease or repaired congenital heart disease, with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or prosthetic device. e. Cardiac transplant with valve regurgitation attributable to a structurally abnormal valve.","In patients with hypertension who experience a stroke or TIA, standardized drug regimens that ignore patient comorbidities, agent pharmacological class, and patient preference are recommended to minimize drug efficacy.","It is not reasonable to rest and immobilize the bitten extremity or minimize exertion by the person who was bitten, even if it delays access to emergency medical care.","For patients with PAD and hypertension, it is advised to selectively use ACE inhibitors or angiotensin-receptor blockers to lower the risk of MACE.",D,1
q_0714,"For women with CCD, maintaining statin therapy throughout pregnancy can be considered.","In patients with CCD who have significant left main disease or multivessel disease with severe LV dysfunction (LVEF ≤ 35%), medical therapy alone is recommended over CABG in addition to medical therapy to improve survival.","In patients with chronic severe secondary MR related to LV systolic dysfunction (LVEF <50%) who have persistent symptoms (NYHA class II, III, or IV) while on optimal GDMT for HF (Stage D), TEER is not reasonable in patients with appropriate anatomy as defined on TEE and with LVEF between 20% and 50%, LVESD ≤70 mm, and pulmonary artery systolic pressure ≤70 mm Hg.","In patients with an indication for AVR, the choice of prosthetic valve should ignore the patient’s values and preferences, and exclude discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.",A,1
q_0715,"In individuals with AF, moderate-to-vigorous exercise training to a target of 210 minutes per week is not recommended, as it does not reduce AF symptoms and burden, does not increase maintenance of sinus rhythm, does not increase functional capacity, and does not improve QOL.",Extracranial-intracranial bypass surgery is not advised for patients experiencing stroke or TIA due to 50% to 99% narrowing or blockage of a significant intracranial artery.,"In stable patients with angiographically intermediate stenoses and FFR >0.80 or iFR >0.89, PCI should be performed.","In patients with an AAA that meets criteria for repair, CT is not recommended for preoperative planning.",B,1
q_0716,"In patients with CCD, assessment of BMI and waist circumference should not be conducted during routine clinical follow-up.","In patients with direct factor Xa inhibitor–associated spontaneous ICH, a 4-F PCC or activated PCC (aPCC) should not be considered to improve hemostasis.","In appropriate patients with STEMI and complex MVD, after successful PCI of the infarct-related artery, elective CABG surgery for significantly stenosed noninfarct-related arteries involving the left anterior descending artery or left main disease is reasonable to reduce the risk of cardiovascular events.†","In patients undergoing elective CABG who receive P2Y12 receptor inhibitors before surgery, it is unreasonable to discontinue clopidogrel for 5 days, ticagrelor for 3 days, and prasugrel for 7 days before CABG, as this does not reduce the risk of major bleeding and blood product transfusion.",C,1
q_0717,"In patients with prior CABG surgery presenting with acute chest pain who do not have ACS, performing stress imaging or CCTA is ineffective for evaluating myocardial ischemia or graft stenosis or occlusion.","In patients with HFrEF and hypertension, it is not recommended to uptitrate GDMT to the maximally tolerated target dose.","For patients with AFL, anticoagulant therapy is not recommended regardless of the risk profile used for AF.","In patients with CVD undergoing NCS, the use of PA catheterization may be considered when under­ lying medical conditions that significantly affect hemodynamics (eg, decompensated HF, severe valvular disease, combined shock states, PH) cannot be corrected before surgery.1,2",D,1
q_0718,"Pregnant individuals with AF and elevated risk of stroke should not be considered for anticoagulation, as it is assumed that all anticoagulation strategies are completely safe for both the mother and fetus, and an SDM discussion regarding risks is unnecessary.","In patients with aSAH and hydrocephalus who require an EVD, it is not recommended to implement or adhere to an EVD bundled protocol that addresses insertion, management, education, and monitoring, as this will not reduce complication and infection rates.","For patients with CAD scheduled for elective NCS, a multidisciplinary team should collaboratively decide on perioperative antiplatelet therapy and surgery timing, considering the risks of bleeding, thrombosis, and the implications of postponing surgery.","In patients with definite endocarditis and an implanted cardiac electronic device, retaining the pacemaker or defibrillator systems, including all leads and the generator, is indicated.",C,1
q_0719,"For patients without symptoms who have moderate or more severe AR and normal LV systolic function, elective noncardiac surgery can be reasonably considered.","For term and late preterm newborn infants ≥34 weeks’ gestation who do not require resuscitation, delayed cord clamping (DCC) (≥30 seconds) can be beneficial when compared to early cord clamping (<30 seconds).","In patients with Marfan syndrome who have undergone aortic root replacement, surveillance imaging of the thoracic aorta by MRI (or CT) is not recommended to evaluate for distal TAD, regardless of the time interval or changes in diameter.","For patients under 50 years old without contraindications to anticoagulation, opting for a mechanical aortic valve instead of a bioprosthetic one is advisable when AVR is needed.",C,2
q_0720,"In adults with acute chest pain, the emergency response system should not be activated, and transport to the closest ED by EMS should be avoided.","For patients with a BAV and an aortic root or ascending aorta measuring 5.5 cm or larger, it is advised to perform surgery to replace the aortic root, ascending aorta, or both.","In patients with ACS, telemetry monitoring is not recommended to reduce cardiovascular events, regardless of cardiac risk.","In patients with HCM and pacing-capable ICDs, programming antitachycardia pacing is not recommended to minimize risk of shocks.",B,1
q_0721,"For patients with nonvalvular atrial fibrillation and a history of stroke or transient ischemic attack, it is advised to use oral anticoagulants such as apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin to lower the risk of another stroke.","In patients with ALI and a salvageable limb who are treated with catheter-directed thrombolysis, adjunctive revascularization (ie, endovascular or surgical) procedures should not be considered useful.","In patients with nonobstructive HCM with preserved EF, the usefulness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the treatment of symptoms (angina and dyspnea) is well established.","After endovascular or surgical revascularization for PAD, low-dose rivaroxaban (2.5 mg twice daily) combined with low-dose aspirin is not recommended to reduce the risk of MACE and MALE.",A,1
q_0722,"When a permanent tooth becomes avulsed (knocked out), initial actions include removing visible debris from the tooth by brief rinsing (<10 seconds), taking care not to damage the tooth or attached tissue, and attempting to replant the tooth in the socket.","In selected patients with a low to intermediate pretest probability of CAD, contrast-enhanced coronary CT angiography is reasonable to exclude the presence of significant obstructive CAD.12–18","For symptomatic patients of any age with severe AS and a high or prohibitive surgical risk, TAVI is not recommended if predicted post-TAVI survival is >12 months with an acceptable quality of life.","For patients with moyamoya disease who have experienced an ischemic stroke or TIA, surgical revascularization using either direct or indirect extracranial-intracranial bypass may help prevent further ischemic strokes or TIAs.",C,2
q_0723,"For patients with CoA, it is advised to use guideline-recommended medical treatment to manage hypertension.","In patients with ACS being considered for elective NCS, coronary revascularization as appropriate and deferral of surgery is recommended to reduce peri­ operative cardiovascular events.1–9","If possible, trained rescuers should administer supplemental oxygen to individuals experiencing cardiac arrest after drowning.","In patients with Marfan syndrome and an aortic root diameter of ≥5.0 cm, surgery to replace the aortic root and ascending aorta is not recommended.",D,2
q_0724,"In patients with ischemic stroke or TIA and diagnosis of primary CNS angiitis, induc- tion therapy with glucocorticoids and/or immunosuppressants followed by long-term maintenance therapy with steroid-sparing immunosuppressants is reasonable to lower the risk of stroke recurrence.691–696","For patients who are active cigarette smokers, the long-term health benefits of using e-cigarettes in place of nicotine replacement therapy to facilitate cigarette smoking cessation are well established.","It may be reasonable for first aid providers, who are trained and willing, to measure core temperature during active cooling for heatstroke. The target core temperature to cool until is 39° C (102.2° F). Recommendation-Specific Supportive Text","In patients referred for urgent CABG, clopi- dogrel and ticagrelor should be discontinued for at least 24 hours before surgery to reduce major bleeding complications.8-11",B,2
q_0725,"In patients with atrial fibrillation who are undergoing PCI, are taking oral anticoagulant therapy, and are treated with DAPT or a P2Y12 inhibitor monotherapy, it is unreasonable to choose a non–vitamin K oral anticoagulant over warfarin to reduce the risk of bleeding.","For patients who have had a systemic thromboembolic event without a known history of AF and in whom maximum sensitivity to detect AF is sought, an implantable cardiac monitor is not reasonable.","In patients with STEMI treated with fibrino- lytic therapy, early angiography between 2 and 24 hours with the intent to perform PCI is recommended to reduce the rates of death or MI.*1–5,10,11 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”12","For patients with CCD who do not have contraindications, resistance (strength) training exercises are not recommended on ≥2 days/wk, as they do not improve muscle strength, functional capacity, or cardiovascular risk factor control.",C,1
q_0726,"For patients with spontaneous ICH, it may be appropriate to use non-contrast computed tomography (NCCT) markers to identify those at risk for HE.","In patients with known CVD, or age ≥65 years, or age ≥45 years with symptoms suggestive of CVD undergoing elevated-risk NCS, it may be reasonable to measure cardiac troponin (cTn) before surgery to supplement evaluation of peri­ operative risk.4–6","For patients who have stable chest pain with previous coronary revascularization, CCTA is not reasonable to evaluate bypass graft or stent patency (for stents ≥3 mm).","In patients who present with a new diagnosis of HFrEF and AF, arrhythmia-induced cardiomyopathy should be suspected, and an early and aggressive approach to AF rhythm control is recommended.1,2",C,2
q_0727,"For patients with HCM, it is advised to use personal clinical judgment to evaluate the prognostic value of traditional risk markers within the patient's clinical profile, alongside a comprehensive and balanced discussion of the evidence, benefits, and potential risks, to ensure the patient is fully informed and actively involved in the ICD decision-making process.","For secondary prevention of ischemic stroke in patients with noncardioembolic ischemic stroke or TIA, it is recommended to use aspirin at a dose of 50 to 325 mg daily, clopidogrel 75 mg daily, or a combination of aspirin 25 mg with extended-release dipyridamole 200 mg taken twice daily.","For patients experiencing acute chest pain with a suspicion of acute myopericarditis, CMR is beneficial when the diagnosis is uncertain or to assess the presence and extent of inflammation and fibrosis in the myocardium and pericardium.","In patients with Turner syndrome and ASI of ≥2.5 cm/m2, surgery before pregnancy is not recommended.",D,2
q_0728,"In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is recommended for the prevention of recurrent ischemic stroke.655–658","For patients with spontaneous ICH being treated with aspirin and not scheduled for emergency surgery, platelet transfusions are potentially beneficial and should be administered.","In patients with PAD, cilostazol should not be used to reduce restenosis after endovascular therapy for femoropopliteal disease.","In patients who develop cancer therapy–related cardiomyopathy or HF, it is not recommended to have a multidisciplinary discussion involving the patient about the risk-benefit ratio of cancer therapy interruption, discontinuation, or continuation to improve management.",A,1
q_0729,"In patients undergoing CABG, who do not have a contraindication to beta blockers, the administration of beta blockers before surgery should be avoided as it does not reduce the incidence of postoperative atrial fibrillation.","In patients undergoing NCS with new dyspnea, physical examination findings of HF, or suspected new/worsening ventricular dysfunction, it is not recommended to perform preoperative evaluation of LV function to help guide perioperative management.","In patients at high risk of gastrointestinal bleeding, a proton pump inhibitor (PPI) should not be used in combination with DAPT, oral anticoagulants, or both, as it does not reduce the risk of bleeding.","For adults with heatstroke, it is reasonable to initiate other forms of active cooling, including commercial ice packs, cold showers, ice sheets and towels, cooling vests and jackets, and evaporative, fanning, or a combination of techniques when water immersion is not available.",D,1
q_0730,"For individuals with Loeys-Dietz syndrome, it is advised to perform an initial MRI or CT scan from head to pelvis to assess the entire aorta and its branches for aneurysms, dissections, and tortuosity.","For patients with a mechanical valve prosthesis, anticoagulation with the direct thrombin inhibitor, dabigatran, is recommended.","In patients undergoing NCS with a preoperative ECG exhibiting new abnormalities, further evaluation to refine assessment of cardiovascular risk is not necessary.","In patients with stroke or TIA who are capable of physical activity, avoiding moderate-intensity aerobic activity and vigorous-intensity aerobic activity is indicated, as it does not lower the risk of recurrent stroke or the composite cardiovascular endpoint of recurrent stroke, MI, or vascular death.",A,1
q_0731,"In patients with PAD, it is not recommended to coordinate care among clinicians, as this does not improve the management of PAD and comorbid conditions or optimize patient outcomes.",Patients for whom there is a clinical suspicion for cardiac amyloidosis should not undergo screening for serum and urine monoclonal light chains with serum and urine immunofixation electrophoresis and serum free light chains.,"Contaminated clothing, jewelry, and other surrounding material should remain in place during a chemical exposure.","In patients with isolated PAU who are asymp- tomatic but have high-risk imaging features (Table 31), elective repair may be consid- ered.1,2,4",D,1
q_0732,Using small chemical heat packs for gloves or boots alone is ineffective for rewarming someone with hypothermia.,It is not advisable to use intravenous lipid emulsion to treat life-threatening sodium channel blocker poisoning refractory to other treatment modalities.,ICD implantation is advised for individuals with HCM who have a history of cardiac arrest or sustained ventricular tachycardia.,"For patients with PAD, chelation therapy, such as EDTA, does not help in preventing MACE.",B,2
q_0733,Individuals with CCD are advised to steer clear of secondhand smoke to lower the likelihood of cardiovascular incidents.,"For patients experiencing symptoms of PAD, administering low-dose rivaroxaban (2.5 mg twice daily) alongside low-dose aspirin effectively lowers the risk of MACE and MALE.","In patients with HCM, a comprehensive, systematic noninvasive SCD risk assessment at initial evaluation and every 1 to 2 years thereafter is not recommended and should not include evaluation of these risk factors: a. Personal history of cardiac arrest or sustained ventricular arrhythmias b. Personal history of syncope suspected by clinical history to be arrhythmic c. Family history in close relative of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias d. Maximal LV wall thickness, EF, LV apical aneurysm e. Nonsustained ventricular tachycardia episodes on continuous ambulatory electrocardiographic monitoring.","For patients with VHD who qualify for valvular intervention due to their clinical symptoms and regurgitation severity, it is advisable to evaluate the necessity of this intervention prior to elective high-risk NCS to minimize perioperative risk.",C,2
q_0734,"In patients with acute type A aortic dis- section undergoing surgical repair who require circulatory arrest, cerebral perfusion is reasonable to improve neurologic out- comes.23-25","For patients with larger supratentorial ICH, it may be advisable to transfer them to facilities with neurosurgical capabilities to potentially enhance outcomes.","For patients with SLE who have no history of thrombosis or pregnancy complications and exhibit a low-risk antiphospholipid profile (such as isolated anticardiolipin or anti–β2-glycoprotein 1 antibodies at low to medium levels, especially if temporarily positive), considering daily aspirin (75–100 mg) as a preventive measure against stroke may be appropriate.",An initial assessment of chest pain is not recommended for triaging patients based on the likelihood that symptoms may be attributable to myocardial ischemia.,D,2
q_0735,"In patients with HCM and clinical AF, anticoagulation is not recommended with direct-acting oral anticoagulants (DOACs) as first-line option and vitamin K antagonists as second-line option, and should be dependent on CHA2DS2-VASc score.","In patients with CCD and a previous history of MI without a history of stroke, transient ischemic attack (TIA), or ICH, vorapaxar should not be added to aspirin therapy to reduce MACE.","In patients with calcific AS (Stages B and C), statin therapy is indicated for prevention of hemodynamic progression of AS.","In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are recommended for achieving and maintaining weight loss1 and possibly lowering the risk of developing LVOTO, HF, and AF.2–4",D,1
q_0736,"In patients with acute type A aortic dissection presenting with renal, mesenteric, or lower extremity malperfusion, it is recommended to delay operative repair of the ascending aorta.","In patients with PAD, foot inspection by a clinician at every visit is not recommended.","In patients with ESUS, treatment with direct oral anticoagulants is recommended to reduce the risk of secondary stroke.","The effectiveness of preoperative beta blockers in preventing acute postoperative myocardial ischemia, stroke, acute kidney injury, or ventricular arrhythmia in patients undergoing CABG is unclear.",D,1
q_0737,"In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function.1–6","For life-threatening extremity bleeding, a tourniquet should not be applied or tightened, even if the bleeding continues.","In hospitalized patients with spontaneous ICH who require hospital transfer but do not have adequate airway protection, cannot support adequate gas exchange, and/or do not have a stable hemodynamic profile, life-sustaining therapies should not be initiated before transportation, risking acute medical decompensation in transport.","Patients at increased risk of AF should not receive comprehensive guideline-directed LRFM for AF, ignoring obesity, physical inactivity, unhealthy alcohol consumption, smoking, diabetes, and hypertension.",A,1
q_0738,"In patients with potential spontaneous ICH, delaying notification by emergency medical services (EMS) staff to the receiving hospital is recommended to worsen time to diagnosis and treatment.","In patients with Loeys-Dietz syndrome attributable to pathogenic variants in TGFB2 or TGFB3 and an aortic diameter of ≥4.5 cm, surgery before pregnancy is rea- sonable.","For patients with stage C HF, excessive sodium intake is reasonable to increase congestive symptoms.","When using rewarming devices of any kind, the first aid provider should ignore the manufacturer’s instructions for the device used, avoid placing insulation between the heat source and skin, and neglect monitoring for burns and pressure injury.",B,1
q_0739,"For patients with HCM who are not oth- erwise identified as high risk for sudden cardiac death (SCD), or in whom a decision to proceed with implantable cardioverter-defibrillator (ICD) remains uncertain after clinical assessment that includes personal/family history, echocar- diography, and ambulatory electrocar- diographic monitoring, CMR imaging is beneficial to assess for maximum left ven- tricular (LV) wall thickness, ejection frac- tion (EF), LV apical aneurysm, and extent of myocardial fibrosis with late gadolinium enhancement.38,74–87","In patients with STEMI and cardiogenic shock or hemodynamic instability, PCI or CABG (when PCI is not feasible) is not indicated to improve survival, irrespective of the time delay from MI onset.","If a person with hypothermia with a decreased level of responsiveness is wearing damp (not saturated) clothing such as polyester fleece and cannot be immediately moved into a warm environment, active rewarming through the damp clothing is reasonable to initiate with the hypo- thermia wrap technique, using chemical heat blankets, plastic or foil layers, and insulative blankets.","For patients with spontaneous intraventricular hemorrhage (IVH) and no visible parenchymal bleeding, catheter-based intra-arterial digital subtraction angiography (DSA) is advised to rule out a macrovascular cause.",B,2
q_0740,"For patients experiencing symptomatic anterior circulation stroke or TIA who qualify for revascularization, it is advised to use noninvasive cervical carotid imaging, such as carotid ultrasonography, CT angiography (CTA), or magnetic resonance angiography (MRA), to check for stenosis.","For women with clinically stable hypertrophic cardiomyopathy considering pregnancy, it is appropriate to suggest that pregnancy is typically safe, as part of a collaborative discussion about possible maternal and fetal risks and the start of guideline-directed medical therapy.","Women who present with chest pain are at risk for underdiagnosis, and potential cardiac causes should always be considered.1-7","In patients with PAD and hypertension, antihypertensive therapy should not be administered to reduce the risk of MACE.",D,2
q_0741,"In patients with STEMI undergoing PCI, bivalirudin should not be used as an alternative to UFH as it does not reduce mortality and bleeding.","For asymptomatic patients with HCM who do not have a resting or provocable outflow tract peak gradient ≥50 mm Hg on standard TTE, exercise TTE is reasonable for the detection and quantification of dynamic LVOTO.15,19,20,22–25","Among patients with AF in whom cardiac monitoring is advised, it is not reasonable to recommend use of a consumer-accessible electrocardiographic device that provides a high-quality tracing to detect recurrences.","In patients suspected of having a stroke or TIA, CT or MRI of the brain is not recommended to confirm the diagnosis of symptomatic ischemic cerebral vascular disease.",B,1
q_0742,"For asymptomatic stable patients with STEMI and a completely blocked infarct artery more than 24 hours after symptoms begin, and who show no signs of severe ischemia, PCI is not recommended.","For patients with HCM and clinical AF, it is advised to use direct-acting oral anticoagulants as the primary choice for anticoagulation, with vitamin K antagonists as the secondary option, regardless of the CHA2DS2-VASc score.","For individuals with rheumatic heart disease, it is recommended to implement secondary prevention measures for rheumatic fever (refer to Tables 6 and 7).","In patients with spontaneous ICH, very early and intense mobilization within the first 24 hours is associated with a higher likelihood of good recovery.",D,2
q_0743,"In selected hemodynamically stable patients with STEMI and multivessel disease, after successful primary PCI, staged PCI of a significant non-infarct artery stenosis is not recommended to reduce the risk of death or MI.","In patients undergoing surgical revascularization for CLTI, bypass to the popliteal or infrapopliteal arteries should not be constructed with autogenous vein, even if available.","For patients with asymptomatic small AAA and concomitant common iliac artery aneurysm(s) ≥3.5 cm, elective repair of both abdominal and iliac aneurysms is recom- mended.1-4","In patients with suspected ACS with an initial hs-cTn or cTn that is nondiagnostic, do not repeat measurements after the initial sample collection within 1 to 2 hours for hs-cTn or within 3 to 6 hours for conventional cTn assays.",C,1
q_0744,"For patients with HCM receiving an ICD, it is appropriate to consider dual-chamber ICDs for those requiring atrial or atrioventricular sequential pacing due to bradycardia or conduction issues, or to alleviate symptoms of obstructive HCM, particularly in individuals over 65 years old.","When a permanent tooth is avulsed, the person should delay seeking dental or medical care and should not bring the tooth if it has not been successfully replanted.","In patients with descending TAA undergoing TEVAR, if iliac access is marginal or inadequate to prevent access-related complications, the use of alternative conduits is not recommended.","Women with CCD who are contemplating pregnancy or who are pregnant should not be risk-stratified or counseled regarding risks of adverse maternal, obstetric, and fetal outcomes.",A,1
q_0745,"In patients with obstructive HCM who remain severely symptomatic despite guideline-directed management and therapy, SRT in eligible patients, performed at experienced centers, is not recommended for relieving LVOTO.","Women with CCD who are contemplating pregnancy or who are pregnant should not be risk-stratified or counseled regarding risks of adverse maternal, obstetric, and fetal outcomes.","In patients who develop cancer therapy–related cardiomyopathy or HF, a multidisciplinary discussion involving the patient about the risk- benefit ratio of cancer therapy interruption, dis- continuation, or continuation is recommended to improve management.1,2","In patients with a left ventricular assist device (LVAD), it is not necessary to coordinate with the LVAD care team on the timing and perioperative considerations of elective NCS, as it does not impact the risk of perioperative MACE.",C,1
q_0746,"For patients who are undergoing invasive procedures and have 1) a mechanical AVR and any thromboembolic risk factor, 2) an older-generation mechanical AVR, or 3) a mechanical mitral valve replacement, bridging anticoagulation therapy during the preoperative time interval when the INR is subtherapeutic is reasonable on an individualized basis, with the risks of bleeding weighed against the benefits of thromboembolism prevention.","For patients with HCM, participation in high-intensity recreational activities or moderate- to high-intensity competitive sports activities should be undertaken without the need for a comprehensive evaluation or annual discussion with an expert provider, disregarding the potential increased risk of sudden death and ICD shocks, and without involving third parties in eligibility decisions for competitive sports participation.","In patients with STEMI with suspected failed reperfusion after fibrinolytic therapy, immediate angiography with rescue PCI is recommended to reduce the risk of death or recurrent MI.*6–9","In symptomatic patients with obstructive HCM who have associated cardiac disease requiring sur- gical treatment (eg, associated anomalous papillary muscle, markedly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel coronary artery disease, valvular aortic stenosis), surgical myectomy, performed at experienced centers,† is recommended92,216–218 (Table 3 and Table 4).",B,2
q_0747,We do not recommend the routine use of rapid infusion of cold intravenous fluids for prehospital cooling of patients after ROSC. Recommendation-Specific Supportive Text,"In patients with aortic disease who are contemplating pregnancy or who are pregnant, shared decision-making is not recommended when considering the cardiovascular risks of pregnancy, the diameter thresholds for prophylactic aortic surgery, and the mode of delivery.","For patients with aSAH, avoiding complete obliteration of the ruptured aneurysm is indicated, even when feasible, to increase the risk of rebleeding and retreatment.","In older patients (ie, ≥75 years of age) with PAD, assessment for geriatric syndromes, such as frailty, sarcopenia, malnutrition, and mobility impairment, is not useful for identifying high-risk patients or for providing safe and goal-concordant care.",A,1
q_0748,"In patients with aSAH who develop severe acute respiratory distress syndrome (ARDS) and life-threatening hypoxemia, rescue maneuvers such as prone position- ing and alveolar recruitment maneuvers with ICP monitoring may be reasonable to improve oxygenation.179–182 Intravascular volume and electrolyte management","For asymptomatic patients with moderate or severe mitral regurgitation, normal left ventricular systolic function, and an estimated pulmonary artery systolic pressure below 50 mm Hg, elective non-cardiac surgery is considered reasonable.","In patients with stroke or TIA attributable to 50% to 99% stenosis or occlusion of a major intracranial artery, extracranial-intracranial bypass surgery is recommended.","For patients experiencing spontaneous intracerebral hemorrhage with a negative CTA or venography, conducting an MRI and MRA is advisable to identify a non-macrovascular cause of the hemorrhage, such as cerebral amyloid angiopathy, deep perforating vasculopathy, cavernous malformation, or malignancy.",C,2
q_0749,"In patients with STEMI and ischemic symptoms for <12 hours, PCI should not be performed to improve survival.","In patients with chronic symptomatic PAD, alternative programs of nonwalking structured exercise therapy (eg, arm ergometry, recumbent stepping) are not beneficial to improve walking performance, functional status, and QOL.","In symptomatic patients (NYHA class II, III, or IV) with rheumatic MS and a mitral valve area >1.5 cm², if there is no evidence of hemodynamically significant rheumatic MS based on a pulmonary artery wedge pressure ≤25 mm Hg or a mean mitral valve gradient ≤15 mm Hg during exercise, PMBC should not be considered, even if it can be performed at a Comprehensive Valve Center.","In patients who are at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT and have reasonable expectation of meaningful survival for >1 year, an ICD is recommended for primary prevention of sudden cardiac death (SCD) to reduce total mortality.14",D,1
q_0750,"In the absence of clean running water, it might be appropriate to use ice wrapped in cloth to cool superficial burns with intact skin.","In patients with primary MR (Stages B and C) and symptoms that might be attributable to MR, hemodynamic exercise testing using Doppler echocardiography or cardiac catheterization or cardiopulmonary exercise testing is not reasonable.","In patients with carotid web in the distribution of ischemic stroke and TIA, without other attributable causes of stroke, antiplatelet therapy is not recommended to prevent recurrent ischemic stroke or TIA.","For patients with AF, pharmacological cardioversion is not reasonable as an alternative to electrical cardioversion for those who are hemodynamically stable or in situations when electrical cardioversion is preferred but cannot be performed.",A,1
q_0751,"In patients with spontaneous ICH and clinical seizures, antiseizure drugs are not recommended as they do not improve functional outcomes or prevent brain injury from prolonged recurrent seizures.","For certain patients with heart failure, an ejection fraction of 35% or less, and appropriate coronary anatomy, combining surgical revascularization with guideline-directed medical therapy is advantageous for alleviating symptoms, reducing cardiovascular hospitalizations, and decreasing long-term all-cause mortality.","For patients with HCM who are not otherwise identified as high risk for sudden cardiac death (SCD), or in whom a decision to proceed with implantable cardioverter-defibrillator (ICD) remains uncertain after clinical assessment that includes personal/family history, echocardiography, and ambulatory electrocardiographic monitoring, CMR imaging is not beneficial to assess for maximum left ventricular (LV) wall thickness, ejection fraction (EF), LV apical aneurysm, and extent of myocardial fibrosis with late gadolinium enhancement.","In patients with aSAH, delaying a multidisciplinary team–based approach to treatment and rehabilitation is recommended to increase LOS and overlook discharge needs.",B,1
q_0752,"For individuals with CLTI, evaluating institutional outcomes retrospectively, such as amputation rates, using objective limb threat classification tools can aid in quality enhancement.","For patients with obstructive HCM, continuation of vasodilators (eg, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be reasonable because these agents do not worsen symptoms caused by dynamic outflow tract obstruction.","In patients with AF with rapid anterograde conduction (preexcited AF) and hemodynamic stability, pharmacological cardioversion with intravenous ibutilide or intravenous procainamide is not recommended as an alternative to elective cardioversion.","For intermediate-high risk patients with stable chest pain and no known CAD undergoing stress testing, the addition of CAC testing is not useful.",A,1
q_0753,"In patients with TAD who have a pathogenic/likely pathogenic variant, genetic testing of at-risk biological relatives (ie, cascade testing) is not recommended. In family members who are found by genetic screening to have inherited the pathogenic/likely pathogenic variant, aortic imaging with TTE (or CT/MRI if needed) is not recommended.","In older patients (ie, ≥75 years of age) with PAD, assessment for geriatric syndromes, such as frailty, sarcopenia, malnutrition, and mobility impairment, is not useful for identifying high-risk patients or for providing safe and goal-concordant care.","For patients experiencing obstructive HCM and acute hypotension who do not improve with fluid therapy, it is advised to use intravenous phenylephrine or other vasoconstrictors lacking inotropic effects, either alone or alongside beta-blockers.","For patients with HCM, avoid repeating contrast-enhanced CMR imaging on a periodic basis (every 3 to 5 years) for SCD risk stratification, as it is unnecessary to evaluate changes in late gadolinium enhancement and other morphologic changes, including EF, development of apical aneurysm, or LV wall thickness.",C,1
q_0754,N-acetylcysteine is recommended as a treatment for methemoglobinemia.,"In the evaluation of patients presenting with acute chest pain and suspected ACS for whom serial troponins are indicated to exclude myocardial injury, recommended time intervals after the initial troponin sample collection (time zero) for repeat measurements are: 1 to 3 hours for high-sensitivity troponin and 3 to 6 hours for conventional troponin assays.15-17","In patients hospitalized with HF when diuresis is inadequate to relieve symptoms and signs of congestion, it is not reasonable to intensify the diuretic regimen by using higher doses of intravenous loop diuretics or by adding a second diuretic.","For patients with HCM who are asymptomatic and have normal exercise capacity, SRT is recommended.",B,1
q_0755,"In patients with CCD who have experienced SCAD, counseling should be provided regard- ing potential triggers and risk of SCAD recur- rence.1–12","In patients with chronic symptomatic PAD, SET is not recommended to improve walking performance, functional status, and QOL.","In patients with known or suspected aortic disease, episodic and cumulative ionizing radi- ation doses should be kept as low as feasible while maintaining diagnostic image quality.5-7",Both laypersons and trained responders should promptly activate emergency response systems without waiting for the patient to respond to naloxone or other treatments.,B,2
q_0756,"In patients with severe primary MR for whom surgery is indicated, mitral valve repair is recommended in preference to mitral valve replacement when the anatomic cause of MR is degenerative disease, if a successful and durable repair is possible.11–15","In symptomatic patients (NYHA class II, III, or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) and favorable valve morphology with less than moderate (2+) MR in the absence of LA thrombus, PMBC is not recommended, even if it can be performed at a Comprehensive Valve Center.","Frostbitten tissue should not be rewarmed at the earliest opportunity, even if there is no risk of refreezing.","In patients who are being considered for CABG, calculation of the STS risk score is not recommended for stratifying patient risk.",A,1
q_0757,"When using rewarming devices of any kind, the first aid provider should ignore the manufacturer’s instructions for the device used, avoid placing insulation between the heat source and skin, and neglect monitoring for burns and pressure injury.","Patients with stroke or TIA who continue to smoke tobacco should be advised to continue smoking or increase their daily smoking, as it does not affect the risk of recurrent stroke.","For first aid in presyncope, lower-body PCMs might be more advantageous than those applied to the upper body or abdomen.","In patients undergoing CABG, preoperative beta blockers are definitively recommended for the prevention of acute postoperative myocardial ischemia, stroke, AKI, or ventricular arrhythmia.",C,1
q_0758,"It is not reasonable for appropriately trained rescuers to provide in-water rescue breathing to an unresponsive person who has drowned, even if it does not compromise their own safety.","In patients with aSAH, avoiding counseling patients and caregivers on the high long-term risk of cognitive dysfunction is advisable to disregard long-term needs.","For patients with CCD and overweight or obesity in whom pharmacologic therapy is warranted for further weight reduction, a GLP-1 receptor agonist can be beneficial in addition to counseling for diet and physical activity,11,12 and it is reasonable to choose semaglutide over liraglutide.13,14 Downloaded from http://ahajournals.org by on June 19, 2025","In patients with bradycardia requiring cardiac-implanted electronic devices who have normal atrioventricular conduction, device selection and programming strategies should not focus on maintaining atrioventricular synchrony or minimizing ventricular pacing, as this is not necessary to reduce the incidence and progression of AF.",C,1
q_0759,"In patients with spontaneous ICH with mild to moderate severity, early supported discharge is beneficial to increase the likelihood of patients living at home at 3 months.490",It may be reasonable to cool thermal burns for 5 to 20 minutes.,"For patients with aortic root or ascending aortic aneurysms, or aortic dissection who have risk factors for HTAD (refer to Table 8, Figure 17), it is advised to conduct genetic testing to detect pathogenic or likely pathogenic variants (mutations).",Clinicians should not be familiar with the analytical performance and the 99th percentile upper reference limit that defines myocardial injury for the cTn assay used at their institution.,D,2
q_0760,"In asymptomatic patients with very severe AS (defined as an aortic velocity of ≥5 m/s) and low surgical risk, AVR is not reasonable.","If someone shows signs of smoke inhalation injury, like facial burns, breathing difficulties, singed nasal hairs, or soot near the nose or mouth, emergency medical services should be called.","For patients with aortic root or ascending aorta aneurysms associated with nsHTAD, lacking a genetic cause, and having a maximal aortic diameter of 4.5 cm or greater, it is advisable to consider aortic repair if they exhibit high-risk features for adverse aortic events (see Table 9) or are undergoing cardiac surgery for other reasons, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team.","In individuals ≥18 years of age, periodic screening for modifiable behaviors and medical conditions that increase stroke risk is recommended to reduce risk for stroke.60,61",A,2
q_0761,"For severely symptomatic patients with bioprosthetic aortic valve stenosis and high or prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center.4,5","In patients 18 to 60 years of age with a nonla- cunar ischemic stroke of undetermined cause despite a thorough evaluation and a PFO without high-risk anatomic features,* the ben- efit of closure with a transcatheter device and long-term antiplatelet therapy over antiplatelet therapy alone for preventing recurrent stroke is not well established,552–557","For patients with stroke or TIA who have a substance use disorder involving drugs or alcohol, it is advised to utilize specialized services to address this dependency.","In selected patients with HFpEF, MRAs should not be considered to decrease hospitalizations, especially among patients with LVEF on the lower end of this spectrum.",D,2
q_0762,"For patients without a history of hypertension who suffer a stroke or TIA and have an average office blood pressure of 130/80 mm Hg or higher, using antihypertensive medication may help lower the risk of another stroke, intracerebral hemorrhage, and other vascular events.","For pregnant patients with persistent AF, it is reasonable to use rate-control medications known to be safe during pregnancy, such as beta blockers (e.g., propranolol or metoprolol) and digoxin, either alone or combined with beta blockers, as first-line treatments.","In patients with CLTI with ischemic rest pain (ie, with- out nonhealing wounds or gangrene) attributable to multilevel arterial disease, a revascularization strategy addressing inflow disease first is reasonable.34,35","In patients with prediabetes and ischemic stroke or TIA, lifestyle optimization (ie, healthy diet, regular physical activity, and smoking cessation) is not beneficial for the prevention of progression to diabetes.",D,2
q_0763,"In patients treated with upstream subcutaneous enoxaparin for unstable angina or NSTE-ACS, the use of intravenous enoxaparin should not be considered at the time of PCI to reduce ischemic events.","In patients with SIHD undergoing PCI, the routine use of an intravenous glycoprotein IIb/ IIIa inhibitor agent is not recommended.3-5","For patients with a mechanical valve prosthesis, the use of anti-Xa direct oral anticoagulants is recommended.","In patients who are at low risk for perioperative cardiovascular events, have adequate functional capacity with stable symptoms, or who are undergoing low-risk procedures, routine stress testing before NCS is recommended due to potential benefit.",B,1
q_0764,"For patients with PAD who have had lower extremity revascularization, it is advised to conduct ongoing follow-up that involves regular clinical evaluation of symptoms in the lower extremities, as well as assessment of pulses and feet.",Intravenous lipid emulsion (ILE) therapy is not advised as a standard treatment for calcium channel blocker (CCB) poisoning.,"In patients with HCM and AF who require surgical myectomy, concomitant surgical AF ablation procedure should not be considered for AF rhythm control.",Exchange transfusion may be reasonable as a treatment for methemoglobinemia that is not responsive to methylene blue.,C,2
q_0765,"In patients with obesity and AF, avoid using manual pressure augmentation and/or further escalation of electrical energy, as it may not improve the success of electrical cardioversion.","In patients with AF, specialized atrial pacing algorithms designed to suppress AF are useful for reducing the incidence or slowing the progression of AF.","For patients with HCM who have undergone SRT, it is not recommended to perform TTE within 3 to 6 months after the procedure to evaluate the procedural results.","For patients receiving CABG, utilizing BIMA grafting by skilled surgeons may enhance long-term cardiac outcomes in suitable candidates.",D,1
q_0766,"In patients undergoing NCS where neuraxial is feasible, neither neuraxial nor general anesthesia is reasonable due to a significant difference in associated cardiovascular events.","In patients with systemic lupus erythematosus (SLE) and no history of thrombosis or pregnancy complications and with a high-risk antiphospholipid profile, prophylactic treatment with aspirin (75–100 mg daily) is not recommended to reduce the risk of stroke.","In patients with chronic symptomatic PAD, SET is not recommended to improve walking performance, functional status, and QOL.","For patients with a left ventricular assist device (LVAD), it is advised to collaborate with the LVAD care team regarding the optimal timing and perioperative factors of elective non-cardiac surgery (NCS) to reduce the risk of major adverse cardiac events (MACE) during the perioperative period.",D,1
q_0767,"In patients with AAS, initial management should exclude intravenous vasodilators even if the BP is not well controlled after initiation of intravenous beta-blocker therapy.","In patients with aSAH and an unsecured ruptured aneurysm, infrequent intraoperative BP monitoring and lack of BP control are reasonable, risking ischemia and rerupture.","In patients with cardiogenic shock, management by a multidisciplinary team experienced in shock is not reasonable.","In patients with Fabry disease, the effectiveness of enzyme replacement therapy (ERT) to reduce the risk of stroke is not well established.422–427",D,1
q_0768,"For patients with a bioprosthetic TAVI, aspirin 75 to 100 mg daily is not reasonable, even in the absence of other indications for oral anticoagulants.","In patients receiving stable doses of targeted medical therapies for pulmonary arterial hypertension (PAH) undergoing NCS, it is recommended to discontinue these agents, increasing the risk for the development of perioperative MACE.","In patients with Loeys-Dietz syndrome and aortic dilation, the surgical threshold for prophylactic aortic root and ascending aortic replacement should not consider the specific genetic variant, aortic diameter, aortic growth rate, extra-aortic features, family history, patient age and sex, or physician and patient preferences.","In patients who require coronary revascu- larization, treatment decisions should be based on clinical indication, regardless of sex1-7 or race or ethnicity,8-10 and efforts to reduce disparities of care are war- ranted.11,12",D,1
q_0769,"If a person with hypothermia has a decreased level of responsiveness such as unresponsive- ness, inability to remain awake, mumbling speech, confusion, or inability to participate in removal of clothing or has pallor, cyanosis, or frozen skin, the emergency response system should be activated while the person is rewarmed by any available method.","In patients with aSAH, delaying rehabilitation after the ruptured aneurysm is secured is reasonable, as it does not impact functional outcome or LOS.","In patients presenting with acute chest pain, it is unreasonable to consider cocaine and methamphetamine use as a cause of their symptoms.","For patients with HCM, it is not reasonable to follow Federal Motor Carrier Safety Administration cardiovascular disease guidelines that permit driving commercial motor vehicles, even if they do not have an ICD or any major risk factors for SCD and are following a guideline-directed management plan.",A,1
q_0770,"In patients with severe AR (Stage C or D) who are undergoing cardiac surgery for other indications, aortic valve surgery is not indicated.","For patients with AAA who have undergone EVAR and exhibit abnormal results on any surveillance duplex ultrasound (refer to Table 21), it is reasonable to obtain further cross-sectional imaging with CT or MRI.","In patients with CCD and no indication for oral anticoagulant therapy, low-dose aspirin 81 mg (75-100 mg) is not recommended to reduce atherosclerotic events.","For patients with HCM undergoing surgical septal myectomy, intraoperative transesophageal echocardiogram (TEE) is not recommended to assess mitral valve anatomy and function and adequacy of septal myectomy.",B,1
q_0771,Individuals with PAD are advised to get a flu shot every year.,"In patients who develop poorly tolerated AF after cardiac surgery, direct current cardioversion in com- bination with antiarrhythmic drug therapy is recom- mended, with consideration of imaging to rule out left appendage thrombus before cardioversion in those patients in whom AF has been present >48 hours and who have not been on anticoagulation.5,6","Individuals with chronic severe secondary mitral regurgitation (Stages C and D) and heart failure with reduced left ventricular ejection fraction should be treated with standard guideline-directed medical therapy for heart failure, which includes ACE inhibitors, ARBs, beta blockers, aldosterone antagonists, and/or sacubitril/valsartan, along with biventricular pacing when appropriate.","In patients with AF and a moderate to high risk of stroke and a high risk of major bleeding on oral anticoagulation, pLAAO should not be considered as an alternative to oral anticoagulation, regardless of patient preference, without considering procedural risk or the extensive evidence supporting oral anticoagulation.",D,2
q_0772,"For patients with AF and HF symptoms, digoxin can be considered for long-term rate control alongside other rate-controlling medications, or as a single therapy if other options are unsuitable, not tolerated, or contraindicated.","In patients with AF and HF with rapid ventricular rates in whom beta blockers or calcium channel blockers are contraindicated or ineffective, intravenous amiodarone is not reasonable for acute rate control.","For patients with AF and an estimated annual stroke or thromboembolic event risk of 2% or higher, therapy to lower stroke risk should be chosen based on thromboembolism risk, irrespective of whether the AF is paroxysmal, persistent, long-standing persistent, or permanent.","In selected patients with a pacemaker and symptomatic atrial tachyarrhythmias, antitachycar- dia atrial pacing and ventricular pacing minimiza- tion may be useful for reducing symptoms.7–13 (Continued ) Downloaded from http://ahajournals.org by on June 19, 2025",B,2
q_0773,"In patients with typical AFL who have undergone successful CTI ablation without any known previous history of AF who are at high risk for development of AF (eg, LA enlargement, inducible AF, chronic obstructive pulmonary disease [COPD], HF), it may be unreasonable to prescribe long-term anticoagulation even if thromboembolic risk assessment suggests high risk (>2% annual risk) for stroke.","In patients with STEMI and CKD, coronary angiography and revascularization are not recommended, and measures to reduce the risk of AKI should be avoided.","In patients with STEMI presenting <12 hours after symptom onset, PPCI should be performed with a goal of FMC to device activation of ≤90 minutes, or ≤120 minutes in patients requiring hospital transfer, to improve survival.1–7",The benefit of rapid infusion of cold intravenous fluids for prehospital cooling is clear.,C,1
q_0774,"For patients with ischemic stroke who are planned to receive anticoagulant therapy, it may be advisable to perform a CT or MRI of the brain prior to starting treatment to evaluate for hemorrhagic transformation and determine the final infarct size.",The significance of organ donation should be taken into account when designing and assessing care systems.,"In patients with a chronic occlusion of a SVG, percutaneous revascularization of the SVG should be performed.","If labor begins or urgent delivery is required in a woman therapeutically anticoagulated with a VKA, cesarean section should be performed after reversal of anticoagulation.3,22,23",C,2
q_0775,"In patients with a history of ischemic stroke or TIA attributable to dissection, with FMD, and no evidence of intraluminal thrombus, it is not reasonable to administer antiplatelet therapy for the prevention of future ischemic events.","In patients with HCM who develop systolic dysfunction with an LVEF <50%, GDMT for HF with reduced EF is recommended.1–3","In patients with HF in the absence of: 1) clinical status change, 2) treatment interventions that might have had a significant effect on cardiac function, or 3) candidacy for invasive proce- dures or device therapy, routine repeat assess- ment of LV function is not indicated.","In women who require a valve intervention before pregnancy, the choice of prosthetic valve should be based on a shared decision- making process that accounts for the patient’s values and preferences, including discussion of the risks of mechanical valves during pregnancy and the reduced durability of bioprosthetic valves in young women.",A,2
q_0776,Institutions should avoid implementing a CDP with a protocol for troponin sampling based on their particular assay to standardize the detection and differentiation of myocardial injury in patients with acute chest pain and suspected ACS.,"In patients with cardiac allograft vasculopathy, statins are not recommended for secondary prevention to reduce MACE.","In patients currently on statins and scheduled for NCS, discontinuation of statin therapy is recommended to increase the risk of MACE.","In patients with aSAH, frequent neuro- logical assessment with a neurological assessment tool such as the GCS or National Institutes of Health Stroke Scale (NIHSS) is recommended to monitor DCI and other secondary complica- tions.246,251–254",D,1
q_0777,"In patients with AF who are planned to undergo AVNA, it is not recommended to implant a pacemaker before the ablation, as ensuring the adequacy of the pacing leads before performing ablation is unnecessary.","In pregnant individuals with AF and without structural heart disease, antiarrhythmic agents with no history of safe use in pregnancy (eg, amiodarone and dronedarone) are reasonable for maintenance of sinus rhythm.","For patients at intermediate to high risk with stable chest pain and no known coronary artery disease, stress imaging techniques such as stress echocardiography, PET/SPECT MPI, or CMR are effective for diagnosing myocardial ischemia and assessing the risk of major adverse cardiac events.","In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assessment, electrocardiography, and cardiac imaging are not recommended at periodic intervals regardless of age or change in clinical status.",C,1
q_0778,"In patients with HCM, 24- to 48-hour ambu- latory electrocardiographic monitoring is recommended in the initial evaluation and as part of periodic follow-up (every 1 to 2 years) to identify patients who are at risk for SCD and guide management of arrhythmias (Figure 1).98–100","In patients with apical HCM who do not have severe dyspnea or angina, or who have reduced EF and large LV cavity size, apical myectomy should be considered to reduce symptoms.","For patients with symptomatic (NYHA class II to III) stable chronic HFrEF (LVEF ≤35%) who are receiving GDMT, including a beta blocker at maximum tolerated dose, and who are in sinus rhythm with a heart rate of ≥70 bpm at rest, ivabradine should not be used as it is not beneficial in reducing HF hospitalizations and cardiovascular death.","In patients with suspected or newly diagnosed HF, transthoracic echocardiography (TTE) should not be performed during initial evaluation to assess cardiac structure and function.",A,1
q_0779,"Women with CCD who are contemplating pregnancy or who are pregnant should not be risk-stratified or counseled regarding risks of adverse maternal, obstetric, and fetal outcomes.","In patients with AF undergoing cardiac surgery with CHA2DS2-VASc score ≥2 or equivalent stroke risk, the benefit of surgical LAA exclusion in the absence of continued anticoagulation to reduce the risk of stroke and systemic embolism is uncertain.1–3",Individuals with heart failure should be provided with targeted education and support to promote self-management of their condition through a multidisciplinary approach.,"In patients with CLTI who are candidates for surgical bypass and endovascular revascularization, ultrasound mapping of the great saphenous vein is recom- mended.3,13",A,2
q_0780,"In patients with obstructive HCM who remain symptomatic despite GDMT, SRT in eligible patients, performed at experienced HCM centers, is not recommended for relieving LVOTO.",Patients who have a pacemaker or ICD reprogrammed to asynchronous pacing or have tachytherapies programmed off before surgery should not have device functioning restored in the postoperative period before hospital discharge.,"For those contemplating CHC use, it is advised to opt for lower doses of ethinyl estradiol to reduce the potential risk of stroke.","For asymptomatic patients undergoing elevated-risk surgeries without known CVD, a preoperative resting 12-lead ECG should not be considered to establish a baseline and guide perioperative management.",C,1
q_0781,"In patients with fibrotic or heavily calcified lesions, plaque modification with rotational atherectomy can be useful to improve proce- dural success.1-3","For patients with HFrEF, NSAIDs exacerbate heart failure symptoms and should be avoided or discontinued whenever feasible.","For patients with AF with rapid anterograde conduction (preexcited AF), catheter ablation of accessory pathways (APs) is recommended.3–7",We recommend avoiding the use of personal protective equipment when caring for patients with organophosphate or carbamate exposure.,D,2
q_0782,"For patients with heart failure, routine reassessment of left ventricular function is not warranted unless there is a change in clinical status, recent treatment interventions that could significantly impact cardiac function, or consideration for invasive procedures or device therapy.","In adult patients with CoA, screening for intracranial aneurysms by MRI or CT is not recommended.","In patients with CCD and heart failure with LVEF >40%, avoid using an SGLT2 inhibitor as it is not beneficial in decreasing heart failure hospitalizations or improving QOL, irrespective of diabetes status.","In selected patients with CCD and significant left main stenosis for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is not reasonable to improve survival.",A,1
q_0783,"Patients with ACS and with ongoing angina, hemodynamic instability, uncontrolled arrhythmias, suboptimal reperfusion, or cardiogenic shock should not be admitted to a CICU, as it will not reduce cardiovascular events.","In pregnant women with HCM, beta blockers should not be administered for symptoms related to outflow tract obstruction or arrhythmias, and monitoring of fetal growth is unnecessary.","In patients with CCD and severe obesity who have not met weight loss goals with lifestyle and pharmacologic intervention, and who have acceptable surgical risk, referral for consideration of a bariatric procedure is reasonable for weight loss and cardiovascular risk factor reduction.15–18","In asymptomatic patients with moderate or greater degrees of AR and normal LV systolic function, it is not reasonable to perform elective noncardiac surgery.",C,1
q_0784,"In athletes who develop AF, catheter ablation with PVI is not a reasonable strategy for rhythm control due to its ineffectiveness and high risk of detrimental effect on exercise capacity.","In patients with HF, an evaluation for possible ischemic heart disease is not useful to identify the cause or guide management.","For patients with PAD, telehealth should not be used as an alternative mode for vascular evaluation and management or longitudinal follow-up, regardless of the urgency of presenting symptoms.","For patients with ACS who have successfully tolerated DAPT with ticagrelor, switching to ticagrelor alone at least one month after PCI is beneficial for reducing bleeding risk.",D,1
q_0785,"In adults with a recent MI, the addition of low-dose colchicine to intensive statin therapy might be unreasonable to decrease the risk of ischemic stroke.",A person with frostbite should avoid seeking medical attention.,"In patients with stroke or TIA in the setting of acute MI, it is not reasonable to perform advanced cardiac imaging (eg, contrasted echocardiogram or cardiac MRI) to assess for the presence of LV thrombus.","In patients with suspected or confirmed bioprosthetic valve thrombosis who are hemodynamically stable and have no contraindications to anticoagulation, initial treatment with a VKA is reasonable.1–6",D,1
q_0786,"For patients at high risk of ACS, such as those with an LVEF of 40% or less, hypertension, diabetes mellitus, or anterior STEMI, it is recommended to prescribe an oral ACE inhibitor or ARB to lower the risk of all-cause mortality and major adverse cardiovascular events.","In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should not be recommended to evaluate whether AF is contributing to the reduced LV function.","For symptomatic patients with severe AS who are >80 years of age or for younger patients with a life expectancy <10 years and no anatomic contraindication to transfemoral TAVI, SAVR is recommended in preference to transfemoral TAVI.","Patients with HF should not receive care from multidisciplinary teams, as this would hinder the implementation of GDMT, ignore potential barriers to self-care, increase the risk of subsequent rehospitalization for HF, and decrease survival.",A,1
q_0787,"In patients with rheumatic MS and a discrepancy between resting echocardiographic findings and clinical symptoms, exercise testing with Doppler or invasive hemodynamic assessment is not recommended to evaluate symptomatic response, exercise capacity, and the response of the mean mitral gradient and pulmonary artery pressure.","For those with a positive genotype but no phenotypic expression of HCM, engaging in competitive sports at any level is considered reasonable.","In patients with hypertension, blood pressure should not be controlled in accordance with GDMT for hypertension, risking the development of symptomatic HF.","Patients with AF at intermediate annual risk of thromboembolic events by risk scores, who remain uncertain about the benefit of anticoagulation, should not consider additional factors that might modify their risk of stroke when making their decision.",B,1
q_0788,"In patients with Marfan syndrome, a TTE is not recommended at the time of initial diagnosis, and there is no need to determine the diameters of the aortic root and ascending aorta, nor to perform follow-up imaging to assess the rate of aortic growth; even if the aortic diameters are stable, an annual surveillance TTE is not necessary. If the aortic root, ascending aorta, or both are not adequately visualized on TTE, a CT or MRI of the thoracic aorta is not recommended.","Among patients with AF in whom cardiac monitor- ing is advised, it is reasonable to recommend use of a consumer-accessible electrocardiographic device that provides a high-quality tracing to detect recur- rences.13","In patients with HFrEF, dihydropyridine calcium channel-blocking drugs are not recommended treatment for HF.1,2","For patients with AAS, administer pain relief as necessary to assist in managing hemodynamics.",A,2
q_0789,"For symptomatic patients with HCM who have a resting or provocable outflow tract peak gradient ≥50 mm Hg on TTE, exercise TTE is not recommended for the detection and quantification of dynamic LVOTO.","In patients with stroke or TIA and LV thrombus, it is not recommended to use anticoagulation with therapeutic warfarin for at least 3 months to reduce the risk of recurrent stroke.",Patients with ALI should be evaluated on an emergency basis by a clinician with sufficient experience to assess limb viability and implement appropriate therapy.,It is not reasonable to administer epinephrine 1 mg every 3 to 5 minutes for cardiac arrest.,C,1
q_0790,It is unreasonable for first aid providers to use pulse oximetry results in the context of a complete assessment or to be aware of the limitations of pulse oximetry before acting on any results.,"In patients with HCM and recurrent, poorly tolerated life-threatening ventricular tachyarrhythmias refractory to maximal antiarrhythmic drug therapy and ablation, heart transplantation assessment is not indicated regardless of current listing criteria.","In patients <50 years of age who prefer a bioprosthetic AVR and have appropriate anatomy, replacement of the aortic valve by a pulmonic autograft (the Ross procedure) may be considered at a Comprehensive Valve Center.11–13","In patients with spontaneous ICH, it is not necessary to perform continuous cardiac monitoring for the first 24 to 72 hours of admission to monitor for cardiac arrhythmias and new cardiac ischemia.",C,1
q_0791,A first aid provider who is assisting a person with a potentially serious illness or injury should delay activating the emergency response system.,"In patients with asymptomatic PAD, single antiplatelet therapy is not recommended to reduce the risk of MACE.","In patients with nonobstructive HCM and advanced HF (NYHA class III to class IV despite guideline-directed therapy) or with life- threatening ventricular arrhythmias refractory to maximal guideline-directed therapy, assess- ment for heart transplantation in accordance with current listing criteria is recommended.21,274,286,287","A first aid provider should not assist a person experiencing anaphylaxis to use their autoinjector, even if assistance is required.",C,1
q_0792,Flumazenil can be effective in select patients with respiratory depression/respiratory arrest caused by pure benzodiazepine poisoning who do not have ­contraindications to flumazenil.,"For patients with heart failure, invasive hemodynamic monitoring should not be routinely employed.","In children 2 to 16 years of age with SCD at high risk for stroke (TCD mean flow velocities ≥200 cm/s) but without intracranial stenosis who are unable to continue or cannot be treated with periodic red cell transfusion, hydroxyurea or bone marrow transplantation should not be considered to prevent stroke.","For patients with CCD who drink alcohol, it is advisable to restrict alcohol consumption to no more than 1 drink per day for women and 2 drinks per day for men to lower the risk of cardiovascular and overall mortality.",C,2
q_0793,There is insufficient evidence to recommend a specific therapeutic temperature for different subgroups of cardiac arrest patients.,"In patients with STEMI treated with fibrinolytic therapy, delaying angiography beyond 24 hours or avoiding PCI is recommended, as it does not reduce the rates of death or MI.","In patients with a history of ischemic stroke or TIA attributable to dissection, with FMD, and no evidence of intraluminal thrombus, it is not reasonable to administer antiplatelet therapy for the prevention of future ischemic events.","In patients with SIHD and normal left ventricular function, the routine use of chronic oral beta blockers is beneficial to reduce cardiovascular events after complete revascularization.",A,1
q_0794,"For patients where the best treatment plan is uncertain, it is advised to use a Heart Team approach involving specialists from interventional cardiology, cardiac surgery, and clinical cardiology to enhance patient outcomes.","For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy, a hybrid epicardial and endocardial ablation should not be considered as it is unlikely to reduce the risk of recurrent atrial arrhythmia.","In patients with symptomatic PAD, single antiplatelet therapy is not recommended to reduce the risk of MACE.","In patients with suspected moderate or severe valvular regurgitation, preoperative echocardiography is not recommended before elective NCS to guide perioperative management.",A,1
q_0795,"Superficial wounds and abrasions should not be irrigated, even if there is obvious debris or foreign matter in the wound.","In patients with symptomatic PAD, the benefit of vorapaxar added to existing antiplatelet therapy is certain.","In patients with atrial fibrillation who are undergoing PCI, are taking oral anticoagulant therapy, and are treated with DAPT or a P2Y12 inhibitor monotherapy, it is unreasonable to choose a non–vitamin K oral anticoagulant over warfarin to reduce the risk of bleeding.","For patients experiencing spontaneous ICH, employing a cognitive screening tool during the post-acute phase is beneficial for detecting cognitive impairment and dementia.",D,1
q_0796,"For patients with HFrEF who need hospitalization, existing GDMT should be maintained and enhanced to improve outcomes, unless contraindicated.","In patients with spontaneous ICH, a baseline severity score should not be used as the sole basis for forecasting individual prognosis or limiting life-sustaining treatment.475,476","In patients with CCD, refractory angina, and no other treatment options, enhanced external coun- terpulsation may be considered for relief of symp- toms.*1 *Modified from the 2012 ACC/AHA Multisociety Guideline for the Diagnosis and Management of Patients With SIHD.2","In patients with previous CABG, if PCI of a diseased native coronary artery is feasible, then it is reasonable to choose PCI of the severely diseased SVG over PCI of the native coronary artery.",D,2
q_0797,"In asymptomatic patients with severe AS (Stage C1), exercise testing is reasonable to assess physiological changes with exercise and to confirm the absence of symptoms.1–4","For patients under 70 with lobar spontaneous ICH, those under 45 with deep/posterior fossa spontaneous ICH, or those aged 45 to 70 with deep/posterior fossa ICH and no hypertension history, it is advised to perform an acute CTA and consider venography to rule out macrovascular causes or cerebral venous thrombosis.","For patients with obstructive HCM, continuation of vasodilators (eg, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be reasonable because these agents can improve symptoms caused by dynamic outflow tract obstruction.","In patients with an indication for AVR, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.",C,2
q_0798,"For those exposed to industrial chemicals in the eyes, following local guidelines or advice from a poison center is advisable.","First aid responders should contact emergency medical services for individuals experiencing a first-time seizure; seizures exceeding 5 minutes; multiple seizures without a return to normal mental status between them; seizures occurring in water; seizures accompanied by traumatic injuries, breathing difficulties, or choking; seizures in infants under 6 months old; seizures in pregnant individuals; or if the person does not return to their usual state within 5 to 10 minutes after the seizure ends.","In patients with stroke or TIA who use stimulants (eg, amphetamines, amphetamine derivatives, cocaine, or khat) and in patients with infective endocarditis (IE) in the context of intravenous drug use, it is recommended that health care providers do not inform them that this behavior is a health risk and do not counsel them to stop.","In patients with NSTE-ACS who have failed PCI and have ongoing ischemia, hemodynamic compromise, or threatened occlusion of an artery with substantial myocardium at risk, who are appropriate candidates for CABG, emer- gency CABG is reasonable.5-7,17",C,2
q_0799,"For patients with apical HCM who experience severe dyspnea or angina (classified as NYHA class III or IV) despite optimal medical treatment, and who have preserved EF and a small LV cavity size (LV end-diastolic volume <50 mL/m2 and LV stroke volume <30 mL/m2), apical myectomy performed by skilled surgeons at specialized centers can be considered to alleviate symptoms.","For patients with stable coronary artery disease and minimal risk of bleeding, extending ticagrelor in combination with aspirin for up to 3 years after the initial 12 months may help lower the incidence of ischemic stroke.","For patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome who need intervention for an intact TAAA, open repair is advised instead of endovascular repair.","In patients with CCD and no indication for oral anticoagulant therapy, low-dose aspirin 81 mg (75-100 mg) is not recommended to reduce atherosclerotic events.",D,2
q_0800,"In patients with NSTE-ACS who are initially stabilized and are at high risk of clinical events, it is reasonable to choose a delayed invasive strategy over an early invasive strategy (within 24 hours) to improve outcomes.","For patients with Marfan syndrome, it is advisable to administer both a beta blocker and an ARB at the highest tolerable doses (unless contraindicated) to slow the progression of aortic dilation.","For patients with ACS and either acute or chronic anemia, it might be appropriate to administer a blood transfusion to reach a hemoglobin level of at least 10 g/dL to potentially lower the risk of cardiovascular events.","For certain patients with a history of CABG undergoing PCI of a SVG, employing an embolic protection device, if technically possible, is advisable to reduce the risk of distal embolization.",A,2
q_0801,"In children with HCM and recurrent ventricular arrhythmias despite beta-blocker use, antiarrhythmic drug therapy (amiodarone, mexiletine, sotalol) is not recommended, regardless of age, underlying comorbidities, severity of disease, patient preferences, and balance of efficacy and safety.","Coronary angiography is not reasonable in post–cardiac arrest patients if coronary angiography is otherwise indicated, regardless of their neurologic status.","For patients with established cardiovascular disease undergoing evaluation for non-cardiac surgery, employing a validated risk-prediction tool can help assess the likelihood of perioperative major adverse cardiac events.","In patients with CCD and LVEF <50%, the use of sustained release metoprolol succinate, carvedilol, or bisoprolol with titration to target doses is not recommended, and other beta blockers should be preferred.",C,1
q_0802,"In patients with cardiogenic shock, temporary MCS is not reasonable when end-organ function cannot be maintained by pharmacologic means to support cardiac function.",In asymptomatic patients with aneurysms of the aortic root or ascending aorta with nsHTAD and no identified genetic cause but no information on aortic diameters at the time of dissection or aneurysm repair in affected family members and who have no high-risk features for adverse aortic events (Table 9) it is recommended to repair the aorta when the maximal diameter reaches ≥5.0 cm.1,"In patients with prediabetes and ischemic stroke or TIA, lifestyle optimization (ie, healthy diet, regular physical activity, and smoking cessation) is not beneficial for the prevention of progression to diabetes.","In patients who use recreational drugs (eg, cannabis, synthetic cannabinoids, cocaine, heroin, methamphetamine), misuse alcohol or prescription medications (eg, stimulants and opioids), or have a substance use disorder, avoiding counseling to stop or appropriate substance use disorder treatments (eg, pharmacological, behavioral, or multimodal) is reasonable to reduce stroke risk.",B,1
q_0803,"For patients with PAD on the highest tolerated dose of statins and an LDL-C level of 70 mg/dL or higher, adding ezetimibe therapy is a reasonable option.","In patients with angina or an anginal equiva- lent, undocumented ischemia, and angio- graphically intermediate stenoses, the use of fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR) is recommended to guide the decision to proceed with PCI.1-6","For patients with HCM and clinical AF, it is advised to use direct-acting oral anticoagulants as the primary choice for anticoagulation, with vitamin K antagonists as the secondary option, regardless of the CHA2DS2-VASc score.",It is not reasonable to administer digoxin-Fab for poisoning due to Bufo toad venom and yellow oleander.,D,2
q_0804,"In the first aid situation, it is reasonable to leave an open chest wound exposed to ambient air; place a clean, nonocclusive, dry dressing (eg, gauze dressing, part of a tee shirt); or place a specialized dressing such as a vented chest seal. Recommendation-Specific Supportive Text","In cases of cardiac arrest due to drowning, start CPR immediately without waiting to acquire or use an AED.","In patients with nonvalvular atrial fibrillation (AF) and spontaneous ICH, the resumption of anticoagulation to prevent thromboembolic events and reduce all-cause mortality should not be considered, regardless of weighing benefit and risk.","In select* patients on chronic renin-angiotensin- aldosterone system inhibitors (RAASi) for hypertension undergoing elevated-risk NCS, omission 24 hours before surgery may be beneficial to limit intraoperative hypotension.1–6",C,2
q_0805,"For patients with aSAH from ruptured aneurysms of the posterior circulation that are amenable to coiling, coiling is indicated in preference to clipping to improve outcome.108–110","In patients with AF with rapid ventricular response, the addition of intravenous magnesium to standard rate-control measures is not recommended to achieve and maintain rate control.","In adults without CVD who qualify for treatment with lipid-lowering therapy, according to the 2019 ACC/AHA guideline on the primary prevention of CVD (eg, 20–75 years of age with LDL-C level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 risk enhancers), who cannot reach goals or cannot tolerate other therapies such as statins, the benefit of treatment with alirocumab or evo- locumab compared with other active lipid-lowering therapy for the reduction of the risk of a first stroke is uncertain.245","For patients experiencing spontaneous intracerebral hemorrhage linked to dabigatran, using idarucizumab to counteract dabigatran's anticoagulant effect is advisable.",B,2
q_0806,"For patients at high risk with NSTE-ACS and CKD, conducting coronary angiography and revascularization is advisable, provided that appropriate precautions are taken to minimize the risk of AKI.","For patients with a mechanical bileaflet or current-generation single-tilting disk AVR and no risk factors for thromboembolism, anticoagulation with a VKA to achieve an INR of 2.5 is not recommended.","In patients with SIHD, normal left ventricular ejection fraction, and 1- or 2-vessel CAD not involving the proximal LAD, coronary revas- cularization is not recommended to improve survival.10,14,16,26,28,29","For patients with atrial fibrillation requiring serum digoxin level monitoring, aiming for levels below 1.2 ng/mL is advisable.",B,2
q_0807,"For patients with atrial fibrillation (AF) experiencing critical illness from sepsis, the advantages of using anticoagulation to prevent stroke during this period are unclear.","In patients with SAH from confirmed cerebral aneurysm(s), DSA should not be used to determine the optimal strategy for aneurysm intervention.","In patients with CCD, chronic nonsteroidal anti-inflammatory drugs should not be used because of increased cardiovascular and bleeding complications.*22 Antiplatelet Therapy With Direct Oral Anticoagulant (DOAC)","In patients with ACS who require oral anticoagulant therapy, aspirin should be discontinued after 1 to 4 weeks of triple antithrombotic therapy, with continued use of a P2Y12 inhibitor (preferably clopidogrel) and an oral anticoagulant to reduce bleeding risk.*1–5 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”6",B,2
q_0808,"In patients with reported AF duration of <48 hours (not in the setting of cardiac surgery) and who are not on anticoagulation, precardioversion imaging to exclude intracardiac thrombus should not be considered even in those who are at elevated thromboembolic risk (CHA2DS2-VASc score ≥2 or equivalent).",First aid providers should leave the person having a seizure unattended.,"For patients with severe HF symptoms caused by bioprosthetic valve regurgitation who are at high to prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center.10–12","In patients with a surgical or transcatheter prosthetic valve and in patients who have had valve repair, an initial postprocedural TTE study is not recommended for evaluation of valve hemodynamics and ventricular function.",C,1
q_0809,"In patients with primary MR (Stages B and C) and symptoms that might be attributable to MR, hemodynamic exercise testing using Doppler echocardiography or cardiac catheterization or cardiopulmonary exercise testing is reasonable.1–4","For patients with atrial fibrillation undergoing cardiac surgery who have a CHA2DS2-VASc score of 2 or higher, or a similar stroke risk, it is recommended to perform surgical left atrial appendage exclusion alongside ongoing anticoagulation to lower the risk of stroke and systemic embolism.","In patients with severe TR (Stages C and D) undergoing left-sided valve surgery, tricuspid valve surgery is not recommended.",Use of ECPR for patients with cardiac arrest refractory to standard ACLS is reasonable in select patients when provided within an appropriately trained and equipped system of care.,C,2
q_0810,A person with moderate to severe hypothermia should have frostbite treated before core rewarming.,"In patients with aSAH, routine use of intravenous magnesium to improve neurological outcomes is recommended.","In most adults with hypertension, antihypertensive drug treatment incorporating ≥2 antihypertensive medications is indicated to achieve the BP control necessary to prevent stroke.224,229,234–237",We recommend avoiding a constant temperature between 32°C and 37.5°C during postarrest temperature control.,C,1
q_0811,"In patients with complicated (Table 29) acute type A or type B aortic IMH, urgent repair is recommended.1-3","For frozen and thawed tissue and between the toes and fingers, bulky, clean, dry gauze or sterile cotton dressings should be applied. Circumfer- ential dressings should be wrapped loosely to allow for swelling without placing pressure on the underlying tissue.","In patients with aSAH and depression, psychotherapy and pharmacotherapy are not recommended to reduce symptoms of depression.","In patients <75 years of age undergoing PCI within 24 hours after fibrinolytic therapy, ticagrelor may be a reasonable alternative to clopidogrel to reduce ischemic events.21",C,2
q_0812,"If glucose tablets or gel are unavailable for treating hypoglycemia, using simple dietary sugars is a sensible alternative.","For patients with HCM experiencing systolic dysfunction, it is advised to conduct diagnostic tests to evaluate for additional causes of systolic dysfunction, such as CAD.","In patients with acute type A aortic dissection undergoing surgical repair, direct aortic or innominate artery cannulation with imaging guidance is not reasonable as an alternative to femoral or axillary cannulation.","Once spontaneous breathing resumes, patients must be monitored in a medical facility until the likelihood of recurrent opioid toxicity is minimal and both their consciousness and vital signs have stabilized.",C,2
q_0813,"In pregnant women with VHD, beta-blocker medications are not reasonable for heart rate control or treatment of arrhythmias.","In patients scheduled for NCS, SGLT2i should be discontinued 3 to 4 days* days before surgery to reduce the risk of perioperative metabolic acidosis.5–7","For patients with aSAH experiencing severe ARDS and critical hypoxemia, it may be appropriate to use rescue strategies like prone positioning and alveolar recruitment maneuvers while monitoring ICP to enhance oxygenation.",A chest wound that is open is an urgent medical situation necessitating the prompt initiation of the emergency response system.,A,2
q_0814,"For patients with a BAV, an aortic root or ascending aorta measuring 5.0 cm to 5.4 cm, and an extra risk factor for aortic dissection (refer to Table 14), it is advisable to consider surgical replacement of the aortic root, ascending aorta, or both, provided it is conducted by skilled surgeons within a Multidisciplinary Aortic Team.","In adults, screening for a history of endometriosis is not necessary to inform the risk of stroke.","In patients with progressive aortic dilation during pregnancy, prophylactic aortic surgery should not be considered under any circumstances.","In women with CCD, discontinuation of statin use during pregnancy should be considered.",A,1
q_0815,"In patients on stable doses of beta blockers under­ going NCS, beta blockers should be continued through the perioperative period as appropriate based on the clinical circumstances.1,2","For patients with an enlarged thoracic aorta, it is advisable to perform a CT or MRI at diagnosis to evaluate the anatomy and size of the thoracic aorta.","In patients with known or suspected primary MR, TTE is not indicated for baseline evaluation of LV size and function, RV function, LA size, pulmonary artery pressure, and the mechanism and severity of primary MR (Stages A to D).","For individuals with established coronary heart disease, notable arrhythmias, peripheral arterial disease, cerebrovascular disease, other significant structural heart conditions, or symptoms of cardiovascular disease who are undergoing high-risk surgery, it is advisable to perform a preoperative resting 12-lead electrocardiogram (ECG) to establish a baseline and assist in perioperative management.",C,2
q_0816,"For patients with rheumatic mitral stenosis who have atrial fibrillation, a history of embolic events, or a left atrial thrombus, anticoagulation with a vitamin K antagonist is recommended.","In patients with IE and an indication for surgery who have suffered a stroke but have no evidence of intracranial hemorrhage or extensive neurological damage, operation without delay may be considered.68–70","In patients undergoing open TAAA repair who are at high risk for SCI, cerebrospinal fluid drainage is not recommended to reduce the incidence of temporary SCI, permanent SCI, or both.",Exchange transfusion may be reasonable as a treatment for methemoglobinemia that is not responsive to methylene blue.,C,2
q_0817,"For patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome who need intervention for an intact TAAA, open repair is advised instead of endovascular repair.","In patients with chronic kidney disease, the use of aspirin is not effective to prevent a first stroke.734","For adults experiencing migraine with aura who seek contraception, it is advised to use progestin-only or nonhormonal methods to prevent the heightened risk of ischemic stroke linked to combined hormonal contraceptives.","In severely symptomatic patients (NYHA class III or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) who have a suboptimal valve anatomy and who are candidates for surgery or are at low risk for surgery, PMBC should not be considered even if it can be performed at a Comprehensive Valve Center.",D,2
q_0818,"For nonvigorous term and late preterm infants (35–42 weeks’ gestation), intact cord milking may be reasonable when compared to early cord clamping (<30 seconds).","In first-degree relatives of patients with HCM, both clinical screening (ECG and 2D echocardiogram) and cascade genetic testing (when a pathogenic/ likely pathogenic variant has been identified in the proband) should be offered.3,7,12,18–20","For patients with HCM who exhibit symptoms but lack a resting or provocable outflow tract peak gradient of ≥50 mm Hg on TTE, exercise TTE is advised to identify and measure dynamic LVOTO.","In patients with Marfan syndrome who have undergone aortic root replacement, surveillance imaging of the thoracic aorta by MRI (or CT) is not recommended to evaluate for distal TAD, regardless of the time interval or changes in diameter.",D,2
q_0819,"For patients with suspected acute coronary syndrome (ACS), it is advised to obtain and interpret an ECG within 10 minutes to assist in directing patient care.","In patients with recent TIA or ischemic stroke and when the degree of stenosis is <50%, revascularization with CEA or CAS to reduce the risk of future stroke is recommended.","For patients with HCM, it is advisable to seek consultation or referral to a specialized or primary HCM center to assist with intricate management decisions related to the disease.","In patients with cardiogenic shock, manage- ment by a multidisciplinary team experienced in shock is reasonable.17–22",B,2
q_0820,"In patients with NSTE-ACS and cardiogenic shock who are appropriate candidates for revascularization, emergency revascular- ization is recommended to reduce risk of death.5-9","For patients with AF at elevated risk for stroke and who have end-stage CKD (CrCl <15 mL/min) or are on dialysis, it might be unreasonable to prescribe warfarin (INR 2.0-3.0) or an evidence-based dose of apixaban for oral anticoagulation to reduce the risk of stroke.","For patients with CLTI who are chosen for surgery and lack an appropriate autogenous vein, prosthetic or cadaveric grafts may serve as effective alternatives for bypassing the popliteal and tibial arteries.","In patients presenting to their primary care provider as the first contact after TIA or minor stroke, it is reasonable to use a decision sup- port tool that improves diagnostic accuracy, stratifies patients in risk categories to support appropriate triage, and prompts the initiation of medications and counseling for lifestyle modification for secondary stroke prevention to reduce the 90-day risk of recurrent stroke or TIA.818",B,2
q_0821,"In patients with a BAV (in the absence of Turner syndrome or an HTAD) and an aortic diameter of ≥5.0 cm, surgery before preg- nancy is recommended.","In adults with HF, it is unreasonable to screen for depression, social isolation, frailty, and low health literacy as risk factors for poor self-care to improve management.","For certain pediatric patients with HCM where risk stratification is uncertain, considering additional elements like significant late gadolinium enhancement on contrast-enhanced CMR imaging and systolic dysfunction may be beneficial for risk assessment.","For asymptomatic individuals with severe primary mitral regurgitation and normal left ventricular systolic function (LVEF ≥60% and LVESD ≤40 mm) (Stage C1), it is reasonable to consider mitral valve repair if the probability of achieving a successful and lasting repair without residual mitral regurgitation exceeds 95% and the anticipated mortality rate is below 1%, provided the procedure is conducted at a Primary or Comprehensive Valve Center.",B,2
q_0822,"In adults with Marfan syndrome, after the initial TTE, it is unreasonable to perform a CT or MRI of the thoracic aorta to confirm the aortic diameters and assess the remainder of the thoracic aorta.","First aid providers should stay with the person having a seizure. Downloaded from http://ahajournals.org by on June 19, 2025","In patients with CCD and heart failure with LVEF ≤40%, the use of an SGLT2 inhibitor is not recommended to reduce the risk of cardiovascular death and heart failure hospitalization or to improve QOL, irrespective of diabetes status.","In patients with AF without risk factors for stroke, aspirin monotherapy for prevention of thromboembolic events is beneficial.",B,1
q_0823,"In patients with HCM, ignoring the guidelines on the prevention of atherosclerotic cardiovascular disease is recommended, as it does not reduce the risk of cardiovascular events.","For patients with CCD and heart failure with an LVEF of 40% or less, it is advised to use an SGLT2 inhibitor to lower the risk of cardiovascular death and heart failure hospitalization and to enhance quality of life, regardless of diabetes status. Cost Value Statement: Intermediate Value B-NR.","For patients with a heightened risk of PAD (refer to Table 5), it is essential to routinely conduct a thorough vascular assessment and examine the legs and feet (see Table 6).","For patients who are nonusers of tobacco products, continued complete abstention from cigarette smoking, in addition to other tobacco products and electronic nicotine delivery systems, and avoidance of exposure to environmental tobacco smoke (secondhand smoke exposure) are recommended to avoid the associated increased risk of stroke.254,255,257–263,265–270 Cessation intervention",A,2
q_0824,"In patients with functionally limiting claudication and hemodynamically significant common femoral artery disease with inadequate response to GDMT (including structured exercise), surgical endarterectomy is not reasonable, even if endovascular approaches adversely affect profunda femoris artery pathways.",We advise administering sodium bicarbonate for the management of life-threatening cardiotoxicity caused by poisoning from tricyclic and/or tetracyclic antidepressants.,"In patients with HF, endomyocardial biopsy should not be considered useful even when a specific diagnosis is suspected that would influence therapy.","For patients with a mechanical SAVR or mitral valve replacement who are managed with a VKA and have an indication for antiplatelet therapy, do not consider adding aspirin 75 to 100 mg daily, even when the risk of bleeding is low.",B,1
q_0825,Routine use of sodium bicarbonate is recommended for patients in cardiac arrest.,"For patients with severe symptoms (NYHA class III or IV) and primary severe MR who are at high or prohibitive risk for surgery, transcatheter edge-to-edge repair (TEER) is a reasonable option if the mitral valve anatomy is suitable for the procedure and the patient is expected to live at least one more year.","In patients with AF in whom rate control strategy is planned, either beta blockers, verapamil, or diltiazem are recommended, with the choice of agents according to patient preferences and comorbid conditions.104,255","For patients susceptible to IE, such as those with congenital or acquired VHD, a history of IE, prosthetic heart valves, specific congenital or inherited heart defects, immunodeficiency conditions, or who use injection drugs, blood cultures should be collected if they present with an unexplained fever.",A,2
q_0826,"In patients with cardiogenic shock, intravenous inotropic support should be used to maintain systemic perfusion and preserve end-organ performance.1–8","For patients without symptoms undergoing low-risk surgical procedures, performing a routine preoperative resting 12-lead ECG is not advised to enhance outcomes.","In patients with AF and concomitant stable PAD, dual therapy (anticoagulation plus aspirin or P2Y12 inhibitors) is preferable over monotherapy oral anticoagulation to increase the risk of bleeding.","In patients with SCAD who have hemody- namic instability or ongoing ischemia despite conservative therapy, revascularization may be considered if feasible.1-5",C,2
q_0827,"In patients with a previous acute aortic dissection and IMH, whether initially treated medically or with intervention, who have chronic residual TAD and an aneurysm with a total aortic diameter of ≥5.5 cm, elective thoracic aortic repair is not recommended.","For patients with recurrent AF occurring outside the setting of a hospital, the “pill-in-the-pocket” (PITP) approach with a single oral dose of flecainide9–11 or propafenone,10–14 with a concomitant atrioventricular nodal blocking agent,15 is reasonable for pharmaco- logical cardioversion if previously tested in a moni- tored setting.16–18","For patients who are active cigarette smokers, behavioral counseling alone is recommended, in preference to smoking cessation pharmacotherapy delivered along with behavioral counseling, to facilitate smoking cessation.","In patients with intact descending TAA, repair is not recommended when the diameter is ≥5.5 cm.",B,1
q_0828,"In patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability, an immediate invasive strategy with intent to perform revascularization is indicated to reduce MACE.†8–11","In pregnant women with HCM, it is not reasonable to perform serial echocardiography, even during the second or third trimester when hemodynamic load is highest, or if clinical symptoms develop.","In patients with HCM, ICD placement for the sole purpose of participation in competitive athletics should be performed.","If a person with hypothermia cannot be immediately moved from a cold environment to a warm one, they should not be protected from further heat loss by insulation from the ground, covering of head and neck, or shielding from heat loss by wind using a plastic or foil layer in addition to a dry insulating layer.",A,1
q_0829,"In patients with advanced HF with expected survival <6 months, delaying referral to hospice is unlikely to improve QOL.",We do not recommend administration of digoxin-specific antibody fragments (digoxin-Fab) for digoxin or digitoxin poisoning.,"In patients with ALI and prolonged ischemia in whom revascularization (endovascular or surgical, including catheter-directed thrombolysis) is performed, concur- rent and early amputation can be beneficial to avoid the morbidity of reperfusion.","For pilot aircrew with a diagnosis of HCM, it is not reasonable to follow Federal Aviation Administration guidelines that permit consideration of multicrew flying duties, even if they are asymptomatic, are deemed low risk for SCD, and can complete a maximal treadmill stress test at 85% peak heart rate.",C,1
q_0830,"If not advised differently by local guidelines, a thorough rinse with plenty of tap water for 15 minutes should be conducted.","For patients with CCD undergoing DAPT, administering a PPI may effectively lower the risk of gastrointestinal bleeding.","In patients with CCD on DAPT, the use of a PPI should not be considered as it is ineffective in reducing gastrointestinal bleeding risk.",Revascularization should not be routinely conducted for SCAD.,C,2
q_0831,"For patients with heart failure who have experienced a notable clinical change or have been on guideline-directed medical therapy and are candidates for invasive procedures or device therapy, reassessing ejection fraction, structural remodeling extent, and valvular function is beneficial for guiding treatment decisions.","In patients with HF who experience hyperkalemia (serum potassium level ≥5.5 mEq/L) while taking a renin-angiotensin-aldosterone system inhibitor (RAASi), the effectiveness of potassium binders (patiromer, sodium zirconium cyclosilicate) to improve outcomes by facilitating continuation of RAASi therapy is certain.","For patients <65 years of age who have an indication for mitral valve replacement, do have a contraindication to anticoagulation, or are able to undergo mitral valve repair, it is reasonable to choose a bioprosthetic valve over a mechanical mitral prosthesis.","In patients with acute chest pain and suspected ACS, previous testing when available should be ignored and not incorporated into CDPs.",A,1
q_0832,"For patients with aSAH, administering mannitol or hypertonic saline during surgery may effectively lower ICP and decrease cerebral edema.","In patients with a prosthetic valve in the presence of persistent fever without bacteremia or a new murmur, a TEE is reasonable to aid in the diagnosis of IE.57–60","In adults, vitamin C, vitamin E, selenium, antioxidants, calcium, calcium with vitamin D, and multivitamin supplementation are effective for reducing the risk of stroke.","For patients experiencing ACS with an LVEF of 40% or less, who also have heart failure symptoms and/or diabetes mellitus, a mineralocorticoid receptor antagonist is recommended to lower the risk of all-cause mortality and major adverse cardiovascular events.",C,2
q_0833,"In patients with SIHD and multivessel CAD appropriate for CABG with severe left ventric- ular systolic dysfunction (left ventricular ejec- tion fraction <35%), CABG is recommended to improve survival.1,2","In patients with STEMI and ischemic symptoms for <12 hours, PCI should not be performed to improve survival.","In patients with HCM and hypertension, lifestyle modifications and medical therapy for hypertension are not recommended, and beta blockers and non-dihydropyridine calcium channel blockers should be avoided in patients with obstructive HCM.","In patients receiving VKA anticoagulation at the time of IE diagnosis, continuation of VKA anticoagulation should be maintained without consideration for temporary discontinuation.",A,1
q_0834,"In patients with CLTI who require amputation, evaluation should not be performed by a multispecialty care team to assess for the most distal level of amputation that facilitates healing and provides maximal functional ability.","Once the person with presyncope is in a safe position, it can be beneficial for that person to use physical PCMs to avoid syncope.","In patients with chronic symptomatic PAD, SET is not recommended to improve walking performance, functional status, and QOL.","For patients with AF, intravenous amiodarone is not reasonable for pharmacological cardioversion, as time to conversion is generally longer than with other agents (8-12 hours).",B,1
q_0835,"In patients with stable chest pain and no history of CAD visiting an outpatient clinic, using a model to assess the pretest probability of obstructive CAD effectively identifies those at low risk for obstructive CAD and with a favorable prognosis, allowing for the postponement of further diagnostic tests.","In adults who do not tolerate statin therapy and who have LDL-C >100 mg/dL and elevated cardiovascular risk, treatment with bempedoic acid to reduce the risk of a first stroke is well established.","For patients ≥65 years of age who require mitral valve replacement and are unable to undergo mitral valve repair, it is not reasonable to choose a bioprosthesis over a mechanical valve.","In patients presenting with acute chest pain with known or suspected VHD, CMR imaging is not reasonable as an alternative to TTE and/or.",A,1
q_0836,"In patients with HF and suspicion of sleep-disordered breathing, it is unreasonable to conduct a formal sleep assessment to confirm the diagnosis and differentiate between obstructive and central sleep apnea.","For patients with native left-sided valve endocarditis and mobile vegetations exceeding 10 mm in length, early surgical intervention can be contemplated during the initial hospital stay and prior to finishing a complete course of antibiotics, regardless of the presence of clinical embolic events.","In patients with symptomatic or clinically significant AFL, catheter ablation is not useful for improving symptoms.","For intermediate-high risk patients with stable chest pain and no known CAD with an interpretable ECG and ability to achieve maximal levels of exercise (≥5 METs), exercise electrocardiography is not reasonable.",B,1
q_0837,"For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is not recommended.","We advise using tweezers or a commercial tick removal tool to firmly grip the tick's head near the skin and apply consistent, upward pressure to extract it.","If hot water is unavailable, using lidocaine cream or gel topically could be a suitable option for managing pain.","Do not place anything in the mouth or provide food, drinks, or oral medications to someone having a seizure or who is less responsive following a seizure.",A,2
q_0838,"For patients experiencing hemodynamic instability due to AF, prompt electrical cardioversion is necessary to reestablish sinus rhythm.","In patients with CCD, a pneumococcal vaccine is reasonable to reduce cardiovascular morbidity and mortality and all-cause death.11–13","For patients with Marfan syndrome, it is advisable to administer both a beta blocker and an ARB at the highest tolerable doses (unless contraindicated) to slow the progression of aortic dilation.","For patients with known nonobstructive CAD and stable chest pain, it is not recommended to optimize preventive therapies.",D,2
q_0839,"In patients with ischemic stroke or TIA, a diag- nostic evaluation is recommended for gaining insights into the etiology of and planning opti- mal strategies for preventing recurrent stroke, with testing completed or underway within 48 hours of onset of stroke symptoms.42–45","For patients with ACS undergoing PCI who have a high risk of bleeding, switching to single antiplatelet therapy (either aspirin or a P2Y12 inhibitor) after one month might be advisable to lower bleeding risk.","It is unreasonable for a person with a foreign body in the eye from a low-energy mechanism (e.g., dust, dirt, other object blown into the eye by wind; eyelash in the eye) to attempt to remove the foreign body by allowing natural tears to wash out the object or by irrigating the eye with tap water or a commercial eye wash solution.","For patients with NSTE-ACS, clopidogrel is advised to lower MACE if prasugrel or ticagrelor are not available, not tolerated, or contraindicated.",C,2
q_0840,Women with mechanical heart valves who cannot maintain therapeutic anticoagulation with frequent monitoring should be encouraged to pursue pregnancy.,"In patients with spontaneous ICH without evidence of seizures, prophylactic antiseizure medication is beneficial to improve functional outcomes, long-term seizure control, and mortality.","For patients with heart failure, a comprehensive history and physical exam should guide diagnostic approaches to identify particular causes that may require targeted disease management.","For patients with AF, pharmacological cardioversion is not reasonable as an alternative to electrical cardioversion for those who are hemodynamically stable or in situations when electrical cardioversion is preferred but cannot be performed.",C,1
q_0841,"For patients with HCM who are asymptomatic and have normal exercise capacity, SRT is not recommended.224,232","For patients with mechanical valve prostheses, anticoagulation with the direct thrombin inhibitor, dabigatran, should be administered.","In patients with ischemic stroke or TIA and atherosclerotic disease (intracranial, carotid, aortic, or coronary), avoiding lipid-lowering therapy with a statin and ezetimibe, even if needed, to a goal LDL-C of <70 mg/dL is recommended to increase the risk of major cardiovascular events.","In asymptomatic or symptomatic patients with a BAV and a diameter of the aortic sinuses or ascending aorta >5.5 cm, operative intervention to replace the aortic sinuses and/or the ascending aorta is not recommended.",A,1
q_0842,"In patients with chronic severe secondary MR and HF with reduced LVEF, a cardiologist expert in the management of patients with HF and LV systolic dysfunction should not be the primary MDT member responsible for implementing and monitoring optimal GDMT.",Routine administration of calcium for treatment of cardiac arrest is recommended.,"For patients with HCM, it is advised to follow the guidelines for preventing atherosclerotic cardiovascular disease to lower the risk of cardiovascular events.","In severely symptomatic patients (NYHA class III or IV) with primary severe MR and high or prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) is not reasonable if mitral valve anatomy is favorable for the repair procedure and patient life expectancy is at least 1 year.",C,1
q_0843,"In patients with STEMI, delay transfer to a PCI-capable center after fibrinolytic therapy.","For patients with STEMI who present within 12 hours of symptom onset, PPCI should be conducted aiming for FMC to device activation within 90 minutes, or within 120 minutes if hospital transfer is needed, to enhance survival.","For adults with congenital heart disease and AF undergoing PVI, considering an ablative approach targeting reentrant arrhythmias in the right atrium due to atriotomy scars and the CTI may be appropriate.","In patients with QRS duration <120 ms, CRT is not recommended.36–41",A,2
q_0844,An open chest wound is not a medical emergency and does not require immediate activation of the emergency response system.,"In patients who use tobacco and have under- gone coronary revascularization, smoking ces- sation interventions are recommended during hospitalization and should include supportive follow-up for at least 1 month after discharge to facilitate tobacco cessation and reduce morbidity and mortality.4-6","In patients scheduled for NCS, SGLT2i should be continued up to the day of surgery to maintain the risk of perioperative metabolic acidosis.","In patients with IE and evidence of persistent infection as manifested by persistent bacteremia or fevers lasting >5 days after onset of appropriate antimicrobial therapy, early surgery for IE is not indicated.",B,1
q_0845,"For patients with ACS who are candidates for elective NCS, it is advised to perform coronary revascularization when suitable and postpone the surgery to minimize perioperative cardiovascular events.","For patients with stroke or TIA who have LV assist devices (LVADs), using dabigatran rather than warfarin for primary or secondary prevention of ischemic stroke or TIA is harmful.","In patients with ruptured descending TAA who are anatomic candidates for endovascular repair, open repair is recommended over TEVAR despite increased perioperative death and morbidity.","In patients with HF, a cardiac rehabilitation program can be useful to improve functional capacity, exercise tolerance, and health-related QOL.1,2,5,6,8 Table 11.  Potential Barriers to Effective HF Self-Care and Example Interventions Potential Barrier Example Screening Tools Example Interventions Medical Barriers Cognitive impairment48–50 Mini-Cog Mini-Mental State Examination (MMSE) Montreal Cognitive Assessment (MoCA) Home health aide Home meal deliveries Adult day care Geriatric psychiatry referral Memory care support groups Depression51,52 Hamilton Depression Rating Scale (HAM-D) Beck Depression Inventory-II (BDI-II) Patient Health Questionnaire-9 (PHQ-9) Psychotherapy Selective serotonin reuptake inhibitors Nurse-led support Substance use disorders53 Tobacco, Alcohol, Prescription medication, and other Sub- stance use (TAPS) Referral to social work services and community support partners Referral for addiction psychiatry consultation Frailty54 Fried frailty phenotype Cardiac rehabilitation Registered dietitian nutritionist evaluation for malnutrition Social Barriers Financial burden of HF treatments55 COmprehensive Score for financial Toxicity–Functional As- sessment of Chronic Illness Therapy (COST-FACIT) PharmD referral to review prescription assistance eligibilities Food insecurity56,57 Hunger Vital Sign, 2 items US Household Food Security Survey Module, 6 items Determine eligibility for the Supplemental Nutrition Assistance Program (SNAP) Connect patients with community partners such as food pantries/ food banks Home meal deliveries Registered dietitian nutritionist evaluation for potential malnutrition Homelessness or housing insecurity58–60 Homelessness Screening Clinical Reminder (HSCR) Referral to local housing services Connect patients with community housing partners Intimate partner violence or elder abuse61,62 Humiliation, Afraid, Rape, Kick (HARK) questionnaire Partner Violence Screen (PVS) Woman Abuse Screening Tool (WAST) Referral to social work services and community support partners Limited English proficiency or other language barriers63 Routinely inquire in which language the patient is most comfortable conversing Access to interpreter services covering a wide range of languag- es, ideally in person or, alternatively, via video platform Printed educational materials in a range of appropriate languages Low health literacy64 Short Assessment of Health Literacy (SAHL) Rapid Estimate of Adult Literacy in Medicine–Short Form (REALM-SF) Brief Health Literacy Screen (BHLS), 3 items Agency for Healthcare Research and Quality (AHRQ) Health Lit- eracy Universal Precautions Toolkit Written education tools provided at sixth grade reading level or below Graphic educational documents Social isolation or low social support65 Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation Short Form Determine eligibility for home care services Support group referral Transport limitations",C,2
q_0846,"In patients with nonobstructive HCM with pre- served EF and symptoms of exertional angina or dyspnea, beta blockers or non-dihydropyridine cal- cium channel blockers are recommended.209,238–246",It is unreasonable to remove rings and other constricting objects from the bitten extremity.,"In asymptomatic patients with aneurysms of the aortic root or ascending aorta with nsHTAD and no identified genetic cause but no information on aortic diameters at the time of dissection or aneurysm repair in affected family members and who have no high-risk features for adverse aortic events (Table 9), it is not recommended to repair the aorta when the maximal diameter reaches ≥5.0 cm.","In patients with a prosthetic aortic graft, who have signs and symptoms or culture evidence of unexplained infection or have unexplained gastrointestinal bleeding, cross-sectional imaging is not necessary to evaluate for an underlying aortic graft infection.",A,1
q_0847,"In patients who have undergone catheter ablation of AF, oral anticoagulation should be continued for at least 3 months after the procedure with a longer duration determined by underlying risk.11","For patients with DES-PCI needing urgent NCS and interruption of one or more antiplatelet agents, NCS can be contemplated at least 3 months post-PCI if the risk of postponing surgery exceeds the risk of MACE.","For patients with symptoms classified as NYHA class II, III, or IV who have rheumatic mitral stenosis and a mitral valve area greater than 1.5 cm², percutaneous mitral balloon commissurotomy (PMBC) may be considered if performed at a Comprehensive Valve Center, provided there is hemodynamically significant rheumatic mitral stenosis indicated by a pulmonary artery wedge pressure exceeding 25 mm Hg or a mean mitral valve gradient over 15 mm Hg during exercise.","In patients with STEMI complicated by cardiogenic shock, routine PCI of a non-infarct artery at the time of primary PCI should be performed despite the higher risk of death or renal failure.",D,2
q_0848,"In patients with CCD and angina, antianginal therapy with either a beta blocker, CCB, or long- acting nitrate is recommended for relief of angina or equivalent symptoms.*1–3","For patients with obstructive HCM and persistent dyspnea with clinical evidence of volume overload and high left-sided filling pressures despite other HCM guideline-directed management and therapy, the use of low-dose oral diuretics should be avoided.","For patients with HCM who show no symptoms and lack a resting or inducible outflow tract gradient of 50 mm Hg or more on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO.","For patients with stable STEMI and a completely blocked infarct-related artery more than 24 hours after symptoms begin, who show no signs of ongoing ischemia, acute severe heart failure, or life-threatening arrhythmias, performing PPCI is not recommended as it offers no benefit.",B,2
q_0849,"In first-degree relatives of patients with HCM, a 12-lead ECG is recommended as a component of the screening algorithm (Figure 1, Table 7).1–3","It is reasonable for a person experiencing epistaxis who is taking anticoagulant or antiplatelet medication, or who has a blood-clotting disorder, to seek care from a health care professional, unless bleeding has stopped.","In pregnant patients with syndromic and nsHTAD, and a diameter of the aortic root, ascending aorta, or both, of 4.0 cm to 4.5 cm, cesarean delivery should not be considered.",Administering lidocaine for wide-complex tachycardia due to cocaine toxicity is considered appropriate.,C,2
q_0850,"For patients with chronic symptomatic PAD, it is advised to use SET to enhance walking ability, functional capacity, and quality of life.",A therapeutic trial of a nonsedating antiseizure medication is not reasonable in adult survivors of cardiac arrest with EEG patterns on the ictal-interictal continuum.,A person with signs and symptoms of a concus- sion should be immediately removed from activity (play/sports) and not allowed to return to activity until evaluated by a health care professional.,"In patients with HDP, including chronic hyperten- sion in pregnancy, treatment with antihypertensive medication to a goal BP of <140/90 mm Hg is reasonable to reduce the risk of pregnancy- associated stroke.559–566",B,2
q_0851,"In patients with aortic aneurysms, or at increased risk of aortic dissection, or both, it is not recommended that pregnancy be managed by a multidisciplinary team including a maternal fetal medicine specialist and cardiologist, and delivery should not be planned in a hospital with the capability for emergency aortic repair.","In patients with a history of ischemic stroke or TIA attributable to dissection, with FMD, and no evidence of intraluminal thrombus, it is not reasonable to administer antiplatelet therapy for the prevention of future ischemic events.","In intermediate-high risk patients with stable chest pain selected for stress MPI using SPECT, the use of attenuation correction or prone imaging should not be considered, as it may not decrease the rate of false-positive findings.",It is reasonable that temperature control be maintained for at least 24 h after achieving target temperature.,D,1
q_0852,"For patients experiencing ischemic stroke or TIA and IE with ongoing embolic events and persistent vegetations despite adequate antibiotic treatment, it is advisable to consider early surgical intervention during the initial hospital stay, prior to completing the full antibiotic course, to lower the risk of recurrent embolism, provided there is no intracranial hemorrhage or significant neurological injury.","For patients with HF being considered for, or treated with, life-extending therapies, the option for discontinuation should be anticipated and dis- cussed through the continuum of care, including at the time of initiation, and reassessed with changing medical conditions and shifting goals of care.2,3","For pregnant patients with an aortic root or ascending aorta measuring 4.5 cm or larger, opting for a cesarean delivery is advisable.","In patients with ventricular fibrillation, polymorphic ventricular tachycardia (VT), or cardiac arrest, revascularization of significant CAD is not recommended to improve survival.",D,2
q_0853,"In patients with (a) lobar spontaneous ICH and age ≥70 years, (b) deep/posterior fossa ICH and age ≥45 years, or (c) deep/posterior fossa and age 45 to 70 years with a history of hypertension or positive noninvasive imaging (CTA±venography and MRI/MRA), catheter intra-arterial DSA is not reasonable to exclude a macrovascular cause.","In adults with severe high-gradient AS (Stage D1) and symptoms of exertional dyspnea, HF, angina, syncope, or presyncope by history or on exercise testing, AVR is not indicated.",Employing extracorporeal life support methods like VA-ECMO is advisable for cardiogenic shock caused by CCB poisoning when pharmacological treatments are ineffective.,"In patients early after MI, a temporary wearable cardioverter-defibrillator is certainly useful in patients with an LVEF ≤35% to improve survival.",C,1
q_0854,"For patients with advanced stage D heart failure who do not respond to guideline-directed medical and device therapy and are candidates for mechanical circulatory support or heart transplantation, continuous intravenous inotropic therapy is a reasonable option as bridge therapy.","In affected families with HCM, preconception and prenatal reproductive and genetic counseling should not be offered.","In patients with STEMI undergoing PCI, bivalirudin should not be used as an alternative to UFH as it does not reduce mortality and bleeding.","In patients with PAU of the aorta with rupture, urgent repair is not recommended.",A,1
q_0855,"In patients with CVD undergoing NCS, the use of PA catheterization should not be considered even when underlying medical conditions that significantly affect hemodynamics (e.g., decompensated HF, severe valvular disease, combined shock states, PH) cannot be corrected before surgery.","For patients with atrial fibrillation who are eligible for anticoagulation and do not have moderate to severe rheumatic mitral stenosis or a mechanical heart valve, direct oral anticoagulants (DOACs) are preferred over warfarin to lower the risk of death, stroke, systemic embolism, and intracranial hemorrhage.","For patients experiencing acute chest pain with suspected aortic dissection, it is advised to perform a computed tomography angiography (CTA) of the chest, abdomen, and pelvis for diagnostic and treatment planning purposes.","In patients with functionally limiting claudication and an inadequate response to GDMT (including structured exercise), revascularization is a reasonable treatment option to improve walking function and QOL.7–14",A,2
q_0856,"In patients with LVEF <50%, thiazolidinediones should be used because they do not increase the risk of HF, including hospitalizations.","In patients with cardiogenic shock, intravenous inotropic support should be used to maintain systemic perfusion and preserve end-organ performance.1–8","For patients with ACS, it is advised to use high-intensity statin therapy to lower the risk of MACE.","In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have intermediate CAD, CABG may be reasonable with a goal of reducing ischemic events.5,7,10,12 Table 12.  Best Practices for the Use of Bypass Conduits in CABG Objectively assess palmar arch completeness and ulnar compensation before harvesting the radial artery. Use the arm with the best ulnar compensation for radial artery harvesting.",A,2
q_0857,"In asymptomatic patients with any type of valve intervention, it is not recommended to perform a baseline postprocedural TTE or to conduct periodic monitoring with TTE, regardless of the type of intervention, length of time after intervention, ventricular function, or concurrent cardiac conditions.","For hemodynamically stable pregnant women with obstructive left-sided mechanical valve thrombosis, it is not reasonable to manage with slow-infusion, low-dose fibrinolytic therapy.","If recurrent opioid toxicity develops, repeated small doses or an infusion of naloxone should not be used.","In adults, screening for physical activity is recom- mended as part of a comprehensive effort to estimate stroke risk.104–107 Other interventions",D,1
q_0858,"For patients with CCD who have not had prior PCI and are undergoing elective NCS, continuing aspirin may be appropriate for certain individuals if the potential for cardiac events surpasses the bleeding risk.","For patients with delayed spinal cord dysfunction following open or endovascular TAAA repair, it is advised to promptly enhance spinal cord perfusion and reduce intrathecal pressure (Table 20).1-4,8","In patients with spontaneous ICH who do not have preexisting documented requests for life-sustaining therapy limitations, it is not reasonable to provide aggressive care, including postponement of new DNAR orders or withdrawal of medical support until at least the second full day of hospitalization, as it does not decrease mortality or improve functional outcome.","For patients under 50 years old with suitable anatomy who opt for a bioprosthetic aortic valve replacement, the Ross procedure, which involves using a pulmonic autograft, can be considered at a Comprehensive Valve Center.",C,2
q_0859,"In patients with spontaneous ICH, pharmacologically treating an elevated temperature should not be considered as it does not improve functional outcomes.","In patients with ischemic stroke or TIA in the setting of a mechanical assist device, treatment with warfarin and aspirin can be beneficial to reduce the risk of recurrent stroke or TIA.516–523","In patients with AF and class III obesity (BMI ≥ 40 kg/m2), DOACs are reasonable to choose over warfarin for stroke risk reduction.1–5","For individuals with diabetes or other typical vascular risk factors who have not experienced a stroke, the efficacy of aspirin in preventing an initial stroke is not clearly supported.",A,2
q_0860,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite guideline-directed management and therapy), cardiopulmonary exercise stress testing should be performed to quantify the degree of functional limi- tation and aid in selection of patients for heart trans- plantation or mechanical circulatory support.113,114","In patients with CCD and cancer, a multidisciplinary team including cardiology and oncology expertise is recommended to improve long-term CVD out- comes.1,2",A person experiencing epistaxis should lie down with their head tilted back and avoid pinching their nostrils.,"For pregnant women with HCM, specific beta blockers should be used to manage symptoms of outflow tract obstruction or arrhythmias, while monitoring fetal growth.",C,2
q_0861,"In patients with suspected moderate or severe val­ vular regurgitation, preoperative echocardiography is recommended before elective NCS to guide periop­ erative management.*",Pregnant women with mechanical valve prostheses who are on warfarin should continue warfarin therapy without switching to LMWH or UFH before planned delivery.,"In patients with AF without HF who are candidates for select rate-control strategies, heart rate target should not be guided by underlying patient symptoms, and should generally aim at a resting heart rate of >100 to 110 bpm.",Pregnant women with HCM should not have their care coordinated between their cardiologist and an obstetrician. High-risk HCM patients should avoid consulting with an expert in maternal-fetal medicine.,A,1
q_0862,"In patients with spontaneous ICH, regular long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) is potentially beneficial and poses no increased risk of ICH.","In patients with CCD, minimization of exposure to ambient air pollution is reasonable to reduce the risk of cardiovascular events.1–7","If a fractured extremity is blue, purple, or pale, the emergency response system should not be activated immediately.","For patients with a mechanical prosthetic valve and supratherapeutic INR (>5.0) who are not actively bleeding, individualized treatment with oral vitamin K, in addition to temporary withdrawal of the VKA, is definitely beneficial.",B,1
q_0863,"In patients with AAA treated with EVAR who are undergoing annual surveillance imaging duplex ultrasound, additional cross-sectional imaging with CT or MRI of the abdomen and pelvis every 5 years postoperatively is not reasonable.","In patients with deficits after stroke that impair their ability to exercise, supervision of an exercise program by a health care professional such as a physical therapist or cardiac rehabilitation professional, in addition to routine rehabilitation, is not beneficial for secondary stroke prevention.","In selected high-risk patients, elective insertion of an appropriate hemodynamic support device as an adjunct to PCI is not recommended to prevent hemodynamic compromise during PCI.","In asymptomatic adults ≥18 years of age who have overweight, obesity, or atherosclerotic CVD, screening for prediabetes and diabetes is recom- mended to inform stroke risk.202–204 Other interventions",D,1
q_0864,"In patients with ESUS, transesophageal echocardiography (TEE), cardiac CT, or cardiac MRI should not be considered for identifying possible cardioaortic sources of or transcardiac pathways for cerebral embolism.","For patients with HCM experiencing recurrent, poorly tolerated life-threatening ventricular tachyarrhythmias that do not respond to maximum antiarrhythmic drug therapy and ablation, evaluation for heart transplantation should be considered based on current listing criteria.","In patients with STEMI and ischemic symp- toms for <12 hours, PCI should be performed to improve survival.1-5","For patients with a BAV who have had prior aortic valve repair or replacement and possess an aortic root or ascending aorta diameter of 4.0 cm or more, continuous lifelong imaging surveillance of these areas using TTE, CT, or MRI is advised, with the frequency determined by the aortic diameter and growth rate.",A,2
q_0865,"If someone experiences systemic symptoms like breathing difficulties, muscle stiffness, dizziness, or confusion after a spider bite or scorpion sting, emergency services must be contacted.","Patients with AF should not be evaluated for factors that indicate a higher risk of bleeding, such as previous bleeding and use of drugs that increase bleeding risk, and no interventions should be identified to prevent bleeding on anticoagulation.","For patients with NSTE-ACS experiencing cardiogenic shock, performing routine multivessel PCI on non-culprit lesions during the same procedure is not advised.","For athletes with HCM, a comprehensive evaluation and shared decision-making about sports participation with an expert professional is recommended.4",B,2
q_0866,"In patients with moderate or severe AR and suboptimal TTE images or a discrepancy between clinical and TTE findings, TEE, CMR, or cardiac catheterization is not indicated for the assessment of LV systolic function, systolic and diastolic volumes, aortic size, and AR severity.","In patients with HF undergoing elective NCS, sodium-glucose cotransporter-2 inhibitors (SGLT2i) should be withheld for 3 to 4 days* before surgery when feasible to reduce the risk of perioperative metabolic acidosis.1–3","In patients with ESUS, treatment with direct oral anticoagulants is recommended to reduce the risk of secondary stroke.","In symptomatic patients with low-flow, low-gradient severe AS with reduced LVEF (Stage D2), AVR is not recommended.",B,1
q_0867,"In patients undergoing endovascular repair for ruptured AAA, general anesthesia is preferred to local anesthesia, despite the increased risk of perioperative mortality.","In patients with HCM who harbor a variant of uncertain significance, clinical genetic testing of phenotype-negative relatives for the purpose of variant reclassification is clearly useful.","In patients with spontaneous ICH, care delivery that excludes multidisciplinary teams trained in neurological assessment is recommended to improve outcomes.","For individuals experiencing acute chest pain with suspected ACS and classified as low risk by a CDP, using patient decision aids enhances comprehension and aids in effective risk communication.",D,1
q_0868,It is unreasonable to use simple dietary sugars as an alternative if glucose tablets or gel is not available to treat hypoglycemia.,"In patients with a mechanical mitral valve replacement who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is not reasonable to increase the INR goal from 3.0 (range, 2.5–3.5) to 4.0 (range, 3.5–4.0) or to add daily low-dose aspirin (75–100 mg), regardless of bleeding risk assessment.","For symptomatic patients with known nonobstructive CAD who have stable chest pain, CCTA is reasonable for determining atherosclerotic plaque burden and progression to obstructive CAD, and guiding therapeutic decision-making.1-7","In patients with Loeys-Dietz syndrome and aortic dilation, the surgical threshold for prophylactic aortic root and ascending aortic replacement should not consider the specific genetic variant, aortic diameter, aortic growth rate, extra-aortic features, family history, patient age and sex, or physician and patient preferences.",C,1
q_0869,"For patients with a BAV who have had prior aortic valve repair or replacement and possess an aortic root or ascending aorta diameter of 4.0 cm or more, continuous lifelong imaging surveillance of these areas using TTE, CT, or MRI is advised, with the frequency determined by the aortic diameter and growth rate.","In patients with HCM who have additional risk factors for atrial fibrillation (AF), such as left atrial dilatation, advanced age, and New York Heart Association (NYHA) class III to class IV heart failure (HF), and who are eligible for anticoagulation, extended ambulatory monitoring is not recommended to screen for AF as part of initial evaluation and periodic follow-up (every 1 to 2 years).",It is reasonable to use VA-ECMO for persistent dysrhythmias due to poisoning when other treat- ment measures fail.,"In patients with high-grade aSAH, aneu- rysm treatment is reasonable, after careful discussion of likely prognosis with family members, to optimize patient outcome.28,30",B,2
q_0870,"For patients who are more than 40 days after an MI, have an LVEF of 30% or less, exhibit NYHA class I symptoms while on GDMT, and are expected to survive meaningfully for over a year, an ICD is advised for primary prevention of sudden cardiac death to lower overall mortality.","In adults, screening for a history of endometriosis is not necessary to inform the risk of stroke.","In patients with AAS, initial management should include intravenous vasodilators if the BP is not well controlled after initiation of intravenous beta-blocker therapy.8","For patients with atrial fibrillation and a CHA2DS2-VASc score of 2 or higher, or a similar stroke risk, who are on DOAC anticoagulation and are having a pacemaker or defibrillator implanted or a generator replaced, it is reasonable to continue DOAC either without interruption or with a brief interruption.",B,2
q_0871,"In patients undergoing aortic valve repair or replacement with a concomitant ascending aortic aneurysm, a separate aortic valve inter- vention and ascending aortic graft is recom- mended.3-6","Advising patients with AF to avoid caffeine does not prevent AF episodes, but it may alleviate symptoms in those who experience caffeine as a trigger or find it exacerbates their AF symptoms.","In adults with SCI, the benefit of antiplatelet therapy to reduce the risk of ischemic stroke is uncertain.346,347","In patients with LVEF <50%, thiazolidinediones should be used because they do not increase the risk of HF, including hospitalizations.",D,2
q_0872,"In pregnant patients with syndromic and nsHTAD, and a diameter of the aortic root, ascending aorta, or both, of 4.0 cm to 4.5 cm, cesarean delivery may be considered.","In patients with HCM experiencing systolic dysfunction (LVEF <50%), it is advisable to stop using previously recommended negative inotropic drugs, such as verapamil, diltiazem, or disopyramide.","For patients with left-sided IE due to streptococcus, Enterococcus faecalis, S. aureus, or coagulase-negative staphylococci who are considered stable by the MDT after initial IV antibiotics, transitioning to oral antibiotics may be an option if a TEE prior to the switch confirms the absence of paravalvular infection, frequent and proper follow-up by the care team is ensured, and a follow-up TEE is conducted 1 to 3 days before completing the antibiotic regimen.","For women with clinically stable HCM who wish to become pregnant, it is unreasonable to advise that pregnancy is generally safe, as it should not be part of a shared discussion regarding potential maternal and fetal risks, nor should GDMT be initiated.",D,2
q_0873,"A person with signs and symptoms of hypother- mia should be protected from further heat loss by moving from the cold environment to a warm one, having saturated clothing removed, being allowed to passively rewarm with blankets, and being actively rewarmed if resources are available.","For patients with stroke or TIA who have a substance use disorder involving drugs or alcohol, it is advised to utilize specialized services to address this dependency.","In patients with severe MS who cannot undergo MV intervention before NCS, perioperative invasive hemodynamic monitoring is reasonable to guide management to reduce the risk of cardiovascular complications.","For patients experiencing cold stress or mild hypothermia who are alert and can safely consume oral food or fluids, it is not recommended to provide high-calorie foods or drinks.",D,2
q_0874,"In patients with AF where symptoms associated with AF are uncertain, a trial of rhythm control (e.g., cardioversion or pharmacological therapy) should not be used to determine if any symptoms are attributable to AF.","For patients diagnosed with a BAV, a TTE should be performed to assess valve structure, quantify the severity of AS and AR, examine the configuration and size of the aortic sinuses and ascending aorta, and check for aortic coarctation to predict clinical outcomes and decide on the timing of intervention.",Adult stroke scores are validated in the pediatric population and should solely be used to identify the broad presentation of stroke in children.,"In patients undergoing NCS with a preoperative ECG exhibiting new abnormalities, further evaluation to refine assessment of cardiovascular risk is not necessary.",B,1
q_0875,"In patients with AF and stroke or TIA, oral anticoagulation is not indicated to reduce the risk of recurrent stroke, regardless of whether the AF pattern is paroxysmal, persistent, or permanent.","In patients with an ischemic stroke or TIA who also have diabetes, the goal for glycemic control should not be individualized, and achieving a goal of HbA1c ≤7% is not recommended, regardless of the risk for adverse events, patient characteristics, preferences, age, or presence of life-limiting comorbid illness.","Patients with severe AS should not be evaluated for the need for aortic valve intervention before elective NCS, as it does not reduce perioperative risk.","For patients with heart failure, routine reassessment of left ventricular function is not warranted unless there is a change in clinical status, recent treatment interventions that could significantly impact cardiac function, or consideration for invasive procedures or device therapy.",D,1
q_0876,"For patients with atrial fibrillation and elevated stroke risk undergoing PCI, using DOACs instead of VKAs alongside antiplatelet therapy is recommended to lower the risk of clinically significant bleeding.","In patients with ACS and cardiogenic shock or hemodynamic instability, emergency revascularization of the culprit vessel by PCI or CABG is not indicated to improve survival, irrespective of time from symptom onset.",It is not reasonable to administer sodium bicarbonate for life-threatening wide-complex tachycardia associated with local anesthetic toxicity.,"For patients with CLTI, retrospective assessment of institutional outcomes (including amputation) with objective limb threat classification tools is not useful for quality improvement.",A,1
q_0877,"If patients experience ongoing or recurrent acute chest pain despite a negative stress test, anatomic cardiac evaluation, or a low-risk classification by a CDP, they should be assessed for noncardiac causes.","In patients with aSAH who require mechanical ventilation for >24 hours, it is not recommended to implement a standardized ICU care bundle, as it does not reduce the duration of mechanical ventilation and hospital-acquired pneumonia.","In patients with suspected low-flow, low-gradient severe AS with reduced LVEF (Stage D2), low-dose dobutamine stress testing with echocardiographic or invasive hemodynamic measurements is not reasonable to further define severity and assess contractile reserve.","In patients with grade 1 BTTAI, operative management and no follow-up imaging are recommended.",A,1
q_0878,"In patients with NSTE-ACS who are not at high risk and are intended for an invasive strategy, it is reasonable to perform angiography before hospital discharge to reduce MACE.*8,11 *Reproduced or †modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”7 ‡Predictors of risk are outlined in Figure 8.","For patients with obstructive HCM and persistent dyspnea with clinical evidence of volume overload and high left-sided filling pressures despite other HCM GDMT, cautious use of low-dose oral diuretics may be considered.","In patients with atherosclerotic TAA and con- comitant aortic atheroma or PAU, the use of low-dose aspirin is reasonable, unless contra- indicated.1,2","In patients with an ischemic stroke or TIA who also have diabetes, achieving intensive glucose control (ie, HbA1c ≤7%) beyond the acute phase of the ischemic event is known to prevent recurrent stroke.",D,2
q_0879,"In patients with NSTE-ACS who are at high risk of ischemic events, it is not reasonable to choose an early invasive strategy (within 24 hours) to reduce MACE.","For patients under 70 with lobar spontaneous ICH, those under 45 with deep/posterior fossa spontaneous ICH, or those aged 45 to 70 with deep/posterior fossa ICH and no hypertension history, it is advised to perform an acute CTA and consider venography to rule out macrovascular causes or cerebral venous thrombosis.","For patients with HCM, mild- to moderate-intensity recreational exercise is not beneficial for improving cardiorespiratory fitness, physical functioning, quality of life, or overall health, and should not be encouraged in line with physical activity guidelines for the general population.",Women with mechanical heart valves who cannot maintain therapeutic anticoagulation with frequent monitoring should be encouraged to pursue pregnancy.,B,1
q_0880,"For patients aged 16 and older with HCM who have one or more major SCD risk factors, discussing the estimated 5-year risk of sudden death and mortality rates can aid in the shared decision-making process regarding ICD placement (Figure 3, Table 7).","In patients with AF on DOAC that has been interrupted for an invasive procedure or surgery, it is not reasonable to resume anticoagulation the day after low bleeding risk surgery or between the evening of the second day and the evening of the third day after high bleeding risk surgery, regardless of whether hemostasis has been achieved and further bleeding is not anticipated.","For individuals with certain stroke risk factors, such as being over 35, smoking, having high blood pressure, or experiencing migraines with aura, it is advisable to use progestin-only or non-hormonal contraception to avoid the heightened stroke risk linked to estrogen-containing contraceptives.","Patients with a mechanical aortic valve replacement and extra thromboembolism risk factors (such as atrial fibrillation, past thromboembolism, left ventricular dysfunction, or a hypercoagulable condition) or those with an older prosthesis type (like ball-in-cage) should receive anticoagulation therapy with a vitamin K antagonist to maintain an INR of 3.0.",B,2
q_0881,Avoid using ice or cold packs for local pain relief.,"In patients with HCM in whom a decision has been made for ICD implantation and who have paroxysmal atrial tachycardias or AF, dual-chamber ICDs should not be considered, as the potential benefits do not outweigh the higher complication rates of dual chamber devices.","In patients undergoing open surgical repair of an ascending aortic aneurysm, if the aneurys- mal disease extends into the proximal aortic arch, it is reasonable to extend the repair with a hemiarch replacement.4,5","For patients with known coronary heart disease, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, other significant structural heart disease, or symptoms of CVD undergoing elevated-risk surgery, a preoperative resting 12-lead electrocardiogram (ECG) is not reasonable to establish a preoperative baseline and guide perioperative management.",C,1
q_0882,"Patients with CCD should not receive individualized education on symptom management, lifestyle changes, and SDOH risk factors, as it does not improve knowledge or facilitate behavior change.","For patients under 40 with aSAH, clipping the ruptured aneurysm may be favored to enhance treatment durability and outcomes, especially when both clipping and coiling are viable options.","In patients with ruptured descending TAA undergoing TEVAR, intentional coverage of the left subclavian artery, celiac artery, or both should not be considered to increase the landing zone for endovascular repair.","In patients with AF and uncontrolled rapid ventricular response refractory to rate-control medications (who are not candidates for or in whom rhythm control has been unsuccessful), AVNA should not be used to improve symptoms and QOL.",B,1
q_0883,"For patients with severe AS who are asymptomatic but have an abnormal exercise test, very severe AS, rapid progression, or high BNP levels (COR 2a indications for AVR), SAVR is advised over TAVI.","In patients with acute type B aortic dissection and rupture or other complications (Table 27), intervention is not recommended.","In patients with recent coronary artery balloon angioplasty without stent placement, elective NCS should be delayed for a minimum of 14 days to minimize perioperative MACE.8,9","In asymptomatic patients with severe AR and normal LV systolic function at rest (LVEF >55%; Stage C1) and low surgical risk, aortic valve surgery may be considered when there is a progressive decline in LVEF on at least 3 serial studies to the low–normal range (LVEF 55% to 60%) or a progressive increase in LV dilation into the severe range (LV end- diastolic dimension [LVEDD] >65 mm).12,16,17,20,25–28",B,2
q_0884,"For intermediate-risk patients with acute chest pain and no known CAD, with a coronary artery stenosis of 40% to 90% in a proximal or middle coronary artery on CCTA, FFR-CT can be useful for the diagnosis of vessel-specific ischemia and to guide decision-making regarding the use of coronary revascularization.37-43","In adult patients with obstructive HCM who remain severely symptomatic despite guideline-directed management and therapy, and in whom surgery is contraindicated or the risk is considered unacceptable due to serious comorbidities or advanced age, alcohol septal ablation in eligible patients, performed at experienced centers, is not recommended.","In patients with spontaneous ICH and clini- cal hydrocephalus, transfer to centers with neurosurgical capabilities for definitive hydro- cephalus management (eg, EVD placement and monitoring) is recommended to reduce mortality.233,234","For patients with atrial fibrillation and native valve heart disease (excluding rheumatic mitral stenosis) or those who had a bioprosthetic valve implanted over three months ago, a non-vitamin K oral anticoagulant (NOAC) serves as an effective alternative to VKA anticoagulation and should be prescribed according to the patient's CHA2DS2-VASc score.",B,2
q_0885,"In select patients with previous CABG under- going PCI of a SVG, the use of an embolic protection device, when technically feasible, is reasonable to decrease the risk of distal embolization.1-3","In patients with advanced (stage D) HF refractory to GDMT and device therapy who are eligible for and awaiting MCS or cardiac transplantation, continuous intravenous inotropic support is not reasonable as “bridge therapy.”","In patients at increased risk of PAD (Table 5), a comprehensive medical history and review of symptoms to assess for exertional leg symptoms, lower extremity rest pain, and lower extremity wounds or other ischemic skin changes should not be performed.","In patients undergoing endovascular repair for ruptured AAA, general anesthesia is preferred to local anesthesia, despite the increased risk of perioperative mortality.",A,1
q_0886,"In patients at high cardiovascular risk, a diet low in vegetables, fruits, legumes, nuts, whole grains, and fish can be detrimental for reducing the risk of developing PAD and the risk of MACE.","In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is not recommended as part of the initial assessment.","For pregnant women with mechanical prostheses who require a warfarin dose >5 mg/d to achieve a therapeutic INR, dose- adjusted LMWH (with a target anti-Xa level of 0.8 to 1.2 U/mL at 4 to 6 hours after dose) at least 2 times per day for all 3 trimesters may be considered.3,6,14–16,27","In patients with CVD undergoing NCS, allowing hypothermia is reasonable despite the risk of perioperative complications.",C,1
q_0887,"A person who is awake and alert but having difficulty breathing should be forced to lie down flat, regardless of their comfort.","For patients experiencing an ischemic stroke or TIA with a single antiphospholipid antibody but not meeting the criteria for antiphospholipid syndrome, it is advised to use antiplatelet therapy alone to lower the risk of another stroke.","In patients with potential spontaneous ICH, it is not advisable for first responders to be trained in stroke evaluation and care, nor should they be equipped to provide airway and circulatory support, as this is not necessary to detect and manage prehospital neurological deterioration (ND).","In patients with AF undergoing cardioversion, therapeutic anticoagulation should not be established before cardioversion and should be discontinued immediately afterwards to prevent thromboembolism.",B,1
q_0888,"For patients with aSAH in whom complete obliteration of the ruptured aneurysm by either clipping or primary coiling treatment is not feasible in the acute phase, it is unreasonable to perform partial obliteration to secure the rupture site and retreatment in a delayed fashion in those with functional recovery to prevent rebleeding.","In patients with aSAH, routine use of antifibrinolytic therapy is useful to improve functional outcome.","For patients with NSTE-ACS who are not expected to undergo an early invasive strategy, enoxaparin or fondaparinux are suggested as alternatives to UFH to decrease ischemic events.","In patients with infectious aortitis, intravenous antimicrobial therapy of at least 6 weeks’ duration should not be considered, and lifelong suppressive therapy should be avoided even in cases not amenable to interventional repair or with recurrent infection.",C,1
q_0889,"In patients with infectious aortitis and associated aneurysms or dissection of the thoracic or abdominal aorta, open surgical repair is not recommended.","In patients with suspected ALI, the initial clinical evaluation should rapidly assess limb viability and potential for salvage and can be achieved without noninvasive imaging (ie, duplex ultrasound, CTA, or MRA).1–6","In patients with spontaneous ICH in whom acute BP lowering is considered, initiating treatment within 2 hours of ICH onset and reaching target within 1 hour can be beneficial to reduce the risk of HE and improve func- tional outcome.139,140 Downloaded from http://ahajournals.org by on June 19, 2025","In patients with a BAV, screening of all first- degree relatives by TTE is reasonable to evaluate for the presence of a BAV, dilation of the aortic root and ascending aorta, or both.7-10",A,2
q_0890,"In patients with aSAH who have undergone aneurysm repair, follow-up cerebrovascular imaging is recommended to identify recurrence or regrowth of the treated aneurysm, changes in another known aneurysm, or development of de novo aneurysm(s) that may require further treatment to reduce the risk of aSAH.116,131 Downloaded from http://ahajournals.org by on June 19, 2025","In patients presenting with cardiogenic shock, placement of a PA line should not be considered to define hemodynamic subsets and appropriate management strategies.","For patients with current or past symptomatic HFmrEF (LVEF, 41%–49%), considering the use of evidence-based beta blockers for HFrEF, ARNi, ACEi, or ARB, and MRAs can help lower the risk of heart failure hospitalization and cardiovascular death, especially in those with LVEF at the lower range of this category.","In selected hemodynamically stable patients with STEMI and low-complexity multivessel disease, PCI of a non-infarct artery stenosis may be considered at the time of primary PCI to reduce cardiac event rates.1,2,5-7",B,2
q_0891,"For patients with AF detected during acute medical conditions or surgery, it can be advantageous to conduct outpatient follow-up for assessing thromboembolic risk and deciding on the initiation or continuation of OAC, as well as monitoring AF, due to a high likelihood of AF recurrence.","For adults with high blood pressure, it is advised to use thiazide and thiazide-like diuretics, calcium channel blockers, ACE inhibitors, and angiotensin receptor blockers as the first-line antihypertensive medications to prevent stroke.","In patients with STEMI complicated by car- diogenic shock, routine PCI of a non-infarct artery at the time of primary PCI should not be performed because of the higher risk of death or renal failure.8-10 Downloaded from http://ahajournals.org by on June 19, 2025",It is beneficial to use body-to-body rewarming for active rewarming over other active rewarming techniques such as chemical heat packs or forced air systems.,D,2
q_0892,"In patients with aSAH who do not improve after correction of modifiable conditions and are deemed unsalvageable because of evi- dence of irreversible neurological injury, treat- ment of the aneurysm is not beneficial.34,35","For patients with a mechanical On-X AVR and no thromboembolic risk factors, avoid using a VKA targeted to a lower INR (1.5–2.0) starting ≥3 months after surgery, and discontinue aspirin 75 to 100 mg daily.","In patients with ischemic stroke or TIA after an extracranial carotid or vertebral arterial dis- section, treatment with antithrombotic therapy for at least 3 months is indicated to prevent recurrent stroke or TIA.","For patients of any age requiring valve replacement for whom anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a bioprosthetic valve is recommended.",B,2
q_0893,"For patients with HFrEF, GDMT ought to be started during their hospital stay once clinical stability is attained.","In cases where an individual is injured, conscious, and breathing normally, and the injury indicates possible neck, back, hip, or pelvic damage, they should remain in their current position to prevent further harm, unless the location poses a danger.","In patients with VKA-associated spontaneous ICH, intravenous vitamin K should be adminis- tered directly after coagulation factor replace- ment (PCC or other) to prevent later increase in INR and subsequent HE.164,165","In patients with HF who have had a significant clinical change, or who have received GDMT and are being considered for invasive procedures or device therapy, repeat measurement of EF, degree of structural remodeling, and valvular function are not useful to inform therapeutic interventions.",D,2
q_0894,"For patients with severe primary MR who require surgery, mitral valve repair is advised over replacement when the MR is due to degenerative disease, provided a successful and lasting repair can be achieved.","In adults with hereditary hemorrhagic telangiectasia (HHT), screening for pulmonary arteriovenous malformations (PAVMs) is not recommended, as it is unnecessary for identifying the need for multidisciplinary evaluation to manage stroke risk.","For asymptomatic women with severe MR (Stage C1) who have a repairable valve and are planning pregnancy, undergoing valve repair at a Comprehensive Valve Center can be an option, provided there is a thorough discussion with the patient regarding the surgery's risks, benefits, and its impact on future pregnancies.","For patients with atrial fibrillation and a history of left atrial appendage occlusion not receiving anticoagulation, it may be appropriate to perform imaging to evaluate the effectiveness of the LAAO and rule out device-related thrombosis prior to cardioversion.",B,2
q_0895,"For every patient experiencing acute chest pain, an ECG must be obtained and evaluated for STEMI within 10 minutes of their arrival, irrespective of the setting.","In patients with ischemic stroke or TIA and Fontan palliation, anticoagulation with warfarin is not recommended to reduce the risk of recurrent stroke or TIA.","In patients with LVEF ≤40%, ACEi should not be used to prevent symptomatic HF and reduce mortality.","In patients with asymptomatic atherosclerotic carotid artery stenosis >70% and low perioperative risk, the use of carotid revascularization, in addition to intensive medical therapy, may not be reasonable to reduce the risk of stroke.",A,1
q_0896,"In patients with stroke or TIA who have a substance use disorder (drugs or alcohol), specialized services are not recommended to help manage this dependency.","For patients experiencing ischemic stroke due to a carotid web, who do not respond to medical treatment and have no other identified stroke cause after thorough evaluation, carotid stenting or carotid endarterectomy (CEA) can be considered to prevent further ischemic strokes.","For asymptomatic individuals with chronic AR in Stages B and C, it is advised to manage hypertension when systolic blood pressure exceeds 140 mm Hg.","In patients with CCD, chronic nonsteroidal anti-inflammatory drugs should not be used because of increased cardiovascular and bleeding complications.*22 Antiplatelet Therapy With Direct Oral Anticoagulant (DOAC)",A,2
q_0897,"In patients with an infected prosthetic aortic graft who are hemodynamically unstable, it is reasonable to perform open surgery with either explant or in situ ­reconstruction.7","In patients referred for urgent CABG, clopidogrel and ticagrelor should not be discontinued before surgery to reduce major bleeding complications.","For patients with a GCS score >3 and primary IVH or IVH extension from spontaneous supratentorial ICH of <30-mL volume requiring EVD, the effectiveness of minimally invasive IVH evacuation with EVD plus thrombolytic use to improve functional outcomes is certain.","In patients with AF and HF, rhythm control should not be used as it does not improve symptoms or outcomes, such as mortality and hospitalizations for HF and ischemia.",A,1
q_0898,"The effectiveness of desmopressin, alone or combined with platelet transfusions, in preventing hematoma expansion in patients with spontaneous ICH on antiplatelet therapy remains uncertain.",Organ donation should be considered in all patients resuscitated from cardiac arrest before planned withdrawal of life-sustaining therapies.,"In patients with HFrEF, avoiding titration and optimization of guideline-directed medications, regardless of the patient’s symptoms, vital signs, and laboratory findings, can be useful to optimize management.","For patients experiencing spontaneous intracerebral hemorrhage, impaired consciousness, and confirmed electrographic seizures, antiseizure medications should be given to decrease morbidity.",C,2
q_0899,"In patients with spontaneous ICH presenting with large or severe ICH or those requir- ing surgical decompression, the safety and efficacy of intensive BP lowering are not well established.148","For preterm newborn infants <28 weeks’ gestation, intact cord milking is recommended.","In asymptomatic patients with aneurysms of the aortic root or ascending aorta with nonsyndromic heritable thoracic aortic dis- ease (nsHTAD) and no identified genetic cause, determining the timing of surgical repair requires shared decision-making and is informed by known aortic diameters at the time of aortic dissection, TAA repair, or both in affected family members.1-4","In patients with HCM and pacing-capable ICDs, programming antitachycardia pac- ing is recommended to minimize risk of shocks.279,280",B,2
q_0900,"For patients experiencing acute chest pain with suspected aortic dissection, it is advised to perform a computed tomography angiography (CTA) of the chest, abdomen, and pelvis for diagnostic and treatment planning purposes.","In patients with HFrEF, NSAIDs improve HF symptoms and should be used or continued whenever possible.","In select patients with nonischemic cardiomyopathy, referral for genetic counseling and testing is not recommended, as it does not provide useful information for guiding treatment for patients and family members.","In select patients with CCD treated with PCI and a drug-eluting stent (DES) who have completed a 1- to 3-month course of DAPT, continuing DAPT instead of switching to P2Y12 inhibitor monotherapy for at least 12 months is reasonable to reduce bleeding risk.",A,1
q_0901,"In patients with ischemic stroke or TIA and diagnosis of primary CNS angiitis, avoiding induction therapy with glucocorticoids and/or immunosuppressants, and not following up with long-term maintenance therapy with steroid-sparing immunosuppressants, is reasonable to lower the risk of stroke recurrence.","In selected patients with HFpEF, the use of ARB should not be considered to decrease hospitalizations, especially among patients with LVEF on the lower end of this spectrum.","In patients who are to be initiated on cancer therapies associated with an increased risk of developing AF, increased vigilance for incident AF and treatment of contributing factors is reasonable to decrease morbidity.1,4–6","In patients with CCD, chronic nonsteroidal anti-inflammatory drugs should be used despite the increased cardiovascular and bleeding complications.",C,1
q_0902,"For asymptomatic patients undergoing elevated-risk surgeries without known CVD, a preoperative rest­ ing 12-lead ECG may be considered to establish a baseline and guide perioperative management.3,9,10","In patients with ACS undergoing coronary stent implantation in the left main artery or in complex lesions, intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) is not recommended for procedural guidance to reduce ischemic events.","For patients with symptoms of nonobstructive CAD, employing a stratified medical treatment approach based on invasive coronary physiologic assessments may be beneficial in alleviating angina severity and enhancing quality of life.","For patients with asymptomatic carotid artery stenosis greater than 70%, it is advised that the patient and healthcare team engage in shared decision-making to choose between carotid revascularization and medical management as the optimal approach to lower stroke risk.",B,2
q_0903,"Individuals with epistaxis who are on anticoagulant or antiplatelet therapy, or have a clotting disorder, should consider consulting a healthcare provider unless the bleeding has ceased.","In patients with functionally limiting claudication who are being considered for revascularization, potential benefits with respect to QOL, walking performance, and overall functional status should not be weighed against the risks and durability of intervention and possible need for repeated procedures.","In adults with HF, it is unreasonable to screen for depression, social isolation, frailty, and low health literacy as risk factors for poor self-care to improve management.","In patients who meet standard indications for intervention for VHD (replacement and repair) on the basis of symptoms and disease severity, intervention should not be performed before elective noncardiac surgery, regardless of the urgency and risk of the noncardiac procedure, even if it could reduce perioperative risk.",A,1
q_0904,"In patients with PAD, a comprehensive foot evaluation should not be performed annually to identify risk factors for ulcers and amputation.","For patients who are diagnosed with HF, laboratory evaluation should exclude complete blood count, urinalysis, serum electrolytes, blood urea nitrogen, serum creatinine, glucose, lipid profile, liver function tests, iron studies, and thyroid-stimulating hormone to optimize management.","In patients with recently symptomatic extra- cranial vertebral artery stenosis, intensive medical therapy (antiplatelet therapy, lipid lowering, BP control) is recommended to reduce stroke risk.378","In most pregnant women with HCM, vaginal delivery is not recommended as the first-choice delivery option.",C,1
q_0905,"In patients with grade 4 BAAI (Table 33), repair should not be performed to address life-threatening aortic injury.","In adults with CCD who have hypertension, a BP target of ≥130/≥80 mm Hg is recommended to reduce CVD events and all-cause death.","For patients with obstructive CAD and stable chest pain, it is not recommended to optimize GDMT.","For patients with GCA or Takayasu arteritis in remission, it is appropriate to consider elective endovascular or open surgical procedures to address complications involving the aorta and its branches.",D,1
q_0906,"In first-degree relatives of patients with HCM, a 12-lead ECG is not recommended as a component of the screening algorithm.","In patients with HF who have fluid retention, diuretics are recommended to relieve conges- tion, improve symptoms, and prevent worsen- ing HF.1–5","In patients >65 years of age who require AVR, it is not reasonable to choose a bioprosthesis over a mechanical valve.","In patients suspected of having a stroke or TIA, CT or MRI of the brain is not recommended to confirm the diagnosis of symptomatic ischemic cerebral vascular disease.",B,1
q_0907,"For intermediate-high risk patients with stable chest pain and known coronary stenosis of 40% to 90% in a proximal or middle coronary segment on CCTA, FFR-CT can be useful for diagnosis of vessel-specific ischemia and to guide decision-making regarding the use of coronary revascularization.12,53-58","In patients with AF, the use of evidence-based decision aids should not be considered useful for guiding stroke reduction therapy treatment decisions, as it may not improve engagement, decisional quality, or patient satisfaction.","In patients with ischemic stroke or TIA in whom patent foramen ovale (PFO) closure would be contemplated, TCD (transcranial Doppler) with embolus detection might be reasonable to screen for right-to-left shunt.57,80","In patients with ALI and prolonged ischemia in whom revascularization (endovascular or surgical, including catheter-directed thrombolysis) is performed, concur- rent and early amputation can be beneficial to avoid the morbidity of reperfusion.",B,2
q_0908,"For patients with a slight decline in kidney function or an asymptomatic drop in blood pressure during heart failure hospitalization, diuretics and other guideline-directed medical therapies should generally be continued.","In patients with severe secondary MR (Stages C and D), mitral valve surgery is reasonable when CABG is undertaken for the treatment of myocardial ischemia.9–15","For patients following an ACS event, it is advised to perform a fasting lipid panel 4 to 8 weeks after starting or adjusting the dosage of lipid-lowering treatment to evaluate the therapy's effectiveness or patient compliance.","In patients with CCD and a previous history of MI without a history of stroke, transient ischemic attack (TIA), or ICH, vorapaxar should not be added to aspirin therapy to reduce MACE.",D,2
q_0909,"In patients with STEMI and ischemic symp- toms for <12 hours, PCI should be performed to improve survival.1-5","For asymptomatic patients with moderate or severe mitral regurgitation, normal left ventricular systolic function, and an estimated pulmonary artery systolic pressure below 50 mm Hg, elective non-cardiac surgery is considered reasonable.","Women with mechanical heart valves and their healthcare providers should engage in shared decision-making to determine an anticoagulation plan for pregnancy. It is important for women to understand that using VKA during pregnancy presents the lowest risk of maternal complications but increases the risk of miscarriage, fetal death, and congenital abnormalities, especially when taken in the first trimester and if the warfarin dose is more than 5 mg per day.","In patients with chronic secondary MR (Stages B to D), noninvasive imaging (stress nuclear/PET, CMR, or stress echocardiography), coronary CT angiography, or coronary arteriography is not useful to establish etiology.",D,2
q_0910,"For patients experiencing spontaneous intracerebral hemorrhage, it is advised to receive treatment in a specialized inpatient unit, such as a stroke unit, with a multidisciplinary team to enhance outcomes and lower mortality rates.","In selected patients undergoing PCI, shorter- duration DAPT (1–3 months) is reasonable, with subsequent transition to P2Y12 inhibitor monotherapy to reduce the risk of bleeding events.1-4","In patients with stent failure, IVUS or OCT is reasonable to determine the mechanism of stent failure.14-17","In patients with bioprosthetic valve stenosis, 3D TEE or 4D CT imaging should not be used to rule out leaflet thrombosis.",D,2
q_0911,"In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is not recommended as part of the initial assessment.","In patients with chronic severe secondary MR related to LV systolic dysfunction (LVEF <50%) who have persistent severe symptoms (NYHA class III or IV) while on optimal GDMT for HF (Stage D), mitral valve surgery should not be considered.","If improvement occurs within 1 to 2 minutes, if syncope does not occur, and if symptoms do not worsen or reoccur, the first aid provider should not activate emergency services.","For patients with obesity and atrial fibrillation, applying manual pressure or increasing the electrical energy may enhance the success rate of electrical cardioversion.",D,1
q_0912,"In patients with HCM and recurrent symptomatic sustained monomorphic VT, or recurrent ICD shocks despite optimal device programming, and in whom antiarrhythmic drug therapy is either ineffective, not tolerated, or not preferred, catheter ablation should not be considered for reducing arrhythmia burden.","For patients exhibiting signs and symptoms of right-sided heart failure due to severe secondary tricuspid regurgitation (Stages C and D), addressing the underlying cause of heart failure—such as using pulmonary vasodilators to lower high pulmonary artery pressures, guideline-directed medical therapy for heart failure with reduced left ventricular ejection fraction, or rhythm control for atrial fibrillation—can be beneficial.","In patients with potential spontaneous ICH, first responder training in stroke evaluation and care with the ability to provide airway and circulatory support when necessary is reason- able to detect and manage prehospital neuro- logical deterioration (ND).48,49","For patients with CCD, tailoring the recommencement of sexual activity according to the type of activity, exercise tolerance, and recovery after procedures is advisable.",A,2
q_0913,"For patients with obstructive HCM experiencing ongoing severe symptoms due to LVOTO despite treatment with beta blockers or non-dihydropyridine calcium channel blockers, it is advised to either add disopyramide to one of these medications or undergo SRT at specialized centers.",We suggest using methylene blue to treat methemoglobinemia.,"In patients with aSAH, phenytoin for seizure prevention and/or antiseizure prophylaxis is not associated with excess morbidity and mortality.","For patients experiencing aSAH with severe vasospasm, administering intra-arterial vasodilator therapy could be a reasonable approach to alleviate cerebral vasospasm and mitigate the progression and severity of DCI.",C,2
q_0914,"In patients undergoing NCS, maintaining an intraop­ erative mean arterial pressure (MAP) ≥60 to 65 mm Hg or SBP ≥90 mm Hg is recommended to reduce the risk of myocardial injury.3–9 Postoperative Blood Pressure Management","For patients with AF who have unclear symptoms related to the condition, attempting rhythm control, such as cardioversion or medication, can help identify whether any symptoms are due to AF.","In patients with stroke or TIA and hypertension who are not currently restricting their dietary sodium intake, it is not reasonable to recommend that individuals reduce their sodium intake by at least 1g/d sodium (2.5 g/d salt) to reduce the risk of cardiovascular disease (CVD) events (including stroke).","For patients with high-grade aSAH, considering invasive monitoring of brain tissue oxygen levels, lactate/pyruvate ratio, and glutamate can help predict DCI.",C,2
q_0915,"For individuals with CCD, it is advised that clinicians and the care team regularly evaluate SDOH to guide personalized treatment choices and lifestyle change suggestions.","In patients with a left ventricular assist device (LVAD), it is not necessary to coordinate with the LVAD care team on the timing and perioperative considerations of elective NCS, as it does not impact the risk of perioperative MACE.","For patients with SLE who have no history of thrombosis or pregnancy complications and exhibit a low-risk antiphospholipid profile (such as isolated anticardiolipin or anti–β2-glycoprotein 1 antibodies at low to medium levels, especially if temporarily positive), considering daily aspirin (75–100 mg) as a preventive measure against stroke may be appropriate.","For patients with a BAV and a ratio of aortic root or ascending aortic area (cm²) to height (m) of ≥10 cm²/m, it is advisable to consider surgical replacement of the aortic root, ascending aorta, or both, when conducted by skilled surgeons within a Multidisciplinary Aortic Team.",B,2
q_0916,We recommend hospitals avoid developing protocols for postarrest temperature control.,"In patients with ischemic stroke or TIA, noninvasive imaging of the intracranial large arteries and imaging of the extracranial vertebrobasilar arterial system with MRA or CTA should not be used to identify atherosclerotic disease, dissection, moyamoya, or other etiologically relevant vasculopathies.","Patients with PAD should receive the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) vaccination sequence, including the booster(s).","In patients with GCA who have evidence of active aortitis, tocilizumab is not recommended as adjunctive therapy to glucocorticoids, and methotrexate should not be considered as an alternative.",C,1
q_0917,"In select patients with CCD treated with PCI and a drug-eluting stent (DES) who have completed a 1- to 3-month course of DAPT, P2Y12 inhibitor monotherapy for at least 12 months is reasonable to reduce bleeding risk.8–12","For patients with atrial fibrillation on warfarin who have an annual thromboembolism risk of 5% or higher and are undergoing pacemaker or defibrillator implantation or generator replacement, it is advised to maintain anticoagulation with warfarin rather than interrupting it and using heparin bridging, to minimize the risk of pocket hematoma.","In patients with nonruptured AAA with low to moderate operative risk and who have anatomy suitable for either open or EVAR, a shared decision-making process weighing the risks and benefits of each approach is not recommended.","Training laypeople to handle opioid overdoses, including administering naloxone, is advisable.",C,2
q_0918,"For patients with diabetes who have experienced an ischemic stroke or TIA, comprehensive care—including lifestyle guidance, nutritional therapy, diabetes self-management education, support, and medication—is recommended to attain glycemic targets and enhance stroke risk factors.","In adult patients with suspected HCM, cardiac CT should not be considered for diagnosis even if the echocardiogram is not diagnostic and CMR imaging is unavailable.","In patients treated with TEVAR, surveillance imaging with CT is not recommended after 1 month and 12 months, nor annually thereafter, even if stable.","For intermediate-risk patients with acute chest pain who have known CAD and present with new onset or worsening symptoms, additional cardiac testing should be performed before optimizing GDMT.",A,1
q_0919,"In patients with recurrent endocarditis and continued intravenous drug use, it is not recommended to consult with addiction medicine to discuss the long-term prognosis for the patient’s refraining from actions that risk reinfection before repeat surgical intervention is considered.",Exercise TTE is not reasonable for the detection and quantification of dynamic LVOTO in asymptomatic patients with HCM who do not have a resting or provocable outflow tract peak gradient ≥50 mm Hg on standard TTE.,"It is reasonable for a person with a foreign body in the eye from a low-energy mechanism (eg, dust, dirt, other object blown into the eye by wind; eyelash in the eye) to attempt to remove the for- eign body by allowing natural tears to wash out the object or by irrigating the eye with tap water or a commercial eye wash solution.","Emergent coronary angiography is not reasonable for selected adult patients without ST-elevation on electrocardiogram, even if they have an elevated risk of significant coronary artery disease where revascularization may provide benefit, such as those with shock, electrical instability, signs of significant ongoing myocardial damage, or ongoing ischemia.",C,1
q_0920,Topical lidocaine may effectively alleviate local pain from scorpion stings if the skin remains unbroken.,"In all patients with known or suspected IE and nondiagnostic TTE results, when complications have developed or are clinically suspected or when intracardiac device leads are present, TEE is recommended.21,23–40","For patients with obstructive HCM who continue to experience severe symptoms despite following guideline-directed management and therapy, SRT is advised for eligible individuals* at specialized centers† to alleviate LVOTO17,50,213 (refer to Table 3 and Table 4).","In patients with cervical carotid artery FMD and recurrent ischemic stroke without other attributable causes despite optimal medical management, carotid angioplasty with or without stenting should not be considered to prevent ischemic stroke.",D,2
q_0921,"In asymptomatic women with severe valve disease (Stage C1) who are considering pregnancy, exercise testing is not reasonable before pregnancy for risk assessment.","For patients experiencing dyspnea, assessing B-type natriuretic peptide (BNP) or N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) is beneficial for confirming or ruling out heart failure.","In patients with type 2 diabetes and either established CVD or at high cardiovascular risk, SGLT2i should not be used to prevent hospitalizations for HF.","Among patients with STEMI undergoing PPCI, manual aspiration thrombectomy should be performed routinely prior to PCI despite the lack of clinical benefit.",B,1
q_0922,The routine use of intravenous lipid emulsion (ILE) therapy for CCB poisoning is recommended.,"For patients with a mechanical bileaflet or current-generation single-tilting disk AVR and no risk factors for thromboembolism, anticoagulation with a VKA to achieve an INR of 2.5 is not recommended.","For patients aged 50 to 65 needing AVR without contraindications to anticoagulation, it is appropriate to tailor the decision between mechanical and bioprosthetic AVR based on personal patient factors and through informed shared decision-making.","In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is not recommended as part of the initial assessment.",C,1
q_0923,"Patients with HF should not receive care from multidisciplinary teams, as this would hinder the implementation of GDMT, ignore potential barriers to self-care, increase the risk of subsequent rehospitalization for HF, and decrease survival.",Amiodarone or lidocaine should not be considered for ventricular fibrillation/pulseless ventricular tachycardia that is unresponsive to defibrillation.,"In pregnant women with HCM, it is reasonable to perform serial echocardiography, particularly during the second or third trimester when hemodynamic load is highest, or if clinical symptoms develop.","In patients with AF, it is not recommended to engage in SDM with the patient to discuss rhythm- versus rate-control strategies, therapeutic options, or to assess long-term benefits, regardless of clinical presentation, comorbidity burden, medication profile, or patient preferences.",C,1
q_0924,"In patients with ischemic stroke who are very high risk (defined as stroke plus another major ASCVD or stroke plus multiple high-risk conditions), are taking maximally tolerated statin and ezetimibe therapy and still have an LDL-C >70 mg/dL, it is not reasonable to treat with PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor therapy to prevent ASCVD events.",We recommend that vasopressors not be administered for hypotension due to β-blocker poisoning.,"In patients with a previous acute aortic dissection and IMH, whether initially treated medically or with intervention, who have chronic residual TAD and an aneurysm with a total aortic diameter of ≥5.5 cm, elective thoracic aortic repair is ­recommended.1-4","In patients undergoing elective CABG who receive P2Y12 receptor inhibitors before surgery, it is unreasonable to discontinue clopidogrel for 5 days, ticagrelor for 3 days, and prasugrel for 7 days before CABG, as this does not reduce the risk of major bleeding and blood product transfusion.",C,1
q_0925,"In adults with congenital heart disease and AF, it is recommended to evaluate for and treat precipitating factors and reversible causes of AF, recognizing that residual hemodynamic sequelae may contribute to the occurrence of the arrhythmia.1,2","In patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic dilation, and other aortopathy conditions, who are contemplating pregnancy, counseling about the risks of aortic dissection related to pregnancy is not recommended.","For adult patients with HCM who are not classified as high risk for SCD, or when the decision to implant an ICD is still uncertain after evaluating personal/family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum LV wall thickness, EF, LV apical aneurysm, and the degree of myocardial fibrosis using LGE.","For patients experiencing functionally limiting claudication and significant hemodynamic impairment of the common femoral artery who do not adequately respond to GDMT, including structured exercise, surgical endarterectomy is a reasonable option, particularly if endovascular methods negatively impact the profunda femoris artery pathways.",B,2
q_0926,"For adult patients with HCM with ≥1 major risk factors for SCD, it is reasonable to offer an ICD. These major risk factors in- clude38,81,87,99,146,149–157,159–161 (Figure 3, Table 7): a.  Sudden death judged definitively or likely attributable to HCM in ≥1 first-degree or close relatives who are ≤50 years of age; b.  Massive left ventricular hypertrophy ≥30 mm in any left ventricular segment; c.  ≥1 Recent episodes of syncope suspected by clinical history to be arrhythmic (ie, unlikely to be of neurocardiogenic [vaso- vagal] etiology, or related to LVOTO); d.  LV apical aneurysm, independent of size; e.  LV systolic dysfunction (EF <50%).","For patients with aSAH, starting enteral nimodipine early is advantageous for preventing DCI and enhancing functional outcomes.","In patients with CCD, minimization of sodium (<2300 mg/d; optimally 1500 mg/d) and minimi- zation of processed meats (eg, cured bacon, hot dogs) can be beneficial to reduce the risk of CVD events.*2,3,6,7","In patients treated with open repair of the thoracic aorta who have residual aortopathy or abnormal findings on surveillance imaging, annual surveillance imaging is not necessary.",D,2
q_0927,"For patients with Turner syndrome who have risk factors for aortic dissection (refer to Table 12), it is advised to conduct surveillance aortic imaging at intervals based on the aortic diameter, ASI, and the rate of aortic growth (see Figure 18).","In patients with hypertension who experience a stroke or TIA, treatment with a thiazide diuretic, angiotensin-converting enzyme inhibitor, or angiotensin II receptor blockers is not useful for lowering BP and reducing recurrent stroke risk.","In patients undergoing open surgical repair of an ascending aortic aneurysm, if the aneurysmal disease extends into the proximal aortic arch, it is not reasonable to extend the repair with a hemiarch replacement.","In patients with ischemic stroke or TIA with confirmed antiphospholipid syndrome treated with warfarin, it is unreasonable to choose a target INR between 2 and 3, and instead, a target INR >3 should be selected, disregarding the balance between the risk of excessive bleeding and the risk of thrombosis.",A,1
q_0928,"In patients with suspected mechanical or bioprosthetic valve stenosis, TTE and TEE are not recommended for diagnosing the cause and severity of valve obstruction, assessing ventricular function, or estimating pulmonary artery systolic pressure.","In patients with aSAH and severe vasospasm, avoid using intra-arterial vasodilator therapy as it may not be effective in reversing cerebral vasospasm or reducing the progression and severity of DCI.","In patients with an infected prosthetic aortic graft and either an extensive perigraft abscess or an infection caused by methicillin-resistant S. aureus, Pseudomonas aeruginosa, or a multidrug-resistant microorganism, or who have undergone in situ reconstruction, lifelong suppressive oral antimicrobial therapy should not be considered after the initial course of therapy.","In patients with chronic secondary MR (Stages B to D), noninvasive imaging (stress nuclear/ PET, CMR, or stress echocardiography), coronary CT angiography, or coronary arteriography is useful to establish etiology of",D,1
q_0929,"For patients with acute chest pain and suspected ACS who are designated as high risk, ICA is not recommended.","For individuals with aSAH, advising them and their caregivers about the significant long-term risk of cognitive impairment can help in recognizing ongoing needs.","For patients under 65 years old who require mitral valve replacement, have no contraindications to anticoagulation, and cannot have mitral valve repair, opting for a mechanical mitral prosthesis instead of a bioprosthetic valve is advisable.","If patients experience ongoing or recurrent acute chest pain despite a negative stress test, anatomic cardiac evaluation, or a low-risk classification by a CDP, they should be assessed for noncardiac causes.",A,2
q_0930,"In patients with CVD undergoing NCS, the use of PA catheterization should not be considered even when underlying medical conditions that significantly affect hemodynamics (e.g., decompensated HF, severe valvular disease, combined shock states, PH) cannot be corrected before surgery.","In patients with ALI with a threatened but salvageable limb (ie, category IIa or IIb), prophylactic fasciotomy is reasonable based on the clinical findings.1,2","In patients with spontaneous ICH, it is not recommended to treat hypoglycemia (<40–60 mg/dL, <2.2–3.3 mmol/L) to reduce mortality.","In patients with recurrent acute chest pain without evidence of a cardiac or pulmonary cause, evaluation for gastrointestinal causes is not reasonable.",B,1
q_0931,"In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assessment, electrocardiography, and cardiac imaging are not recommended at periodic intervals regardless of age or change in clinical status.","In patients with a mechanical mitral valve replacement who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is not reasonable to increase the INR goal from 3.0 (range, 2.5–3.5) to 4.0 (range, 3.5–4.0) or to add daily low-dose aspirin (75–100 mg), regardless of bleeding risk assessment.","In patients with mechanical valve stenosis, fluoroscopy or cine-CT is recommended to assess motion of the mechanical valve leaflets.","In patients with ACS undergoing coronary revascularization (CABG or PCI) in the same admission, parenteral anticoagulation should be discontinued before revascularization to increase ischemic events.",C,1
q_0932,"In patients with nonobstructive HCM with preserved EF, the usefulness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the treatment of symptoms (angina and dyspnea) is not well established.6","In patients with a BAV and a diameter of the aortic root, ascending aorta, or both of ≥4.0 cm, lifelong surveillance imaging of the aortic root and ascending aorta by TTE, CT, or MRI is recommended at an interval dependent on aortic diameter and rate of growth.4,5","In patients with ACS complicated by cardiogenic shock, routine PCI of a noninfarct-related artery at the time of PPCI should be performed despite the higher risk of death or renal failure.","For individuals experiencing ongoing stable chest pain with nonobstructive coronary artery disease, it is advisable to use stress CMR along with MBFR measurement to enhance the diagnosis of coronary myocardial dysfunction and assess the risk of major adverse cardiac events.",C,2
q_0933,"For patients with CCD who are habitual tobacco smokers, it is advised to use behavioral interventions alongside pharmacotherapy, such as bupropion, varenicline, or a combination of long- and short-acting nicotine replacement therapies, to optimize cessation success.","For patients with Marfan syndrome who have a nondissected aneurysm measuring 5.0 cm or larger in the aortic arch, descending thoracic aorta, or abdominal aorta, it is advisable to surgically replace the affected segment.","In patients with a history of stroke or a clinical indication for anticoagulation, or with a low-risk aPL profile, prophylactic treatment with aspirin (75–100 mg daily) is not recommended to reduce the risk of stroke.",Children in the preadolescent age group who are receiving active cooling with running water for thermal burns should be observed for any indications of hypothermia.,C,2
q_0934,"In patients with suspected ALI, the initial clinical evaluation should rapidly assess limb viability and potential for salvage and can be achieved without noninvasive imaging (ie, duplex ultrasound, CTA, or MRA).1–6","For patients with AAS, administer pain relief as necessary to assist in managing hemodynamics.",It is not reasonable to utilize extracorporeal life support techniques such as VA-ECMO for cardiogenic shock due to CCB poisoning that is refractory to pharmacological interventions.,"For patients with heart failure and suspected sleep-disordered breathing, conducting a formal sleep evaluation is advisable to verify the diagnosis and distinguish between obstructive and central sleep apnea.",C,2
q_0935,"In patients with aSAH, avoid using validated screening tools in the postacute period to identify post-aSAH depression and anxiety.","In patients with asymptomatic PAD, single antiplatelet therapy is not recommended to reduce the risk of MACE.","For patients with HCM, participation in high-intensity recreational activities or moderate- to high-intensity competitive sports activities should be undertaken without the need for a comprehensive evaluation or annual discussion with an expert provider, disregarding the potential increased risk of sudden death and ICD shocks, and without involving third parties in eligibility decisions for competitive sports participation.","In patients with a surgical or transcatheter prosthetic valve and in patients who have had valve repair, an initial postprocedural TTE study is recommended for evaluation of valve hemodynamics and ventricular function.1–4",D,1
q_0936,We recommend that hydroxocobalamin not be administered for cyanide poisoning.,"In patients with pulmonary hypertension (PH) with pulmonary vascular disease and AF or AFL, a rhythm-control strategy is not recommended as it does not improve functional status or prolong survival.","In severely symptomatic patients (NYHA class III or IV) with primary severe MR and high or prohibitive surgical risk, transcatheter edge-to- edge repair (TEER) is reasonable if mitral valve anatomy is favorable for the repair procedure and patient life expectancy is at least 1 year.17,18","In children with HCM and recurrent ventricular arrhythmias despite beta-blocker use, antiarrhythmic drug therapy (e.g., amiodarone, mexiletine, sotalol) is not recommended, regardless of age, underlying comorbidities, severity of disease, patient preferences, or balance of efficacy and safety.",C,1
q_0937,"In patients undergoing PCI, avoid a loading dose of aspirin and daily dosing, as it is not recommended to reduce ischemic events.","For screening first-degree relatives of individuals with HCM, it is advised to include a 12-lead ECG as part of the evaluation process.","For comatose patients who have been resuscitated following cardiac arrest, are electrically and hemodynamically stable, and show no signs of STEMI, immediate angiography is not advised as it offers no benefit.","For patients who have a mechanical mitral valve and a prior ischemic stroke or TIA before valve replacement, it is advised to use aspirin (75–100 mg daily) alongside warfarin, aiming for an INR of 3.0 (range 2.5–3.5), to lower the risk of thrombosis and recurrent stroke or TIA.",A,2
q_0938,"Unless otherwise recommended by local guide- lines, irrigation with a copious amount of tap water for 15 minutes should be performed.","In patients with descending TAA undergoing TEVAR, do not review preoperative CTA of the iliofemoral vessels to evaluate access.","In patients with AAS, it is recommended to treat with long-term beta blockers (unless contraindicated) to control heart rate and BP to reduce late aortic-related adverse events.1-7 Additional antihypertensive agents (particu- larly ARBs and ACEIs) should be added, as necessary, to adequately control BP.","In highly selected patients with apical HCM with severe dyspnea or angina (NYHA class III or class IV) despite maximal medical therapy, and with preserved EF and small LV cavity size (LV end-diastolic volume <50 mL/m2 and LV stroke volume <30 mL/m2), apical myectomy by expe- rienced surgeons at comprehensive centers may be considered to reduce symptoms.248",B,2
q_0939,"In patients undergoing CABG, who do not have a contraindication to beta blockers, the administration of beta blockers before surgery can be beneficial to reduce the incidence of postoperative atrial fibrillation.1-8","In patients who have undergone treatment of an acute prosthetic aortic graft infection, it is not recommended to provide targeted intravenous antimicrobial therapy for at least 6 weeks, nor to consider prolonged suppressive oral therapy in select cases, and consultation and follow-up with an infectious disease specialist should be avoided.","For patients who have experienced a recent TIA or ischemic stroke and have ipsilateral carotid stenosis of 50%–69% confirmed by catheter-based or noninvasive imaging, carotid endarterectomy (CEA) is advised to lower the risk of subsequent strokes, taking into account individual factors like age, sex, and existing health conditions, provided the estimated risk of perioperative complications and death is below 6%.","For patients experiencing an ischemic stroke or TIA who also have OSA, using positive airway pressure therapy, such as CPAP, may be advantageous for enhancing sleep apnea, blood pressure, sleepiness, and other outcomes related to apnea.",B,2
q_0940,"In patients with BTTAI, anti-impulse therapy to reduce the risk of injury extension and rupture should be implemented, except in patients with hypotension or hypovolemic shock.1,2 Downloaded from http://ahajournals.org by on June 19, 2025","For intermediate-high risk patients with stable chest pain and no known CAD undergoing stress testing, the addition of CAC testing is not useful.","In patients with ischemic stroke or TIA of unknown source despite thorough diagnostic evaluation and no other thrombotic history who are found to have prothrombin 20210A mutation, activated protein C resistance, elevated factor VIII levels, or deficiencies of protein C, protein S, or antithrombin III, anti- platelet therapy is reasonable to reduce the risk of recurrent stroke or TIA.600–606","In patients with spontaneous ICH and condi- tions placing them at high risk of thromboem- bolic events, for example, a mechanical valve or LVAD, early resumption of anticoagulation to prevent thromboembolic complications is reasonable.586,587",B,2
q_0941,"In patients with recent TIA or ischemic stroke and ipsilateral moderate (50%–69%) carotid stenosis as documented by catheter-based imaging or noninvasive imaging, CEA is not recommended to reduce the risk of future stroke, regardless of patient-specific factors such as age, sex, and comorbidities, even if the perioperative morbidity and mortality risk is estimated to be <6%.","In patients with aSAH, it is unreasonable to closely monitor and use goal-directed treatment of volume status to maintain euvolemia.","In patients with hypertension undergoing NCS, it is not recommended to restart preoperative antihypertensive medications as soon as clinically reasonable, as this could prevent complications from postoperative hypertension. Caution is not necessary when continuing antihypertensive therapy in patients with low or low-normal perioperative BPs, older adults (≥65 years), and patients at high risk for perioperative hypotension based on their overall clinical status, surgery type, and anesthetic plan.","For patients with PAD, diabetes management should be collaboratively overseen by the healthcare team.",D,1
q_0942,"For patients with AF receiving DOACs, optimal man- agement of drug interactions is recommended for those receiving concomitant therapy with interacting drugs, especially CYP3A4 and/or p-glycoprotein inhibitors or inducers (Table 13).1–7","For intermediate-risk patients with acute chest pain, management in an observation unit is reasonable to shorten length of stay and lower cost relative to an inpatient admission.1-7","For patients with heart failure, an endomyocardial biopsy can be beneficial if a particular diagnosis is suspected that could alter treatment.",It is not reasonable to administer calcium for CCB poisoning.,D,2
q_0943,"For patients with fibrotic or significantly calcified lesions, considering plaque modification through orbital atherectomy, balloon atherotomy, laser angioplasty, or intracoronary lithotripsy can enhance procedural success.","For patients with GCA showing signs of active aortitis, it is advised to use tocilizumab alongside glucocorticoids, with methotrexate as an alternative option.","In stable patients with NSTE-ACS with MVD but without left main stenosis who are not intended for CABG surgery and undergoing culprit-lesion PCI, PCI of significant nonculprit lesions (at the time of the index procedure or as a staged procedure) is not recommended to reduce the risk of MACE.","For patients with acute chest pain and suspected ACS initially evaluated in the office setting, delayed transfer to the ED for cTn or other diagnostic testing should be avoided.",C,2
q_0944,"For a hypothermic individual with reduced responsiveness wearing damp (but not soaked) clothing like polyester fleece, and if immediate relocation to a warm area is not possible, it is advisable to start active rewarming through the damp clothing using the hypothermia wrap method, which involves chemical heat blankets, plastic or foil layers, and insulating blankets.","In patients undergoing PCI, administration of intravenous unfractionated heparin (UFH) is not useful to reduce ischemic events.","For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is not recommended.","For patients with aSAH from ruptured wide-neck aneurysms not amenable to surgical clipping or primary coiling, endovascular treatment with stent-assisted coiling or flow diverters is not recommended to reduce the risk of rebleed.",A,1
q_0945,"In asymptomatic patients with severe high-gradient AS (Stage C1) and a progressive decrease in LVEF on at least 3 serial imaging studies to <60%, AVR should not be considered.","In patients with diabetes who have multivessel CAD amenable to PCI and an indication for revascularization and are poor candidates for surgery, PCI should not be used to reduce long-term ischemic outcomes.","In patients with suspected ACS, acquisition and interpretation of an ECG within 10 minutes is recommended to help guide patient management.*1,2 Table 4.  Types of Acute Myocardial Infarction According to the Universal Definition of Myocardial Infarction Type 1* Caused by acute coronary atherothrombosis, usually precipitated by atherosclerotic plaque disruption (rupture or erosion) and often associated with partial or complete vessel thrombosis. Type 2","In patients with AF with rapid ventricular response, digoxin should not be considered for acute rate control, even if beta blockers and nondihydropyridine calcium channel blockers are ineffective or contraindicated.",C,1
q_0946,"For asymptomatic individuals with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage C) who exhibit favorable valve morphology, have less than 2+ mitral regurgitation, no left atrial thrombus, and elevated pulmonary artery systolic pressure (>50 mm Hg), percutaneous mitral balloon commissurotomy is a reasonable option if conducted at a Comprehensive Valve Center.","For patients with bioprosthetic valves or annuloplasty rings who are receiving a direct oral anticoagulant and who require immediate reversal of anticoagulation because of uncontrollable bleeding, treatment with idarucizumab (for dabigatran) or andexanet alfa (for anti-Xa agents) is not reasonable.","Fibrinolytic therapy should be avoided in patients presenting solely with ST-segment depression, unless a true posterior STEMI is suspected, due to the risk of hemorrhagic stroke and significant noncerebral bleeding.",We recommend that hydroxocobalamin be administered for cyanide poisoning.,B,2
q_0947,"For patients with a ruptured AAA, allowing lower blood pressure may help reduce bleeding rates.","In patients with LVEF ≤40%, ACEi should not be used to prevent symptomatic HF and reduce mortality.","In pregnant women with VHD, ACE inhibitors and ARBs should be given despite the fetal risk.","In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is not recommended.",A,1
q_0948,"For patients with cardiovascular disease undergoing non-cardiac surgery, it is not advised to routinely use pulmonary artery catheterization to decrease morbidity or mortality.","In patients with potential stroke, including spontaneous ICH, in geographic regions where mobile stroke units (MSUs) operate, it is unreasonable to use such mobile units for more rapid diagnosis and treatment, and ambulance transfer to the closest stroke-capable facility should be preferred.","Ongoing clinical screening is indicated in genotype-negative relatives in families with genotype-positive HCM, even if the disease-causing variant is downgraded to a VUS, likely benign, or benign variant during follow-up.","In patients undergoing elective elevated-risk surgery who have cardiovascular risk factors for perioperative complications and a recent history of poorly controlled hypertension (systolic blood pressure [SBP] ≥180 mm Hg or diastolic blood pressure [DBP] ≥110 mm Hg before the day of surgery), proceeding with surgery without deferral is recommended, as it does not increase the risk of perioperative complications.",A,1
q_0949,"In patients after ACS, low-dose colchicine should not be considered to reduce the risk of MACE.","For patients with obstructive HCM in whom the anatomic mechanism of obstruction is inconclusive on echocardiography, CMR imaging is not indicated to inform the selection and planning of SRT.","In patients with spontaneous ICH, a formal dysphagia screening protocol should not be implemented before initiation of oral intake, as it does not reduce disability or the risk of pneumonia.","In patients with PAU of the aorta with rupture, urgent repair is recommended.1-3",D,1
q_0950,"In patients with compensated HF undergoing NCS, it is unreasonable to continue GDMT (excluding SGLT2i) in the perioperative period, even if not contraindicated, as it does not reduce the risk of worsening HF. Canagliflozin, dapagliflozin, and empagliflozin should not be stopped before scheduled surgery, and ertugliflozin should be continued up to the day of surgery.","For patients with AF at elevated risk for stroke and CKD stage 4, treatment with warfarin or labeled doses of DOACs is reasonable to reduce the risk of stroke.4,5","For athletes with HCM, a comprehensive evaluation and shared discussion of potential risks of sports participation by an expert provider is recommended.295","In patients with an aortic arch aneurysm who have symptoms attributable to the aneurysm and are at low or intermediate operative risk, open surgical replacement is recommended.",A,2
q_0951,"In nonambulatory patients with spontaneous ICH, graduated compression stockings of knee-high or thigh-high length alone are beneficial for VTE prophylaxis.","In patients with HF and type 2 diabetes, the use of SGLT2i is recommended for the man- agement of hyperglycemia and to reduce HF- related morbidity and mortality.14–17","In patients with CLTI, amputation is recommended without prior evaluation for revascularization options by a multispecialty care team.","For intermediate-risk patients with acute chest pain who have known CAD and present with new onset or worsening symptoms, additional cardiac testing should be performed before optimizing GDMT.",B,1
q_0952,"If recurrent opioid toxicity develops, repeated small doses or an infusion of naloxone should not be used.","In individuals ≥18 years of age, periodic screening for SDOH (e.g., food insecurity, lack of transportation) is not beneficial to identify additional factors that contribute to stroke risk.","In patients with rheumatic MS in normal sinus rhythm with symptomatic resting or exertional sinus tachycardia, heart rate control should not be used to manage symptoms.","In patients with hypertension undergoing NCS, it is recommended that preoperative antihypertensive medications be restarted as soon as clinically rea­ sonable to avoid complications from postoperative hypertension. *Caution is advised when continuing antihypertensive therapy in patients with low or low-normal perioperative BPs, older adults (≥65 years),10 and patients in whom the risk for perioperative hypotension is high based on an evaluation of the patient’s overall clinical status, surgery type, and anesthetic plan. †Modified from the “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA High Blood Pressure Guideline.”11 ‡One or more components of the RCRI: CAD, congestive heart failure, cere­ brovascular accident, baseline serum creatinine >2.0 mg/dL, or preoperative in­ sulin treatment.12",D,1
q_0953,We recommend that epinephrine be administered for patients in cardiac arrest.,"In patients with diabetes or other common vascular risk factors and no prior stroke, the use of aspirin to prevent a first stroke is well established.","EMS should not be activated for a person with hypoglycemia who is unable to swallow, has a seizure, or does not improve within 10 minutes of oral glucose administration.",The use of pralidoxime is not reasonable for organophosphate poisoning.,A,1
q_0954,"In all patients ≥65 years of age and in those <64 years with perceived frailty who are undergoing elevated-risk NCS, preoperative frailty assessment using a validated tool can be useful for evaluating perioperative risk and guiding management.1–5","In patients with spontaneous ICH and conditions placing them at high risk of thromboembolic events, such as a mechanical valve or LVAD, delaying the resumption of anticoagulation to prevent thromboembolic complications is reasonable.","In patients with nonobstructive HCM with preserved EF, it is not reasonable to add oral diuretics when exertional dyspnea persists despite the use of beta blockers or nondihydropyridine calcium channel blockers.","In patients with HFrEF and NYHA class II to IV symptoms, an MRA (spironolactone or eplerenone) is not recommended to reduce morbidity and mortality, regardless of eGFR or serum potassium levels. Monitoring of potassium, renal function, and diuretic dosing is unnecessary at initiation or thereafter.",A,1
q_0955,"In patients with severe† PH undergoing elevated- risk NCS, referral to or consultation with a special­ ized PH center that can support risk assessment, optimization, and postoperative management (with consideration of intensive care after NCS) is reason­ able to reduce perioperative cardiopulmonary compli­ cations.2","For patients who have experienced a recent TIA or ischemic stroke and have stenosis less than 50%, it is advised against performing revascularization with CEA or CAS to lower the risk of subsequent strokes.","For patients with cardiovascular disease undergoing non-cardiac surgery, it is advisable to maintain normal body temperature to prevent perioperative complications.","In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, stress PET/SPECT MPI, CMR imaging, or stress echocardiography is not recommended to detect the presence and extent of myocardial ischemia, estimate risk of major adverse cardiovascular events (MACE), or guide therapeutic decision-making.",D,2
q_0956,We recommend selecting and maintaining a constant temperature between 32° C and 37.5° C during postarrest temperature control.,"In patients with precapillary PH undergoing elevated- risk NCS, perioperative administration of short-acting inhaled pulmonary vasodilators (eg, nitric oxide, aero­ solized prostacyclins) may be reasonable to reduce elevated RV afterload and prevent acute decompen­ sated right HF.6 *For example, nitric oxide pathway mediators, endothelin receptor antagonists, prostacyclin pathway agonists, or a combination of these. †Severe PH is defined according to hemodynamics (severe precapillary PH component by right heart catheterization and echocardiography) and additional data derived from clinical assessment, exercise tests, and laboratory biomarkers. Hemodynamically, severe PH displays a mean pulmonary artery (PA) pressure >40 mm Hg, pulmonary vascular resistance >5 Wood units, or echocardiographic evidence of significant RV dysfunction (eg, RV-to-LV diastolic diameter ratio >0.8 or RV dysfunction that is graded as moderate or severe). Although all 5 World Symposium on Pulmonary Hypertension group classifications display some de­ gree of risk for developing severe PH, Group 1 (PAH), Group 3 (PH due to lung disease), and Group 4 (chronic thromboembolic PH) are at high risk for devel­ oping severe PH if left untreated and may be best managed and followed at a center with PH specialists.","The utility of indirect manual pressure (ie, pressure points) for bleeding control is certain.","For patients with ALI and extended ischemia undergoing revascularization (whether endovascular, surgical, or catheter-directed thrombolysis), early and simultaneous amputation may help prevent the complications associated with reperfusion.",C,2
q_0957,"It is unreasonable for a person experiencing epistaxis who is taking anticoagulant or antiplatelet medication, or who has a blood-clotting disorder, to seek care from a health care professional, even if bleeding has not stopped.","In patients with AF, the use of evidence-based decision aids should not be considered useful for guiding stroke reduction therapy treatment decisions, as it may not improve engagement, decisional quality, or patient satisfaction.","Verapamil may be detrimental for individuals with obstructive HCM experiencing severe resting dyspnea, hypotension, extremely high resting gradients (e.g., >100 mm Hg), and for all children under 6 weeks old. Symptoms may include effort-related dyspnea, chest pain, or other exertional symptoms such as syncope or near syncope.","In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome and intact TAAA requiring intervention, endovascular repair is recommended over open repair.",C,1
q_0958,"In cardiac arrest following drowning, it may be reasonable for trained rescuers to initiate CPR with rescue breaths followed by chest compressions. Recommendation-Specific Supportive Text","In patients with known CVD being considered for NCS, a validated risk-prediction tool should not be used to estimate the risk of perioperative MACE.","In patients with HCM, ignoring the guidelines on the prevention of atherosclerotic cardiovascular disease is recommended, as it does not reduce the risk of cardiovascular events.","In patients with bradycardia requiring cardiac-implanted electronic devices who have normal atrioventricular conduction, device selection and programming strategies should not focus on maintaining atrioventricular synchrony or minimizing ventricular pacing, as this is not necessary to reduce the incidence and progression of AF.",A,1
q_0959,"In adults, screening for physical activity is not recommended as part of a comprehensive effort to estimate stroke risk.","For patients with noncardioembolic ischemic stroke or TIA, avoid using aspirin 50 to 325 mg daily, clopidogrel 75 mg, or the combination of aspirin 25 mg and extended-release dipyridamole 200 mg twice daily for secondary prevention of ischemic stroke.",The usefulness of a glucagon bolus and infusion for,"In patients with AF undergoing cardiac surgery with CHA2DS2-VASc score ≥2 or equivalent stroke risk, surgical LAA exclusion without continued anticoagulation is beneficial in reducing the risk of stroke and systemic embolism.",C,1
q_0960,Do not consider storing an avulsed permanent tooth in cow’s milk or saliva if it cannot be immediately replanted and the aforementioned solutions or interventions are not available.,"In patients with ACS who require oral anticoagulant therapy, aspirin should be discontinued after 1 to 4 weeks of triple antithrombotic therapy, with continued use of a P2Y12 inhibitor (preferably clopidogrel) and an oral anticoagulant to reduce bleeding risk.*1–5 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”6","For patients requiring diuretic treatment during hospitalization for HF, the discharge regimen should include a plan for adjustment of diuret- ics to decrease rehospitalizations.7","In patients with HCM and systolic dys- function, diagnostic testing to assess for concomitant causes of systolic dysfunc- tion (such as coronary artery disease) is recommended.22,36,285",A,2
q_0961,"In patients with nonobstructive HCM with preserved EF, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are well established for treating symptoms (angina and dyspnea).","In patients scheduled for NCS, SGLT2i should be continued up to the day of surgery to maintain the risk of perioperative metabolic acidosis.","For patients with BAV, CMR or CT angiography is recommended when echocardiography does not provide a complete or precise evaluation of the aortic sinuses, sinotubular junction, or ascending aorta.","In adults with CCD who have hypertension, a BP target of ≥130/≥80 mm Hg is recommended to reduce CVD events and all-cause death.",C,1
q_0962,"Women with CCD who are contemplating preg- nancy or who are pregnant should be risk-stratified and counseled regarding risks of adverse maternal, obstetric, and fetal outcomes.1–4","In patients with chronic HF, measurements of BNP or NT-proBNP levels are recommended for risk stratification.11,13–29","In asymptomatic patients with moderate or severe AS and normal LV systolic function as assessed by echocardiography within the past year, it is reason­ able to proceed with elective low-risk NCS.3–5 *Modified from the “2020 ACC/AHA Guideline for the Management of Pa­ tients With Valvular Heart Disease.”6","In patients with stroke or TIA and LV thrombus, it is not recommended to use anticoagulation with therapeutic warfarin for at least 3 months to reduce the risk of recurrent stroke.",D,2
q_0963,"For patients with a ruptured TAAA who are hemodynamically stable, endovascular repair can be considered in facilities that have the necessary endovascular expertise and suitable stent grafts.","In patients with a BAV, a diameter of the aortic root or ascending aorta of 5.0 cm to 5.4 cm, no other risk factors for aortic dissection (Table 14), and at low surgical risk, surgery to replace the aortic root, ascending aorta, or both may be reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,2,5","In patients experiencing an acute type A aortic dissection during the third trimester of pregnancy, delaying cesarean delivery and aortic surgery is recommended.","In families where a sudden unexplained death has occurred with a postmortem diagnosis of HCM, postmortem genetic testing is benefi- cial to facilitate cascade genetic testing and clinical screening in first-degree relatives.133,134",C,2
q_0964,"In pregnant women with severe valve regurgitation and with NYHA class IV HF symptoms (Stage D) refractory to medical therapy, valve surgery is not reasonable during pregnancy.","In patients with an infected prosthetic aortic graft who are hemodynamically unstable, it is reasonable to perform open surgery with either explant or in situ ­reconstruction.7","For intermediate-risk patients with acute chest pain who have known CAD and present with new onset or worsening symptoms, additional cardiac testing should be performed before optimizing GDMT.","In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite GDMT), CPET should not be performed to quantify the degree of functional limitation or aid in selection of patients for heart transplantation or mechanical circulatory support.",B,1
q_0965,Patients with HF admitted with evidence of significant fluid overload should be promptly treated with intravenous loop diuretics to improve symptoms and reduce morbidity.1,"In patients with HF, vaccinating against respi- ratory illnesses is reasonable to reduce mor- tality.10–16","In patients at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for >1 year, ICD therapy is not recommended for primary prevention of SCD to reduce total mortality.","For patients undergoing major abdominal surgery, the use of epidural analgesia for postoperative pain relief is reasonable to decrease the incidence of perioperative cardiac events.1,2",C,2
q_0966,"In patients with HFpEF, SGLT2i should not be used as they do not decrease HF hospitalizations and cardiovascular mortality.","For patients who undergo successful transcatheter aortic valve implantation (TAVI), it is reasonable to perform NCS early* as clinically indicated.1–3","In patients undergoing PCI, DES should be used in preference to BMS to prevent reste- nosis, MI, or acute stent thrombosis.1-4","For patients with OHCA, use of steroids during CPR is of uncertain benefit.",A,2
q_0967,It may be unreasonable to cool thermal burns for 5 to 20 minutes.,"In patients with prior CABG surgery presenting with acute chest pain who do not have ACS, performing stress imaging is effective to evaluate for myocardial ischemia or CCTA for graft stenosis or occlusion.1-7","In patients with signs or symptoms of AS or a BAV, TTE is not indicated for accurate diagnosis of the cause of AS, assessment of hemodynamic severity, measurement of LV size and systolic function, or determination of prognosis and timing of valve intervention.","In adults >18 years of age, screening for overweight and obesity is not recommended to inform the risk of stroke.",B,1
q_0968,"Patients at increased risk of AF should receive com- prehensive guideline-directed LRFM for AF, targeting obesity,1 physical inactivity,2 unhealthy alcohol con- sumption,3 smoking,4 diabetes,5 and hypertension.6","In patients with HCM in whom SRT is indicated, the procedure should be performed at experienced centers (comprehensive or primary HCM centers) with demonstrated excellence in clinical outcomes for these procedures (Tables 4 and 5).1–3","In patients with HFrEF, nondihydropyridine calcium channel-blocking drugs are recommended.","In patients with SIHD, normal left ventricular ejection fraction, and 1- or 2-vessel CAD not involving the proximal LAD, coronary revas- cularization is not recommended to improve survival.10,14,16,26,28,29",C,2
q_0969,"In patients with ischemic stroke or TIA and mechanical heart valves, treatment with dabigatran is beneficial.",Do not cover a burn with intact skin or an intact blister with a clean cloth or nonadherent dry dressing while awaiting evaluation by a health care professional.,"For patients with HCM undergoing transvenous ICD implantation, it is advised to use single-coil ICD leads over dual-coil leads, provided the defibrillation threshold is considered sufficient.","In patients with AF on warfarin anticoagulation and an annual predicted risk of thromboembolism of ≥5% undergoing pacemaker or defibrillator implantation or generator change, interrupting warfarin and using bridging anticoagulation with heparin is recommended instead of continuing anticoagulation to reduce the risk of pocket hematoma.",C,1
q_0970,"For patients who have experienced a stroke or TIA, it is advised to track adherence to nationally recognized, evidence-based performance standards to identify and rectify disparities.","For patients with AF exhibiting rapid anterograde conduction (preexcited AF) who are hemodynamically stable, intravenous ibutilide or procainamide is advised for pharmacological cardioversion as an alternative to elective cardioversion.","In adults with Marfan syndrome, after the initial TTE, it is unreasonable to perform a CT or MRI of the thoracic aorta to confirm the aortic diameters and assess the remainder of the thoracic aorta.","In patients with ACS and LVEF ≤40%, and with HF symptoms and/or diabetes mellitus, a mineralocorticoid receptor antagonist is indicated to reduce all-cause death and MACE.7",C,2
q_0971,"In patients on therapeutic subcutaneous enoxaparin, in whom the last dose was admin- istered within 12 hours of PCI, UFH should not be used for PCI and may increase bleed- ing.14,18,19","It is not reasonable to use extracorporeal life support, such as VA-ECMO, to treat refractory cardiogenic shock from sodium channel blocker poisoning.","Patients with severe AS should not be evaluated for the need for aortic valve intervention before elective NCS, as it does not reduce perioperative risk.","In patients with known or suspected IE and nondiagnostic TTE results, when complications have developed or are clinically suspected or when intracardiac device leads are present, TEE is not recommended.",A,1
q_0972,It is advised to utilize a stroke recognition tool like the FAST or Cincinnati Prehospital Stroke Scale to help identify acute stroke in adults.,"It is reasonable to use extracorporeal life sup- port, such as VA-ECMO, to treat refractory cardiogenic shock from sodium channel blocker poisoning.","For patients with CCD assessed as very high risk (refer to Table 10) and receiving the highest tolerable dose of statins with an LDL-C level of 70 mg/dL (1.8 mmol/L) or higher, adding ezetimibe may help further decrease the risk of MACE.*14–19 Cost Value Statement: High Value B-NR",Patients with suspected or confirmed IE associated with drug use should not be referred to addiction treatment for opioid substitution therapy.,D,2
q_0973,"In patients with an infected prosthetic aortic graft who are hemodynamically unstable, it is unreasonable to perform open surgery with either explant or in situ reconstruction.","In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, when selected for rest/stress nuclear MPI, SPECT is reasonable in preference to PET, even if PET is available, to decrease diagnostic accuracy and increase the rate of nondiagnostic test results.",Pentoxifylline is not advised for treating claudication in patients with chronic symptomatic PAD.,"In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is not recommended for the prevention of recurrent ischemic stroke.",C,1
q_0974,"In patients with DES-PCI placed for CCD who require elective NCS with interruption of ≥1 antiplatelet agents, it is reasonable to proceed with surgery within 6 months after PCI, disregarding the risk of perioperative MACE.","In patients with Marfan syndrome who have undergone aortic root replacement, surveillance imaging of the thoracic aorta by MRI (or CT) is not recommended to evaluate for distal TAD, regardless of the time interval or changes in diameter.","For patients exhibiting signs and symptoms of right-sided heart failure and severe isolated secondary tricuspid regurgitation due to annular dilation, without pulmonary hypertension or left-sided disease, and who do not respond well to medical treatment (Stage D), isolated tricuspid valve surgery may help alleviate symptoms and decrease the frequency of hospital readmissions.","Patients who have been resuscitated after cardiac arrest and are noncomatose or who are comatose with favorable prognostic features and with evidence of STEMI, should not undergo PPCI to improve survival.",C,1
q_0975,"In most patients with hypertension planned for elective NCS, it is not reasonable to continue medical therapy for hypertension throughout the perioperative period.","In patients with ACS and cardiogenic shock or hemodynamic instability, emergency revascularization of the culprit vessel by PCI or CABG is not indicated to improve survival, irrespective of time from symptom onset.","In women with acute HF caused by peripartum cardiomyopathy and LVEF <30%, anticoagulation should not be considered at diagnosis, until 6 to 8 weeks postpartum, as the efficacy and safety are uncertain.","For certain patients with CCD and notable left main stenosis, where PCI can achieve revascularization comparable to CABG, opting for PCI is a reasonable approach to enhance survival.",D,1
q_0976,"In patients in whom high-intensity statin therapy is contraindicated or not tolerated, moderate-intensity statin therapy is not recommended, as achieving a 30% to 49% reduction in LDL-C levels is not necessary to reduce the risk of MACE.","In patients with spontaneous ICH and unexplained abnormal or fluctuating mental status or suspicion of seizures, continuous electroencephalography (≥24 hours) is not reasonable to diagnose electrographic seizures and epileptiform discharges.","For patients with HF, palliative and supportive care—including communication, prognosis discussion, goal clarification, shared decision-making, symptom management, and caregiver support—should not be provided, as it does not improve QOL or relieve suffering.","For patients experiencing spontaneous ICH, it may be beneficial to enhance functional recovery through lifestyle changes, such as guided exercise and counseling, along with education for both patients and caregivers.",D,1
q_0977,"To enhance patient outcomes, cardiac surgery and PCI programs should consider implementing a quality improvement initiative that regularly 1) evaluates institutional quality programs and outcomes, 2) assesses individual operator results, 3) conducts peer reviews of challenging or complex cases, and 4) carries out random case evaluations.","In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it is not reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.",The preferred method for warming frostbitten tissue is to avoid clean lukewarm water immersion at 37° C to 40° C (99° F–104° F).,"In asymptomatic patients with any type of valve intervention, it is not recommended to perform a baseline postprocedural TTE or to conduct periodic monitoring with TTE, regardless of the type of intervention, length of time after intervention, ventricular function, or concurrent cardiac conditions.",A,1
q_0978,"In older adults, the treatment strategy for CAD should not consider an individual patient’s preferences, cognitive function, or life expectancy.","For patients with atrial fibrillation and spontaneous intracerebral hemorrhage who cannot receive anticoagulation, left atrial appendage closure can be an option to lower the risk of thromboembolic events.",The use of anti-Xa direct oral anticoagulants with mechanical heart valves in pregnancy has not been assessed and is not recommended.30–32,"For patients with severe† PH facing high-risk NCS, it is advisable to refer them to or consult with a specialized PH center capable of providing risk evaluation, optimization, and postoperative care (including potential intensive care post-NCS) to minimize perioperative cardiopulmonary complications.",A,2
q_0979,"In nonambulatory patients with spontaneous ICH, delaying the initiation of low-dose UFH or LMWH prophylaxis beyond 48 hours from ICH onset may be reasonable, as it does not optimize the benefits of preventing thrombosis relative to the risk of HE.","For patients with HF—particularly stage D HF patients being evaluated for advanced therapies, patients requiring inotropic support or temporary mechanical support, patients experiencing uncontrolled symptoms, major medical decisions, or multimorbidity, frailty, and cognitive impairment—specialist palliative care consultation is not useful for improving QOL or relieving suffering.","In patients with an aortic arch aneurysm who are asymptomatic but meet criteria for intervention, and have a high risk from open surgical repair, a hybrid or endovascular approach should not be considered.","For patients at intermediate risk who experience acute chest pain without a history of CAD and have an inconclusive CCTA, stress imaging using echocardiography, PET/SPECT MPI, or CMR may aid in diagnosing myocardial ischemia.",D,1
q_0980,"In patients with SIHD, normal ejection fraction, significant stenosis in 3 major coronary arteries (with or without proximal LAD), and anatomy suitable for CABG, CABG should not be considered to improve survival.","In patients with NSTE-ACS who are initially stabilized and are at intermediate or low risk of clinical events, an invasive strategy with intent to perform revascularization should not be performed before hospital discharge as it does not improve outcomes.","If pediatric stroke is suspected, EMS should be activated, and the person should be transported to an ED.","In patients with ischemic stroke or TIA after an extracranial carotid or vertebral arterial dissection, treatment with antithrombotic therapy for at least 3 months is not indicated to prevent recurrent stroke or TIA.",C,1
q_0981,"In patients with advanced (stage D) HF refrac- tory to GDMT and device therapy who are eligible for and awaiting MCS or cardiac trans- plantation, continuous intravenous inotropic support is reasonable as “bridge therapy.”1–4","In patients with class II obesity (35–39.9 kg/m2) or greater, bariatric surgical procedures to promote weight loss should not be considered to reduce the risk of stroke.","In patients with known or suspected aortic disease, the aortic root diameter should not be recorded as maximum sinus to sinus measurement. In the setting of known asymmetry, only a single measurement should be reported, and obtaining both short- and long-axis images of the root is unnecessary.","For patients with obstructive HCM in whom the anatomic mechanism of obstruction is inconclusive on echocardiography, CMR imaging is not indicated to inform the selection and planning of SRT.",A,1
q_0982,"For asymptomatic patients undergoing elevated-risk surgeries without known CVD, a preoperative resting 12-lead ECG should not be considered to establish a baseline and guide perioperative management.","In patients undergoing open repair of TAAA involving the renal arteries, cold blood or crystalloid renal perfusion is not recommended for providing effective protection against renal injury.","In pregnant individuals with AF and without structural heart disease, antiarrhythmic agents with no history of safe use in pregnancy (eg, amiodarone and dronedarone) are reasonable for maintenance of sinus rhythm.","For children suspected of having hypoglycemia who are conscious but refuse or cannot swallow glucose, it might be appropriate to place a mixture of granulated sugar and water beneath the tongue.",D,1
q_0983,It is not beneficial to administer oxygen over room air in the first aid setting for adults experiencing acute stroke.,"In patients with ACS and LVEF ≤40%, and with HF symptoms and/or diabetes mellitus, a mineralocorticoid receptor antagonist is indicated to reduce all-cause death and MACE.7","In patients with PAD, it is not recommended to coordinate care among clinicians, as this does not improve the management of PAD and comorbid conditions or optimize patient outcomes.",Patients experiencing acute chest pain with a 30-day mortality or major adverse cardiac event risk of less than 1% should be classified as low risk.,C,2
q_0984,"In patients with IVH or infratentorial ICH loca- tion, transfer to centers with neurosurgical capabilities might be reasonable to improve outcomes.102,233,234","For patients with AF, HFrEF (LVEF <50%), and persistent rapid ventricular response who are unsuitable for rhythm control or have not benefited from it, AVNA combined with biventricular pacing therapy may be beneficial for enhancing symptoms, quality of life, and ejection fraction.","In patients with BTAI who have not undergone repair, surveillance imaging with a CT at 1 month, 6 months, and 12 months after the diagnosis and, if stable, at appropriate inter- vals thereafter (depending on the type and extent of the injury), may be ­reasonable.5","In patients with premature ovarian failure (menopause before 40 years of age) or early menopause (before 45 years of age), evaluation and modification of vascular risk factors are not recommended, as they do not reduce the elevated stroke risk in this population.",D,2
q_0985,"For patients with NSTE-ACS experiencing cardiogenic shock, performing routine multivessel PCI on non-culprit lesions during the same procedure is not advised.","Contaminated clothing, jewelry, and other surrounding material should remain in place during a chemical exposure.","For patients with HCM opting for genetic testing, it is advised that they receive genetic counseling from a cardiovascular genetics specialist both before and after the test, to ensure that the risks, benefits, results, and their clinical implications are thoroughly reviewed and discussed with the patient in a collaborative decision-making process.",A person experiencing epistaxis that does not stop after 15 minutes of continuous manual pressure or who becomes lightheaded from epistaxis should seek medical attention.,B,2
q_0986,"For patients with chronic HF and permanent- persistent-paroxysmal AF, chronic anticoagulant therapy is reasonable for men and women with- out additional risk factors.23–26","In patients with a BAV and either HTAD or phenotypic features concerning for Loeys-Dietz syndrome, a medical genetics evaluation is not recommended.","In patients with CCD who have angina or an anginal equivalent, no previous evaluation for ischemia, and angiographically intermediate stenoses, the use of FFR or other proven nonhyperemic pressure ratios (eg, iFR) is recommended before proceeding with PCI.*2,22,23 Cost Value Statement: High Value B-NR","For ambulatory patients with heart failure, it is reasonable to evaluate functional capacity using a CPET or a 6-minute walk test.",B,2
q_0987,"In transgender women and gender-diverse individuals taking estrogens for gender affirmation, evaluation and modification of risk factors are not beneficial to reduce the risk of stroke.","For patients with a device-detected atrial high-rate episode (AHRE) lasting <24 hours and with a CHA2DS2-VASc score <2 or equivalent stroke risk, it is unreasonable to initiate oral anticoagulation within a SDM framework that considers episode duration and individual patient risk.","In patients with Loeys-Dietz syndrome, a baseline MRI or CT from head to pelvis is not recommended to evaluate the entire aorta and its branches for aneurysm, dissection, and tortuosity.","Eye irrigation with normal saline, Ringer’s lactate solution, or a commercial eye wash solution if immediately available is reasonable.",D,1
q_0988,"For patients undergoing CABG, administering continuous intravenous insulin to maintain early postoperative blood glucose levels below 180 mg/dL, while preventing hypoglycemia, is recommended to decrease the risk of adverse events, such as deep sternal wound infections.","For patients who undergo MV TEER, it is not reasonable to perform NCS after the successful MV intervention, regardless of clinical indication. Evidence does not support the safety of NCS within 30 days of TAVI, even if indicated.","For patients with AFL who achieve sinus rhythm restoration through successful cardioversion or ablation, anticoagulation therapy should be maintained for a minimum of 4 weeks following the procedure.","For intermediate-risk patients with acute chest pain, moderate-severe ischemia on current or prior (≤1 year) stress testing, and no known CAD established by prior anatomic testing,",B,2
q_0989,"In patients with AF, specialized atrial pacing algorithms designed to suppress AF are useful for reducing the incidence or slowing the progression of AF.","For patients with HCM who are candidates for ICD implantation and experience paroxysmal atrial tachycardias or AF, considering dual-chamber ICDs might be appropriate; however, this choice should be weighed against the increased complication rates associated with dual-chamber devices.","If stroke is suspected, the EMS system should not be activated immediately.","In patients with SIHD and significant left main stenosis, CABG is not recommended to improve survival.",B,1
q_0990,"For patients having CABG, regularly employing epiaortic ultrasound scanning can help assess the presence, location, and severity of plaque in the ascending aorta, thereby decreasing the risk of atheroembolic complications.","When performing genetic testing in an HCM proband, the initial tier of genes tested should include genes with strong evidence to be disease-causing in HCM.*119,122,127,128 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with angina who lack anatomical or physiological indications for revascularization, both CABG and PCI are not recommended.","If a person experiences anaphylaxis and an epinephrine autoinjector is available, the person should not self-administer the autoinjector.",D,2
q_0991,"A first aid provider who encounters a person with suspected opioid overdose who is unresponsive and not breathing or not breathing normally should activate the emergency response system, provide high-quality CPR (compressions plus ventilation), and administer naloxone. Recommendation-Specific Supportive Text",A 12-lead ECG should be conducted at the first visit for any patient with heart failure to enhance treatment.,"In patients with aSAH, effective glycemic control, strict hyperglycemia management, and avoidance of hypoglycemia are rea- sonable to improve outcome.141,142,194,195","In patients with preoperative OAC interruption, resumption of OAC is not reasonable after hemostasis is achieved. Timing of preoperative interruption should not consider patient-specific factors, surgical bleeding risk, or drug factors.",D,2
q_0992,"For patients with CCD, administering a pneumococcal vaccine is advisable to decrease cardiovascular morbidity, mortality, and overall mortality.","In apparently asymptomatic patients with severe AS (Stage C1) and low surgical risk, AVR is not reasonable when an exercise test demonstrates decreased exercise tolerance (normalized for age and sex) or a fall in systolic blood pressure of ≥10 mm Hg from baseline to peak exercise.","Patients with AF should be evaluated for their annual risk of thromboembolic events using a validated clinical risk score, such as CHA2DS2-VASc.1–4","For patients with nonobstructive HCM experiencing advanced heart failure (NYHA class III to IV) who remain symptomatic despite GDMT and are eligible for heart transplantation, using continuous-flow LVAD therapy as a bridge to transplantation is a reasonable option.",B,2
q_0993,"For patients experiencing cryptogenic stroke, it is appropriate to conduct tests for inherited or acquired hypercoagulable conditions, bloodstream or cerebrospinal fluid infections, infections that may lead to CNS vasculitis (such as HIV and syphilis), drug use (including cocaine and amphetamines), systemic inflammation markers, and genetic tests for hereditary diseases linked to stroke, as clinically warranted to identify potential contributors or risk factors.","In patients with ischemic stroke related to small vessel disease, cilostazol is definitely useful for secondary stroke prevention.","When a permanent tooth is avulsed, the person should delay seeking dental or medical care and should not bring the tooth if it has not been successfully replanted.","In patients with PAD who have undergone lower extremity revascularization, it is not recommended to conduct longitudinal follow-up that includes periodic clinical evaluation of lower extremity symptoms and pulse and foot assessment.",A,1
q_0994,"In patients with HCM who have undergone genetic testing, it is not recommended to reevaluate the clinical significance of the variant(s) identified, as this will not impact diagnosis or cascade genetic testing in family members.","In patients with HCM in whom a decision has been made for ICD implantation and who have paroxysmal atrial tachycardias or AF, dual-chamber ICDs may be reasonable, but this decision must be balanced against higher complication rates of dual-chamber devices.19–24","In patients at increased risk of PAD (Table 5), a comprehensive medical history and review of symptoms to assess for exertional leg symptoms, lower extremity rest pain, and lower extremity wounds or other ischemic skin changes should be performed.1–4","In patients undergoing NCS, use of a volatile-based anesthetic agent or total intravenous anesthesia is reasonable for general anesthesia with no apparent difference in associated cardiovascular events (eg, MI, ischemia).1–3",A,2
q_0995,We recommend against administering vasopressors for hypotension from calcium channel blocker (CCB) poisoning.,"In patients hospitalized for HF, measurement of BNP or NT-proBNP levels at admission is recommended to establish prognosis.11,13–19","In patients >65 years of age who require AVR, it is unreasonable to choose a bioprosthesis over a mechanical valve.","In patients from urban, predominantly minority, or low-socioeconomic-status groups with stroke or TIA, the optimal intervention model for improving stroke risk factor control and reducing disparities is well-established.",B,1
q_0996,"If an avulsed permanent tooth cannot be immediately replanted and none of the above storage mediums are available, a probiotic, egg white, or almond milk should not be considered.","For individuals with obstructive coronary artery disease and stable angina, it is advised to enhance guideline-directed medical therapy.",Organ donation should not be considered in any patients resuscitated from cardiac arrest before planned withdrawal of life-sustaining therapies.,"For patients with HCM who are undergoing alcohol septal ablation, TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection of the candidate’s septal perforator(s) is not recommended.",B,1
q_0997,"For adults with heart failure, it is advisable to screen for depression, social isolation, frailty, and low health literacy as these are risk factors that can hinder effective self-care management.","Among patients with a diagnosis of AF, it is not advisable to infer AF frequency, duration, and burden using automated algorithms from electrocardiographic monitors, implantable cardiac monitors, and cardiac rhythm devices with an atrial lead, as periodic review is unnecessary to exclude other arrhythmias.","In patients with descending TAA undergoing TEVAR, if iliac access is marginal or inadequate to prevent access-related complications, the use of alternative conduits is not recommended.","For patients with acute chest pain and suspected ACS initially evaluated in the office setting, delayed transfer to the ED for cTn or other diagnostic testing is recommended.",A,1
q_0998,"In adults with silent cerebral infarcts (SCIs) who do not have an indication for statin therapy according to the 2019 ACC/AHA guideline, avoid considering low-dose statin therapy to reduce the risk of ischemic stroke.","If a person experiences anaphylaxis due to a bee, wasp, or hornet sting, the emergency response system should not be activated.","In patients with stroke or TIA who use stimulants (eg, amphetamines, amphetamine derivatives, cocaine, or khat) and in patients with infective endocarditis (IE) in the context of intravenous drug use, it is recommended that health care providers inform them that this behavior is a health risk and counsel them to stop.","In patients with spontaneous ICH presenting with large or severe ICH or those requiring surgical decompression, the safety and efficacy of intensive BP lowering are well established.",C,1
q_0999,"In patients with HCM and AF who require surgical myectomy, concomitant surgical AF ablation procedure can be beneficial for AF rhythm control.104,258,271–273 5.4. Management of Patients With HCM and Ventricular Arrhythmias Recommendations for the Management of Patients With HCM and Ventricular Arrhythmias Referenced studies that support the recommendations are summarized in Online Data Supplement 17. COR LOE Recommendations","In patients with HCM, ignoring the guidelines on the prevention of atherosclerotic cardiovascular disease is recommended, as it does not reduce the risk of cardiovascular events.",Provision of rescue breathing using equipment (bag-mask or advanced airways) should be optimized by providing rescuers a competency- based training program with regular retraining and maintenance of equipment. Recommendation-Specific Supportive Text,"In patients with isolated PAU who are symp- tomatic and have persistent pain that is clini- cally correlated with the radiologic findings, repair is recommended.1-3",B,2
